1	ORIGINAL	JJ	O	original	amod	2	SENT_1	[p1l906t81r1086b109],
2	ARTICLE	NN	O	article	_	0	SENT_1	[p1l1103t81r1252b109],

1	The	DT	O	the	det	3	SENT_2	[p1l193t184r363b265],
2	COMT	NNP	O	COMT	nn	3	SENT_2	[p1l411t187r726b265],
3	Va	NNP	O	Va	nsubj	4	SENT_2	[p1l750t184r1254b265],
4	|	VBD	O	|	_	0	SENT_2	[p1l750t184r1254b265],
5	158Met	NNP	O	158Met	nn	6	SENT_2	[p1l750t184r1254b265],
6	Polymorphism	NN	O	polymorphism	nsubj	7	SENT_2	[p1l1303t184r1959b293],
7	Affects	VBZ	O	affect	ccomp	4	SENT_2	[p1l148t299r479b381],
8	the	DT	O	the	det	9	SENT_2	[p1l519t300r669b381],
9	Response	NN	O	response	dobj	7	SENT_2	[p1l717t305r1160b409],
10	to	TO	O	to	_	0	SENT_2	[p1l1198t316r1294b381],
11	Entacapone	NNP	O	Entacapone	prep_to	9	SENT_2	[p1l1343t305r1890b409],
12	in	IN	O	in	prep	7	SENT_2	[p1l1934t305r2004b380],

1	Parkinson	NNP	O	Parkinson	_	0	SENT_3	[p1l243t417r763b497],
2	's	POS	O	's	possessive	1	SENT_3	[p1l243t417r763b497],
3	Disease	NN	O	disease	dep	1	SENT_3	[p1l810t422r1188b497],
4	:	:	O	:	_	0	SENT_3	[p1l810t422r1188b497],
5	A	DT	O	a	dep	3	SENT_3	[p1l1231t422r1304b496],
6	Randomized	VBN	O	randomize	partmod	1	SENT_3	[p1l1349t417r1917b497],

1	Crossover	NNP	O	Crossover	_	0	SENT_4	[p1l541t536r1011b614],
2	Clinical	JJ	O	clinical	amod	3	SENT_4	[p1l1054t533r1377b614],
3	Trial	NN	O	trial	dep	1	SENT_4	[p1l1420t533r1615b614],

1	Jean	NNP	PERSON	Jean	_	0	SENT_5	[p1l386t697r751b747],
2	.	.	O	.	_	0	SENT_5	[p1l386t697r751b747],

1	—	NN	O	—	_	0	SENT_6	[p1l386t697r751b747],
2	.	.	O	.	_	0	SENT_6	[p1l386t697r751b747],

1	Christophe	NNP	PERSON	Christophe	nn	2	SENT_7	[p1l386t697r751b747],
2	Corvol	NNP	PERSON	Corvol	_	0	SENT_7	[p1l772t697r925b742],
3	,	,	O	,	_	0	SENT_7	[p1l772t697r925b742],
4	MD	NNP	O	MD	appos	2	SENT_7	[p1l950t700r1036b742],
5	,	,	O	,	_	0	SENT_7	[p1l950t700r1036b742],
6	PhD	NNP	O	PhD	appos	2	SENT_7	[p1l1061t689r1269b742],
7	,	,	O	,	_	0	SENT_7	[p1l1061t689r1269b742],
8	l'	NN	O	l'	appos	2	SENT_7	[p1l1061t689r1269b742],
9	2	CD	NUMBER	2	num	8	SENT_7	[p1l1061t689r1269b742],
10	'	''	O	'	_	0	SENT_7	[p1l1061t689r1269b742],
11	3	CD	NUMBER	3	dep	8	SENT_7	[p1l1061t689r1269b742],
12	'	''	O	'	_	0	SENT_7	[p1l1061t689r1269b742],
13	4	CD	NUMBER	4	num	15	SENT_7	[p1l1061t689r1269b742],
14	Cécilia	NNP	ORGANIZATION	Cécilia	nn	15	SENT_7	[p1l1289t697r1432b736],
15	Bonnet	NNP	ORGANIZATION	Bonnet	dep	2	SENT_7	[p1l1457t700r1622b742],
16	,	,	O	,	_	0	SENT_7	[p1l1457t700r1622b742],
17	MD	NNP	O	MD	appos	15	SENT_7	[p1l1646t689r1748b742],
18	,	,	O	,	_	0	SENT_7	[p1l1646t689r1748b742],
19	l	NN	O	l	tmod	15	SENT_7	[p1l1646t689r1748b742],
20	Fanny	NNP	PERSON	Fanny	nn	21	SENT_7	[p1l344t773r471b821],
21	Charbonnier	NNP	PERSON	Charbonnier	dep	15	SENT_7	[p1l490t771r974b821],
22	.	.	O	.	_	0	SENT_7	[p1l490t771r974b821],

1	—	NN	O	—	_	0	SENT_8	[p1l490t771r974b821],
2	.	.	O	.	_	0	SENT_8	[p1l490t771r974b821],

1	Beaupel	NNP	PERSON	Beaupel	nn	3	SENT_9	[p1l490t771r974b821],
2	,	,	O	,	_	0	SENT_9	[p1l490t771r974b821],
3	PharmD	NNP	O	PharmD	_	0	SENT_9	[p1l999t763r1198b816],
4	,	,	O	,	_	0	SENT_9	[p1l999t763r1198b816],
5	l	NN	O	l	appos	3	SENT_9	[p1l999t763r1198b816],
6	Anne	NNP	PERSON	Anne	dep	5	SENT_9	[p1l1222t773r1480b810],
7	.	.	O	.	_	0	SENT_9	[p1l1222t773r1480b810],

1	—	NN	O	—	_	0	SENT_10	[p1l1222t773r1480b810],
2	.	.	O	.	_	0	SENT_10	[p1l1222t773r1480b810],

1	Marie	NNP	PERSON	Marie	nn	2	SENT_11	[p1l1222t773r1480b810],
2	Bonnet	NNP	PERSON	Bonnet	_	0	SENT_11	[p1l1503t774r1668b816],
3	,	,	O	,	_	0	SENT_11	[p1l1503t774r1668b816],
4	MD	NNP	O	MD	appos	2	SENT_11	[p1l1693t763r1801b816],
5	,2	CD	NUMBER	,2	num	4	SENT_11	[p1l1693t763r1801b816],

1	Marie	NNP	PERSON	Marie	_	0	SENT_12	[p1l84t844r368b884],
2	.	.	O	.	_	0	SENT_12	[p1l84t844r368b884],

1	—	NN	O	—	_	0	SENT_13	[p1l84t844r368b884],
2	.	.	O	.	_	0	SENT_13	[p1l84t844r368b884],

1	Héléne	NNP	PERSON	Héléne	_	0	SENT_14	[p1l84t844r368b884],
2	Fiévet	NNP	PERSON	Fiévet	nn	4	SENT_14	[p1l386t847r519b890],
3	,	,	O	,	_	0	SENT_14	[p1l386t847r519b890],
4	PharmD	NNP	O	PharmD	dep	1	SENT_14	[p1l539t836r738b890],
5	,4	CD	NUMBER	,4	rcmod	4	SENT_14	[p1l539t836r738b890],
6	Agnes	NNP	PERSON	Agnes	rcmod	5	SENT_14	[p1l750t847r889b895],
7	Bellanger	NNP	PERSON	Bellanger	rcmod	6	SENT_14	[p1l913t844r1129b895],
8	,	,	O	,	_	0	SENT_14	[p1l913t844r1129b895],
9	PharmD	NNP	O	PharmD	prep	7	SENT_14	[p1l1154t836r1359b890],
10	,4	CD	NUMBER	,4	dep	9	SENT_14	[p1l1154t836r1359b890],
11	Emmanuel	NNP	PERSON	Emmanuel	nn	16	SENT_14	[p1l1381t844r1608b884],
12	Roze	NNP	PERSON	Roze	nn	16	SENT_14	[p1l1634t847r1747b890],
13	,	,	O	,	_	0	SENT_14	[p1l1634t847r1747b890],
14	MD	NNP	O	MD	appos	16	SENT_14	[p1l1771t847r1858b890],
15	,	,	O	,	_	0	SENT_14	[p1l1771t847r1858b890],
16	PhD	NNP	O	PhD	dep	7	SENT_14	[p1l1883t836r2061b890],
17	,1	CD	NUMBER	,1	num	16	SENT_14	[p1l1883t836r2061b890],
18	'	''	O	'	_	0	SENT_14	[p1l1883t836r2061b890],
19	2	CD	NUMBER	2	dep	16	SENT_14	[p1l1883t836r2061b890],
20	'	''	O	'	_	0	SENT_14	[p1l1883t836r2061b890],
21	é	SYM	O	é	dep	6	SENT_14	[p1l1883t836r2061b890],
22	’	SYM	O	’	dep	5	SENT_14	[p1l1883t836r2061b890],

1	Gayané	NNP	PERSON	Gayané	nn	2	SENT_15	[p1l153t920r318b968],
2	Meliksetyan	NNP	PERSON	Meliksetyan	_	0	SENT_15	[p1l341t918r608b968],
3	,	,	O	,	_	0	SENT_15	[p1l341t918r608b968],
4	MD	NNP	O	MD	appos	2	SENT_15	[p1l632t910r734b963],
5	,	,	O	,	_	0	SENT_15	[p1l632t910r734b963],
6	l	NN	O	l	tmod	2	SENT_15	[p1l632t910r734b963],
7	Mouna	NNP	PERSON	Mouna	nn	9	SENT_15	[p1l762t920r910b957],
8	Ben	NNP	PERSON	Ben	nn	9	SENT_15	[p1l935t920r1013b957],
9	Djebara	NNP	PERSON	Djebara	dep	2	SENT_15	[p1l1037t918r1218b968],
10	,	,	O	,	_	0	SENT_15	[p1l1037t918r1218b968],
11	MD	NNP	O	MD	appos	9	SENT_15	[p1l1243t910r1345b963],
12	,	,	O	,	_	0	SENT_15	[p1l1243t910r1345b963],
13	l	NN	O	l	nn	15	SENT_15	[p1l1243t910r1345b963],
14	Andreas	NNP	PERSON	Andreas	nn	15	SENT_15	[p1l1369t918r1551b957],
15	Hartmann	NNP	PERSON	Hartmann	appos	9	SENT_15	[p1l1575t920r1798b963],
16	,	,	O	,	_	0	SENT_15	[p1l1575t920r1798b963],
17	MD	NNP	O	MD	appos	9	SENT_15	[p1l1823t910r1990b963],
18	,	,	O	,	_	0	SENT_15	[p1l1823t910r1990b963],
19	l'	NN	O	l'	appos	9	SENT_15	[p1l1823t910r1990b963],
20	2	CD	NUMBER	2	num	19	SENT_15	[p1l1823t910r1990b963],
21	'	''	O	'	_	0	SENT_15	[p1l1823t910r1990b963],
22	6	CD	NUMBER	6	dep	19	SENT_15	[p1l1823t910r1990b963],

1	Lucette	NNP	PERSON	Lucette	nn	2	SENT_16	[p1l304t994r462b1031],
2	Lacomblez	NNP	PERSON	Lacomblez	_	0	SENT_16	[p1l486t991r729b1037],
3	,	,	O	,	_	0	SENT_16	[p1l486t991r729b1037],
4	MD	NNP	O	MD	appos	2	SENT_16	[p1l754t983r919b1037],
5	,3	CD	NUMBER	,3	rcmod	4	SENT_16	[p1l754t983r919b1037],
6	'	''	O	'	_	0	SENT_16	[p1l754t983r919b1037],
7	5	CD	NUMBER	5	dep	5	SENT_16	[p1l754t983r919b1037],
8	'	''	O	'	_	0	SENT_16	[p1l754t983r919b1037],
9	7	CD	NUMBER	7	dep	5	SENT_16	[p1l754t983r919b1037],
10	Cédric	NNP	ORGANIZATION	Cédric	nn	11	SENT_16	[p1l941t991r1084b1031],
11	Vrignaud	NNP	ORGANIZATION	Vrignaud	dep	2	SENT_16	[p1l1101t991r1312b1042],
12	,	,	O	,	_	0	SENT_16	[p1l1101t991r1312b1042],
13	BSc	NNP	O	BSc	nn	16	SENT_16	[p1l1337t983r1446b1037],
14	,3	CD	NUMBER	,3	num	16	SENT_16	[p1l1337t983r1446b1037],
15	Noel	NNP	PERSON	Noel	nn	16	SENT_16	[p1l1469t991r1568b1031],
16	Zahr	NNP	PERSON	Zahr	appos	11	SENT_16	[p1l1590t991r1696b1037],
17	,	,	O	,	_	0	SENT_16	[p1l1590t991r1696b1037],
18	PhD	NNP	O	PhD	appos	11	SENT_16	[p1l1721t983r1841b1037],
19	,3	CD	NUMBER	,3	num	18	SENT_16	[p1l1721t983r1841b1037],

1	Yves	NNP	PERSON	Yves	nn	6	SENT_17	[p1l548t1082r646b1119],
2	Agid	NNP	PERSON	Agid	nn	6	SENT_17	[p1l665t1080r782b1130],
3	,	,	O	,	_	0	SENT_17	[p1l665t1080r782b1130],
4	MD	NNP	O	MD	appos	6	SENT_17	[p1l807t1082r893b1125],
5	,	,	O	,	_	0	SENT_17	[p1l807t1082r893b1125],
6	PhD	NNP	O	PhD	_	0	SENT_17	[p1l918t1072r1096b1125],
7	,	,	O	,	_	0	SENT_17	[p1l918t1072r1096b1125],
8	l'	NN	O	l'	dep	6	SENT_17	[p1l918t1072r1096b1125],
9	2	CD	NUMBER	2	num	8	SENT_17	[p1l918t1072r1096b1125],
10	'	''	O	'	_	0	SENT_17	[p1l918t1072r1096b1125],
11	5	CD	NUMBER	5	dep	8	SENT_17	[p1l918t1072r1096b1125],
12	Jean	NNP	PERSON	Jean	nn	15	SENT_17	[p1l1115t1083r1216b1119],
13	Costentin	NNP	PERSON	Costentin	nn	15	SENT_17	[p1l1238t1082r1460b1125],
14	,	,	O	,	_	0	SENT_17	[p1l1238t1082r1460b1125],
15	MD	NNP	O	MD	dep	6	SENT_17	[p1l1484t1072r1592b1125],
16	,8	CD	NUMBER	,8	num	15	SENT_17	[p1l1484t1072r1592b1125],

1	Jean	NNP	PERSON	Jean	_	0	SENT_18	[p1l348t1153r683b1193],
2	.	.	O	.	_	0	SENT_18	[p1l348t1153r683b1193],

1	—	NN	O	—	_	0	SENT_19	[p1l348t1153r683b1193],
2	.	.	O	.	_	0	SENT_19	[p1l348t1153r683b1193],

1	Sébastien	NNP	PERSON	Sébastien	_	0	SENT_20	[p1l348t1153r683b1193],
2	Hulot	NNP	PERSON	Hulot	rcmod	1	SENT_20	[p1l708t1153r834b1199],
3	,	,	O	,	_	0	SENT_20	[p1l708t1153r834b1199],
4	MD	NNP	O	MD	dep	2	SENT_20	[p1l859t1156r945b1199],
5	,	,	O	,	_	0	SENT_20	[p1l859t1156r945b1199],
6	PhD	NNP	O	PhD	dep	2	SENT_20	[p1l970t1145r1119b1199],
7	,3	CD	NUMBER	,3	num	6	SENT_20	[p1l970t1145r1119b1199],
8	'	''	O	'	_	0	SENT_20	[p1l970t1145r1119b1199],
9	5	CD	NUMBER	5	dep	2	SENT_20	[p1l970t1145r1119b1199],
10	and	CC	O	and	_	0	SENT_20	[p1l1140t1153r1218b1193],
11	Marie	NNP	PERSON	Marie	nn	12	SENT_20	[p1l1243t1156r1362b1193],
12	Vidailhet	NNP	PERSON	Vidailhet	conj_and	9	SENT_20	[p1l1381t1153r1585b1199],
13	,	,	O	,	_	0	SENT_20	[p1l1381t1153r1585b1199],
14	MDl	NN	O	mdl	appos	12	SENT_20	[p1l1610t1145r1793b1192],
15	'	''	O	'	_	0	SENT_20	[p1l1610t1145r1793b1192],
16	2	CD	NUMBER	2	dep	14	SENT_20	[p1l1610t1145r1793b1192],
17	'	''	O	'	_	0	SENT_20	[p1l1610t1145r1793b1192],
18	5	CD	NUMBER	5	dep	1	SENT_20	[p1l1610t1145r1793b1192],
19	"	``	O	"	punct	18	SENT_20	[p1l1610t1145r1793b1192],
20	’	NN	O	’	dep	18	SENT_20	[p1l1610t1145r1793b1192],

1	Objective	NN	O	objective	dep	5	SENT_21	[p1l80t1271r257b1309],
2	:	:	O	:	_	0	SENT_21	[p1l80t1271r257b1309],
3	In	IN	O	in	dep	1	SENT_21	[p1l276t1273r300b1300],
4	Parkinson	NNP	O	Parkinson	pobj	3	SENT_21	[p1l320t1271r477b1300],
5	disease	NN	O	disease	dep	8	SENT_21	[p1l494t1271r616b1300],
6	(	CD	NUMBER	(	num	5	SENT_21	[p1l633t1273r710b1306],
7	PD	NN	O	pd	nn	8	SENT_21	[p1l633t1273r710b1306],
8	)	NN	O	)	dep	14	SENT_21	[p1l633t1273r710b1306],
9	,	,	O	,	_	0	SENT_21	[p1l633t1273r710b1306],
10	the	DT	O	the	det	11	SENT_21	[p1l727t1271r780b1300],
11	selective	JJ	O	selective	dep	14	SENT_21	[p1l795t1271r939b1300],
12	C-O-methyltransferase	NN	O	c-o-methyltransferase	nn	14	SENT_21	[p1l955t1271r1333b1309],
13	(	CD	NUMBER	(	num	14	SENT_21	[p1l1350t1272r1480b1306],
14	COMT	NNP	MISC	COMT	_	0	SENT_21	[p1l1350t1272r1480b1306],
15	)	CD	NUMBER	)	num	17	SENT_21	[p1l1350t1272r1480b1306],
16	inhibitor	NN	O	inhibitor	nn	17	SENT_21	[p1l1498t1271r1636b1300],
17	entacapone	NN	O	entacapone	nsubj	18	SENT_21	[p1l1651t1277r1847b1309],
18	prolongs	VBZ	O	prolong	rcmod	14	SENT_21	[p1l1864t1271r2010b1309],
19	the	DT	O	the	det	20	SENT_21	[p1l2025t1271r2078b1300],
20	effect	NN	O	effect	nsubj	26	SENT_21	[p1l81t1312r174b1341],
21	of	IN	O	of	_	0	SENT_21	[p1l205t1312r238b1341],
22	levodopa	NN	O	levodopa	prep_of	20	SENT_21	[p1l267t1312r420b1350],
23	on	IN	O	on	_	0	SENT_21	[p1l452t1323r491b1341],
24	motor	NN	O	motor	nn	25	SENT_21	[p1l524t1318r624b1341],
25	symptoms	NNS	O	symptom	prep_on	22	SENT_21	[p1l653t1318r824b1350],
26	(	VBP	O	(	ccomp	18	SENT_21	[p1l854t1314r920b1347],
27	ON	IN	O	on	_	0	SENT_21	[p1l854t1314r920b1347],
28	time	NN	O	time	nn	29	SENT_21	[p1l952t1314r1035b1347],
29	)	NN	O	)	prep_on	14	SENT_21	[p1l952t1314r1035b1347],
30	by	IN	O	by	_	0	SENT_21	[p1l1067t1312r1106b1350],
31	increasing	VBG	O	increase	prepc_by	29	SENT_21	[p1l1136t1314r1301b1350],
32	its	PRP$	O	its	poss	33	SENT_21	[p1l1334t1314r1369b1341],
33	bioavailability	NN	O	bioavailability	dobj	31	SENT_21	[p1l1400t1312r1635b1350],
34	.	.	O	.	_	0	SENT_21	[p1l1400t1312r1635b1350],

1	The	DT	O	the	det	4	SENT_22	[p1l1666t1312r1728b1341],
2	COMT	NNP	O	COMT	nn	4	SENT_22	[p1l1758t1314r1870b1342],
3	Val158Met	NN	O	val158met	nn	4	SENT_22	[p1l1898t1312r2079b1341],
4	polymorphism	NN	O	polymorphism	nsubj	12	SENT_22	[p1l81t1354r317b1392],
5	is	VBZ	O	be	auxpass	7	SENT_22	[p1l343t1356r365b1383],
6	equally	RB	O	equally	advmod	7	SENT_22	[p1l389t1354r507b1392],
7	distributed	VBN	O	distribute	ccomp	39	SENT_22	[p1l531t1354r711b1383],
8	in	IN	O	in	_	0	SENT_22	[p1l737t1356r762b1383],
9	PD	NN	O	pd	nn	10	SENT_22	[p1l790t1356r835b1383],
10	patients	NNS	O	patient	prep_in	7	SENT_22	[p1l861t1356r992b1391],
11	and	CC	O	and	_	0	SENT_22	[p1l1017t1354r1076b1383],
12	modulates	VBZ	O	modulate	ccomp	39	SENT_22	[p1l1103t1354r1275b1383],
13	COMT	NN	MISC	comt	nn	14	SENT_22	[p1l1300t1355r1411b1383],
14	activity	NN	O	activity	dobj	12	SENT_22	[p1l1435t1356r1559b1392],
15	,	,	O	,	_	0	SENT_22	[p1l1435t1356r1559b1392],
16	which	WDT	O	which	nsubj	21	SENT_22	[p1l1584t1354r1677b1383],
17	can	MD	O	can	aux	21	SENT_22	[p1l1703t1364r1757b1383],
18	be	VB	O	be	cop	21	SENT_22	[p1l1783t1354r1823b1383],
19	high	JJ	O	high	amod	21	SENT_22	[p1l1849t1354r1917b1392],
20	(	NN	O	(	nn	21	SENT_22	[p1l1943t1354r2077b1388],
21	ValNal	NNP	O	ValNal	rcmod	14	SENT_22	[p1l1943t1354r2077b1388],
22	,	,	O	,	_	0	SENT_22	[p1l1943t1354r2077b1388],
23	COMTHH	NNP	O	COMTHH	conj_or	21	SENT_22	[p1l82t1389r251b1430],
24	)	CD	NUMBER	)	num	23	SENT_22	[p1l82t1389r251b1430],
25	,	,	O	,	_	0	SENT_22	[p1l82t1389r251b1430],
26	intermediate	JJ	O	intermediate	amod	28	SENT_22	[p1l282t1395r493b1425],
27	(	NN	O	(	nn	28	SENT_22	[p1l522t1395r672b1430],
28	Val/Met	NN	O	val/met	conj_or	21	SENT_22	[p1l522t1395r672b1430],
29	,	,	O	,	_	0	SENT_22	[p1l522t1395r672b1430],
30	COMTHL	NNP	O	COMTHL	conj_or	21	SENT_22	[p1l704t1389r867b1430],
31	)	CD	NUMBER	)	num	30	SENT_22	[p1l704t1389r867b1430],
32	,	,	O	,	_	0	SENT_22	[p1l704t1389r867b1430],
33	or	CC	O	or	_	0	SENT_22	[p1l897t1406r930b1425],
34	low	JJ	O	low	amod	36	SENT_22	[p1l959t1395r1015b1425],
35	(	NN	O	(	nn	36	SENT_22	[p1l1043t1396r1209b1430],
36	Met/Met	NN	O	met/met	conj_or	21	SENT_22	[p1l1043t1396r1209b1430],
37	,	,	O	,	_	0	SENT_22	[p1l1043t1396r1209b1430],
38	COMT	NNP	O	COMT	nsubj	39	SENT_22	[p1l1241t1389r1397b1430],
39	”	VBD	O	”	_	0	SENT_22	[p1l1241t1389r1397b1430],
40	)	CD	NUMBER	)	dobj	39	SENT_22	[p1l1241t1389r1397b1430],
41	.	.	O	.	_	0	SENT_22	[p1l1241t1389r1397b1430],

1	The	DT	O	the	det	2	SENT_23	[p1l1426t1395r1487b1425],
2	objective	NN	O	objective	nsubj	6	SENT_23	[p1l1516t1395r1667b1433],
3	of	IN	O	of	_	0	SENT_23	[p1l1696t1395r1729b1425],
4	this	DT	O	this	det	5	SENT_23	[p1l1754t1395r1811b1425],
5	study	NN	O	study	prep_of	2	SENT_23	[p1l1839t1395r1929b1433],
6	was	VBD	O	be	_	0	SENT_23	[p1l1956t1406r2017b1425],
7	to	TO	O	to	aux	8	SENT_23	[p1l2044t1401r2078b1425],
8	determine	VB	O	determine	xcomp	6	SENT_23	[p1l81t1437r251b1466],
9	the	DT	O	the	det	10	SENT_23	[p1l265t1437r318b1466],
10	response	NN	O	response	dobj	8	SENT_23	[p1l334t1448r483b1475],
11	to	TO	O	to	_	0	SENT_23	[p1l497t1443r531b1466],
12	entacapone	NN	O	entacapone	prep_to	8	SENT_23	[p1l547t1443r742b1475],
13	in	IN	O	in	_	0	SENT_23	[p1l758t1439r783b1466],
14	COMTHH	NNP	O	COMTHH	nn	18	SENT_23	[p1l801t1431r952b1467],
15	and	CC	O	and	_	0	SENT_23	[p1l966t1437r1025b1466],
16	COMTLL	NNP	O	COMTLL	nn	18	SENT_23	[p1l1043t1431r1182b1467],
17	PD	NN	O	pd	nn	18	SENT_23	[p1l1197t1439r1242b1466],
18	patients	NNS	O	patient	prep_in	12	SENT_23	[p1l1259t1439r1399b1475],
19	.	.	O	.	_	0	SENT_23	[p1l1259t1439r1399b1475],

1	Methods	NNS	O	method	_	0	SENT_24	[p1l82t1479r243b1508],
2	:	:	O	:	_	0	SENT_24	[p1l82t1479r243b1508],
3	Thirty-three	CD	NUMBER	thirty-three	num	5	SENT_24	[p1l258t1479r454b1517],
4	PD	NN	O	pd	nn	5	SENT_24	[p1l471t1481r516b1508],
5	patients	NNS	O	patient	nsubjpass	28	SENT_24	[p1l533t1481r674b1516],
6	,	,	O	,	_	0	SENT_24	[p1l533t1481r674b1516],
7	homozygous	JJ	O	homozygous	amod	17	SENT_24	[p1l692t1479r902b1517],
8	for	IN	O	for	_	0	SENT_24	[p1l917t1479r963b1508],
9	the	DT	O	the	det	11	SENT_24	[p1l977t1479r1030b1508],
10	COMT	NNP	ORGANIZATION	COMT	nn	11	SENT_24	[p1l1048t1480r1161b1508],
11	alleles	NNS	O	allele	prep_for	7	SENT_24	[p1l1172t1479r1273b1508],
12	COMTHH	NNP	O	COMTHH	nn	14	SENT_24	[p1l1291t1473r1442b1508],
13	(	CD	NUMBER	(	num	14	SENT_24	[p1l1456t1480r1483b1513],
14	n	NN	O	n	dep	11	SENT_24	[p1l1456t1480r1483b1513],
15	=	JJ	O	=	amod	17	SENT_24	[p1l1500t1494r1526b1503],
16	17	CD	NUMBER	17	tmod	15	SENT_24	[p1l1544t1480r1590b1513],
17	)	NN	O	)	appos	5	SENT_24	[p1l1544t1480r1590b1513],
18	and	CC	O	and	_	0	SENT_24	[p1l1607t1479r1666b1508],
19	COMT	NN	O	comt	nn	22	SENT_24	[p1l1684t1473r1823b1508],
20	”	CD	NUMBER	”	num	22	SENT_24	[p1l1684t1473r1823b1508],
21	(	NN	O	(	nn	22	SENT_24	[p1l1837t1480r1864b1513],
22	n	NN	O	n	conj_and	17	SENT_24	[p1l1837t1480r1864b1513],
23	=	JJ	O	=	amod	25	SENT_24	[p1l1881t1494r1907b1503],
24	16	CD	NUMBER	16	tmod	23	SENT_24	[p1l1925t1480r1981b1513],
25	)	NN	O	)	dep	22	SENT_24	[p1l1925t1480r1981b1513],
26	,	,	O	,	_	0	SENT_24	[p1l1925t1480r1981b1513],
27	were	VBD	O	be	auxpass	28	SENT_24	[p1l1998t1489r2078b1508],
28	randomized	VBN	O	randomize	dep	1	SENT_24	[p1l81t1520r277b1549],
29	in	IN	O	in	_	0	SENT_24	[p1l299t1522r324b1549],
30	a	DT	O	a	det	33	SENT_24	[p1l345t1531r361b1549],
31	double-blind	JJ	O	double-blind	amod	33	SENT_24	[p1l382t1520r594b1549],
32	crossover	NN	O	crossover	nn	33	SENT_24	[p1l615t1531r772b1549],
33	trial	NN	O	trial	prep_in	28	SENT_24	[p1l790t1520r851b1549],
34	consisting	VBG	O	consist	partmod	33	SENT_24	[p1l873t1522r1037b1558],
35	of	IN	O	of	_	0	SENT_24	[p1l1058t1520r1091b1549],
36	2	CD	NUMBER	2	num	40	SENT_24	[p1l1109t1522r1127b1549],
37	successive	JJ	O	successive	amod	40	SENT_24	[p1l1146t1522r1317b1549],
38	acute	JJ	O	acute	amod	40	SENT_24	[p1l1337t1526r1426b1549],
39	levodopa	NN	O	levodopa	nn	40	SENT_24	[p1l1448t1520r1600b1558],
40	challenges	NNS	O	challenge	prep_of	34	SENT_24	[p1l1622t1520r1796b1558],
41	associated	VBN	O	associate	partmod	40	SENT_24	[p1l1816t1520r1989b1549],
42	with	IN	O	with	_	0	SENT_24	[p1l2009t1520r2077b1549],
43	200mg	JJ	O	200mg	amod	44	SENT_24	[p1l81t1562r194b1599],
44	entacapone	NN	O	entacapone	prep_with	41	SENT_24	[p1l212t1567r407b1599],
45	or	CC	O	or	_	0	SENT_24	[p1l424t1571r457b1590],
46	placebo	NN	O	placebo	conj_or	44	SENT_24	[p1l474t1561r615b1599],
47	.	.	O	.	_	0	SENT_24	[p1l474t1561r615b1599],

1	The	DT	O	the	det	3	SENT_25	[p1l632t1561r694b1590],
2	primary	JJ	O	primary	amod	3	SENT_25	[p1l712t1563r837b1599],
3	endpoint	NN	O	endpoint	nsubj	6	SENT_25	[p1l853t1561r1003b1599],
4	was	VBD	O	be	cop	6	SENT_25	[p1l1019t1571r1080b1590],
5	the	DT	O	the	det	6	SENT_25	[p1l1096t1561r1149b1590],
6	gain	NN	O	gain	_	0	SENT_25	[p1l1166t1563r1234b1599],
7	in	IN	O	in	_	0	SENT_25	[p1l1253t1563r1278b1590],
8	the	DT	O	the	det	9	SENT_25	[p1l1294t1561r1347b1590],
9	best	JJS	O	best	prep_in	6	SENT_25	[p1l1365t1561r1435b1590],
10	ON	IN	O	on	_	0	SENT_25	[p1l1452t1562r1507b1591],
11	time	NN	O	time	prep_on	9	SENT_25	[p1l1525t1563r1607b1590],
12	.	.	O	.	_	0	SENT_25	[p1l1525t1563r1607b1590],

1	Secondary	JJ	O	secondary	amod	2	SENT_26	[p1l1626t1561r1800b1599],
2	endpoints	NNS	O	endpoint	nsubj	5	SENT_26	[p1l1816t1561r1982b1599],
3	were	VBD	O	be	cop	5	SENT_26	[p1l1998t1571r2078b1590],
4	levodopa	NN	O	levodopa	nn	5	SENT_26	[p1l82t1602r234b1640],
5	pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_26	[p1l252t1602r542b1640],
6	and	CC	O	and	_	0	SENT_26	[p1l557t1602r616b1632],
7	COMT	NN	O	comt	nn	8	SENT_26	[p1l632t1603r744b1632],
8	activity	NN	O	activity	conj_and	5	SENT_26	[p1l758t1604r874b1640],
9	in	IN	O	in	_	0	SENT_26	[p1l889t1604r914b1631],
10	red	JJ	O	red	amod	12	SENT_26	[p1l932t1602r984b1632],
11	blood	NN	O	blood	nn	12	SENT_26	[p1l1001t1602r1096b1632],
12	cells	NNS	O	cell	prep_in	8	SENT_26	[p1l1112t1602r1191b1632],
13	.	.	O	.	_	0	SENT_26	[p1l1112t1602r1191b1632],

1	Results	NNS	O	result	_	0	SENT_27	[p1l82t1644r212b1673],
2	:	:	O	:	_	0	SENT_27	[p1l82t1644r212b1673],
3	The	DT	O	the	det	4	SENT_27	[p1l227t1644r287b1673],
4	gain	NN	O	gain	dep	1	SENT_27	[p1l299t1646r365b1682],
5	in	IN	O	in	_	0	SENT_27	[p1l378t1646r402b1673],
6	the	DT	O	the	det	7	SENT_27	[p1l414t1644r466b1673],
7	best	JJS	O	best	prep_in	4	SENT_27	[p1l478t1644r546b1673],
8	ON	IN	O	on	_	0	SENT_27	[p1l557t1645r612b1674],
9	time	NN	O	time	prep_on	7	SENT_27	[p1l624t1646r696b1673],
10	was	VBD	O	be	cop	11	SENT_27	[p1l706t1655r766b1673],
11	higher	JJR	O	higher	partmod	9	SENT_27	[p1l779t1644r880b1682],
12	in	IN	O	in	_	0	SENT_27	[p1l891t1646r915b1673],
13	COMTHH	NNP	O	COMTHH	prep_in	11	SENT_27	[p1l930t1638r1077b1674],
14	than	IN	O	than	prep	11	SENT_27	[p1l1086t1644r1155b1673],
15	in	IN	O	in	pcomp	14	SENT_27	[p1l1169t1646r1193b1673],
16	COMTLI	NNP	O	COMTLI	nn	18	SENT_27	[p1l1208t1638r1342b1674],
17	‘	CD	NUMBER	‘	num	18	SENT_27	[p1l1208t1638r1342b1674],
18	patients	NNS	O	patient	pobj	15	SENT_27	[p1l1353t1646r1480b1682],
19	(	IN	O	(	_	0	SENT_27	[p1l1492t1645r1539b1679],
20	39	CD	NUMBER	39	prep_(	11	SENT_27	[p1l1492t1645r1539b1679],
21	:	:	O	:	_	0	SENT_27	[p1l1554t1649r1576b1672],
22	10	CD	NUMBER	10	dep	1	SENT_27	[p1l1594t1646r1630b1673],
23	vs	CC	O	vs	_	0	SENT_27	[p1l1640t1655r1672b1673],
24	9	CD	NUMBER	9	conj_vs	22	SENT_27	[p1l1683t1646r1702b1673],
25	:	:	O	:	_	0	SENT_27	[p1l1716t1649r1739b1672],
26	9	CD	DURATION	9	num	27	SENT_27	[p1l1754t1646r1772b1673],
27	minutes	NNS	NUMBER	minute	dep	1	SENT_27	[p1l1785t1646r1917b1678],
28	,	,	O	,	_	0	SENT_27	[p1l1785t1646r1917b1678],
29	p	NN	O	p	appos	27	SENT_27	[p1l1930t1655r1951b1682],
30	=	JJ	O	=	amod	29	SENT_27	[p1l1963t1659r1988b1668],
31	0.04	CD	NUMBER	0.04	tmod	30	SENT_27	[p1l2000t1646r2077b1678],
32	,	,	O	,	_	0	SENT_27	[p1l2000t1646r2077b1678],
33	interaction	NN	O	interaction	appos	1	SENT_27	[p1l81t1687r248b1715],
34	between	IN	O	between	_	0	SENT_27	[p1l265t1686r403b1715],
35	treatment	NN	O	treatment	nn	38	SENT_27	[p1l417t1691r577b1715],
36	and	CC	O	and	_	0	SENT_27	[p1l591t1686r649b1715],
37	genotype	NN	O	genotype	nn	38	SENT_27	[p1l665t1687r837b1723],
38	)	NN	O	)	prep_between	33	SENT_27	[p1l665t1687r837b1723],
39	.	.	O	.	_	0	SENT_27	[p1l665t1687r837b1723],

1	Area	NN	O	area	nsubj	10	SENT_28	[p1l852t1687r927b1715],
2	under	IN	O	under	_	0	SENT_28	[p1l944t1686r1037b1715],
3	the	DT	O	the	det	4	SENT_28	[p1l1049t1686r1101b1715],
4	concentration	NN	O	concentration	prep_under	1	SENT_28	[p1l1116t1687r1335b1715],
5	over	IN	O	over	_	0	SENT_28	[p1l1351t1696r1420b1715],
6	time	NN	O	time	nn	7	SENT_28	[p1l1433t1687r1504b1715],
7	curve	NN	O	curve	prep_over	4	SENT_28	[p1l1519t1696r1604b1715],
8	of	IN	O	of	_	0	SENT_28	[p1l1619t1685r1651b1715],
9	levodopa	NN	O	levodopa	prep_of	7	SENT_28	[p1l1665t1686r1812b1723],
10	increased	VBD	O	increase	_	0	SENT_28	[p1l1829t1686r1979b1715],
11	more	RBR	O	more	dobj	10	SENT_28	[p1l1996t1696r2078b1715],
12	after	IN	O	after	_	0	SENT_28	[p1l81t1727r154b1756],
13	entacapone	NN	O	entacapone	prep_after	10	SENT_28	[p1l165t1733r354b1764],
14	in	IN	O	in	_	0	SENT_28	[p1l367t1729r391b1756],
15	COMTHH	NNP	O	COMTHH	prep_in	13	SENT_28	[p1l406t1721r553b1756],
16	than	IN	O	than	dep	10	SENT_28	[p1l562t1727r631b1756],
17	in	IN	O	in	_	0	SENT_28	[p1l645t1729r669b1756],
18	COMT	NNP	O	COMT	nn	20	SENT_28	[p1l684t1721r819b1756],
19	”	CD	NUMBER	”	num	20	SENT_28	[p1l684t1721r819b1756],
20	patients	NNS	O	patient	prep_in	10	SENT_28	[p1l830t1729r957b1764],
21	(	IN	O	(	_	0	SENT_28	[p1l969t1728r1045b1761],
22	+62	CD	NUMBER	+62	prep_(	20	SENT_28	[p1l969t1728r1045b1761],
23	:	:	O	:	_	0	SENT_28	[p1l1060t1732r1082b1755],
24	6	CD	PERCENT	6	num	25	SENT_28	[p1l1098t1728r1146b1757],
25	%	NN	PERCENT	%	dep	20	SENT_28	[p1l1098t1728r1146b1757],
26	vs	CC	O	vs	_	0	SENT_28	[p1l1157t1737r1189b1756],
27	+34	CD	NUMBER	+34	dep	20	SENT_28	[p1l1201t1728r1268b1759],
28	:	:	O	:	_	0	SENT_28	[p1l1282t1732r1305b1755],
29	8	CD	PERCENT	8	num	30	SENT_28	[p1l1321t1728r1377b1761],
30	%	NN	PERCENT	%	dep	20	SENT_28	[p1l1321t1728r1377b1761],
31	,	,	O	,	_	0	SENT_28	[p1l1321t1728r1377b1761],
32	p	NN	O	p	appos	30	SENT_28	[p1l1390t1737r1412b1764],
33	:	:	O	:	_	0	SENT_28	[p1l1423t1742r1449b1751],
34	0.01	CD	NUMBER	0.01	num	35	SENT_28	[p1l1461t1728r1547b1761],
35	)	NN	O	)	dep	20	SENT_28	[p1l1461t1728r1547b1761],
36	.	.	O	.	_	0	SENT_28	[p1l1461t1728r1547b1761],

1	COMT	NN	O	comt	nn	2	SENT_29	[p1l1561t1728r1670b1756],
2	inhibition	NN	O	inhibition	nsubj	6	SENT_29	[p1l1682t1727r1827b1756],
3	by	IN	O	by	_	0	SENT_29	[p1l1841t1727r1878b1765],
4	entacapone	NN	O	entacapone	prep_by	2	SENT_29	[p1l1889t1733r2078b1764],
5	was	VBD	O	be	cop	6	SENT_29	[p1l79t1779r139b1798],
6	higher	JJR	O	higher	_	0	SENT_29	[p1l152t1769r252b1806],
7	in	IN	O	in	_	0	SENT_29	[p1l264t1771r288b1797],
8	COMTHH	NNP	O	COMTHH	prep_in	6	SENT_29	[p1l302t1763r450b1798],
9	than	IN	O	than	dep	6	SENT_29	[p1l458t1769r527b1798],
10	in	IN	O	in	_	0	SENT_29	[p1l540t1771r565b1797],
11	COMT	NNP	O	COMT	nn	13	SENT_29	[p1l579t1763r714b1798],
12	”	CD	NUMBER	”	num	13	SENT_29	[p1l579t1763r714b1798],
13	patients	NNS	O	patient	prep_in	6	SENT_29	[p1l724t1771r851b1806],
14	(	IN	O	(	_	0	SENT_29	[p1l863t1770r969b1803],
15	-0.54	CD	NUMBER	-0.54	prep_(	13	SENT_29	[p1l863t1770r969b1803],
16	:	:	O	:	_	0	SENT_29	[p1l983t1774r1006b1796],
17	0.07	CD	NUMBER	0.07	dep	13	SENT_29	[p1l1020t1770r1087b1798],
18	vs	CC	O	vs	_	0	SENT_29	[p1l1099t1779r1130b1798],
19	-0.31	CD	NUMBER	-0.31	conj_vs	17	SENT_29	[p1l1143t1770r1232b1798],
20	:	:	O	:	_	0	SENT_29	[p1l1252t1774r1275b1796],
21	0.06	CD	NUMBER	0.06	num	23	SENT_29	[p1l1290t1770r1358b1798],
22	pmol/min/mg	NN	O	pmol/min/mg	nn	23	SENT_29	[p1l1370t1769r1588b1806],
23	protein	NN	O	protein	dep	13	SENT_29	[p1l1602t1771r1724b1806],
24	,	,	O	,	_	0	SENT_29	[p1l1602t1771r1724b1806],
25	p	NN	O	p	appos	23	SENT_29	[p1l1737t1779r1758b1806],
26	:	:	O	:	_	0	SENT_29	[p1l1769t1783r1795b1792],
27	0.02	CD	NUMBER	0.02	num	28	SENT_29	[p1l1807t1770r1893b1803],
28	)	NN	O	)	dep	13	SENT_29	[p1l1807t1770r1893b1803],
29	.	.	O	.	_	0	SENT_29	[p1l1807t1770r1893b1803],

1	Interpretation	NN	O	interpretation	_	0	SENT_30	[p1l82t1812r333b1848],
2	:	:	O	:	_	0	SENT_30	[p1l82t1812r333b1848],
3	The	DT	O	the	det	5	SENT_30	[p1l349t1810r410b1840],
4	COMTHH	NNP	O	COMTHH	nn	5	SENT_30	[p1l428t1804r579b1840],
5	genotype	NN	O	genotype	nsubj	9	SENT_30	[p1l594t1816r752b1848],
6	in	IN	O	in	_	0	SENT_30	[p1l769t1812r794b1839],
7	PD	NN	O	pd	nn	8	SENT_30	[p1l813t1812r859b1839],
8	patients	NNS	O	patient	prep_in	5	SENT_30	[p1l876t1812r1008b1848],
9	enhances	VBZ	O	enhance	dep	1	SENT_30	[p1l1024t1810r1179b1840],
10	the	DT	O	the	det	11	SENT_30	[p1l1194t1810r1247b1840],
11	effect	NN	O	effect	dobj	9	SENT_30	[p1l1263t1810r1357b1840],
12	of	IN	O	of	_	0	SENT_30	[p1l1373t1810r1406b1840],
13	entacapone	NN	O	entacapone	prep_of	11	SENT_30	[p1l1420t1816r1616b1848],
14	on	IN	O	on	_	0	SENT_30	[p1l1632t1821r1671b1840],
15	the	DT	O	the	det	16	SENT_30	[p1l1687t1810r1740b1840],
16	pharmacodynamics	NNS	O	pharmacodynamic	prep_on	9	SENT_30	[p1l1757t1810r2078b1848],
17	and	CC	O	and	_	0	SENT_30	[p1l81t1852r140b1881],
18	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	9	SENT_30	[p1l159t1852r449b1889],
19	of	IN	O	of	_	0	SENT_30	[p1l465t1851r499b1881],
20	levodopa	NN	O	levodopa	prep_of	16	SENT_30	[p1l515t1852r677b1889],
21	.	.	O	.	_	0	SENT_30	[p1l515t1852r677b1889],

1	The	DT	O	the	det	2	SENT_31	[p1l694t1852r756b1881],
2	response	NN	O	response	nsubj	12	SENT_31	[p1l773t1862r922b1889],
3	to	TO	O	to	_	0	SENT_31	[p1l938t1857r971b1881],
4	entacapone	NN	O	entacapone	prep_to	2	SENT_31	[p1l989t1857r1184b1889],
5	after	IN	O	after	_	0	SENT_31	[p1l1201t1851r1278b1881],
6	repeated	VBN	O	repeat	amod	7	SENT_31	[p1l1294t1852r1444b1889],
7	administrations	NNS	O	administration	prep_after	4	SENT_31	[p1l1462t1852r1716b1881],
8	and	CC	O	and	_	0	SENT_31	[p1l1732t1852r1792b1881],
9	in	IN	O	in	_	0	SENT_31	[p1l1810t1853r1835b1880],
10	heterozygous	JJ	O	heterozygous	amod	11	SENT_31	[p1l1854t1852r2078b1889],
11	patients	NNS	O	patient	prep_in	2	SENT_31	[p1l81t1895r213b1930],
12	remains	VBZ	O	remain	_	0	SENT_31	[p1l229t1895r357b1922],
13	to	TO	O	to	aux	15	SENT_31	[p1l371t1899r404b1922],
14	be	VB	O	be	auxpass	15	SENT_31	[p1l421t1893r461b1922],
15	determined	VBN	O	determine	xcomp	12	SENT_31	[p1l476t1893r679b1922],
16	.	.	O	.	_	0	SENT_31	[p1l476t1893r679b1922],

1	ANN	NNP	O	ANN	nn	2	SENT_32	[p1l1572t1939r1646b1963],
2	NEUROL	NNP	O	NEUROL	_	0	SENT_32	[p1l1662t1938r1796b1963],
3	2011	CD	DATE	2011	num	5	SENT_32	[p1l1808t1938r2078b1967],
4	;	:	O	;	_	0	SENT_32	[p1l1808t1938r2078b1967],
5	69:111	CD	NUMBER	69:111	dep	2	SENT_32	[p1l1808t1938r2078b1967],
6	—	NN	O	—	dep	2	SENT_32	[p1l1808t1938r2078b1967],
7	118	CD	NUMBER	118	num	6	SENT_32	[p1l1808t1938r2078b1967],

1	he	PRP	O	he	dep	2	SENT_33	[p1l147t2012r183b2043],
2	symptoms	NNS	O	symptom	nsubj	16	SENT_33	[p1l203t2023r366b2053],
3	of	IN	O	of	_	0	SENT_33	[p1l386t2012r422b2043],
4	Parkinson	NNP	O	Parkinson	prep_of	2	SENT_33	[p1l436t2012r594b2043],
5	disease	NN	O	disease	nn	8	SENT_33	[p1l614t2012r720b2043],
6	(	CD	NUMBER	(	num	8	SENT_33	[p1l742t2013r818b2049],
7	PD	NN	O	pd	nn	8	SENT_33	[p1l742t2013r818b2049],
8	)	NN	O	)	dep	4	SENT_33	[p1l742t2013r818b2049],
9	are	VBP	O	be	cop	16	SENT_33	[p1l840t2025r885b2043],
10	in	IN	O	in	_	0	SENT_33	[p1l904t2014r935b2043],
11	large	JJ	O	large	amod	14	SENT_33	[p1l954t2012r1028b2054],
12	mine	NN	O	mine	nn	14	SENT_33	[p1l1130t2014r1211b2043],
13	precursor	NN	O	precursor	nn	14	SENT_33	[p1l1228t2024r1378b2053],
14	L	NN	O	l	prep_in	16	SENT_33	[p1l1394t2012r1518b2053],
15	—	CD	NUMBER	—	num	16	SENT_33	[p1l1394t2012r1518b2053],
16	dopa	NN	O	dopa	_	0	SENT_33	[p1l1394t2012r1518b2053],
17	,	,	O	,	_	0	SENT_33	[p1l1394t2012r1518b2053],
18	which	WDT	O	which	nsubj	23	SENT_33	[p1l1535t2012r1632b2043],
19	remains	VBZ	O	remain	cop	23	SENT_33	[p1l1650t2014r1773b2043],
20	the	DT	O	the	det	23	SENT_33	[p1l1791t2012r1840b2043],
21	gold	JJ	O	gold	amod	23	SENT_33	[p1l1857t2012r1926b2054],
22	standard	JJ	O	standard	amod	23	SENT_33	[p1l1943t2012r2079b2043],
23	part	NN	O	part	rcmod	16	SENT_33	[p1l147t2077r210b2108],
24	caused	VBN	O	cause	partmod	23	SENT_33	[p1l230t2067r335b2098],
25	by	IN	O	by	_	0	SENT_33	[p1l355t2067r394b2107],
26	the	DT	O	the	det	27	SENT_33	[p1l413t2067r461b2097],
27	loss	NN	O	loss	agent	24	SENT_33	[p1l481t2067r537b2097],
28	of	IN	O	of	_	0	SENT_33	[p1l558t2067r594b2097],
29	dopaminergic	JJ	O	dopaminergic	amod	30	SENT_33	[p1l610t2067r830b2108],
30	neurons	NNS	O	neuron	prep_of	27	SENT_33	[p1l850t2079r977b2098],
31	in	IN	O	in	dep	24	SENT_33	[p1l998t2069r1029b2097],
32	for	IN	O	for	_	0	SENT_33	[p1l1130t2067r1176b2097],
33	the	DT	O	the	det	34	SENT_33	[p1l1193t2067r1242b2097],
34	treatment	NN	O	treatment	prep_for	24	SENT_33	[p1l1259t2077r1414b2097],
35	of	IN	O	of	_	0	SENT_33	[p1l1432t2067r1468b2097],
36	PD	NN	O	pd	prep_of	34	SENT_33	[p1l1481t2069r1543b2102],
37	,	,	O	,	_	0	SENT_33	[p1l1481t2069r1543b2102],
38	and	CC	O	and	_	0	SENT_33	[p1l1563t2067r1621b2098],
39	dopamine	NN	O	dopamine	nn	40	SENT_33	[p1l1638t2067r1798b2108],
40	agonists	NNS	O	agonist	rcmod	16	SENT_33	[p1l1817t2060r1966b2108],
41	.1	CD	NUMBER	.1	num	43	SENT_33	[p1l1817t2060r1966b2108],
42	Howthe	NN	O	howthe	nn	43	SENT_33	[p1l1987t2069r2078b2097, p1l80t2121r129b2151],
43	mesencephalon	NN	O	mesencephalon	dep	40	SENT_33	[p1l149t2121r402b2162],
44	.	.	O	.	_	0	SENT_33	[p1l149t2121r402b2162],

1	Pharmacotherapy	NNP	O	Pharmacotherapy	nsubj	4	SENT_34	[p1l425t2121r707b2162],
2	for	IN	O	for	_	0	SENT_34	[p1l726t2121r772b2151],
3	PD	NN	O	pd	prep_for	1	SENT_34	[p1l792t2123r844b2151],
4	has	VBZ	O	have	_	0	SENT_34	[p1l865t2121r915b2151],
5	there	EX	O	there	expl	6	SENT_34	[p1l936t2121r1028b2151],
6	—	CD	NUMBER	—	xcomp	4	SENT_34	[p1l936t2121r1028b2151],
7	ever	RB	O	ever	advmod	6	SENT_34	[p1l1130t2133r1200b2156],
8	,	,	O	,	_	0	SENT_34	[p1l1130t2133r1200b2156],
9	as	IN	O	as	mark	12	SENT_34	[p1l1216t2134r1244b2151],
10	the	DT	O	the	det	11	SENT_34	[p1l1259t2121r1307b2151],
11	disease	NN	O	disease	nsubj	12	SENT_34	[p1l1322t2121r1429b2152],
12	progresses	VBZ	O	progress	advcl	4	SENT_34	[p1l1443t2133r1612b2162],
13	,	,	O	,	_	0	SENT_34	[p1l1443t2133r1612b2162],
14	elimination	NN	O	elimination	nsubj	21	SENT_34	[p1l1628t2121r1813b2151],
15	of	IN	O	of	_	0	SENT_34	[p1l1827t2121r1863b2151],
16	L	NN	O	l	nn	18	SENT_34	[p1l1872t2121r1987b2162],
17	—	CD	NUMBER	—	num	18	SENT_34	[p1l1872t2121r1987b2162],
18	dopa	NN	O	dopa	prep_of	14	SENT_34	[p1l1872t2121r1987b2162],
19	from	IN	O	from	_	0	SENT_34	[p1l2001t2121r2078b2151],
20	fore	NN	O	fore	prep_from	18	SENT_34	[p1l80t2175r141b2206],
21	focused	VBD	O	focus	ccomp	12	SENT_34	[p1l164t2175r284b2207],
22	on	IN	O	on	_	0	SENT_34	[p1l307t2188r347b2206],
23	dopaminergic	JJ	O	dopaminergic	amod	24	SENT_34	[p1l370t2175r591b2217],
24	drugs	NNS	O	drug	prep_on	21	SENT_34	[p1l613t2175r709b2217],
25	,	,	O	,	_	0	SENT_34	[p1l613t2175r709b2217],
26	mainly	RB	O	mainly	advmod	28	SENT_34	[p1l733t2175r844b2216],
27	the	DT	O	the	det	28	SENT_34	[p1l866t2175r914b2206],
28	dopa	NN	O	dopa	appos	24	SENT_34	[p1l937t2175r1028b2216],
29	-	:	O	-	_	0	SENT_34	[p1l937t2175r1028b2216],
30	plasma	NN	O	plasma	dep	28	SENT_34	[p1l1130t2175r1241b2216],
31	plays	VBZ	O	play	rcmod	30	SENT_34	[p1l1261t2175r1339b2217],
32	an	DT	O	a	det	35	SENT_34	[p1l1360t2188r1397b2206],
33	increasingly	RB	O	increasingly	advmod	34	SENT_34	[p1l1418t2175r1607b2217],
34	important	JJ	O	important	amod	35	SENT_34	[p1l1626t2177r1788b2216],
35	role	NN	O	role	dobj	31	SENT_34	[p1l1808t2175r1876b2211],
36	;	:	O	;	_	0	SENT_34	[p1l1808t2175r1876b2211],
37	after	IN	O	after	_	0	SENT_34	[p1l1898t2175r1969b2206],
38	a	DT	O	a	det	39	SENT_34	[p1l1989t2188r2005b2206],
39	few	JJ	O	few	prep_after	28	SENT_34	[p1l2025t2175r2080b2206],

1	Published	VBN	O	publish	_	0	SENT_35	[p1l499t2292r622b2315],
2	online	NN	O	online	dep	1	SENT_35	[p1l635t2292r712b2315],
3	in	IN	O	in	_	0	SENT_35	[p1l725t2294r744b2315],
4	Wiley	NNP	ORGANIZATION	Wiley	nn	9	SENT_35	[p1l756t2292r827b2322],
5	Online	NNP	ORGANIZATION	Online	nn	9	SENT_35	[p1l838t2292r922b2315],
6	Library	NNP	ORGANIZATION	Library	nn	9	SENT_35	[p1l936t2292r1020b2322],
7	(	NN	O	(	nn	9	SENT_35	[p1l1032t2292r1339b2322],
8	wileyonlinelibrarycom	NN	O	wileyonlinelibrarycom	nn	9	SENT_35	[p1l1032t2292r1339b2322],
9	)	NN	O	)	prep_in	1	SENT_35	[p1l1032t2292r1339b2322],
10	.	.	O	.	_	0	SENT_35	[p1l1032t2292r1339b2322],

1	DOI	NNP	O	DOI	_	0	SENT_36	[p1l1353t2293r1410b2315],
2	:	:	O	:	_	0	SENT_36	[p1l1353t2293r1410b2315],
3	10.1002	CD	NUMBER	10.1002	dep	1	SENT_36	[p1l1425t2293r1661b2316],
4	/	:	O	/	punct	1	SENT_36	[p1l1425t2293r1661b2316],
5	ana	NN	O	ana	nsubj	7	SENT_36	[p1l1425t2293r1661b2316],
6	.22155	CD	NUMBER	.22155	num	5	SENT_36	[p1l1425t2293r1661b2316],
7	Received	VBN	O	receive	dep	1	SENT_36	[p1l469t2330r583b2353],
8	May	NNP	DATE	May	tmod	7	SENT_36	[p1l597t2331r649b2360],
9	28	CD	DATE	28	num	8	SENT_36	[p1l660t2331r695b2357],
10	,	,	DATE	,	_	0	SENT_36	[p1l660t2331r695b2357],
11	2010	CD	DATE	2010	num	8	SENT_36	[p1l708t2331r773b2357],
12	,	,	O	,	_	0	SENT_36	[p1l708t2331r773b2357],
13	and	CC	O	and	_	0	SENT_36	[p1l786t2330r832b2353],
14	in	IN	O	in	_	0	SENT_36	[p1l846t2332r865b2353],
15	revised	JJ	O	revised	amod	17	SENT_36	[p1l879t2330r968b2353],
16	form	NN	O	form	nn	17	SENT_36	[p1l980t2330r1038b2353],
17	Jul	NNP	DATE	Jul	prep_in	20	SENT_36	[p1l1050t2330r1084b2353],
18	4	CD	DATE	4	num	17	SENT_36	[p1l1097t2331r1117b2357],
19	,	,	DATE	,	_	0	SENT_36	[p1l1097t2331r1117b2357],
20	2010	CD	DATE	2010	conj_and	7	SENT_36	[p1l1130t2331r1195b2353],
21	.	.	O	.	_	0	SENT_36	[p1l1130t2331r1195b2353],

1	Accepted	JJ	O	accepted	_	0	SENT_37	[p1l1208t2330r1331b2360],
2	for	IN	O	for	_	0	SENT_37	[p1l1343t2330r1378b2353],
3	publication	NN	O	publication	prep_for	1	SENT_37	[p1l1390t2330r1532b2360],
4	Jul	NNP	DATE	Jul	dep	3	SENT_37	[p1l1544t2330r1578b2353],
5	9	CD	DATE	9	num	4	SENT_37	[p1l1591t2331r1611b2357],
6	,	,	DATE	,	_	0	SENT_37	[p1l1591t2331r1611b2357],
7	2010	CD	DATE	2010	num	4	SENT_37	[p1l1624t2331r1689b2353],
8	.	.	O	.	_	0	SENT_37	[p1l1624t2331r1689b2353],

1	Address	NN	O	address	nn	2	SENT_38	[p1l163t2368r269b2391],
2	correspondence	NN	O	correspondence	nsubj	4	SENT_38	[p1l281t2368r490b2398],
3	to	TO	O	to	aux	4	SENT_38	[p1l501t2373r526b2391],
4	Dr	VB	O	dr	_	0	SENT_38	[p1l540t2370r569b2391],
5	Corvol	NNP	PERSON	Corvol	dobj	4	SENT_38	[p1l580t2368r670b2395],
6	,	,	O	,	_	0	SENT_38	[p1l580t2368r670b2395],
7	Centre	NNP	O	Centre	nn	9	SENT_38	[p1l683t2369r769b2391],
8	d'lnvestigation	NNP	O	d'lnvestigation	nn	9	SENT_38	[p1l781t2368r969b2398],
9	Clinique	NNP	ORGANIZATION	Clinique	appos	5	SENT_38	[p1l982t2368r1094b2398],
10	,	,	O	,	_	0	SENT_38	[p1l982t2368r1094b2398],
11	Hépital	JJ	O	hépital	amod	12	SENT_38	[p1l1109t2368r1199b2398],
12	pitié	NN	O	pitié	appos	9	SENT_38	[p1l1213t2368r1425b2398],
13	.	.	O	.	_	0	SENT_38	[p1l1213t2368r1425b2398],

1	—	NN	O	—	_	0	SENT_39	[p1l1213t2368r1425b2398],
2	.	.	O	.	_	0	SENT_39	[p1l1213t2368r1425b2398],

1	Salpétriére	NNP	O	Salpétriére	_	0	SENT_40	[p1l1213t2368r1425b2398],
2	,	,	O	,	_	0	SENT_40	[p1l1213t2368r1425b2398],
3	47/83	CD	NUMBER	47/83	num	4	SENT_40	[p1l1438t2369r1508b2392],
4	Bd	NN	O	bd	appos	1	SENT_40	[p1l1521t2368r1553b2391],
5	de	IN	O	de	_	0	SENT_40	[p1l1566t2368r1598b2391],
6	l’	NN	O	l’	nn	7	SENT_40	[p1l1611t2368r1724b2398],
7	H	NN	O	h	prep_de	4	SENT_40	[p1l1611t2368r1724b2398],
8	€	CD	NUMBER	€	num	10	SENT_40	[p1l1611t2368r1724b2398],
9	>	JJR	O	>	amod	10	SENT_40	[p1l1611t2368r1724b2398],
10	pital	NN	O	pital	dep	4	SENT_40	[p1l1611t2368r1724b2398],
11	,	,	O	,	_	0	SENT_40	[p1l1611t2368r1724b2398],
12	75013	CD	NUMBER	75013	num	15	SENT_40	[p1l1737t2369r1811b2391],
13	Paris	NNP	LOCATION	Paris	nn	15	SENT_40	[p1l1824t2370r1888b2395],
14	,	,	O	,	_	0	SENT_40	[p1l1824t2370r1888b2395],
15	France	NNP	LOCATION	France	appos	1	SENT_40	[p1l1903t2370r1993b2391],
16	.	.	O	.	_	0	SENT_40	[p1l1903t2370r1993b2391],

1	E	NN	O	e	nn	3	SENT_41	[p1l808t2405r892b2428],
2	—	CD	NUMBER	—	num	3	SENT_41	[p1l808t2405r892b2428],
3	mail	NN	O	mail	_	0	SENT_41	[p1l808t2405r892b2428],
4	:	:	O	:	_	0	SENT_41	[p1l808t2405r892b2428],
5	jean—christophe.corvol@psl.aphp.fr	NN	O	jean—christophe.corvol@psl.aphp.fr	dep	3	SENT_41	[p1l903t2405r1352b2435],

1	From	IN	O	from	dep	21	SENT_42	[p1l90t2444r153b2466],
2	the	DT	O	the	det	3	SENT_42	[p1l166t2443r206b2466],
3	WINSERM	NNP	O	WINSERM	pobj	1	SENT_42	[p1l219t2438r333b2466],
4	(	CD	NUMBER	(	num	3	SENT_42	[p1l347t2443r439b2470],
5	French	NNP	ORGANIZATION	French	nn	7	SENT_42	[p1l347t2443r439b2470],
6	National	NNP	ORGANIZATION	National	nn	7	SENT_42	[p1l453t2443r559b2466],
7	Institute	NNP	ORGANIZATION	Institute	dep	3	SENT_42	[p1l574t2444r674b2466],
8	of	IN	ORGANIZATION	of	_	0	SENT_42	[p1l687t2443r712b2466],
9	Medical	NNP	ORGANIZATION	Medical	nn	10	SENT_42	[p1l723t2443r822b2466],
10	Research	NNP	ORGANIZATION	Research	prep_of	7	SENT_42	[p1l837t2443r949b2466],
11	and	CC	ORGANIZATION	and	_	0	SENT_42	[p1l962t2443r1008b2466],
12	Health	NNP	ORGANIZATION	Health	nn	13	SENT_42	[p1l1023t2443r1118b2470],
13	)	NNP	O	)	conj_and	10	SENT_42	[p1l1023t2443r1118b2470],
14	,	,	O	,	_	0	SENT_42	[p1l1023t2443r1118b2470],
15	Clinical	JJ	O	clinical	amod	21	SENT_42	[p1l1131t2443r1222b2466],
16	Investigation	NNP	O	Investigation	nn	21	SENT_42	[p1l1236t2444r1398b2472],
17	Center	NNP	O	Center	nn	21	SENT_42	[p1l1411t2444r1498b2466],
18	(	NN	O	(	nn	21	SENT_42	[p1l1509t2444r1648b2470],
19	C	NN	O	c	nn	21	SENT_42	[p1l1509t2444r1648b2470],
20	|	NN	O	|	nn	21	SENT_42	[p1l1509t2444r1648b2470],
21	C	NN	O	c	_	0	SENT_42	[p1l1509t2444r1648b2470],
22	—	CD	NUMBER	—	num	24	SENT_42	[p1l1509t2444r1648b2470],
23	9503	CD	NUMBER	9503	num	24	SENT_42	[p1l1509t2444r1648b2470],
24	)	NN	O	)	dep	21	SENT_42	[p1l1509t2444r1648b2470],
25	,	,	O	,	_	0	SENT_42	[p1l1509t2444r1648b2470],
26	Pitié	NNP	O	Pitié	dep	21	SENT_42	[p1l1663t2443r1866b2472],
27	.	.	O	.	_	0	SENT_42	[p1l1663t2443r1866b2472],

1	—	NN	O	—	_	0	SENT_43	[p1l1663t2443r1866b2472],
2	.	.	O	.	_	0	SENT_43	[p1l1663t2443r1866b2472],

1	Salpétriere	NNP	LOCATION	Salpétriere	dep	116	SENT_44	[p1l1663t2443r1866b2472],
2	Hospital	NNP	LOCATION	Hospital	dep	116	SENT_44	[p1l1880t2443r1990b2472],
3	,	,	O	,	_	0	SENT_44	[p1l1880t2443r1990b2472],
4	Paris	NNP	LOCATION	Paris	dep	116	SENT_44	[p1l2005t2444r2069b2469],
5	,	,	O	,	_	0	SENT_44	[p1l2005t2444r2069b2469],
6	France	NNP	LOCATION	France	dep	116	SENT_44	[p1l99t2481r189b2506],
7	;	:	O	;	_	0	SENT_44	[p1l99t2481r189b2506],
8	ZAPHP	NNP	O	ZAPHP	dep	116	SENT_44	[p1l201t2475r285b2502],
9	(	CD	NUMBER	(	dep	116	SENT_44	[p1l298t2481r439b2507],
10	Assistance	NNP	ORGANIZATION	Assistance	dep	116	SENT_44	[p1l298t2481r439b2507],
11	Publique	NNP	ORGANIZATION	Publique	dep	116	SENT_44	[p1l452t2480r563b2509],
12	Hopitaux	NNP	ORGANIZATION	Hopitaux	dep	116	SENT_44	[p1l577t2481r692b2509],
13	de	IN	ORGANIZATION	de	dep	116	SENT_44	[p1l704t2480r735b2503],
14	Paris	NNP	ORGANIZATION	Paris	dep	116	SENT_44	[p1l749t2481r813b2506],
15	,	,	O	,	_	0	SENT_44	[p1l749t2481r813b2506],
16	Public	NNP	ORGANIZATION	Public	dep	116	SENT_44	[p1l827t2480r903b2503],
17	Hospital	NNP	ORGANIZATION	Hospital	dep	116	SENT_44	[p1l916t2480r1019b2509],
18	of	IN	ORGANIZATION	of	dep	116	SENT_44	[p1l1032t2480r1058b2503],
19	Paris	NNP	ORGANIZATION	Paris	dep	116	SENT_44	[p1l1069t2481r1141b2507],
20	)	NNP	O	)	dep	116	SENT_44	[p1l1069t2481r1141b2507],
21	,	,	O	,	_	0	SENT_44	[p1l1069t2481r1141b2507],
22	Department	NNP	ORGANIZATION	Department	dep	116	SENT_44	[p1l1155t2481r1310b2509],
23	of	IN	ORGANIZATION	of	dep	116	SENT_44	[p1l1321t2480r1347b2503],
24	Neurology	NNP	ORGANIZATION	Neurology	dep	116	SENT_44	[p1l1358t2480r1499b2509],
25	,	,	O	,	_	0	SENT_44	[p1l1358t2480r1499b2509],
26	and	CC	O	and	dep	116	SENT_44	[p1l1512t2480r1558b2503],
27	3Department	NN	O	3department	dep	116	SENT_44	[p1l1571t2475r1738b2509],
28	of	IN	O	of	dep	116	SENT_44	[p1l1749t2480r1775b2503],
29	Pharmacology	NNP	O	Pharmacology	dep	116	SENT_44	[p1l1786t2480r1974b2509],
30	,	,	O	,	_	0	SENT_44	[p1l1786t2480r1974b2509],
31	Pitié	NNP	LOCATION	Pitié	dep	116	SENT_44	[p1l1998t2481r2061b2503],
32	Salpétriere	NNP	LOCATION	Salpétriere	dep	116	SENT_44	[p1l98t2516r236b2546],
33	hospital	NN	O	hospital	dep	116	SENT_44	[p1l249t2516r355b2546],
34	,	,	O	,	_	0	SENT_44	[p1l249t2516r355b2546],
35	Paris	NNP	LOCATION	Paris	dep	116	SENT_44	[p1l370t2518r434b2543],
36	,	,	O	,	_	0	SENT_44	[p1l370t2518r434b2543],
37	France	NNP	LOCATION	France	dep	116	SENT_44	[p1l448t2518r539b2543],
38	;	:	O	;	_	0	SENT_44	[p1l448t2518r539b2543],
39	4Department	NN	O	4department	dep	116	SENT_44	[p1l551t2512r718b2546],
40	of	IN	O	of	dep	116	SENT_44	[p1l730t2516r755b2539],
41	Pharmacy	NNP	O	Pharmacy	dep	116	SENT_44	[p1l767t2516r895b2546],
42	,	,	O	,	_	0	SENT_44	[p1l767t2516r895b2546],
43	Assistance	NNP	ORGANIZATION	Assistance	dep	116	SENT_44	[p1l907t2518r1042b2539],
44	Publique	NNP	ORGANIZATION	Publique	dep	116	SENT_44	[p1l1055t2516r1166b2546],
45	Hopitaux	NNP	ORGANIZATION	Hopitaux	dep	116	SENT_44	[p1l1180t2518r1296b2546],
46	de	IN	ORGANIZATION	de	dep	116	SENT_44	[p1l1307t2516r1338b2539],
47	Paris	NNP	ORGANIZATION	Paris	dep	116	SENT_44	[p1l1352t2518r1416b2543],
48	;	:	O	;	_	0	SENT_44	[p1l1352t2518r1416b2543],
49	SUPMC	NNP	O	SUPMC	dep	116	SENT_44	[p1l1429t2512r1522b2539],
50	(	CD	NUMBER	(	dep	116	SENT_44	[p1l1534t2517r1614b2543],
51	Pierre	NNP	PERSON	Pierre	dep	116	SENT_44	[p1l1534t2517r1614b2543],
52	and	CC	O	and	dep	116	SENT_44	[p1l1627t2516r1672b2539],
53	Marie	NNP	PERSON	Marie	dep	116	SENT_44	[p1l1687t2518r1757b2539],
54	Curie	NNP	PERSON	Curie	dep	116	SENT_44	[p1l1769t2517r1836b2539],
55	university	NN	O	university	dep	116	SENT_44	[p1l1849t2517r1981b2546],
56	)	NN	O	)	dep	116	SENT_44	[p1l1849t2517r1981b2546],
57	,	,	O	,	_	0	SENT_44	[p1l1849t2517r1981b2546],
58	Paris	NNP	LOCATION	Paris	dep	116	SENT_44	[p1l1996t2518r2060b2543],
59	,	,	O	,	_	0	SENT_44	[p1l1996t2518r2060b2543],
60	France	NNP	LOCATION	France	dep	116	SENT_44	[p1l90t2554r180b2580],
61	;	:	O	;	_	0	SENT_44	[p1l90t2554r180b2580],
62	‘	CD	NUMBER	‘	dep	116	SENT_44	[p1l192t2548r308b2576],
63	SINSERM	NNP	O	SINSERM	dep	116	SENT_44	[p1l192t2548r308b2576],
64	(	CD	NUMBER	(	dep	116	SENT_44	[p1l322t2553r414b2580],
65	French	NNP	ORGANIZATION	French	dep	116	SENT_44	[p1l322t2553r414b2580],
66	National	NNP	ORGANIZATION	National	dep	116	SENT_44	[p1l428t2553r534b2576],
67	Institute	NNP	ORGANIZATION	Institute	dep	116	SENT_44	[p1l548t2554r649b2576],
68	of	IN	ORGANIZATION	of	dep	116	SENT_44	[p1l662t2552r687b2576],
69	Medical	NNP	ORGANIZATION	Medical	dep	116	SENT_44	[p1l698t2553r797b2576],
70	Research	NNP	ORGANIZATION	Research	dep	116	SENT_44	[p1l811t2553r924b2576],
71	and	CC	ORGANIZATION	and	dep	116	SENT_44	[p1l937t2553r983b2576],
72	Health	NNP	ORGANIZATION	Health	dep	116	SENT_44	[p1l997t2553r1093b2580],
73	)	NNP	O	)	dep	116	SENT_44	[p1l997t2553r1093b2580],
74	,	,	O	,	_	0	SENT_44	[p1l997t2553r1093b2580],
75	UMRS_975	NNP	O	UMRS_975	dep	116	SENT_44	[p1l1107t2554r1243b2579],
76	unit	NN	O	unit	dep	116	SENT_44	[p1l1256t2555r1309b2580],
77	,	,	O	,	_	0	SENT_44	[p1l1256t2555r1309b2580],
78	CRICM	NNP	O	CRICM	dep	116	SENT_44	[p1l1322t2554r1410b2576],
79	(	NNP	O	(	dep	116	SENT_44	[p1l1424t2553r1545b2580],
80	Research	NNP	ORGANIZATION	Research	dep	116	SENT_44	[p1l1424t2553r1545b2580],
81	Center	NNP	ORGANIZATION	Center	dep	116	SENT_44	[p1l1559t2554r1646b2576],
82	of	IN	O	of	dep	116	SENT_44	[p1l1657t2553r1682b2576],
83	the	DT	O	the	dep	116	SENT_44	[p1l1691t2553r1732b2576],
84	Brain	NN	O	brain	dep	116	SENT_44	[p1l1745t2554r1807b2576],
85	and	CC	O	and	dep	116	SENT_44	[p1l1820t2553r1866b2576],
86	Spine	NN	O	spine	dep	116	SENT_44	[p1l1880t2554r1950b2582],
87	lnsitute	JJ	O	lnsitute	dep	116	SENT_44	[p1l1964t2554r2069b2580],
88	)	NN	O	)	dep	116	SENT_44	[p1l1964t2554r2069b2580],
89	,	,	O	,	_	0	SENT_44	[p1l1964t2554r2069b2580],
90	Paris	NNP	LOCATION	Paris	dep	116	SENT_44	[p1l115t2591r179b2616],
91	,	,	O	,	_	0	SENT_44	[p1l115t2591r179b2616],
92	France	NNP	LOCATION	France	dep	116	SENT_44	[p1l194t2591r284b2616],
93	;	:	O	;	_	0	SENT_44	[p1l194t2591r284b2616],
94	7	CD	NUMBER	7	dep	116	SENT_44	[p1l297t2585r412b2613],
95	|	CD	NUMBER	|	dep	116	SENT_44	[p1l297t2585r412b2613],
96	NSERM	NNP	O	NSERM	dep	116	SENT_44	[p1l297t2585r412b2613],
97	(	CD	NUMBER	(	dep	116	SENT_44	[p1l426t2590r518b2616],
98	French	NNP	ORGANIZATION	French	dep	116	SENT_44	[p1l426t2590r518b2616],
99	National	NNP	ORGANIZATION	National	dep	116	SENT_44	[p1l532t2590r638b2613],
100	Institute	NNP	ORGANIZATION	Institute	dep	116	SENT_44	[p1l652t2591r753b2613],
101	of	IN	ORGANIZATION	of	dep	116	SENT_44	[p1l766t2590r791b2613],
102	Medical	NNP	ORGANIZATION	Medical	dep	116	SENT_44	[p1l802t2590r901b2613],
103	Research	NNP	ORGANIZATION	Research	dep	116	SENT_44	[p1l916t2590r1028b2613],
104	and	CC	ORGANIZATION	and	dep	116	SENT_44	[p1l1041t2590r1087b2613],
105	Health	NNP	ORGANIZATION	Health	dep	116	SENT_44	[p1l1102t2590r1197b2617],
106	)	NNP	O	)	dep	116	SENT_44	[p1l1102t2590r1197b2617],
107	,	,	O	,	_	0	SENT_44	[p1l1102t2590r1197b2617],
108	UMRS_678	NNP	O	UMRS_678	dep	116	SENT_44	[p1l1211t2591r1348b2616],
109	unit	NN	O	unit	dep	116	SENT_44	[p1l1361t2592r1413b2616],
110	,	,	O	,	_	0	SENT_44	[p1l1361t2592r1413b2616],
111	Paris	NNP	LOCATION	Paris	dep	116	SENT_44	[p1l1428t2591r1491b2616],
112	,	,	O	,	_	0	SENT_44	[p1l1428t2591r1491b2616],
113	France	NNP	LOCATION	France	dep	116	SENT_44	[p1l1506t2591r1596b2616],
114	;	:	O	;	_	0	SENT_44	[p1l1506t2591r1596b2616],
115	8Neuropharmacology	NNP	O	8Neuropharmacology	dep	116	SENT_44	[p1l1609t2585r1887b2619],
116	Laboratory	NNP	O	Laboratory	_	0	SENT_44	[p1l1900t2590r2043b2619],
117	,	,	O	,	_	0	SENT_44	[p1l1900t2590r2043b2619],

1	University	NNP	ORGANIZATION	University	_	0	SENT_45	[p1l848t2628r971b2656],
2	of	IN	ORGANIZATION	of	_	0	SENT_45	[p1l982t2626r1008b2649],
3	Rouen	NNP	ORGANIZATION	Rouen	prep_of	1	SENT_45	[p1l1019t2628r1105b2653],
4	,	,	O	,	_	0	SENT_45	[p1l1019t2628r1105b2653],
5	Rouen	NNP	LOCATION	Rouen	nn	7	SENT_45	[p1l1119t2628r1206b2653],
6	,	,	O	,	_	0	SENT_45	[p1l1119t2628r1206b2653],
7	France	NNP	LOCATION	France	appos	3	SENT_45	[p1l1220t2628r1310b2649],
8	.	.	O	.	_	0	SENT_45	[p1l1220t2628r1310b2649],

1	©	NN	O	©	_	0	SENT_46	[p1l1389t2732r1414b2757],
2	201	CD	NUMBER	201	number	3	SENT_46	[p1l1426t2733r1474b2757],
3	1	CD	NUMBER	1	dep	1	SENT_46	[p1l1483t2733r1492b2756],
4	American	NNP	ORGANIZATION	American	nn	6	SENT_46	[p1l1507t2732r1639b2757],
5	Neurological	NNP	ORGANIZATION	Neurological	nn	6	SENT_46	[p1l1652t2731r1828b2766],
6	Association	NNP	ORGANIZATION	Association	dep	3	SENT_46	[p1l1839t2732r1995b2757],
7	111	CD	NUMBER	111	dep	1	SENT_46	[p1l2031t2733r2075b2757],

1	ANNALS	NN	O	annals	nsubjpass	10	SENT_47	[p1l8t2951r370b3017],
2	of	IN	O	of	_	0	SENT_47	[p1l428t2935r534b3046],
3	Neurology	NNP	O	Neurology	nn	4	SENT_47	[p1l541t2935r988b3046],
4	years	NNS	DURATION	year	prep_of	1	SENT_47	[p1l8t3243r204b3306],
5	,	,	O	,	_	0	SENT_47	[p1l8t3243r204b3306],
6	motor	NN	O	motor	nn	7	SENT_47	[p1l241t3238r463b3284],
7	performance	NN	O	performance	appos	4	SENT_47	[p1l493t3215r945b3306],
8	is	VBZ	O	be	auxpass	10	SENT_47	[p1l979t3220r1028b3284],
9	closely	RB	O	closely	advmod	10	SENT_47	[p1l1062t3215r1299b3306],
10	correlated	VBN	O	correlate	_	0	SENT_47	[p1l1328t3215r1680b3285],
11	with	IN	O	with	_	0	SENT_47	[p1l1710t3215r1871b3284],
12	fluctuations	NNS	O	fluctuation	prep_with	10	SENT_47	[p1l1903t3215r2140b3285, p1l11t3342r221b3406],
13	in	IN	O	in	_	0	SENT_47	[p1l266t3342r335b3405],
14	the	DT	O	the	det	16	SENT_47	[p1l380t3337r488b3406],
15	plasma	NN	O	plasma	nn	16	SENT_47	[p1l531t3337r781b3429],
16	concentration	NN	O	concentration	prep_in	12	SENT_47	[p1l824t3342r1319b3406],
17	of	IN	O	of	_	0	SENT_47	[p1l1363t3337r1444b3406],
18	L	NN	O	l	nn	21	SENT_47	[p1l1476t3322r1842b3429],
19	—	CD	NUMBER	—	num	21	SENT_47	[p1l1476t3322r1842b3429],
20	dopa	NN	O	dopa	nn	21	SENT_47	[p1l1476t3322r1842b3429],
21	.2	NN	NUMBER	.2	prep_of	16	SENT_47	[p1l1476t3322r1842b3429],
22	’	CD	NUMBER	’	number	23	SENT_47	[p1l1476t3322r1842b3429],
23	3	CD	NUMBER	3	dobj	10	SENT_47	[p1l1476t3322r1842b3429],
24	At	IN	O	at	_	0	SENT_47	[p1l1883t3341r1972b3406],
25	this	DT	O	this	det	26	SENT_47	[p1l2015t3337r2140b3406],
26	stage	NN	O	stage	prep_at	37	SENT_47	[p1l10t3509r202b3578],
27	,	,	O	,	_	0	SENT_47	[p1l10t3509r202b3578],
28	patients	NNS	O	patient	appos	26	SENT_47	[p1l242t3490r521b3577],
29	experience	NN	O	experience	nn	30	SENT_47	[p1l560t3490r932b3577],
30	periods	NNS	O	period	nsubj	37	SENT_47	[p1l970t3486r1229b3577],
31	during	IN	O	during	_	0	SENT_47	[p1l1269t3486r1508b3578],
32	which	WDT	O	which	rel	34	SENT_47	[p1l1540t3485r1758b3554],
33	they	PRP	O	they	nsubj	34	SENT_47	[p1l1795t3486r1948b3576],
34	have	VBP	O	have	rcmod	30	SENT_47	[p1l1982t3486r2142b3554],
35	parkinsonian	JJ	O	parkinsonian	amod	36	SENT_47	[p2l10t33r478b124],
36	symptoms	NNS	O	symptom	dobj	34	SENT_47	[p2l524t56r891b124],
37	(	VBP	O	(	rcmod	23	SENT_47	[p2l943t34r1136b115],
38	OFF	NN	O	off	nn	40	SENT_47	[p2l943t34r1136b115],
39	state	NN	O	state	nn	40	SENT_47	[p2l1186t34r1368b115],
40	)	NN	O	)	dobj	37	SENT_47	[p2l1186t34r1368b115],
41	and	CC	O	and	_	0	SENT_47	[p2l1420t33r1551b103],
42	periods	NNS	O	period	dobj	37	SENT_47	[p2l1596t33r1856b124],
43	during	IN	O	during	_	0	SENT_47	[p2l1904t33r2143b125],
44	which	WDT	O	which	rel	49	SENT_47	[p2l7t144r225b213],
45	the	DT	O	the	det	46	SENT_47	[p2l279t144r388b213],
46	symptoms	NNS	O	symptom	nsubjpass	49	SENT_47	[p2l441t168r807b236],
47	are	VBP	O	be	auxpass	49	SENT_47	[p2l863t172r965b213],
48	effectively	RB	O	effectively	advmod	49	SENT_47	[p2l1018t144r1378b235],
49	alleviated	VBN	O	alleviate	rcmod	42	SENT_47	[p2l1428t144r1762b214],
50	by	IN	O	by	_	0	SENT_47	[p2l1815t144r1902b235],
51	treatment	NN	O	treatment	agent	49	SENT_47	[p2l1953t167r2140b213, p2l11t279r196b324],
52	(	CD	NUMBER	(	num	51	SENT_47	[p2l232t257r400b338],
53	ON	IN	O	on	_	0	SENT_47	[p2l232t257r400b338],
54	state	NN	O	state	nn	55	SENT_47	[p2l433t257r640b338],
55	)	NN	O	)	prep_on	51	SENT_47	[p2l433t257r640b338],
56	.	.	O	.	_	0	SENT_47	[p2l433t257r640b338],

1	The	DT	O	the	det	3	SENT_48	[p2l215t367r359b436],
2	major	JJ	O	major	amod	3	SENT_48	[p2l405t373r615b459],
3	pathway	NN	O	pathway	nsubj	13	SENT_48	[p2l659t367r961b458],
4	for	IN	O	for	_	0	SENT_48	[p2l1004t367r1105b436],
5	the	DT	O	the	det	6	SENT_48	[p2l1150t367r1259b436],
6	metabolism	NN	O	metabolism	prep_for	3	SENT_48	[p2l1305t367r1722b436],
7	of	IN	O	of	_	0	SENT_48	[p2l1769t367r1850b436],
8	L	NN	O	l	nn	10	SENT_48	[p2l1884t367r2143b458],
9	—	CD	NUMBER	—	num	10	SENT_48	[p2l1884t367r2143b458],
10	dopa	NN	O	dopa	prep_of	6	SENT_48	[p2l1884t367r2143b458],
11	is	VBZ	O	be	cop	13	SENT_48	[p2l11t483r60b547],
12	its	PRP$	O	its	poss	13	SENT_48	[p2l116t483r193b547],
13	decarboxylation	NN	O	decarboxylation	_	0	SENT_48	[p2l248t478r818b569],
14	to	TO	O	to	_	0	SENT_48	[p2l872t502r940b547],
15	dopamine	NN	O	dopamine	prep_to	13	SENT_48	[p2l996t478r1356b570],
16	by	IN	O	by	_	0	SENT_48	[p2l1409t478r1497b569],
17	aromatic	JJ	O	aromatic	amod	20	SENT_48	[p2l1547t483r1861b547],
18	amino	NN	O	amino	nn	20	SENT_48	[p2l1915t483r2139b547],
19	acid	NN	O	acid	nn	20	SENT_48	[p2l11t589r154b658],
20	decarboxylase	NN	O	decarboxylase	prep_by	13	SENT_48	[p2l224t589r714b679],
21	(	CD	NUMBER	(	num	22	SENT_48	[p2l788t570r1153b671],
22	AADC	NN	O	aadc	tmod	13	SENT_48	[p2l788t570r1153b671],
23	)	CD	NUMBER	)	number	24	SENT_48	[p2l788t570r1153b671],
24	.4	CD	NUMBER	.4	num	26	SENT_48	[p2l788t570r1153b671],
25	Peripheral	JJ	O	peripheral	amod	26	SENT_48	[p2l1225t589r1584b680],
26	inhibitors	NNS	O	inhibitor	nsubjpass	39	SENT_48	[p2l1654t589r2001b657],
27	of	IN	O	of	_	0	SENT_48	[p2l2073t588r2153b657],
28	AADC	NNP	O	AADC	prep_of	26	SENT_48	[p2l6t703r261b769],
29	(	CD	NUMBER	(	num	28	SENT_48	[p2l309t701r697b782],
30	AADCIS	NNP	O	AADCIS	dep	26	SENT_48	[p2l309t701r697b782],
31	)	CD	NUMBER	)	num	30	SENT_48	[p2l309t701r697b782],
32	,	,	O	,	_	0	SENT_48	[p2l309t701r697b782],
33	benserazide	NN	O	benserazide	appos	26	SENT_48	[p2l743t700r1152b769],
34	or	CC	O	or	_	0	SENT_48	[p2l1196t727r1270b768],
35	carbidopa	NN	O	carbidopa	conj_or	33	SENT_48	[p2l1311t700r1683b791],
36	,	,	O	,	_	0	SENT_48	[p2l1311t700r1683b791],
37	are	VBP	O	be	auxpass	39	SENT_48	[p2l1730t727r1832b768],
38	systematically	RB	O	systematically	advmod	39	SENT_48	[p2l1874t723r2140b790, p2l11t811r263b902],
39	coadministered	VBN	O	coadminister	rcmod	22	SENT_48	[p2l308t811r857b881],
40	with	IN	O	with	_	0	SENT_48	[p2l900t811r1062b880],
41	L	NN	O	l	nn	43	SENT_48	[p2l1110t811r1369b903],
42	—	CD	NUMBER	—	num	43	SENT_48	[p2l1110t811r1369b903],
43	dopa	NN	O	dopa	prep_with	39	SENT_48	[p2l1110t811r1369b903],
44	to	TO	O	to	aux	45	SENT_48	[p2l1415t834r1483b880],
45	enhance	VB	O	enhance	xcomp	39	SENT_48	[p2l1533t811r1823b880],
46	its	PRP$	O	its	poss	47	SENT_48	[p2l1872t816r1949b880],
47	bioavailability	NN	O	bioavailability	dobj	45	SENT_48	[p2l1998t811r2140b880, p2l11t921r408b1012],
48	.	.	O	.	_	0	SENT_48	[p2l1998t811r2140b880, p2l11t921r408b1012],

1	In	IN	O	in	_	0	SENT_49	[p2l462t926r537b989],
2	the	DT	O	the	det	3	SENT_49	[p2l585t922r694b990],
3	presence	NN	O	presence	prep_in	12	SENT_49	[p2l741t949r1044b1013],
4	of	IN	O	of	_	0	SENT_49	[p2l1093t921r1174b990],
5	AADCIS	NNP	LOCATION	AADCIS	prep_of	3	SENT_49	[p2l1205t925r1543b1000],
6	,	,	O	,	_	0	SENT_49	[p2l1205t925r1543b1000],
7	L	NNP	O	L	nsubjpass	12	SENT_49	[p2l1594t922r1853b1013],
8	—	CD	NUMBER	—	num	9	SENT_49	[p2l1594t922r1853b1013],
9	dopa	NN	O	dopa	dep	7	SENT_49	[p2l1594t922r1853b1013],
10	is	VBZ	O	be	auxpass	12	SENT_49	[p2l1901t926r1950b990],
11	predominantly	RB	O	predominantly	advmod	12	SENT_49	[p2l1998t949r2140b1013, p2l11t1033r431b1123],
12	metabolized	VBN	O	metabolize	_	0	SENT_49	[p2l491t1033r927b1102],
13	to	TO	O	to	_	0	SENT_49	[p2l990t1056r1058b1101],
14	3	CD	NUMBER	3	prep_to	12	SENT_49	[p2l1125t1033r1735b1124],
15	.	.	O	.	_	0	SENT_49	[p2l1125t1033r1735b1124],

1	—	NN	O	—	_	0	SENT_50	[p2l1125t1033r1735b1124],
2	.	.	O	.	_	0	SENT_50	[p2l1125t1033r1735b1124],

1	O-methyldopa	NN	O	o-methyldopa	_	0	SENT_51	[p2l1125t1033r1735b1124],
2	by	IN	O	by	_	0	SENT_51	[p2l1798t1033r1885b1123],
3	C	NN	O	c	prep_by	1	SENT_51	[p2l1947t1036r2140b1102],
4	.	.	O	.	_	0	SENT_51	[p2l1947t1036r2140b1102],

1	—	NN	O	—	_	0	SENT_52	[p2l1947t1036r2140b1102],
2	.	.	O	.	_	0	SENT_52	[p2l1947t1036r2140b1102],

1	O	NN	O	o	nn	2	SENT_53	[p2l1947t1036r2140b1102],
2	methyltransferase	NN	O	methyltransferase	nsubjpass	14	SENT_53	[p2l11t1145r636b1236],
3	(	CD	NUMBER	(	num	4	SENT_53	[p2l674t1129r1069b1228],
4	COMT	NNP	MISC	COMT	dep	2	SENT_53	[p2l674t1129r1069b1228],
5	)	CD	NUMBER	)	num	4	SENT_53	[p2l674t1129r1069b1228],
6	.5	CD	NUMBER	.5	num	7	SENT_53	[p2l674t1129r1069b1228],
7	Potent	NN	O	potent	dep	2	SENT_53	[p2l1107t1150r1338b1214],
8	and	CC	O	and	_	0	SENT_53	[p2l1371t1145r1502b1215],
9	selective	JJ	O	selective	amod	11	SENT_53	[p2l1535t1145r1825b1214],
10	COMT	NN	O	comt	nn	11	SENT_53	[p2l1860t1147r2142b1214],
11	inhibitors	NNS	O	inhibitor	dep	2	SENT_53	[p2l11t1256r357b1324],
12	have	VBP	O	have	aux	14	SENT_53	[p2l387t1256r546b1324],
13	been	VBN	O	be	auxpass	14	SENT_53	[p2l574t1256r741b1324],
14	developed	VBN	O	develop	_	0	SENT_53	[p2l769t1255r1129b1347],
15	to	TO	O	to	aux	16	SENT_53	[p2l1158t1279r1225b1324],
16	increase	VB	O	increase	xcomp	14	SENT_53	[p2l1256t1260r1535b1324],
17	the	DT	O	the	det	20	SENT_53	[p2l1564t1256r1673b1324],
18	bioavailabil	NN	O	bioavailabil	nn	20	SENT_53	[p2l1701t1255r2139b1324],
19	—	NN	O	—	nn	20	SENT_53	[p2l1701t1255r2139b1324],
20	ity	NN	O	ity	dobj	16	SENT_53	[p2l11t1371r104b1457],
21	of	IN	O	of	_	0	SENT_53	[p2l138t1367r219b1435],
22	L	NN	O	l	nn	24	SENT_53	[p2l244t1367r520b1458],
23	—	CD	NUMBER	—	num	24	SENT_53	[p2l244t1367r520b1458],
24	dopa	NN	O	dopa	prep_of	20	SENT_53	[p2l244t1367r520b1458],
25	.	.	O	.	_	0	SENT_53	[p2l244t1367r520b1458],

1	One	CD	NUMBER	one	nsubjpass	9	SENT_54	[p2l562t1370r717b1436],
2	of	IN	O	of	_	0	SENT_54	[p2l755t1367r835b1435],
3	these	DT	O	these	prep_of	1	SENT_54	[p2l861t1367r1056b1445],
4	,	,	O	,	_	0	SENT_54	[p2l861t1367r1056b1445],
5	entacapone	NN	O	entacapone	appos	3	SENT_54	[p2l1098t1390r1519b1458],
6	,	,	O	,	_	0	SENT_54	[p2l1098t1390r1519b1458],
7	has	VBZ	O	have	aux	9	SENT_54	[p2l1560t1367r1671b1435],
8	been	VBN	O	be	auxpass	9	SENT_54	[p2l1709t1367r1875b1435],
9	shown	VBN	O	show	_	0	SENT_54	[p2l1912t1367r2142b1436],
10	to	TO	O	to	aux	11	SENT_54	[p2l11t1501r79b1546],
11	prolong	VB	O	prolong	xcomp	9	SENT_54	[p2l113t1477r396b1570],
12	the	DT	O	the	det	15	SENT_54	[p2l428t1478r536b1546],
13	half	NN	O	half	nn	15	SENT_54	[p2l569t1477r844b1546],
14	—	JJ	O	—	amod	15	SENT_54	[p2l569t1477r844b1546],
15	life	NN	O	life	dobj	11	SENT_54	[p2l569t1477r844b1546],
16	of	IN	O	of	_	0	SENT_54	[p2l878t1477r959b1546],
17	L	NN	O	l	nn	19	SENT_54	[p2l980t1477r1256b1569],
18	—	CD	NUMBER	—	num	19	SENT_54	[p2l980t1477r1256b1569],
19	dopa	NN	O	dopa	prep_of	15	SENT_54	[p2l980t1477r1256b1569],
20	,	,	O	,	_	0	SENT_54	[p2l980t1477r1256b1569],
21	increasing	VBG	O	increase	partmod	11	SENT_54	[p2l1293t1482r1653b1570],
22	its	PRP$	O	its	poss	25	SENT_54	[p2l1684t1482r1762b1546],
23	bioavaila	NN	O	bioavailum	nn	25	SENT_54	[p2l1796t1478r2140b1546],
24	—	NN	O	—	nn	25	SENT_54	[p2l1796t1478r2140b1546],
25	bility	NN	O	bility	dobj	21	SENT_54	[p2l11t1589r206b1679],
26	.	.	O	.	_	0	SENT_54	[p2l11t1589r206b1679],

1	In	IN	O	in	_	0	SENT_55	[p2l241t1593r316b1656],
2	PD	NN	O	pd	nn	3	SENT_55	[p2l345t1593r462b1657],
3	patients	NNS	O	patient	prep_in	6	SENT_55	[p2l493t1593r792b1680],
4	,	,	O	,	_	0	SENT_55	[p2l493t1593r792b1680],
5	entacapone	NN	O	entacapone	nsubj	27	SENT_55	[p2l826t1612r1227b1680],
6	increases	VBZ	O	increase	_	0	SENT_55	[p2l1258t1593r1566b1657],
7	the	DT	O	the	det	8	SENT_55	[p2l1597t1589r1706b1657],
8	duration	NN	O	duration	dobj	6	SENT_55	[p2l1735t1589r2043b1658],
9	of	IN	O	of	_	0	SENT_55	[p2l2073t1589r2153b1657],
10	the	DT	O	the	det	12	SENT_55	[p2l11t1700r120b1768],
11	motor	NN	O	motor	nn	12	SENT_55	[p2l153t1723r375b1768],
12	response	NN	O	response	prep_of	8	SENT_55	[p2l407t1727r711b1791],
13	by	IN	O	by	_	0	SENT_55	[p2l744t1700r831b1790],
14	30	CD	NUMBER	30	number	16	SENT_55	[p2l861t1707r948b1772],
15	to	TO	O	to	dep	16	SENT_55	[p2l983t1723r1051b1768],
16	40	CD	PERCENT	40	num	17	SENT_55	[p2l1085t1701r1252b1771],
17	%	NN	PERCENT	%	prep_by	6	SENT_55	[p2l1085t1701r1252b1771],
18	after	IN	O	after	_	0	SENT_55	[p2l1288t1700r1446b1768],
19	an	DT	O	a	det	21	SENT_55	[p2l1478t1727r1561b1768],
20	acute	JJ	O	acute	amod	21	SENT_55	[p2l1594t1723r1778b1769],
21	challenge	NN	O	challenge	prep_after	17	SENT_55	[p2l1811t1700r2141b1792],
22	with	IN	O	with	_	0	SENT_55	[p2l7t1811r169b1879],
23	L	NN	O	l	nn	25	SENT_55	[p2l231t1811r491b1902],
24	—	CD	NUMBER	—	num	25	SENT_55	[p2l231t1811r491b1902],
25	dopa	NN	O	dopa	prep_with	21	SENT_55	[p2l231t1811r491b1902],
26	and	CC	O	and	_	0	SENT_55	[p2l552t1811r682b1880],
27	decreases	VBZ	O	decrease	conj_and	6	SENT_55	[p2l745t1811r1064b1880],
28	motor	NN	O	motor	nn	29	SENT_55	[p2l1128t1834r1351b1879],
29	fluctuations	NNS	O	fluctuation	dobj	27	SENT_55	[p2l1412t1810r1855b1880],
30	.	.	O	.	_	0	SENT_55	[p2l1412t1810r1855b1880],

1	\	NN	O	\	_	0	SENT_56	[p2l1919t1811r2141b1879],
2	When	WRB	O	when	advmod	3	SENT_56	[p2l1919t1811r2141b1879],
3	administered	VBN	O	administer	dep	1	SENT_56	[p2l11t1922r477b1991],
4	repeatedly	RB	O	repeatedly	advmod	3	SENT_56	[p2l530t1922r897b2013],
5	With	IN	O	with	_	0	SENT_56	[p2l944t1922r1106b1991],
6	each	DT	O	each	det	7	SENT_56	[p2l1158t1922r1314b1990],
7	dose	NN	O	dose	prep_with	3	SENT_56	[p2l1367t1922r1523b1991],
8	of	IN	O	of	_	0	SENT_56	[p2l1577t1922r1658b1990],
9	L	NN	O	l	nn	11	SENT_56	[p2l1699t1922r1976b2013],
10	—	CD	NUMBER	—	num	11	SENT_56	[p2l1699t1922r1976b2013],
11	dopa	NN	O	dopa	prep_of	7	SENT_56	[p2l1699t1922r1976b2013],
12	,	,	O	,	_	0	SENT_56	[p2l1699t1922r1976b2013],
13	the	DT	O	the	det	14	SENT_56	[p2l2033t1922r2141b1990],
14	length	NN	O	length	appos	11	SENT_56	[p2l10t2033r234b2125],
15	of	IN	O	of	_	0	SENT_56	[p2l264t2033r345b2101],
16	the	DT	O	the	det	18	SENT_56	[p2l364t2033r472b2101],
17	ON	NNP	O	ON	nn	18	SENT_56	[p2l503t2036r644b2102],
18	state	NN	O	state	prep_of	1	SENT_56	[p2l675t2056r833b2101],
19	during	IN	O	during	_	0	SENT_56	[p2l863t2033r1102b2125],
20	Waking	VBG	O	wake	prepc_during	1	SENT_56	[p2l1128t2033r1388b2125],
21	hours	NNS	DURATION	hour	nn	22	SENT_56	[p2l1415t2033r1614b2102],
22	increases	NNS	O	increase	dobj	20	SENT_56	[p2l1645t2038r1953b2101],
23	by	IN	O	by	_	0	SENT_56	[p2l1985t2033r2072b2123],
24	2	CD	DURATION	2	number	26	SENT_56	[p2l2098t2040r2139b2100],
25	to	TO	DURATION	to	dep	26	SENT_56	[p2l11t2177r79b2223],
26	2.5	CD	DURATION	2.5	num	27	SENT_56	[p2l108t2160r216b2227],
27	hours	NNS	NUMBER	hour	prep_by	20	SENT_56	[p2l248t2154r466b2223],
28	.	.	O	.	_	0	SENT_56	[p2l248t2154r466b2223],

1	COMT	NNP	O	COMT	nsubjpass	3	SENT_57	[p2l218t2267r500b2334],
2	is	VBZ	O	be	auxpass	3	SENT_57	[p2l545t2270r595b2334],
3	involved	VBN	O	involve	_	0	SENT_57	[p2l645t2265r948b2335],
4	in	IN	O	in	_	0	SENT_57	[p2l997t2270r1066b2333],
5	the	DT	O	the	det	6	SENT_57	[p2l1115t2265r1223b2334],
6	metabolism	NN	O	metabolism	prep_in	3	SENT_57	[p2l1272t2265r1689b2334],
7	of	IN	O	of	_	0	SENT_57	[p2l1739t2265r1820b2334],
8	endogenous	JJ	O	endogenous	amod	11	SENT_57	[p2l1857t2265r2140b2357, p2l11t2403r178b2446],
9	and	CC	O	and	_	0	SENT_57	[p2l230t2376r361b2446],
10	exogenous	JJ	O	exogenous	amod	11	SENT_57	[p2l410t2404r779b2468],
11	substrates	NNS	O	substrate	prep_of	6	SENT_57	[p2l830t2376r1173b2446],
12	with	IN	O	with	_	0	SENT_57	[p2l1221t2376r1383b2445],
13	catechol	NN	O	catechol	nn	14	SENT_57	[p2l1433t2376r1722b2445],
14	structures	NNS	O	structure	prep_with	11	SENT_57	[p2l1772t2399r2138b2455],
15	,	,	O	,	_	0	SENT_57	[p2l1772t2399r2138b2455],
16	such	JJ	O	such	_	0	SENT_57	[p2l10t2487r170b2556],
17	as	IN	O	as	_	0	SENT_57	[p2l223t2515r286b2556],
18	dopamine	NN	O	dopamine	prep_such_as	6	SENT_57	[p2l340t2487r699b2578],
19	and	CC	O	and	_	0	SENT_57	[p2l753t2487r884b2557],
20	L	NN	O	l	nn	22	SENT_57	[p2l937t2487r1212b2578],
21	—	CD	NUMBER	—	num	22	SENT_57	[p2l937t2487r1212b2578],
22	dopa	NN	O	dopa	prep_such_as	6	SENT_57	[p2l937t2487r1212b2578],
23	.	.	O	.	_	0	SENT_57	[p2l937t2487r1212b2578],

1	In	IN	O	in	_	0	SENT_58	[p2l1271t2491r1346b2555],
2	humans	NNS	O	human	prep_in	7	SENT_58	[p2l1397t2487r1700b2565],
3	,	,	O	,	_	0	SENT_58	[p2l1397t2487r1700b2565],
4	COMT	NNP	O	COMT	nsubjpass	7	SENT_58	[p2l1759t2489r2041b2556],
5	is	VBZ	O	be	auxpass	7	SENT_58	[p2l2091t2492r2140b2556],
6	ubiquitously	RB	O	ubiquitously	advmod	7	SENT_58	[p2l12t2606r465b2697],
7	expressed	VBN	O	express	_	0	SENT_58	[p2l513t2606r866b2697],
8	;	:	O	;	_	0	SENT_58	[p2l513t2606r866b2697],
9	the	DT	O	the	det	11	SENT_58	[p2l921t2606r1030b2675],
10	greatest	JJS	O	greatest	amod	11	SENT_58	[p2l1080t2629r1350b2698],
11	activity	NN	O	activity	nsubjpass	13	SENT_58	[p2l1400t2611r1660b2697],
12	is	VBZ	O	be	auxpass	13	SENT_58	[p2l1708t2611r1757b2675],
13	found	VBN	O	find	parataxis	7	SENT_58	[p2l1808t2606r2022b2676],
14	in	IN	O	in	_	0	SENT_58	[p2l2073t2611r2142b2674],
15	the	DT	O	the	det	16	SENT_58	[p2l11t2717r120b2785],
16	liver	NN	O	liver	prep_in	13	SENT_58	[p2l164t2717r331b2795],
17	,	,	O	,	_	0	SENT_58	[p2l164t2717r331b2795],
18	kidney	NN	O	kidney	prep_in	13	SENT_58	[p2l379t2717r632b2807],
19	,	,	O	,	_	0	SENT_58	[p2l379t2717r632b2807],
20	and	CC	O	and	_	0	SENT_58	[p2l680t2717r812b2786],
21	gastrointestinal	JJ	O	gastrointestinal	amod	22	SENT_58	[p2l855t2717r1398b2809],
22	tract	NN	O	tract	prep_in	13	SENT_58	[p2l1444t2740r1621b2785],
23	.	.	O	.	_	0	SENT_58	[p2l1444t2740r1621b2785],

1	Early	JJ	O	early	amod	2	SENT_59	[p2l1670t2717r1858b2807],
2	studies	NNS	O	study	nsubj	3	SENT_59	[p2l1899t2717r2140b2786],
3	noted	VBD	O	note	_	0	SENT_59	[p2l11t2828r215b2897],
4	a	DT	O	a	dep	18	SENT_59	[p2l256t2856r292b2896],
5	4	LS	NUMBER	4	dep	4	SENT_59	[p2l331t2828r403b2895],
6	-	:	O	-	_	0	SENT_59	[p2l331t2828r403b2895],
7	to	TO	O	to	dep	4	SENT_59	[p2l446t2851r514b2896],
8	5-fold	RB	O	5-fold	advmod	9	SENT_59	[p2l561t2828r776b2901],
9	interindividual	JJ	O	interindividual	amod	10	SENT_59	[p2l817t2828r1349b2897],
10	variation	NN	O	variation	pobj	7	SENT_59	[p2l1388t2832r1706b2896],
11	in	IN	O	in	_	0	SENT_59	[p2l1748t2832r1817b2895],
12	COMT	NN	O	comt	nn	13	SENT_59	[p2l1860t2830r2142b2897],
13	activity	NN	O	activity	prep_in	10	SENT_59	[p2l11t2944r271b3030],
14	in	IN	O	in	_	0	SENT_59	[p2l314t2944r382b3007],
15	red	JJ	O	red	amod	17	SENT_59	[p2l428t2939r541b3009],
16	blood	NN	O	blood	nn	17	SENT_59	[p2l585t2939r791b3009],
17	cells	NNS	O	cell	prep_in	13	SENT_59	[p2l836t2924r1040b3008],
18	.9	CD	NUMBER	.9	dep	3	SENT_59	[p2l836t2924r1040b3008],
19	The	DT	O	the	det	20	SENT_59	[p2l1085t2939r1229b3008],
20	distribution	NN	O	distribution	dobj	3	SENT_59	[p2l1275t2939r1698b3009],
21	of	IN	O	of	_	0	SENT_59	[p2l1745t2939r1825b3008],
22	COMT	NN	O	comt	nn	23	SENT_59	[p2l1860t2941r2142b3008],
23	activity	NN	O	activity	prep_of	20	SENT_59	[p2l11t3064r271b3150],
24	in	IN	O	in	_	0	SENT_59	[p2l312t3064r381b3127],
25	the	DT	O	the	det	26	SENT_59	[p2l424t3059r533b3128],
26	population	NN	O	population	prep_in	23	SENT_59	[p2l575t3059r971b3151],
27	and	CC	O	and	_	0	SENT_59	[p2l1015t3059r1145b3129],
28	its	PRP$	O	its	poss	29	SENT_59	[p2l1188t3064r1265b3128],
29	segregation	NN	O	segregation	nsubj	32	SENT_59	[p2l1309t3064r1710b3151],
30	in	IN	O	in	_	0	SENT_59	[p2l1754t3064r1823b3127],
31	families	NNS	O	family	prep_in	29	SENT_59	[p2l1866t3059r2140b3128],
32	indicated	VBD	O	indicate	conj_and	3	SENT_59	[p2l11t3169r341b3239],
33	that	IN	O	that	complm	36	SENT_59	[p2l381t3170r521b3238],
34	it	PRP	O	it	nsubjpass	36	SENT_59	[p2l561t3174r611b3238],
35	is	VBZ	O	be	auxpass	36	SENT_59	[p2l650t3174r699b3238],
36	regulated	VBN	O	regulate	ccomp	32	SENT_59	[p2l742t3170r1070b3262],
37	by	IN	O	by	_	0	SENT_59	[p2l1111t3170r1198b3260],
38	a	DT	O	a	det	41	SENT_59	[p2l1236t3198r1271b3238],
39	single	JJ	O	single	amod	41	SENT_59	[p2l1309t3170r1512b3262],
40	autosomal	JJ	O	autosomal	amod	41	SENT_59	[p2l1553t3170r1920b3239],
41	locus	NN	O	locus	agent	36	SENT_59	[p2l1960t3170r2140b3239],
42	with	IN	O	with	_	0	SENT_59	[p2l7t3282r169b3351],
43	2	CD	NUMBER	2	num	45	SENT_59	[p2l208t3289r250b3350],
44	codominant	NN	O	codominant	nn	45	SENT_59	[p2l291t3282r726b3352],
45	alleles	NNS	O	allele	prep_with	41	SENT_59	[p2l766t3267r1150b3351],
46	.1	CD	NUMBER	.1	num	47	SENT_59	[p2l766t3267r1150b3351],
47	O’11	NN	O	o’11	tmod	36	SENT_59	[p2l766t3267r1150b3351],
48	Subsequent	JJ	O	subsequent	amod	49	SENT_59	[p2l1197t3282r1608b3374],
49	studies	NNS	O	study	nsubj	50	SENT_59	[p2l1646t3282r1886b3352],
50	found	VBD	O	find	rcmod	47	SENT_59	[p2l1928t3282r2142b3352],
51	that	IN	O	that	complm	58	SENT_59	[p2l11t3393r151b3462],
52	the	DT	O	the	det	53	SENT_59	[p2l196t3393r305b3462],
53	variability	NN	O	variability	nsubj	58	SENT_59	[p2l347t3393r709b3484],
54	in	IN	O	in	_	0	SENT_59	[p2l753t3398r822b3461],
55	COMT	NN	O	comt	nn	56	SENT_59	[p2l869t3395r1151b3462],
56	activity	NN	O	activity	prep_in	53	SENT_59	[p2l1187t3398r1447b3484],
57	is	VBZ	O	be	cop	58	SENT_59	[p2l1490t3398r1540b3462],
58	due	JJ	O	due	ccomp	50	SENT_59	[p2l1587t3393r1715b3463],
59	to	TO	O	to	_	0	SENT_59	[p2l1762t3416r1829b3462],
60	a	DT	O	a	det	61	SENT_59	[p2l1878t3422r1913b3462],
61	polymorphism	NN	O	polymorphism	prep_to	58	SENT_59	[p2l1956t3393r2140b3484, p2l11t3504r381b3595],
62	in	IN	O	in	_	0	SENT_59	[p2l435t3509r504b3571],
63	the	DT	O	the	det	69	SENT_59	[p2l556t3504r665b3572],
64	COM	NN	O	com	nn	69	SENT_59	[p2l724t3507r935b3573],
65	T	NN	O	t	nn	69	SENT_59	[p2l938t3506r998b3571],
66	gene	NN	O	gene	nn	69	SENT_59	[p2l1034t3531r1195b3596],
67	(	CD	NUMBER	(	num	69	SENT_59	[p2l1252t3505r1547b3586],
68	rs4608	NN	O	rs4608	nn	69	SENT_59	[p2l1252t3505r1547b3586],
69	)	NN	O	)	prep_in	61	SENT_59	[p2l1252t3505r1547b3586],
70	that	WDT	O	that	nsubj	71	SENT_59	[p2l1606t3504r1745b3572],
71	results	VBZ	O	result	rcmod	69	SENT_59	[p2l1796t3504r2018b3573],
72	in	IN	O	in	_	0	SENT_59	[p2l2073t3509r2141b3571],
73	the	DT	O	the	det	74	SENT_59	[p2l11t3615r120b3684],
74	conversion	NN	O	conversion	prep_in	71	SENT_59	[p2l167t3620r551b3684],
75	in	IN	O	in	_	0	SENT_59	[p2l599t3620r668b3683],
76	the	DT	O	the	det	77	SENT_59	[p2l716t3615r824b3684],
77	enzyme	NN	O	enzyme	prep_in	74	SENT_59	[p2l871t3643r1139b3706],
78	of	IN	O	of	_	0	SENT_59	[p2l1188t3615r1268b3684],
79	valine	NN	O	valine	prep_of	77	SENT_59	[p2l1300t3615r1510b3684],
80	158	CD	NUMBER	158	num	79	SENT_59	[p2l1566t3621r1690b3688],
81	to	TO	O	to	_	0	SENT_59	[p2l1741t3638r1809b3684],
82	methionine	NN	O	methionine	nn	85	SENT_59	[p2l1857t3615r2139b3684, p2l11t3731r166b3795],
83	(	CD	NUMBER	(	num	85	SENT_59	[p2l221t3726r698b3808],
84	Val158Met	NN	O	val158met	nn	85	SENT_59	[p2l221t3726r698b3808],
85	)	NN	O	)	prep_to	71	SENT_59	[p2l221t3726r698b3808],
86	.	.	O	.	_	0	SENT_59	[p2l221t3726r698b3808],

1	The	DT	O	the	det	3	SENT_60	[p2l752t3726r897b3795],
2	158Val	JJ	O	158val	amod	3	SENT_60	[p2l955t3726r1200b3799],
3	allele	NN	O	allele	nsubjpass	5	SENT_60	[p2l1251t3726r1429b3795],
4	is	VBZ	O	be	auxpass	5	SENT_60	[p2l1480t3731r1529b3795],
5	associated	VBN	O	associate	_	0	SENT_60	[p2l1580t3726r1934b3795],
6	with	IN	O	with	_	0	SENT_60	[p2l1980t3726r2142b3795],
7	a	DT	O	a	det	13	SENT_60	[p3l11t58r47b98],
8	higher	JJR	O	higher	dep	9	SENT_60	[p3l137t29r366b122],
9	enzymatic	JJ	O	enzymatic	amod	13	SENT_60	[p3l459t34r820b120],
10	activity	NN	O	activity	nn	13	SENT_60	[p3l913t34r1173b120],
11	(	CD	NUMBER	(	num	13	SENT_60	[p3l1268t31r1511b112],
12	COM	NNP	O	COM	nn	13	SENT_60	[p3l1268t31r1511b112],
13	TH	NN	O	th	prep_with	5	SENT_60	[p3l1515t14r1622b97],
14	allele	NN	O	allele	nn	15	SENT_60	[p3l1707t29r1935b112],
15	)	NN	O	)	tmod	13	SENT_60	[p3l1707t29r1935b112],
16	,	,	O	,	_	0	SENT_60	[p3l1707t29r1935b112],
17	the	DT	O	the	det	19	SENT_60	[p3l2032t30r2141b98],
18	158Met	NN	O	158met	nn	19	SENT_60	[p3l19t146r298b215],
19	allele	NN	O	allele	appos	15	SENT_60	[p3l345t141r523b210],
20	with	IN	O	with	_	0	SENT_60	[p3l568t141r729b210],
21	a	DT	O	a	det	23	SENT_60	[p3l777t170r813b210],
22	lower	JJR	O	lower	amod	23	SENT_60	[p3l857t141r1054b210],
23	activity	NN	O	activity	prep_with	5	SENT_60	[p3l1100t146r1361b232],
24	(	CD	NUMBER	(	num	27	SENT_60	[p3l1410t143r1653b224],
25	COM	NNP	O	COM	nn	27	SENT_60	[p3l1410t143r1653b224],
26	TL	NN	O	tl	nn	27	SENT_60	[p3l1656t125r1740b209],
27	allele	NN	O	allele	dep	23	SENT_60	[p3l1787t141r2014b224],
28	)	NN	O	)	dep	27	SENT_60	[p3l1787t141r2014b224],
29	.	.	O	.	_	0	SENT_60	[p3l1787t141r2014b224],

1	In	IN	O	in	_	0	SENT_61	[p3l2067t146r2143b209],
2	Caucasian	JJ	O	caucasian	amod	4	SENT_61	[p3l12t265r375b331],
3	PD	NN	O	pd	nn	4	SENT_61	[p3l432t266r549b330],
4	patients	NNS	O	patient	prep_in	17	SENT_61	[p3l607t266r907b353],
5	,	,	O	,	_	0	SENT_61	[p3l607t266r907b353],
6	the	DT	O	the	det	8	SENT_61	[p3l967t261r1076b330],
7	COM	NNP	O	COM	nn	8	SENT_61	[p3l1139t265r1350b330],
8	TH	NN	O	th	nsubjpass	17	SENT_61	[p3l1353t246r1460b329],
9	and	CC	O	and	_	0	SENT_61	[p3l1507t262r1638b331],
10	COM	NN	O	com	nn	11	SENT_61	[p3l1700t265r1911b330],
11	TL	NN	O	tl	nsubjpass	17	SENT_61	[p3l1915t246r1998b329],
12	al	NNP	O	al	nn	14	SENT_61	[p3l2054t262r2140b330],
13	—	NNP	O	—	nn	14	SENT_61	[p3l2054t262r2140b330],
14	leles	NNS	O	lele	dep	8	SENT_61	[p3l10t373r157b441],
15	are	VBP	O	be	auxpass	17	SENT_61	[p3l226t400r328b441],
16	equally	RB	O	equally	advmod	17	SENT_61	[p3l397t373r653b464],
17	distributed	VBN	O	distribute	_	0	SENT_61	[p3l717t372r1126b451],
18	,	,	O	,	_	0	SENT_61	[p3l717t372r1126b451],
19	similarly	RB	O	similarly	advmod	17	SENT_61	[p3l1199t373r1508b463],
20	to	TO	O	to	_	0	SENT_61	[p3l1573t396r1641b441],
21	the	DT	O	the	det	23	SENT_61	[p3l1711t373r1820b441],
22	general	JJ	O	general	amod	23	SENT_61	[p3l1888t373r2141b465],
23	population	NN	O	population	prep_to	17	SENT_61	[p3l10t477r498b584],
24	.	.	O	.	_	0	SENT_61	[p3l10t477r498b584],

1	”	NN	O	”	_	0	SENT_62	[p3l10t477r498b584],
2	Thus	RB	O	thus	advmod	6	SENT_62	[p3l536t492r741b571],
3	,	,	O	,	_	0	SENT_62	[p3l536t492r741b571],
4	COMT	NN	O	comt	nn	5	SENT_62	[p3l787t494r1069b561],
5	activity	NN	O	activity	nsubj	6	SENT_62	[p3l1098t497r1359b583],
6	has	VBZ	O	have	rcmod	1	SENT_62	[p3l1394t492r1506b561],
7	the	DT	O	the	det	12	SENT_62	[p3l1547t492r1656b561],
8	same	JJ	O	same	amod	12	SENT_62	[p3l1696t520r1871b561],
9	trimo	NN	O	trimo	nn	12	SENT_62	[p3l1911t497r2139b561],
10	—	NN	O	—	nn	12	SENT_62	[p3l1911t497r2139b561],
11	dal	JJ	O	dal	amod	12	SENT_62	[p3l11t603r115b673],
12	distribution	NN	O	distribution	dobj	6	SENT_62	[p3l190t603r615b673],
13	as	IN	O	as	_	0	SENT_62	[p3l689t632r752b672],
14	the	DT	O	the	det	17	SENT_62	[p3l828t603r936b672],
15	COM	NN	O	com	nn	17	SENT_62	[p3l1018t606r1229b672],
16	T	NN	O	t	nn	17	SENT_62	[p3l1233t606r1292b670],
17	genotype	NN	O	genotype	prep_as	12	SENT_62	[p3l1351t626r1693b695],
18	:	:	O	:	_	0	SENT_62	[p3l1351t626r1693b695],
19	25	CD	PERCENT	25	num	20	SENT_62	[p3l1772t609r1938b676],
20	%	NN	PERCENT	%	conj_and	12	SENT_62	[p3l1772t609r1938b676],
21	low	JJ	O	low	amod	20	SENT_62	[p3l2015t603r2145b672],
22	(	CD	NUMBER	(	num	25	SENT_62	[p3l15t724r259b805],
23	COM	NN	MISC	com	nn	25	SENT_62	[p3l15t724r259b805],
24	TM	NN	MISC	tm	nn	25	SENT_62	[p3l262t706r432b805],
25	)	NN	O	)	tmod	21	SENT_62	[p3l262t706r432b805],
26	,	,	O	,	_	0	SENT_62	[p3l262t706r432b805],
27	50	CD	PERCENT	50	number	28	SENT_62	[p3l508t728r671b796],
28	%	NN	PERCENT	%	amod	25	SENT_62	[p3l508t728r671b796],
29	intermediate	JJ	O	intermediate	amod	33	SENT_62	[p3l743t723r1195b792],
30	(	NN	O	(	nn	33	SENT_62	[p3l1269t724r1512b805],
31	COM	NN	O	com	nn	33	SENT_62	[p3l1269t724r1512b805],
32	THL	NN	O	thl	nn	33	SENT_62	[p3l1516t706r1701b805],
33	)	NN	O	)	dep	20	SENT_62	[p3l1516t706r1701b805],
34	,	,	O	,	_	0	SENT_62	[p3l1516t706r1701b805],
35	and	CC	O	and	_	0	SENT_62	[p3l1774t723r1905b792],
36	25	CD	PERCENT	25	num	37	SENT_62	[p3l1972t728r2139b796],
37	%	NN	PERCENT	%	dobj	6	SENT_62	[p3l1972t728r2139b796],

1	high	JJ	O	high	amod	3	SENT_63	[p3l10t887r169b979],
2	(	NN	O	(	nn	3	SENT_63	[p3l214t871r660b969],
3	COMTHH	NN	O	comthh	_	0	SENT_63	[p3l214t871r660b969],
4	)	CD	NUMBER	)	dep	3	SENT_63	[p3l214t871r660b969],
5	.	.	O	.	_	0	SENT_63	[p3l214t871r660b969],

1	The	DT	O	the	det	2	SENT_64	[p3l215t1008r359b1077],
2	objective	NN	O	objective	nsubj	6	SENT_64	[p3l411t1008r727b1100],
3	of	IN	O	of	_	0	SENT_64	[p3l779t1008r860b1077],
4	this	DT	O	this	det	5	SENT_64	[p3l899t1008r1024b1077],
5	study	NN	O	study	prep_of	2	SENT_64	[p3l1077t1008r1271b1099],
6	was	VBD	O	be	_	0	SENT_64	[p3l1317t1037r1444b1077],
7	to	TO	O	to	aux	8	SENT_64	[p3l1498t1032r1565b1077],
8	determine	VB	O	determine	xcomp	6	SENT_64	[p3l1619t1008r1980b1078],
9	the	DT	O	the	det	10	SENT_64	[p3l2033t1008r2141b1077],
10	consequences	NNS	O	consequence	dobj	8	SENT_64	[p3l11t1146r489b1210],
11	of	IN	O	of	_	0	SENT_64	[p3l568t1118r649b1187],
12	the	DT	O	the	det	14	SENT_64	[p3l714t1118r823b1187],
13	COMT	NNP	ORGANIZATION	COMT	nn	14	SENT_64	[p3l900t1120r1182b1187],
14	polymorphism	NN	O	polymorphism	prep_of	10	SENT_64	[p3l1258t1119r1787b1210],
15	on	IN	O	on	_	0	SENT_64	[p3l1865t1146r1955b1187],
16	the	DT	O	the	det	17	SENT_64	[p3l2033t1119r2141b1187],
17	response	NN	O	response	prep_on	8	SENT_64	[p3l11t1267r314b1331],
18	of	IN	O	of	_	0	SENT_64	[p3l372t1240r453b1308],
19	PD	NN	O	pd	nn	20	SENT_64	[p3l498t1244r615b1307],
20	patients	NNS	O	patient	prep_of	17	SENT_64	[p3l673t1244r952b1331],
21	to	TO	O	to	_	0	SENT_64	[p3l1009t1263r1077b1308],
22	entacapone	NN	O	entacapone	prep_to	8	SENT_64	[p3l1136t1263r1556b1331],
23	.	.	O	.	_	0	SENT_64	[p3l1136t1263r1556b1331],

1	To	TO	O	to	aux	2	SENT_65	[p3l1616t1242r1708b1308],
2	investigate	VB	O	investigate	purpcl	12	SENT_65	[p3l1767t1244r2141b1332],
3	this	DT	O	this	det	4	SENT_65	[p3l11t1351r136b1420],
4	issue	NN	O	issue	dobj	2	SENT_65	[p3l184t1356r369b1430],
5	,	,	O	,	_	0	SENT_65	[p3l184t1356r369b1430],
6	the	DT	O	the	det	7	SENT_65	[p3l419t1351r528b1420],
7	gain	NN	O	gain	nsubjpass	12	SENT_65	[p3l573t1356r723b1443],
8	in	IN	O	in	_	0	SENT_65	[p3l770t1356r838b1419],
9	ON	NNP	O	ON	nn	10	SENT_65	[p3l886t1355r1027b1420],
10	time	NN	O	time	prep_in	7	SENT_65	[p3l1074t1356r1234b1420],
11	was	VBD	O	be	auxpass	12	SENT_65	[p3l1276t1380r1404b1420],
12	assessed	VBN	O	assess	_	0	SENT_65	[p3l1452t1351r1728b1421],
13	during	IN	O	during	_	0	SENT_65	[p3l1775t1351r2014b1443],
14	an	DT	O	a	det	16	SENT_65	[p3l2059t1379r2141b1420],
15	acute	JJ	O	acute	amod	16	SENT_65	[p3l11t1485r195b1531],
16	administration	NN	O	administration	prep_during	12	SENT_65	[p3l257t1462r785b1531],
17	of	IN	O	of	_	0	SENT_65	[p3l846t1461r927b1530],
18	L	NN	O	l	nn	20	SENT_65	[p3l977t1462r1236b1553],
19	—	CD	NUMBER	—	num	20	SENT_65	[p3l977t1462r1236b1553],
20	dopa	NN	O	dopa	prep_of	16	SENT_65	[p3l977t1462r1236b1553],
21	.	.	O	.	_	0	SENT_65	[p3l1298t1474r1360b1536],

1	—	NN	O	—	_	0	SENT_66	[p3l1298t1474r1360b1536],
2	.	.	O	.	_	0	SENT_66	[p3l1298t1474r1360b1536],

1	|	RB	O	|	dep	3	SENT_67	[p3l1298t1474r1360b1536],
2	200mg	JJ	O	200mg	amod	3	SENT_67	[p3l1424t1469r1679b1554],
3	entacapone	NN	O	entacapone	_	0	SENT_67	[p3l1739t1485r2141b1553],
4	compared	VBN	O	compare	_	0	SENT_67	[p3l11t1573r366b1664],
5	to	TO	O	to	prepc_compared_to	3	SENT_67	[p3l408t1596r476b1641],
6	L	NN	O	l	nn	8	SENT_67	[p3l519t1573r778b1664],
7	—	CD	NUMBER	—	num	8	SENT_67	[p3l519t1573r778b1664],
8	dopa	NN	O	dopa	pobj	3	SENT_67	[p3l519t1573r778b1664],
9	.	.	O	.	_	0	SENT_67	[p3l820t1585r882b1648],

1	—	NN	O	—	_	0	SENT_68	[p3l820t1585r882b1648],
2	.	.	O	.	_	0	SENT_68	[p3l820t1585r882b1648],

1	|	NN	O	|	nn	2	SENT_69	[p3l820t1585r882b1648],
2	placebo	NN	O	placebo	_	0	SENT_69	[p3l926t1573r1197b1664],
3	in	IN	O	in	_	0	SENT_69	[p3l1241t1577r1309b1640],
4	PD	NN	O	pd	nn	5	SENT_69	[p3l1351t1577r1468b1641],
5	patients	NNS	O	patient	prep_in	2	SENT_69	[p3l1512t1577r1790b1664],
6	with	IN	O	with	_	0	SENT_69	[p3l1830t1573r1991b1641],
7	the	DT	O	the	det	11	SENT_69	[p3l2033t1573r2141b1641],
8	extreme	JJ	O	extreme	amod	11	SENT_69	[p3l11t1719r291b1764],
9	COM	NN	O	com	nn	11	SENT_69	[p3l333t1699r544b1764],
10	T	NN	O	t	nn	11	SENT_69	[p3l548t1698r607b1763],
11	genotypes	NNS	O	genotype	prep_with	2	SENT_69	[p3l627t1719r1000b1788],
12	,	,	O	,	_	0	SENT_69	[p3l627t1719r1000b1788],
13	COM	NNP	O	COM	nn	14	SENT_69	[p3l1046t1699r1257b1764],
14	THH	NNP	O	THH	conj_and	11	SENT_69	[p3l1261t1679r1421b1763],
15	and	CC	O	and	_	0	SENT_69	[p3l1447t1695r1578b1765],
16	COM	NNP	O	COM	nn	17	SENT_69	[p3l1619t1699r1830b1764],
17	TM	NNP	O	TM	conj_and	11	SENT_69	[p3l1834t1679r1972b1763],
18	.	.	O	.	_	0	SENT_69	[p3l1834t1679r1972b1763],

1	Patients	NNS	O	patient	_	0	SENT_70	[p3l16t2075r394b2151],
2	and	CC	O	and	_	0	SENT_70	[p3l435t2071r604b2151],
3	Methods	NNS	O	method	conj_and	1	SENT_70	[p3l654t2071r1069b2151],

1	Patients	NNS	O	patient	nn	2	SENT_71	[p3l15t2205r364b2274],
2	Patients	NNS	O	patient	nsubjpass	4	SENT_71	[p3l11t2316r260b2373],
3	were	VBD	O	be	auxpass	4	SENT_71	[p3l316t2336r465b2374],
4	recruited	VBN	O	recruit	_	0	SENT_71	[p3l524t2312r809b2374],
5	consecutively	RB	O	consecutively	advmod	4	SENT_71	[p3l867t2312r1296b2393],
6	in	IN	O	in	_	0	SENT_71	[p3l1351t2316r1413b2373],
7	the	DT	O	the	det	8	SENT_71	[p3l1470t2312r1568b2373],
8	Department	NNP	O	Department	prep_in	4	SENT_71	[p3l1627t2316r2023b2394],
9	of	IN	O	of	_	0	SENT_71	[p3l2080t2312r2153b2373],
10	Neurology	NNP	O	Neurology	prep_of	8	SENT_71	[p3l9t2413r357b2496],
11	of	IN	O	of	_	0	SENT_71	[p3l420t2413r493b2475],
12	the	DT	O	the	det	16	SENT_71	[p3l549t2413r647b2475],
13	Pitié-Salpetriere	NNP	LOCATION	Pitié-Salpetriere	nn	16	SENT_71	[p3l714t2413r1227b2495],
14	Hospital	NNP	LOCATION	Hospital	nn	16	SENT_71	[p3l1294t2413r1570b2495],
15	(	NNP	O	(	nn	16	SENT_71	[p3l1641t2414r1832b2487],
16	Paris	NNP	LOCATION	Paris	prep_of	10	SENT_71	[p3l1641t2414r1832b2487],
17	,	,	O	,	_	0	SENT_71	[p3l1641t2414r1832b2487],
18	France	NNP	LOCATION	France	conj_and	16	SENT_71	[p3l1903t2414r2136b2487],
19	)	CD	NUMBER	)	num	18	SENT_71	[p3l1903t2414r2136b2487],
20	between	IN	O	between	_	0	SENT_71	[p3l10t2512r273b2574],
21	September	NNP	DATE	September	prep_between	18	SENT_71	[p3l316t2512r658b2594],
22	2006	CD	DATE	2006	num	21	SENT_71	[p3l699t2514r862b2574],
23	and	CC	O	and	_	0	SENT_71	[p3l906t2512r1023b2575],
24	June	NNP	DATE	June	prep_of	10	SENT_71	[p3l1058t2516r1207b2590],
25	2009	CD	DATE	2009	num	24	SENT_71	[p3l1248t2518r1430b2577],
26	.	.	O	.	_	0	SENT_71	[p3l1248t2518r1430b2577],

1	Included	VBN	O	include	csubj	7	SENT_72	[p3l1477t2512r1761b2575],
2	were	VBD	O	be	cop	7	SENT_72	[p3l1799t2537r1948b2574],
3	male	JJ	O	male	amod	7	SENT_72	[p3l1990t2512r2142b2574],
4	and	CC	O	and	_	0	SENT_72	[p3l11t2612r129b2674],
5	female	JJ	O	female	amod	7	SENT_72	[p3l159t2612r368b2673],
6	PD	NN	O	pd	nn	7	SENT_72	[p3l401t2616r506b2673],
7	patients	NNS	O	patient	_	0	SENT_72	[p3l539t2616r790b2694],
8	older	JJR	O	older	amod	7	SENT_72	[p3l823t2612r986b2674],
9	than	IN	O	than	_	0	SENT_72	[p3l1017t2612r1159b2673],
10	30	CD	DURATION	30	num	11	SENT_72	[p3l1192t2618r1269b2677],
11	years	NNS	NUMBER	year	prep_than	8	SENT_72	[p3l1300t2636r1457b2693],
12	with	IN	O	with	_	0	SENT_72	[p3l1487t2612r1632b2674],
13	motor	NN	O	motor	nn	14	SENT_72	[p3l1663t2633r1863b2673],
14	fluctuations	NNS	O	fluctuation	prep_with	7	SENT_72	[p3l1893t2612r2140b2674, p3l10t2728r183b2786],
15	.	.	O	.	_	0	SENT_72	[p3l1893t2612r2140b2674, p3l10t2728r183b2786],

1	Exclusion	NN	MISC	exclusion	nn	2	SENT_73	[p3l229t2724r542b2786],
2	criteria	NNS	O	criterion	nsubj	5	SENT_73	[p3l583t2728r807b2786],
3	were	VBD	O	be	cop	5	SENT_73	[p3l844t2749r994b2786],
4	atypical	JJ	O	atypical	amod	5	SENT_73	[p3l1036t2724r1282b2806],
5	parkinsonism	NN	O	parkinsonism	_	0	SENT_73	[p3l1323t2724r1777b2806],
6	,	,	O	,	_	0	SENT_73	[p3l1323t2724r1777b2806],
7	dementia	NN	O	dementia	conj_and	5	SENT_73	[p3l1823t2724r2138b2794],
8	,	,	O	,	_	0	SENT_73	[p3l1823t2724r2138b2794],
9	and	CC	O	and	_	0	SENT_73	[p3l11t2824r129b2887],
10	treatment	NN	O	treatment	conj_and	5	SENT_73	[p3l162t2845r475b2886],
11	with	IN	O	with	_	0	SENT_73	[p3l505t2824r650b2886],
12	clozapine	NN	O	clozapine	nn	16	SENT_73	[p3l684t2824r984b2906],
13	or	CC	O	or	_	0	SENT_73	[p3l1018t2849r1084b2886],
14	monoamine	NN	O	monoamine	nn	16	SENT_73	[p3l1117t2828r1506b2886],
15	oxidase	NN	O	oxidase	nn	16	SENT_73	[p3l1541t2824r1773b2887],
16	inhibitors	NNS	O	inhibitor	prep_with	10	SENT_73	[p3l1808t2824r2137b2886],
17	.	.	O	.	_	0	SENT_73	[p3l1808t2824r2137b2886],

1	At	IN	O	at	_	0	SENT_74	[p3l6t2928r86b2986],
2	inclusion	NN	O	inclusion	prep_at	6	SENT_74	[p3l121t2925r431b2995],
3	,	,	O	,	_	0	SENT_74	[p3l121t2925r431b2995],
4	patients	NNS	O	patient	nsubjpass	6	SENT_74	[p3l470t2929r720b3007],
5	were	VBD	O	be	auxpass	6	SENT_74	[p3l753t2949r903b2987],
6	genotyped	VBN	O	genotype	_	0	SENT_74	[p3l937t2925r1272b3008],
7	for	IN	O	for	_	0	SENT_74	[p3l1307t2925r1398b2986],
8	the	DT	O	the	det	10	SENT_74	[p3l1433t2925r1531b2986],
9	COM	NN	O	com	nn	10	SENT_74	[p3l1572t2928r1762b2987],
10	T	NN	O	t	prep_for	6	SENT_74	[p3l1764t2927r1817b2986],
11	polymorphism	NN	O	polymorphism	nn	14	SENT_74	[p3l1839t2925r2140b3007, p3l9t3038r208b3120],
12	(	CD	NUMBER	(	num	14	SENT_74	[p3l258t3038r544b3112],
13	rs4608	NN	O	rs4608	nn	14	SENT_74	[p3l258t3038r544b3112],
14	)	NN	O	)	dep	10	SENT_74	[p3l258t3038r544b3112],
15	.	.	O	.	_	0	SENT_74	[p3l258t3038r544b3112],

1	Subjects	NNS	O	subject	_	0	SENT_75	[p3l595t3038r854b3121],
2	homozygous	JJ	O	homozygous	dep	1	SENT_75	[p3l899t3037r1305b3121],
3	for	IN	O	for	_	0	SENT_75	[p3l1351t3037r1442b3099],
4	either	CC	O	either	dep	7	SENT_75	[p3l1486t3038r1668b3100],
5	the	DT	O	the	det	7	SENT_75	[p3l1712t3038r1810b3100],
6	COM	NNP	O	COM	nn	7	SENT_75	[p3l1861t3041r2050b3100],
7	TH	NN	O	th	prep_for	2	SENT_75	[p3l2053t3023r2150b3099],

1	(	NN	O	(	nn	3	SENT_76	[p3l15t3187r233b3260],
2	COM	NN	O	com	nn	3	SENT_76	[p3l15t3187r233b3260],
3	THH	NN	O	thh	dep	9	SENT_76	[p3l236t3171r394b3260],
4	)	CD	NUMBER	)	dep	3	SENT_76	[p3l236t3171r394b3260],
5	or	CC	O	or	_	0	SENT_76	[p3l432t3210r499b3248],
6	COM	NNP	O	COM	dep	3	SENT_76	[p3l536t3189r726b3248],
7	TL	NN	O	tl	dep	9	SENT_76	[p3l728t3171r804b3247],
8	(	CD	NUMBER	(	num	7	SENT_76	[p3l839t3187r1058b3260],
9	COM	NN	O	com	dep	14	SENT_76	[p3l839t3187r1058b3260],
10	TLL	NN	O	tll	dep	9	SENT_76	[p3l1062t3171r1191b3260],
11	)	CD	NUMBER	)	num	12	SENT_76	[p3l1062t3171r1191b3260],
12	allele	NN	O	allele	nsubjpass	14	SENT_76	[p3l1229t3186r1389b3248],
13	were	VBD	O	be	auxpass	14	SENT_76	[p3l1419t3210r1568b3248],
14	randomized	VBN	O	randomize	dep	28	SENT_76	[p3l1601t3186r1985b3249],
15	in	IN	O	in	_	0	SENT_76	[p3l2017t3190r2078b3247],
16	a	DT	O	a	det	18	SENT_76	[p3l2111t3211r2143b3248],
17	double	JJ	O	double	amod	18	SENT_76	[p3l11t3298r447b3368],
18	—	NN	O	—	prep_in	14	SENT_76	[p3l11t3298r447b3368],
19	blind	JJ	O	blind	amod	18	SENT_76	[p3l11t3298r447b3368],
20	,	,	O	,	_	0	SENT_76	[p3l11t3298r447b3368],
21	placebo	NN	O	placebo	nn	22	SENT_76	[p3l509t3298r1130b3380],
22	—	NN	O	—	nsubj	28	SENT_76	[p3l509t3298r1130b3380],
23	controlled	VBN	O	control	partmod	22	SENT_76	[p3l509t3298r1130b3380],
24	,	,	O	,	_	0	SENT_76	[p3l509t3298r1130b3380],
25	crossover	NN	O	crossover	nn	26	SENT_76	[p3l1193t3322r1486b3360],
26	trial	NN	O	trial	dobj	23	SENT_76	[p3l1543t3298r1670b3359],
27	(	CD	NUMBER	(	num	26	SENT_76	[p3l1733t3299r1846b3372],
28	see	VBP	O	see	_	0	SENT_76	[p3l1733t3299r1846b3372],
29	below	IN	O	below	_	0	SENT_76	[p3l1905t3298r2137b3372],
30	)	NN	O	)	prep_below	28	SENT_76	[p3l1905t3298r2137b3372],
31	.	.	O	.	_	0	SENT_76	[p3l1905t3298r2137b3372],

1	Heterozygous	JJ	O	heterozygous	amod	2	SENT_77	[p3l11t3415r451b3494],
2	patients	NNS	O	patient	nsubjpass	9	SENT_77	[p3l505t3415r754b3493],
3	(	IN	O	(	_	0	SENT_77	[p3l813t3412r1031b3485],
4	COM	NNP	O	COM	nn	6	SENT_77	[p3l813t3412r1031b3485],
5	THL	NNP	O	THL	nn	6	SENT_77	[p3l1034t3396r1179b3485],
6	)	NN	O	)	prep_(	2	SENT_77	[p3l1034t3396r1179b3485],
7	were	VBD	O	be	auxpass	9	SENT_77	[p3l1234t3435r1383b3473],
8	not	RB	O	not	neg	9	SENT_77	[p3l1437t3432r1545b3473],
9	included	VBN	O	include	_	0	SENT_77	[p3l1597t3410r1876b3473],
10	in	IN	O	in	_	0	SENT_77	[p3l1928t3415r1990b3472],
11	the	DT	O	the	det	12	SENT_77	[p3l2044t3410r2142b3473],
12	study	NN	O	study	prep_in	9	SENT_77	[p4l10t30r192b111],
13	.	.	O	.	_	0	SENT_77	[p4l10t30r192b111],

1	Investigators	NNS	O	investigator	nsubj	5	SENT_78	[p4l269t34r672b112],
2	and	CC	O	and	_	0	SENT_78	[p4l745t30r863b92],
3	patients	NNS	O	patient	conj_and	1	SENT_78	[p4l934t34r1184b112],
4	were	VBD	O	be	cop	5	SENT_78	[p4l1254t54r1404b91],
5	blind	JJ	O	blind	_	0	SENT_78	[p4l1475t30r1644b92],
6	to	TO	O	to	_	0	SENT_78	[p4l1716t50r1777b91],
7	genotype	NN	O	genotype	prep_to	5	SENT_78	[p4l1850t50r2141b112],
8	throughout	IN	O	throughout	_	0	SENT_78	[p4l11t131r379b214],
9	the	DT	O	the	det	10	SENT_78	[p4l409t131r507b192],
10	study	NN	O	study	prep_throughout	5	SENT_78	[p4l538t131r721b212],
11	.	.	O	.	_	0	SENT_78	[p4l538t131r721b212],

1	The	DT	O	the	det	5	SENT_79	[p4l215t230r344b292],
2	study	NN	O	study	nn	5	SENT_79	[p4l385t230r560b311],
3	(	NN	O	(	nn	5	SENT_79	[p4l602t230r879b304],
4	number	NN	O	number	nn	5	SENT_79	[p4l602t230r879b304],
5	NCT00373087	NN	O	nct00373087	_	0	SENT_79	[p4l919t232r1451b300],
6	,	,	O	,	_	0	SENT_79	[p4l919t232r1451b300],
7	http://wvvw.clinical—	JJ	O	http://wvvw.clinical—	amod	8	SENT_79	[p4l1494t230r2140b312],
8	trial	NN	O	trial	appos	5	SENT_79	[p4l11t330r295b412],
9	.	.	O	.	_	0	SENT_79	[p4l11t330r295b412],

1	gov	NN	O	gov	nn	2	SENT_80	[p4l11t330r295b412],
2	)	NN	O	)	nsubjpass	4	SENT_80	[p4l11t330r295b412],
3	was	VBD	O	be	auxpass	4	SENT_80	[p4l331t355r446b391],
4	carried	VBN	O	carry	_	0	SENT_80	[p4l481t330r700b392],
5	out	RP	O	out	prt	4	SENT_80	[p4l734t351r841b392],
6	in	IN	O	in	_	0	SENT_80	[p4l874t334r936b390],
7	accordance	NN	O	accordance	prep_in	4	SENT_80	[p4l970t330r1323b392],
8	with	IN	O	with	_	0	SENT_80	[p4l1355t329r1500b391],
9	the	DT	O	the	det	10	SENT_80	[p4l1534t330r1632b391],
10	Declaration	NN	O	declaration	prep_with	4	SENT_80	[p4l1667t330r2045b391],
11	of	IN	O	of	_	0	SENT_80	[p4l2080t329r2153b391],
12	Helsinki	NNP	LOCATION	Helsinki	prep_of	10	SENT_80	[p4l11t431r282b492],
13	and	CC	O	and	_	0	SENT_80	[p4l317t431r435b493],
14	the	DT	O	the	det	15	SENT_80	[p4l469t431r567b492],
15	rules	NNS	O	rule	conj_and	10	SENT_80	[p4l601t431r748b493],
16	for	IN	O	for	_	0	SENT_80	[p4l783t431r875b492],
17	clinical	JJ	O	clinical	amod	19	SENT_80	[p4l908t431r1134b492],
18	good	JJ	O	good	amod	19	SENT_80	[p4l1168t431r1328b514],
19	practice	NN	O	practice	prep_for	15	SENT_80	[p4l1361t435r1610b513],
20	and	CC	O	and	_	0	SENT_80	[p4l1645t431r1762b493],
21	local	JJ	O	local	amod	22	SENT_80	[p4l1795t431r1942b492],
22	legislation	NN	O	legislation	conj_and	10	SENT_80	[p4l1976t431r2140b514, p4l10t531r195b593],
23	in	IN	O	in	_	0	SENT_80	[p4l234t535r296b592],
24	the	DT	O	the	det	30	SENT_80	[p4l334t531r432b593],
25	Neuroscience	NNP	O	Neuroscience	nn	30	SENT_80	[p4l471t535r903b593],
26	Clinical	JJ	O	clinical	amod	30	SENT_80	[p4l943t531r1194b593],
27	Investigation	NN	O	investigation	nn	30	SENT_80	[p4l1234t535r1649b614],
28	Center	NNP	O	Center	nn	30	SENT_80	[p4l1689t534r1907b593],
29	(	CD	NUMBER	(	num	30	SENT_80	[p4l1949t532r2140b605],
30	CIC	NNP	ORGANIZATION	CIC	prep_in	22	SENT_80	[p4l1949t532r2140b605],
31	—	CD	NUMBER	—	number	32	SENT_80	[p4l1949t532r2140b605],
32	9503	CD	DATE	9503	dep	30	SENT_80	[p4l12t635r193b700],
33	,	,	O	,	_	0	SENT_80	[p4l12t635r193b700],
34	Pitié	NNP	O	Pitié	appos	30	SENT_80	[p4l243t630r756b712],
35	.	.	O	.	_	0	SENT_80	[p4l243t630r756b712],

1	—	NN	O	—	_	0	SENT_81	[p4l243t630r756b712],
2	.	.	O	.	_	0	SENT_81	[p4l243t630r756b712],

1	Salp	JJ	O	salp	amod	2	SENT_82	[p4l243t630r756b712],
2	€	NN	O	€	_	0	SENT_82	[p4l243t630r756b712],
3	:	:	O	:	_	0	SENT_82	[p4l243t630r756b712],
4	triere	VB	O	triere	dep	2	SENT_82	[p4l243t630r756b712],
5	Hospital	NN	O	hospital	nn	6	SENT_82	[p4l802t630r1123b712],
6	)	NN	O	)	dobj	4	SENT_82	[p4l802t630r1123b712],
7	.	.	O	.	_	0	SENT_82	[p4l802t630r1123b712],

1	The	DT	O	the	det	2	SENT_83	[p4l1171t630r1301b691],
2	study	NN	O	study	nsubjpass	4	SENT_83	[p4l1347t630r1522b711],
3	was	VBD	O	be	auxpass	4	SENT_83	[p4l1562t655r1677b691],
4	approved	VBN	O	approve	_	0	SENT_83	[p4l1724t630r2021b712],
5	by	IN	O	by	_	0	SENT_83	[p4l2066t630r2145b711],
6	the	DT	O	the	det	9	SENT_83	[p4l11t731r108b792],
7	French	JJ	MISC	french	amod	9	SENT_83	[p4l145t731r366b792],
8	drug	NN	O	drug	nn	9	SENT_83	[p4l402t731r552b814],
9	agency	NN	O	agency	agent	4	SENT_83	[p4l586t755r804b814],
10	(	CD	NUMBER	(	num	12	SENT_83	[p4l841t732r1095b814],
11	Agence	NNP	O	Agence	nn	12	SENT_83	[p4l841t732r1095b814],
12	Francaise	NNP	O	Francaise	dep	9	SENT_83	[p4l1132t735r1426b792],
13	de	IN	O	de	_	0	SENT_83	[p4l1463t731r1535b793],
14	Sécurité	NNP	O	Sécurité	nn	15	SENT_83	[p4l1572t732r1825b793],
15	Sanitaire	NNP	O	Sanitaire	nn	20	SENT_83	[p4l1863t734r2141b793],
16	des	NNP	O	des	nn	20	SENT_83	[p4l11t831r109b893],
17	Produits	NNP	O	Produits	nn	20	SENT_83	[p4l153t831r422b893],
18	de	IN	O	de	amod	20	SENT_83	[p4l464t831r537b893],
19	Santé	NNP	O	Santé	nn	20	SENT_83	[p4l579t832r774b905],
20	)	NN	O	)	prep_de	12	SENT_83	[p4l579t832r774b905],
21	and	CC	O	and	_	0	SENT_83	[p4l821t831r939b893],
22	the	DT	O	the	det	24	SENT_83	[p4l980t831r1078b893],
23	ethics	NNS	O	ethic	nn	24	SENT_83	[p4l1119t831r1298b893],
24	committee	NN	O	committee	conj_and	9	SENT_83	[p4l1342t835r1685b893],
25	of	IN	O	of	_	0	SENT_83	[p4l1727t831r1799b893],
26	the	DT	O	the	det	29	SENT_83	[p4l1830t831r1928b893],
27	Pitié	NNP	ORGANIZATION	Pitié	nn	29	SENT_83	[p4l1971t832r2140b893],
28	Salpetriere	NNP	ORGANIZATION	Salpetriere	nn	29	SENT_83	[p4l11t929r349b1012],
29	Hospital	NNP	ORGANIZATION	Hospital	prep_of	24	SENT_83	[p4l407t930r699b1012],
30	.	.	O	.	_	0	SENT_83	[p4l407t930r699b1012],

1	Signed	VBN	O	sign	csubjpass	5	SENT_84	[p4l761t930r977b1012],
2	informed	JJ	O	informed	amod	3	SENT_84	[p4l1034t929r1333b992],
3	consent	NN	O	consent	dobj	1	SENT_84	[p4l1390t950r1635b991],
4	was	VBD	O	be	auxpass	5	SENT_84	[p4l1688t955r1803b991],
5	obtained	VBN	O	obtain	_	0	SENT_84	[p4l1861t930r2142b992],
6	from	IN	O	from	_	0	SENT_84	[p4l10t1030r167b1091],
7	all	DT	O	all	det	8	SENT_84	[p4l199t1030r271b1091],
8	patients	NNS	O	patient	prep_from	5	SENT_84	[p4l302t1034r552b1112],
9	before	IN	O	before	mark	13	SENT_84	[p4l586t1030r784b1091],
10	any	DT	O	any	det	11	SENT_84	[p4l816t1054r930b1111],
11	procedures	NNS	O	procedure	nsubjpass	13	SENT_84	[p4l957t1030r1306b1112],
12	were	VBD	O	be	auxpass	13	SENT_84	[p4l1336t1055r1486b1092],
13	performed	VBN	O	perform	advcl	5	SENT_84	[p4l1517t1030r1871b1112],
14	.	.	O	.	_	0	SENT_84	[p4l1517t1030r1871b1112],

1	Procedure	NN	O	procedure	_	0	SENT_85	[p4l15t1143r460b1215],

1	Consecutive	JJ	O	consecutive	amod	2	SENT_86	[p4l11t1288r404b1347],
2	patients	NNS	O	patient	nsubj	6	SENT_86	[p4l457t1289r707b1367],
3	with	IN	O	with	_	0	SENT_86	[p4l760t1285r905b1347],
4	homozygous	JJ	O	homozygous	amod	5	SENT_86	[p4l958t1285r1363b1368],
5	genotypes	NNS	O	genotype	prep_with	2	SENT_86	[p4l1418t1306r1736b1368],
6	received	VBD	O	receive	_	0	SENT_86	[p4l1791t1285r2050b1347],
7	2	CD	NUMBER	2	num	10	SENT_86	[p4l2103t1291r2140b1346],
8	standardized	JJ	O	standardized	amod	10	SENT_86	[p4l10t1385r415b1448],
9	acute	JJ	O	acute	amod	10	SENT_86	[p4l449t1406r614b1448],
10	challenges	NNS	O	challenge	dobj	6	SENT_86	[p4l650t1385r972b1468],
11	with	IN	O	with	_	0	SENT_86	[p4l1005t1385r1150b1447],
12	L	NN	O	l	nn	14	SENT_86	[p4l1185t1385r1418b1467],
13	—	CD	NUMBER	—	num	14	SENT_86	[p4l1185t1385r1418b1467],
14	dopa	NN	O	dopa	prep_with	10	SENT_86	[p4l1185t1385r1418b1467],
15	and	CC	O	and	_	0	SENT_86	[p4l1451t1385r1568b1448],
16	placebo	NN	O	placebo	conj_and	14	SENT_86	[p4l1601t1385r1844b1467],
17	or	CC	O	or	_	0	SENT_86	[p4l1881t1410r1948b1447],
18	entacapone	NN	O	entacapone	conj_or	14	SENT_86	[p4l1981t1406r2140b1447, p4l11t1508r253b1566],
19	,	,	O	,	_	0	SENT_86	[p4l1981t1406r2140b1447, p4l11t1508r253b1566],
20	separated	VBN	O	separate	partmod	10	SENT_86	[p4l314t1484r612b1566],
21	by	IN	O	by	_	0	SENT_86	[p4l669t1483r748b1565],
22	a	DT	O	a	det	24	SENT_86	[p4l801t1509r833b1545],
23	1-week	JJ	DURATION	1-week	amod	24	SENT_86	[p4l895t1483r1119b1545],
24	washout	NN	O	washout	agent	20	SENT_86	[p4l1170t1484r1456b1554],
25	,	,	O	,	_	0	SENT_86	[p4l1170t1484r1456b1554],
26	in	IN	O	in	_	0	SENT_86	[p4l1517t1488r1578b1544],
27	a	DT	O	a	det	32	SENT_86	[p4l1636t1509r1668b1545],
28	double	JJ	O	double	amod	32	SENT_86	[p4l1723t1483r2142b1546],
29	—	NN	O	—	nn	32	SENT_86	[p4l1723t1483r2142b1546],
30	blind	JJ	O	blind	amod	32	SENT_86	[p4l1723t1483r2142b1546],
31	crossover	NN	O	crossover	nn	32	SENT_86	[p4l11t1610r303b1647],
32	design	NN	O	design	prep_in	10	SENT_86	[p4l333t1585r552b1668],
33	.	.	O	.	_	0	SENT_86	[p4l333t1585r552b1668],

1	Patients	NNS	O	patient	nsubjpass	3	SENT_87	[p4l589t1589r838b1647],
2	were	VBD	O	be	auxpass	3	SENT_87	[p4l869t1610r1018b1647],
3	randomized	VBN	O	randomize	_	0	SENT_87	[p4l1050t1585r1433b1648],
4	to	TO	O	to	aux	5	SENT_87	[p4l1464t1606r1526b1647],
5	receive	VB	O	receive	xcomp	3	SENT_87	[p4l1559t1590r1774b1647],
6	either	CC	O	either	prep	5	SENT_87	[p4l1807t1585r1989b1647],
7	placebo	NN	O	placebo	dep	6	SENT_87	[p4l2019t1585r2140b1667, p4l11t1684r155b1746],
8	first	JJ	ORDINAL	first	amod	7	SENT_87	[p4l197t1684r322b1746],
9	followed	VBN	O	follow	partmod	7	SENT_87	[p4l360t1684r638b1747],
10	by	IN	O	by	_	0	SENT_87	[p4l677t1684r755b1766],
11	entacapone	NN	O	entacapone	agent	9	SENT_87	[p4l792t1705r1154b1766],
12	or	CC	O	or	_	0	SENT_87	[p4l1195t1709r1261b1746],
13	entacapone	NN	O	entacapone	agent	9	SENT_87	[p4l1300t1705r1662b1766],
14	first	JJ	ORDINAL	first	advmod	15	SENT_87	[p4l1702t1684r1827b1746],
15	followed	VBN	O	follow	partmod	11	SENT_87	[p4l1865t1684r2142b1747],
16	by	IN	O	by	_	0	SENT_87	[p4l10t1797r89b1878],
17	placebo	NN	O	placebo	agent	15	SENT_87	[p4l137t1797r399b1879],
18	.	.	O	.	_	0	SENT_87	[p4l137t1797r399b1879],

1	L	NN	O	l	nsubjpass	6	SENT_88	[p4l455t1796r688b1879],
2	—	CD	NUMBER	—	num	4	SENT_88	[p4l455t1796r688b1879],
3	dopa	NN	O	dopa	nn	4	SENT_88	[p4l455t1796r688b1879],
4	challenges	NNS	O	challenge	dep	1	SENT_88	[p4l739t1796r1062b1879],
5	were	VBD	O	be	auxpass	6	SENT_88	[p4l1112t1821r1262b1858],
6	performed	VBN	O	perform	_	0	SENT_88	[p4l1313t1796r1652b1879],
7	as	IN	O	as	mark	9	SENT_88	[p4l1704t1822r1760b1858],
8	previously	RB	DATE	previously	advmod	9	SENT_88	[p4l1813t1796r2145b1879],
9	described	VBN	O	describe	advcl	6	SENT_88	[p4l11t1885r394b1968],
10	,13	CD	NUMBER	,13	dobj	9	SENT_88	[p4l11t1885r394b1968],
11	in	IN	O	in	_	0	SENT_88	[p4l431t1902r493b1958],
12	the	DT	O	the	det	13	SENT_88	[p4l528t1897r625b1959],
13	morning	NN	TIME	morning	prep_in	9	SENT_88	[p4l660t1902r942b1980],
14	after	IN	O	after	_	0	SENT_88	[p4l974t1897r1117b1959],
15	an	DT	O	a	det	20	SENT_88	[p4l1151t1922r1225b1959],
16	18	CD	NUMBER	18	number	17	SENT_88	[p4l1267t1897r1524b1960],
17	—	CD	NUMBER	—	num	20	SENT_88	[p4l1267t1897r1524b1960],
18	hour	NN	NUMBER	hour	nn	20	SENT_88	[p4l1267t1897r1524b1960],
19	(	NN	O	(	nn	20	SENT_88	[p4l1561t1898r1932b1971],
20	minimum	NN	O	minimum	prep_after	9	SENT_88	[p4l1561t1898r1932b1971],
21	)	JJ	O	)	amod	22	SENT_88	[p4l1561t1898r1932b1971],
22	withdrawal	NN	O	withdrawal	dep	20	SENT_88	[p4l1970t1898r2140b1959, p4l11t2009r222b2072],
23	of	IN	O	of	_	0	SENT_88	[p4l306t2009r379b2071],
24	dopaminergic	JJ	O	dopaminergic	amod	25	SENT_88	[p4l450t2009r896b2092],
25	agonists	NNS	O	agonist	prep_of	22	SENT_88	[p4l978t2014r1232b2092],
26	and	CC	O	and	_	0	SENT_88	[p4l1316t2009r1433b2072],
27	entacapone	NN	O	entacapone	prep_of	22	SENT_88	[p4l1516t2030r1894b2091],
28	.	.	O	.	_	0	SENT_88	[p4l1516t2030r1894b2091],

1	After	IN	O	after	amod	3	SENT_89	[p4l1977t2009r2143b2071],
2	fast	JJ	O	fast	amod	3	SENT_89	[p4l10t2107r120b2169],
3	intake	NN	O	intake	dep	13	SENT_89	[p4l153t2107r348b2169],
4	of	IN	O	of	_	0	SENT_89	[p4l382t2107r454b2169],
5	the	DT	O	the	det	10	SENT_89	[p4l478t2108r576b2169],
6	usual	JJ	O	usual	amod	10	SENT_89	[p4l610t2108r774b2170],
7	morning	NN	TIME	morning	tmod	6	SENT_89	[p4l808t2112r1089b2190],
8	equivalent	JJ	O	equivalent	amod	10	SENT_89	[p4l1122t2108r1453b2190],
9	dose	NN	O	dose	nn	10	SENT_89	[p4l1487t2108r1627b2170],
10	—	NN	O	—	prep_of	3	SENT_89	[p4l1663t2118r1720b2175],
11	l	NN	O	l	tmod	10	SENT_89	[p4l1663t2118r1720b2175],
12	—	CD	NUMBER	—	dep	13	SENT_89	[p4l1663t2118r1720b2175],
13	50mg	CD	NUMBER	50mg	dep	26	SENT_89	[p4l1760t2112r1943b2190],
14	of	IN	O	of	_	0	SENT_89	[p4l1976t2107r2048b2169],
15	Ldopa	FW	LOCATION	ldopa	nn	18	SENT_89	[p4l2072t2112r2140b2168, p4l11t2208r170b2290],
16	(	FW	O	(	nn	18	SENT_89	[p4l221t2208r587b2282],
17	immediate	JJ	O	immediate	amod	18	SENT_89	[p4l221t2208r587b2282],
18	release	NN	O	release	prep_of	13	SENT_89	[p4l636t2208r842b2270],
19	L	NN	O	l	nn	22	SENT_89	[p4l891t2208r1124b2290],
20	—	CD	NUMBER	—	num	22	SENT_89	[p4l891t2208r1124b2290],
21	dopa	NN	O	dopa	nn	22	SENT_89	[p4l891t2208r1124b2290],
22	—	NN	O	—	dep	18	SENT_89	[p4l1173t2219r1230b2276],
23	l	NN	O	l	tmod	18	SENT_89	[p4l1173t2219r1230b2276],
24	—	CD	PERCENT	—	num	26	SENT_89	[p4l1173t2219r1230b2276],
25	25	CD	PERCENT	25	num	26	SENT_89	[p4l1281t2213r1431b2274],
26	%	NN	PERCENT	%	dep	31	SENT_89	[p4l1281t2213r1431b2274],
27	benserazide	NN	O	benserazide	dep	26	SENT_89	[p4l1482t2208r1868b2279],
28	;	:	O	;	_	0	SENT_89	[p4l1482t2208r1868b2279],
29	Roche	NNP	PERSON	Roche	nn	31	SENT_89	[p4l1920t2208r2138b2279],
30	,	,	O	,	_	0	SENT_89	[p4l1920t2208r2138b2279],
31	Neuilly	NNP	LOCATION	Neuilly	_	0	SENT_89	[p4l9t2308r603b2390],
32	.	.	O	.	_	0	SENT_89	[p4l9t2308r603b2390],

1	—	NN	O	—	_	0	SENT_90	[p4l9t2308r603b2390],
2	.	.	O	.	_	0	SENT_90	[p4l9t2308r603b2390],

1	Sur	NNP	O	Sur	_	0	SENT_91	[p4l9t2308r603b2390],
2	.	.	O	.	_	0	SENT_91	[p4l9t2308r603b2390],

1	—	NN	O	—	_	0	SENT_92	[p4l9t2308r603b2390],
2	.	.	O	.	_	0	SENT_92	[p4l9t2308r603b2390],

1	Seine	NNP	O	Seine	nn	3	SENT_93	[p4l9t2308r603b2390],
2	,	,	O	,	_	0	SENT_93	[p4l9t2308r603b2390],
3	France	NNP	LOCATION	France	_	0	SENT_93	[p4l654t2309r887b2382],
4	)	CD	NUMBER	)	num	3	SENT_93	[p4l654t2309r887b2382],
5	with	IN	O	with	_	0	SENT_93	[p4l936t2308r1081b2370],
6	either	CC	O	either	preconj	7	SENT_93	[p4l1127t2308r1310b2370],
7	placebo	NN	O	placebo	prep_with	3	SENT_93	[p4l1354t2308r1598b2390],
8	or	CC	O	or	_	0	SENT_93	[p4l1647t2333r1713b2370],
9	entacapone	NN	O	entacapone	prep_with	3	SENT_93	[p4l1759t2329r2138b2390],
10	,	,	O	,	_	0	SENT_93	[p4l1759t2329r2138b2390],
11	motor	NN	O	motor	nn	12	SENT_93	[p4l10t2429r211b2469],
12	disability	NN	O	disability	appos	3	SENT_93	[p4l281t2408r577b2489],
13	(	CD	NUMBER	(	num	25	SENT_93	[p4l650t2407r919b2481],
14	Unified	NNP	O	Unified	nn	25	SENT_93	[p4l650t2407r919b2481],
15	Parkinson	NNP	O	Parkinson	nn	25	SENT_93	[p4l992t2407r1311b2469],
16	Disease	NNP	O	Disease	nn	25	SENT_93	[p4l1385t2412r1622b2469],
17	Rating	NNP	O	Rating	nn	25	SENT_93	[p4l1696t2412r1911b2490],
18	Scale	NNP	O	Scale	nn	25	SENT_93	[p4l1983t2408r2141b2469],
19	[	CD	NUMBER	[	num	25	SENT_93	[p4l17t2511r324b2582],
20	UPDRS	NNP	O	UPDRS	nn	25	SENT_93	[p4l17t2511r324b2582],
21	]	CD	NUMBER	]	num	25	SENT_93	[p4l17t2511r324b2582],
22	part	NN	O	part	nn	25	SENT_93	[p4l369t2530r497b2591],
23	III	CD	NUMBER	iii	num	25	SENT_93	[p4l534t2513r613b2570],
24	score	NN	NUMBER	score	nn	25	SENT_93	[p4l650t2510r831b2583],
25	)	NN	O	)	nsubjpass	27	SENT_93	[p4l650t2510r831b2583],
26	was	VBD	O	be	auxpass	27	SENT_93	[p4l871t2535r986b2571],
27	assessed	VBN	O	assess	rcmod	12	SENT_93	[p4l1024t2509r1273b2572],
28	by	IN	O	by	_	0	SENT_93	[p4l1310t2509r1389b2591],
29	the	DT	O	the	det	31	SENT_93	[p4l1423t2509r1521b2571],
30	same	JJ	O	same	amod	31	SENT_93	[p4l1557t2534r1715b2571],
31	investigator	NN	O	investigator	agent	27	SENT_93	[p4l1753t2513r2138b2592],
32	,	,	O	,	_	0	SENT_93	[p4l1753t2513r2138b2592],
33	at	IN	O	at	_	0	SENT_93	[p4l11t2629r68b2670],
34	O	NN	O	o	nn	37	SENT_93	[p4l116t2615r152b2670],
35	(	CD	NUMBER	(	num	37	SENT_93	[p4l207t2608r528b2682],
36	baseline	NN	O	baseline	nn	37	SENT_93	[p4l207t2608r528b2682],
37	)	NN	O	)	prep_at	3	SENT_93	[p4l207t2608r528b2682],
38	,	,	O	,	_	0	SENT_93	[p4l207t2608r528b2682],
39	15	CD	NUMBER	15	prep_at	3	SENT_93	[p4l588t2613r679b2679],
40	,	,	O	,	_	0	SENT_93	[p4l588t2613r679b2679],
41	30	CD	NUMBER	30	prep_at	3	SENT_93	[p4l732t2615r830b2679],
42	,	,	O	,	_	0	SENT_93	[p4l732t2615r830b2679],
43	45	CD	NUMBER	45	prep_at	3	SENT_93	[p4l881t2609r980b2679],
44	,	,	O	,	_	0	SENT_93	[p4l881t2609r980b2679],
45	and	CC	DURATION	and	_	0	SENT_93	[p4l1033t2608r1151b2671],
46	60	CD	DURATION	60	num	47	SENT_93	[p4l1199t2610r1278b2670],
47	minutes	NNS	NUMBER	minute	prep_at	3	SENT_93	[p4l1328t2613r1604b2679],
48	,	,	O	,	_	0	SENT_93	[p4l1328t2613r1604b2679],
49	then	RB	O	then	advmod	3	SENT_93	[p4l1656t2608r1798b2670],
50	every	DT	O	every	det	52	SENT_93	[p4l1847t2633r2015b2690],
51	30	CD	DURATION	30	num	52	SENT_93	[p4l2062t2615r2140b2673],
52	minutes	NNS	NUMBER	minute	npadvmod	53	SENT_93	[p4l10t2712r267b2770],
53	up	IN	DURATION	up	advmod	3	SENT_93	[p4l301t2732r381b2790],
54	to	TO	DURATION	to	_	0	SENT_93	[p4l415t2728r476b2769],
55	4	CD	DURATION	4	num	56	SENT_93	[p4l509t2708r548b2768],
56	hours	NNS	NUMBER	hour	prep_to	3	SENT_93	[p4l580t2708r777b2770],
57	.	.	O	.	_	0	SENT_93	[p4l580t2708r777b2770],

1	Peak	JJ	O	peak	amod	2	SENT_94	[p4l814t2707r962b2769],
2	dose	NN	O	dose	nsubjpass	8	SENT_94	[p4l992t2707r1132b2770],
3	and	CC	O	and	_	0	SENT_94	[p4l1165t2708r1283b2770],
4	biphasic	JJ	O	biphasic	amod	5	SENT_94	[p4l1315t2707r1579b2790],
5	dyskinesias	NNS	O	dyskinesia	conj_and	2	SENT_94	[p4l1610t2707r1962b2789],
6	were	VBD	O	be	auxpass	8	SENT_94	[p4l1992t2732r2142b2769],
7	systematically	RB	O	systematically	advmod	8	SENT_94	[p4l10t2819r454b2901],
8	assessed	VBN	O	assess	_	0	SENT_94	[p4l485t2819r734b2882],
9	at	IN	O	at	_	0	SENT_94	[p4l766t2840r823b2881],
10	each	DT	O	each	det	12	SENT_94	[p4l855t2819r995b2881],
11	time	NN	O	time	nn	12	SENT_94	[p4l1027t2823r1171b2881],
12	point	NN	O	point	prep_at	8	SENT_94	[p4l1203t2823r1377b2901],
13	(	CD	NUMBER	(	num	16	SENT_94	[p4l1412t2820r1628b2893],
14	Goetz	NNP	PERSON	Goetz	nn	16	SENT_94	[p4l1412t2820r1628b2893],
15	scale14	NN	O	scale14	nn	16	SENT_94	[p4l1659t2802r1912b2893],
16	)	NN	O	)	dep	12	SENT_94	[p4l1659t2802r1912b2893],
17	.	.	O	.	_	0	SENT_94	[p4l1659t2802r1912b2893],

1	Blood	NN	O	blood	nn	2	SENT_95	[p4l1950t2819r2142b2882],
2	samples	NNS	O	sample	nsubjpass	4	SENT_95	[p4l10t2919r258b3001],
3	were	VBD	O	be	auxpass	4	SENT_95	[p4l288t2944r438b2981],
4	collected	VBN	O	collect	_	0	SENT_95	[p4l470t2919r752b2982],
5	at	IN	O	at	_	0	SENT_95	[p4l784t2940r841b2981],
6	O	NN	O	o	prep_at	4	SENT_95	[p4l872t2926r927b2990],
7	,	,	O	,	_	0	SENT_95	[p4l872t2926r927b2990],
8	20	CD	NUMBER	20	prep_at	4	SENT_95	[p4l962t2926r1061b2990],
9	,	,	O	,	_	0	SENT_95	[p4l962t2926r1061b2990],
10	40	CD	NUMBER	40	prep_at	4	SENT_95	[p4l1096t2920r1195b2990],
11	,	,	O	,	_	0	SENT_95	[p4l1096t2920r1195b2990],
12	and	CC	DURATION	and	_	0	SENT_95	[p4l1231t2919r1349b2982],
13	60	CD	DURATION	60	num	14	SENT_95	[p4l1380t2921r1458b2981],
14	minutes	NNS	NUMBER	minute	conj_and	6	SENT_95	[p4l1492t2924r1767b2990],
15	,	,	O	,	_	0	SENT_95	[p4l1492t2924r1767b2990],
16	then	RB	O	then	dep	23	SENT_95	[p4l1803t2919r1945b2981],
17	every	DT	O	every	det	23	SENT_95	[p4l1977t2944r2144b3001],
18	30	CD	DURATION	30	num	19	SENT_95	[p4l11t3027r89b3085],
19	minutes	NNS	NUMBER	minute	dep	22	SENT_95	[p4l123t3025r379b3083],
20	up	IN	DURATION	up	quantmod	22	SENT_95	[p4l412t3045r492b3103],
21	to	TO	DURATION	to	dep	22	SENT_95	[p4l525t3041r586b3082],
22	4	CD	DURATION	4	num	23	SENT_95	[p4l618t3021r657b3081],
23	hours	NNS	NUMBER	hour	dep	14	SENT_95	[p4l688t3020r867b3083],
24	for	IN	O	for	_	0	SENT_95	[p4l899t3020r990b3082],
25	determination	NN	O	determination	prep_for	23	SENT_95	[p4l1020t3020r1478b3083],
26	of	IN	O	of	_	0	SENT_95	[p4l1510t3020r1582b3082],
27	the	DT	O	the	det	30	SENT_95	[p4l1603t3021r1701b3082],
28	pharmacoki	NN	O	pharmacokus	nn	30	SENT_95	[p4l1732t3021r2141b3103],
29	—	NN	O	—	nn	30	SENT_95	[p4l1732t3021r2141b3103],
30	netics	NNS	O	netic	prep_of	14	SENT_95	[p4l11t3124r191b3181],
31	of	IN	O	of	_	0	SENT_95	[p4l227t3119r300b3181],
32	L	NN	O	l	nn	34	SENT_95	[p4l325t3119r574b3201],
33	—	CD	NUMBER	—	num	34	SENT_95	[p4l325t3119r574b3201],
34	dopa	NN	O	dopa	prep_of	30	SENT_95	[p4l325t3119r574b3201],
35	,	,	O	,	_	0	SENT_95	[p4l325t3119r574b3201],
36	and	CC	O	and	_	0	SENT_95	[p4l613t3119r731b3182],
37	at	IN	O	at	_	0	SENT_95	[p4l765t3140r823b3181],
38	O	NN	O	o	conj_and	6	SENT_95	[p4l858t3126r893b3181],
39	and	CC	O	and	_	0	SENT_95	[p4l931t3119r1049b3182],
40	90	CD	DURATION	90	num	41	SENT_95	[p4l1084t3126r1161b3185],
41	minutes	NNS	NUMBER	minute	conj_and	6	SENT_95	[p4l1199t3124r1455b3182],
42	to	TO	O	to	aux	43	SENT_95	[p4l1492t3140r1553b3181],
43	measure	VB	O	measure	xcomp	4	SENT_95	[p4l1590t3144r1852b3182],
44	COMT	NNP	O	COMT	nn	45	SENT_95	[p4l1889t3121r2142b3181],
45	activity	NN	O	activity	dobj	43	SENT_95	[p4l11t3236r245b3313],
46	and	CC	O	and	_	0	SENT_95	[p4l279t3231r397b3294],
47	plasma	NN	O	plasma	nn	48	SENT_95	[p4l432t3231r658b3313],
48	concentrations	NNS	O	concentration	dobj	43	SENT_95	[p4l693t3236r1164b3293],
49	of	IN	O	of	_	0	SENT_95	[p4l1202t3231r1275b3293],
50	entacapone	NN	O	entacapone	prep_of	45	SENT_95	[p4l1301t3252r1679b3313],
51	.	.	O	.	_	0	SENT_95	[p4l1301t3252r1679b3313],

1	The	DT	O	the	det	3	SENT_96	[p4l1719t3231r1849b3293],
2	primary	JJ	O	primary	amod	3	SENT_96	[p4l1885t3236r2144b3313],
3	endpoint	NN	O	endpoint	nsubj	6	SENT_96	[p5l11t35r304b117],
4	was	VBD	O	be	cop	6	SENT_96	[p5l331t60r446b96],
5	the	DT	O	the	det	6	SENT_96	[p5l480t34r577b96],
6	effect	NN	O	effect	_	0	SENT_96	[p5l609t34r781b96],
7	of	IN	O	of	_	0	SENT_96	[p5l812t34r885b96],
8	entacapone	NN	O	entacapone	prep_of	6	SENT_96	[p5l906t55r1268b117],
9	on	IN	O	on	_	0	SENT_96	[p5l1300t59r1380b96],
10	the	DT	O	the	det	12	SENT_96	[p5l1413t35r1510b96],
11	motor	NN	O	motor	nn	12	SENT_96	[p5l1543t55r1742b96],
12	response	NN	O	response	prep_on	8	SENT_96	[p5l1774t59r2046b117],
13	to	TO	O	to	_	0	SENT_96	[p5l2079t55r2140b96],
14	L	NN	O	l	nn	16	SENT_96	[p5l11t136r244b218],
15	—	CD	NUMBER	—	num	16	SENT_96	[p5l11t136r244b218],
16	dopa	NN	O	dopa	prep_to	6	SENT_96	[p5l11t136r244b218],
17	estimated	VBN	O	estimate	partmod	16	SENT_96	[p5l276t136r583b199],
18	by	IN	O	by	_	0	SENT_96	[p5l616t136r695b218],
19	the	DT	O	the	det	20	SENT_96	[p5l725t136r823b198],
20	gain	NN	O	gain	agent	17	SENT_96	[p5l856t141r990b219],
21	in	IN	O	in	_	0	SENT_96	[p5l1024t141r1086b197],
22	best	JJS	O	best	prep_in	20	SENT_96	[p5l1120t136r1245b198],
23	ON	IN	O	on	_	0	SENT_96	[p5l1279t139r1405b198],
24	time	NN	O	time	prep_on	22	SENT_96	[p5l1440t141r1584b198],
25	between	IN	O	between	_	0	SENT_96	[p5l1617t136r1880b198],
26	entacapone	NN	O	entacapone	prep_between	24	SENT_96	[p5l1914t157r2140b198, p5l9t260r168b317],
27	and	CC	O	and	_	0	SENT_96	[p5l224t235r342b298],
28	placebo	NN	O	placebo	prep_between	24	SENT_96	[p5l396t235r658b317],
29	.	.	O	.	_	0	SENT_96	[p5l396t235r658b317],

1	Best	JJS	O	best	nsubjpass	5	SENT_97	[p5l716t239r844b297],
2	ON	IN	O	on	_	0	SENT_97	[p5l899t238r1025b298],
3	time	NN	O	time	prep_on	1	SENT_97	[p5l1069t240r1212b297],
4	Was	VBD	O	be	auxpass	5	SENT_97	[p5l1264t261r1379b297],
5	deﬁned	VBN	O	deﬁned	_	0	SENT_97	[p5l1436t235r1676b298],
6	as	IN	O	as	_	0	SENT_97	[p5l1731t261r1787b297],
7	the	DT	O	the	det	8	SENT_97	[p5l1845t235r1942b297],
8	time	NN	O	time	prep_as	5	SENT_97	[p5l1998t240r2142b297],
9	between	IN	O	between	_	0	SENT_97	[p5l10t337r273b398],
10	the	DT	O	the	det	11	SENT_97	[p5l312t337r410b398],
11	peak	NN	O	peak	prep_between	8	SENT_97	[p5l446t336r598b419],
12	and	CC	O	and	_	0	SENT_97	[p5l633t336r751b399],
13	the	DT	O	the	det	14	SENT_97	[p5l789t336r886b398],
14	time	NN	O	time	dep	18	SENT_97	[p5l925t341r1068b398],
15	at	IN	O	at	_	0	SENT_97	[p5l1106t357r1163b398],
16	which	WDT	O	which	prep_at	14	SENT_97	[p5l1197t336r1393b398],
17	the	DT	O	the	det	18	SENT_97	[p5l1431t337r1528b398],
18	UPDRS	NNP	O	UPDRS	conj_and	5	SENT_97	[p5l1566t340r1944b398],
19	.	.	O	.	_	0	SENT_97	[p5l1566t340r1944b398],

1	—	NN	O	—	_	0	SENT_98	[p5l1566t340r1944b398],
2	.	.	O	.	_	0	SENT_98	[p5l1566t340r1944b398],

1	HI	NN	O	hus	nn	2	SENT_99	[p5l1566t340r1944b398],
2	score	NN	NUMBER	score	nsubj	3	SENT_99	[p5l1982t361r2141b398],
3	decreased	VBD	O	decrease	_	0	SENT_99	[p5l11t435r316b498],
4	to	TO	O	to	_	0	SENT_99	[p5l366t456r427b497],
5	50	CD	PERCENT	50	num	6	SENT_99	[p5l482t440r629b501],
6	%	NN	PERCENT	%	prep_to	3	SENT_99	[p5l482t440r629b501],
7	of	IN	O	of	_	0	SENT_99	[p5l682t435r755b497],
8	the	DT	O	the	det	10	SENT_99	[p5l795t435r893b497],
9	maximal	JJ	O	maximal	amod	10	SENT_99	[p5l943t435r1220b497],
10	response	NN	O	response	prep_of	6	SENT_99	[p5l1271t460r1560b517],
11	.	.	O	.	_	0	SENT_99	[p5l1271t460r1560b517],

1	Secondary	JJ	O	secondary	amod	2	SENT_100	[p5l1617t435r1950b517],
2	endpoints	NNS	O	endpoint	nsubj	7	SENT_100	[p5l1998t435r2140b498, p5l9t540r208b617],
3	Were	VBD	O	be	cop	7	SENT_100	[p5l254t560r403b597],
4	the	DT	O	the	det	7	SENT_100	[p5l451t535r549b597],
5	peak	NN	O	peak	nn	7	SENT_100	[p5l594t535r746b617],
6	motor	NN	O	motor	nn	7	SENT_100	[p5l790t556r990b597],
7	response	NN	O	response	_	0	SENT_100	[p5l1037t560r1310b617],
8	(	CD	NUMBER	(	num	10	SENT_100	[p5l1361t536r1715b609],
9	maximum	NN	O	maximum	nn	10	SENT_100	[p5l1361t536r1715b609],
10	UPDRS	NNP	O	UPDRS	dep	7	SENT_100	[p5l1763t538r2140b597],
11	.	.	O	.	_	0	SENT_100	[p5l1763t538r2140b597],

1	—	NN	O	—	_	0	SENT_101	[p5l1763t538r2140b597],
2	.	.	O	.	_	0	SENT_101	[p5l1763t538r2140b597],

1	III	NNP	O	III	nn	3	SENT_102	[p5l1763t538r2140b597],
2	score	NN	NUMBER	score	nn	3	SENT_102	[p5l10t638r215b710],
3	)	NN	O	)	_	0	SENT_102	[p5l10t638r215b710],
4	,	,	O	,	_	0	SENT_102	[p5l10t638r215b710],
5	time	NN	O	time	appos	3	SENT_102	[p5l262t641r406b698],
6	to	TO	O	to	aux	7	SENT_102	[p5l450t657r511b698],
7	peak	VB	O	peak	infmod	5	SENT_102	[p5l556t637r707b719],
8	(	JJ	O	(	amod	9	SENT_102	[p5l752t637r1153b710],
9	UPDRS	NNS	O	updr	dobj	7	SENT_102	[p5l752t637r1153b710],
10	.	.	O	.	_	0	SENT_102	[p5l752t637r1153b710],

1	—	NN	O	—	_	0	SENT_103	[p5l752t637r1153b710],
2	.	.	O	.	_	0	SENT_103	[p5l752t637r1153b710],

1	HI	NN	O	hus	nn	3	SENT_104	[p5l752t637r1153b710],
2	Tmax	NN	O	tmax	nn	3	SENT_104	[p5l1196t637r1421b710],
3	)	NN	O	)	_	0	SENT_104	[p5l1196t637r1421b710],
4	,	,	O	,	_	0	SENT_104	[p5l1196t637r1421b710],
5	pharmacokinetics	NNS	O	pharmacokinetic	appos	3	SENT_104	[p5l1467t637r2034b719],
6	of	IN	O	of	_	0	SENT_104	[p5l2080t636r2153b698],
7	L	NN	O	l	nn	9	SENT_104	[p5l11t735r244b817],
8	—	CD	NUMBER	—	num	9	SENT_104	[p5l11t735r244b817],
9	dopa	NN	O	dopa	prep_of	5	SENT_104	[p5l11t735r244b817],
10	(	CD	NUMBER	(	num	11	SENT_104	[p5l287t736r438b809],
11	area	NN	O	area	dep	20	SENT_104	[p5l287t736r438b809],
12	under	IN	O	under	_	0	SENT_104	[p5l476t735r664b798],
13	the	DT	O	the	det	14	SENT_104	[p5l703t735r801b797],
14	concentration	NN	O	concentration	prep_under	11	SENT_104	[p5l842t739r1287b797],
15	over	IN	O	over	_	0	SENT_104	[p5l1327t760r1463b797],
16	time	NN	O	time	prep_over	14	SENT_104	[p5l1501t739r1644b797],
17	curve	NN	O	curve	dep	20	SENT_104	[p5l1685t760r1856b798],
18	(	CD	NUMBER	(	num	17	SENT_104	[p5l1900t736r2139b809],
19	AUC	NN	O	auc	nn	20	SENT_104	[p5l1900t736r2139b809],
20	)	NN	O	)	dep	5	SENT_104	[p5l1900t736r2139b809],
21	,	,	O	,	_	0	SENT_104	[p5l1900t736r2139b809],
22	half	NN	O	half	nn	24	SENT_104	[p5l9t835r275b906],
23	—	CD	NUMBER	—	num	24	SENT_104	[p5l9t835r275b906],
24	life	NN	O	life	conj_and	20	SENT_104	[p5l9t835r275b906],
25	,	,	O	,	_	0	SENT_104	[p5l9t835r275b906],
26	Tmax	NN	PERSON	tmax	conj_and	20	SENT_104	[p5l317t837r515b906],
27	,	,	O	,	_	0	SENT_104	[p5l317t837r515b906],
28	and	CC	O	and	_	0	SENT_104	[p5l559t835r677b898],
29	Cmax	NN	ORGANIZATION	cmax	nn	30	SENT_104	[p5l717t836r953b909],
30	)	NN	O	)	conj_and	20	SENT_104	[p5l717t836r953b909],
31	,	,	O	,	_	0	SENT_104	[p5l717t836r953b909],
32	and	CC	O	and	_	0	SENT_104	[p5l998t835r1115b898],
33	COMT	NN	O	comt	nn	34	SENT_104	[p5l1156t837r1410b897],
34	activity	NN	O	activity	appos	3	SENT_104	[p5l1441t839r1676b917],
35	in	IN	O	in	_	0	SENT_104	[p5l1713t840r1775b896],
36	red	JJ	O	red	amod	38	SENT_104	[p5l1816t835r1917b898],
37	blood	NN	O	blood	nn	38	SENT_104	[p5l1956t835r2142b898],
38	cells	NNS	O	cell	prep_in	34	SENT_104	[p5l11t934r159b996],
39	.	.	O	.	_	0	SENT_104	[p5l11t934r159b996],

1	Volume	NN	O	volume	_	0	SENT_105	[p5l1565t1165r1804b1224],
2	69	CD	NUMBER	69	num	1	SENT_105	[p5l1835t1167r1927b1230],
3	,	,	O	,	_	0	SENT_105	[p5l1835t1167r1927b1230],
4	No.	NN	O	no.	appos	1	SENT_105	[p5l1960t1169r2072b1223],
5	1	CD	NUMBER	1	num	4	SENT_105	[p5l2112t1171r2134b1222],

1	Randomization	NN	O	randomization	nn	4	SENT_106	[p5l16t1254r660b1326],
2	and	CC	O	and	_	0	SENT_106	[p5l698t1254r860b1326],
3	Drug	NN	MISC	drug	conj_and	1	SENT_106	[p5l895t1258r1107b1347],
4	Preparation	NN	MISC	preparation	nsubj	31	SENT_106	[p5l1146t1257r1651b1346],
5	The	DT	MISC	the	det	6	SENT_106	[p5l10t1365r140b1427],
6	order	NN	O	order	nsubjpass	15	SENT_106	[p5l187t1365r357b1428],
7	in	IN	O	in	_	0	SENT_106	[p5l403t1369r465b1426],
8	which	WDT	O	which	rel	13	SENT_106	[p5l508t1365r705b1427],
9	placebo	NN	O	placebo	nsubjpass	13	SENT_106	[p5l751t1365r994b1447],
10	or	CC	O	or	_	0	SENT_106	[p5l1043t1390r1109b1427],
11	entacapone	NN	O	entacapone	conj_or	9	SENT_106	[p5l1156t1386r1517b1447],
12	was	VBD	O	be	auxpass	13	SENT_106	[p5l1562t1391r1677b1427],
13	administered	VBN	O	administer	rcmod	6	SENT_106	[p5l1725t1365r2143b1428],
14	was	VBD	O	be	auxpass	15	SENT_106	[p5l8t1493r123b1529],
15	determined	VBN	O	determine	rcmod	4	SENT_106	[p5l166t1467r534b1530],
16	by	IN	O	by	_	0	SENT_106	[p5l575t1467r653b1548],
17	the	DT	O	the	det	18	SENT_106	[p5l691t1467r789b1529],
18	Department	NNP	ORGANIZATION	Department	agent	15	SENT_106	[p5l830t1471r1226b1549],
19	of	IN	ORGANIZATION	of	_	0	SENT_106	[p5l1266t1467r1339b1529],
20	Pharmacy	NNP	ORGANIZATION	Pharmacy	prep_of	18	SENT_106	[p5l1370t1467r1691b1548],
21	of	IN	O	of	_	0	SENT_106	[p5l1729t1467r1802b1529],
22	the	DT	O	the	det	25	SENT_106	[p5l1833t1467r1930b1529],
23	Pitié	NNP	LOCATION	Pitié	nn	25	SENT_106	[p5l1972t1469r2141b1529],
24	Salpétriere	NNP	LOCATION	Salpétriere	nn	25	SENT_106	[p5l13t1579r350b1661],
25	Hospital	NNP	LOCATION	Hospital	prep_of	20	SENT_106	[p5l395t1579r670b1661],
26	according	VBG	O	accord	_	0	SENT_106	[p5l715t1579r1028b1662],
27	to	TO	O	to	prepc_according_to	15	SENT_106	[p5l1071t1600r1132b1641],
28	a	DT	O	a	det	30	SENT_106	[p5l1178t1605r1210b1641],
29	computer	NN	O	computer	nn	30	SENT_106	[p5l1252t1579r1901b1662],
30	—	NN	O	—	pobj	15	SENT_106	[p5l1252t1579r1901b1662],
31	generated	VBD	O	generate	_	0	SENT_106	[p5l1252t1579r1901b1662],
32	list	NN	O	list	dobj	31	SENT_106	[p5l1944t1579r2038b1641],
33	of	IN	O	of	_	0	SENT_106	[p5l2081t1579r2154b1641],
34	random	JJ	O	random	amod	35	SENT_106	[p5l12t1706r264b1768],
35	numbers	NNS	O	number	prep_of	32	SENT_106	[p5l314t1706r612b1777],
36	;	:	O	;	_	0	SENT_106	[p5l314t1706r612b1777],
37	after	IN	O	after	_	0	SENT_106	[p5l664t1706r807b1768],
38	genotyping	VBG	O	genotype	prep_after	32	SENT_106	[p5l855t1710r1234b1789],
39	,	,	O	,	_	0	SENT_106	[p5l855t1710r1234b1789],
40	COM	NNP	O	COM	nn	41	SENT_106	[p5l1292t1709r1481b1768],
41	THH	NNP	O	THH	prep_after	32	SENT_106	[p5l1484t1691r1628b1767],
42	and	CC	O	and	_	0	SENT_106	[p5l1670t1706r1787b1768],
43	COM	NNP	O	COM	nn	44	SENT_106	[p5l1841t1709r2031b1768],
44	TU	NNP	O	TU	prep_after	32	SENT_106	[p5l2034t1691r2143b1767],
45	‘	CD	NUMBER	‘	dep	44	SENT_106	[p5l2034t1691r2143b1767],

1	patients	NNS	O	patient	nsubjpass	3	SENT_107	[p5l11t1844r261b1922],
2	were	VBD	O	be	auxpass	3	SENT_107	[p5l306t1865r455b1902],
3	assigned	VBN	O	assign	_	0	SENT_107	[p5l502t1840r767b1923],
4	consecutively	RB	O	consecutively	advmod	3	SENT_107	[p5l814t1840r1242b1922],
5	the	DT	O	the	det	6	SENT_107	[p5l1286t1840r1383b1902],
6	numbers	NNS	O	number	dobj	3	SENT_107	[p5l1430t1840r1710b1903],
7	on	IN	O	on	_	0	SENT_107	[p5l1757t1865r1839b1902],
8	the	DT	O	the	det	9	SENT_107	[p5l1885t1840r1983b1902],
9	list	NN	O	list	prep_on	3	SENT_107	[p5l2029t1840r2138b1902],
10	.	.	O	.	_	0	SENT_107	[p5l2029t1840r2138b1902],

1	Entacapone	NNP	O	Entacapone	dep	17	SENT_108	[p5l11t1946r389b2024],
2	(	CD	NUMBER	(	num	4	SENT_108	[p5l461t1943r713b2025],
3	200mg	JJ	O	200mg	amod	4	SENT_108	[p5l461t1943r713b2025],
4	tablets	NNS	O	tablet	dep	1	SENT_108	[p5l778t1942r1000b2013],
5	,	,	O	,	_	0	SENT_108	[p5l778t1942r1000b2013],
6	Novartis	NNP	ORGANIZATION	Novartis	nn	8	SENT_108	[p5l1070t1946r1343b2004],
7	Pharma	NNP	ORGANIZATION	Pharma	nn	8	SENT_108	[p5l1412t1942r1662b2004],
8	SAS	NNP	ORGANIZATION	SAS	appos	4	SENT_108	[p5l1728t1945r1876b2013],
9	,	,	O	,	_	0	SENT_108	[p5l1728t1945r1876b2013],
10	Rueil	NNP	O	Rueil	nn	12	SENT_108	[p5l1947t1942r2142b2005],
11	—	NNP	O	—	nn	12	SENT_108	[p5l1947t1942r2142b2005],
12	Malmaison	NNP	LOCATION	Malmaison	appos	4	SENT_108	[p5l11t2043r392b2114],
13	,	,	O	,	_	0	SENT_108	[p5l11t2043r392b2114],
14	France	NNP	LOCATION	France	nn	15	SENT_108	[p5l449t2044r681b2117],
15	)	NNP	O	)	nsubjpass	17	SENT_108	[p5l449t2044r681b2117],
16	was	VBD	O	be	auxpass	17	SENT_108	[p5l737t2069r852b2105],
17	transferred	VBN	O	transfer	_	0	SENT_108	[p5l906t2043r1251b2106],
18	to	TO	O	to	_	0	SENT_108	[p5l1304t2064r1365b2105],
19	capsules	NNS	O	capsule	prep_to	17	SENT_108	[p5l1419t2043r1676b2125],
20	(	CD	NUMBER	(	num	22	SENT_108	[p5l1734t2043r1988b2125],
21	capsule	NN	O	capsule	nn	22	SENT_108	[p5l1734t2043r1988b2125],
22	oo	NN	O	oo	tmod	17	SENT_108	[p5l2042t2049r2139b2114],
23	,	,	O	,	_	0	SENT_108	[p5l2042t2049r2139b2114],
24	Cooper	NNP	ORGANIZATION	Cooper	nn	29	SENT_108	[p5l13t2148r254b2227],
25	Laboratory	NNP	ORGANIZATION	Laboratory	nn	29	SENT_108	[p5l288t2145r653b2226],
26	,	,	O	,	_	0	SENT_108	[p5l288t2145r653b2226],
27	Melun	NNP	LOCATION	Melun	appos	29	SENT_108	[p5l689t2145r921b2216],
28	,	,	O	,	_	0	SENT_108	[p5l689t2145r921b2216],
29	France	NNP	LOCATION	France	appos	22	SENT_108	[p5l959t2146r1214b2219],
30	)	CD	NUMBER	)	num	29	SENT_108	[p5l959t2146r1214b2219],
31	.	.	O	.	_	0	SENT_108	[p5l959t2146r1214b2219],

1	Placebo	NN	O	placebo	nn	2	SENT_109	[p5l1253t2145r1498b2207],
2	capsules	NNS	O	capsule	nsubj	3	SENT_109	[p5l1534t2145r1791b2227],
3	contained	VBD	O	contain	_	0	SENT_109	[p5l1827t2145r2143b2208],
4	crystalline	JJ	O	crystalline	amod	8	SENT_109	[p5l12t2247r335b2329],
5	microcellulose	NN	O	microcellulose	nn	8	SENT_109	[p5l405t2247r866b2310],
6	(	NN	O	(	nn	8	SENT_109	[p5l940t2247r1259b2321],
7	sufficient	JJ	O	sufficient	amod	8	SENT_109	[p5l940t2247r1259b2321],
8	quantity	NN	O	quantity	dobj	3	SENT_109	[p5l1328t2251r1600b2329],
9	for	IN	O	for	_	0	SENT_109	[p5l1665t2247r1757b2309],
10	0.95	CD	NUMBER	0.95	num	11	SENT_109	[p5l1826t2252r1964b2313],
11	ml	NN	O	ml	prep_for	3	SENT_109	[p5l2038t2247r2139b2318],
12	,	,	O	,	_	0	SENT_109	[p5l2038t2247r2139b2318],
13	Cooper	NNP	ORGANIZATION	Cooper	nn	15	SENT_109	[p5l13t2362r254b2441],
14	Laboratory	NNP	ORGANIZATION	Laboratory	nn	15	SENT_109	[p5l287t2359r687b2440],
15	)	NN	O	)	appos	11	SENT_109	[p5l287t2359r687b2440],
16	,	,	O	,	_	0	SENT_109	[p5l287t2359r687b2440],
17	the	DT	O	the	det	19	SENT_109	[p5l723t2359r821b2421],
18	major	JJ	O	major	amod	19	SENT_109	[p5l854t2364r1043b2442],
19	excipient	NN	O	excipient	appos	15	SENT_109	[p5l1075t2363r1363b2441],
20	in	IN	O	in	_	0	SENT_109	[p5l1396t2363r1458b2420],
21	the	DT	O	the	det	23	SENT_109	[p5l1491t2359r1589b2421],
22	entacapone	NN	O	entacapone	nn	23	SENT_109	[p5l1622t2380r1984b2441],
23	tablets	NNS	O	tablet	prep_in	3	SENT_109	[p5l2018t2359r2141b2421, p5l11t2460r132b2522],
24	.	.	O	.	_	0	SENT_109	[p5l2018t2359r2141b2421, p5l11t2460r132b2522],

1	The	DT	O	the	det	2	SENT_110	[p5l175t2460r305b2522],
2	solubility	NN	O	solubility	nsubjpass	11	SENT_110	[p5l345t2460r647b2541],
3	and	CC	O	and	_	0	SENT_110	[p5l685t2460r803b2523],
4	stability	NN	O	stability	conj_and	2	SENT_110	[p5l843t2460r1098b2541],
5	of	IN	O	of	_	0	SENT_110	[p5l1137t2460r1209b2522],
6	entacapone	NN	O	entacapone	prep_of	2	SENT_110	[p5l1239t2481r1601b2542],
7	in	IN	O	in	_	0	SENT_110	[p5l1643t2464r1705b2521],
8	the	DT	O	the	det	9	SENT_110	[p5l1745t2460r1843b2522],
9	capsules	NNS	O	capsule	prep_in	6	SENT_110	[p5l1884t2460r2142b2542],
10	were	VBD	O	be	auxpass	11	SENT_110	[p5l8t2588r158b2625],
11	controlled	VBN	O	control	_	0	SENT_110	[p5l199t2563r527b2626],
12	by	IN	O	by	_	0	SENT_110	[p5l566t2563r645b2645],
13	the	DT	O	the	det	15	SENT_110	[p5l682t2563r780b2625],
14	French	JJ	MISC	french	amod	15	SENT_110	[p5l821t2563r1042b2625],
15	agency	NN	O	agency	agent	11	SENT_110	[p5l1082t2588r1300b2646],
16	for	IN	O	for	_	0	SENT_110	[p5l1337t2563r1429b2625],
17	health	NN	O	health	nn	18	SENT_110	[p5l1467t2563r1665b2625],
18	products	NNS	O	product	prep_for	15	SENT_110	[p5l1703t2563r1983b2645],
19	and	CC	O	and	_	0	SENT_110	[p5l2026t2563r2143b2626],
20	equipment	NN	O	equipment	agent	11	SENT_110	[p5l12t2679r361b2757],
21	(	CD	NUMBER	(	num	20	SENT_110	[p5l409t2676r663b2758],
22	Agence	NNP	O	Agence	nn	25	SENT_110	[p5l409t2676r663b2758],
23	Générale	NNP	O	Générale	nn	25	SENT_110	[p5l709t2675r995b2737],
24	des	FW	O	des	nn	25	SENT_110	[p5l1040t2675r1138b2737],
25	Equipements	NNP	O	Equipements	dep	20	SENT_110	[p5l1184t2679r1608b2757],
26	et	FW	O	et	nn	29	SENT_110	[p5l1655t2696r1710b2737],
27	Produits	FW	O	produits	nn	29	SENT_110	[p5l1755t2675r2024b2738],
28	de	FW	O	de	nn	29	SENT_110	[p5l2070t2675r2143b2738],
29	Santé	FW	O	santé	tmod	11	SENT_110	[p5l13t2778r203b2848],
30	,	,	O	,	_	0	SENT_110	[p5l13t2778r203b2848],
31	Paris	NNP	LOCATION	Paris	nn	33	SENT_110	[p5l241t2781r408b2848],
32	,	,	O	,	_	0	SENT_110	[p5l241t2781r408b2848],
33	France	NNP	LOCATION	France	appos	29	SENT_110	[p5l446t2778r701b2851],
34	)	CD	NUMBER	)	num	33	SENT_110	[p5l446t2778r701b2851],
35	.	.	O	.	_	0	SENT_110	[p5l446t2778r701b2851],

1	To	TO	O	to	aux	2	SENT_111	[p5l737t2779r821b2839],
2	ensure	VB	O	ensure	purpcl	11	SENT_111	[p5l856t2802r1061b2840],
3	blinding	JJ	O	blinding	acomp	2	SENT_111	[p5l1095t2777r1384b2860],
4	,	,	O	,	_	0	SENT_111	[p5l1095t2777r1384b2860],
5	the	DT	O	the	det	9	SENT_111	[p5l1421t2777r1519b2839],
6	placebo	NN	O	placebo	nn	9	SENT_111	[p5l1552t2777r1796b2859],
7	and	CC	O	and	_	0	SENT_111	[p5l1831t2777r1949b2839],
8	entacapone	NN	O	entacapone	nn	9	SENT_111	[p5l1983t2798r2141b2839, p5l12t2914r237b2971],
9	capsules	NNS	O	capsule	nsubjpass	11	SENT_111	[p5l271t2889r527b2971],
10	were	VBD	O	be	auxpass	11	SENT_111	[p5l559t2914r708b2951],
11	administered	VBN	O	administer	_	0	SENT_111	[p5l741t2889r1160b2952],
12	by	IN	O	by	_	0	SENT_111	[p5l1192t2889r1270b2971],
13	a	DT	O	a	det	14	SENT_111	[p5l1300t2915r1332b2951],
14	nurse	NN	O	nurse	agent	11	SENT_111	[p5l1364t2914r1535b2952],
15	Who	WP	O	who	nsubj	18	SENT_111	[p5l1565t2889r1702b2951],
16	did	VBD	O	do	aux	18	SENT_111	[p5l1737t2889r1842b2952],
17	not	RB	O	not	neg	18	SENT_111	[p5l1874t2910r1982b2951],
18	participate	VB	O	participate	rcmod	14	SENT_111	[p5l2013t2914r2141b2971, p5l12t2995r246b3073],
19	in	IN	O	in	_	0	SENT_111	[p5l279t2995r340b3052],
20	the	DT	O	the	det	22	SENT_111	[p5l372t2991r469b3053],
21	clinical	JJ	O	clinical	amod	22	SENT_111	[p5l501t2991r727b3053],
22	evaluation	NN	O	evaluation	prep_in	18	SENT_111	[p5l760t2991r1106b3053],
23	.	.	O	.	_	0	SENT_111	[p5l760t2991r1106b3053],

1	Genotyping	VBG	O	genotype	amod	3	SENT_112	[p6l17t73r527b164],
2	Genomic	JJ	O	genomic	amod	3	SENT_112	[p6l13t181r313b240],
3	DNA	NN	O	dna	nsubjpass	5	SENT_112	[p6l344t181r526b240],
4	was	VBD	O	be	auxpass	5	SENT_112	[p6l548t204r663b240],
5	extracted	VBN	O	extract	_	0	SENT_112	[p6l696t178r984b241],
6	by	IN	O	by	_	0	SENT_112	[p6l1015t178r1093b260],
7	standard	JJ	O	standard	amod	8	SENT_112	[p6l1120t178r1397b241],
8	methods	NNS	O	method	agent	5	SENT_112	[p6l1427t178r1702b241],
9	from	IN	O	from	_	0	SENT_112	[p6l1734t178r1890b240],
10	venous	JJ	O	venous	amod	12	SENT_112	[p6l1919t203r2142b240],
11	blood	NN	O	blood	nn	12	SENT_112	[p6l12t276r197b338],
12	samples	NNS	O	sample	prep_from	5	SENT_112	[p6l246t276r512b358],
13	.	.	O	.	_	0	SENT_112	[p6l246t276r512b358],

1	The	DT	O	the	det	5	SENT_113	[p6l565t276r695b338],
2	COM	NN	O	com	nn	5	SENT_113	[p6l751t279r940b338],
3	T	NN	O	t	nn	5	SENT_113	[p6l943t278r996b337],
4	polymorphism	NN	O	polymorphism	nn	5	SENT_113	[p6l1032t276r1508b358],
5	G185A	NN	O	g185a	nsubjpass	7	SENT_113	[p6l1560t279r1800b342],
6	was	VBD	O	be	auxpass	7	SENT_113	[p6l1841t302r1956b338],
7	analyzed	VBN	O	analyze	_	0	SENT_113	[p6l2007t301r2141b338, p6l11t374r174b455],
8	by	IN	O	by	_	0	SENT_113	[p6l217t374r296b455],
9	an	DT	O	a	det	19	SENT_113	[p6l336t399r411b436],
10	allelic	JJ	O	allelic	amod	19	SENT_113	[p6l454t374r637b436],
11	discrimination	NN	O	discrimination	nn	19	SENT_113	[p6l680t374r1150b436],
12	Taqman	NN	MISC	taqman	nn	19	SENT_113	[p6l1192t376r1458b456],
13	assay	NN	O	assay	nn	19	SENT_113	[p6l1501t400r1660b455],
14	(	CD	NUMBER	(	num	19	SENT_113	[p6l1705t375r1854b448],
15	ABI	NNP	O	ABI	nn	19	SENT_113	[p6l1705t375r1854b448],
16	PRISM	NNP	O	PRISM	nn	19	SENT_113	[p6l1900t377r2141b436],
17	7900	CD	NUMBER	7900	num	19	SENT_113	[p6l11t478r175b537],
18	sequence	NN	O	sequence	nn	19	SENT_113	[p6l209t496r495b553],
19	detection	NN	O	detection	agent	7	SENT_113	[p6l528t471r824b534],
20	system	NN	O	system	nn	21	SENT_113	[p6l857t472r1092b553],
21	)	NN	O	)	dep	19	SENT_113	[p6l857t472r1092b553],
22	that	WDT	O	that	nsubj	23	SENT_113	[p6l1131t471r1256b533],
23	uses	VBZ	O	use	rcmod	21	SENT_113	[p6l1288t497r1414b534],
24	the	DT	O	the	det	28	SENT_113	[p6l1447t471r1545b533],
25	5	CD	NUMBER	5	num	28	SENT_113	[p6l1581t468r1633b537],
26	'	''	O	'	_	0	SENT_113	[p6l1581t468r1633b537],
27	nuclease	NN	O	nuclease	nn	28	SENT_113	[p6l1670t471r1935b534],
28	activity	NN	O	activity	nsubj	34	SENT_113	[p6l1968t476r2141b533, p6l12t574r96b651],
29	of	IN	O	of	_	0	SENT_113	[p6l126t570r198b632],
30	721g	JJ	O	721g	amod	32	SENT_113	[p6l230t572r339b654],
31	DNA	NN	O	dna	nn	32	SENT_113	[p6l371t573r553b632],
32	polymerase	NN	O	polymerase	prep_of	28	SENT_113	[p6l581t570r943b652],
33	to	TO	O	to	aux	34	SENT_113	[p6l977t591r1038b632],
34	detect	VB	O	detect	xcomp	23	SENT_113	[p6l1072t570r1263b632],
35	a	DT	O	a	det	38	SENT_113	[p6l1296t596r1328b632],
36	fluorescent	JJ	O	fluorescent	amod	38	SENT_113	[p6l1359t570r1710b632],
37	reporter	NN	O	reporter	nn	38	SENT_113	[p6l1743t591r2000b652],
38	signal	NN	O	signal	dobj	34	SENT_113	[p6l2032t574r2141b653, p6l12t668r106b730],
39	generated	VBN	O	generate	partmod	38	SENT_113	[p6l142t668r451b751],
40	after	IN	O	after	_	0	SENT_113	[p6l486t668r629b730],
41	the	DT	O	the	det	44	SENT_113	[p6l662t668r760b730],
42	polymerase	NN	O	polymerase	nn	44	SENT_113	[p6l794t668r1156b750],
43	chain	NN	O	chain	nn	44	SENT_113	[p6l1192t668r1364b730],
44	reaction	NN	O	reaction	prep_after	39	SENT_113	[p6l1400t672r1673b730],
45	.	.	O	.	_	0	SENT_113	[p6l1400t672r1673b730],

1	Two	CD	NUMBER	two	num	2	SENT_114	[p6l1710t670r1849b730],
2	controls	NNS	O	control	nsubjpass	17	SENT_114	[p6l1885t668r2141b730],
3	each	DT	O	each	dep	2	SENT_114	[p6l12t781r152b843],
4	with	IN	O	with	_	0	SENT_114	[p6l193t781r339b843],
5	the	DT	O	the	det	7	SENT_114	[p6l383t781r480b843],
6	COM	NNP	O	COM	nn	7	SENT_114	[p6l531t784r721b843],
7	THH	NN	O	thh	prep_with	2	SENT_114	[p6l723t766r877b852],
8	,	,	O	,	_	0	SENT_114	[p6l723t766r877b852],
9	COM	NNP	ORGANIZATION	COM	nn	10	SENT_114	[p6l931t784r1120b843],
10	THL	NNP	ORGANIZATION	THL	prep_with	2	SENT_114	[p6l1123t766r1263b852],
11	,	,	O	,	_	0	SENT_114	[p6l1123t766r1263b852],
12	and	CC	O	and	_	0	SENT_114	[p6l1311t781r1430b844],
13	COM	NNP	O	COM	nn	15	SENT_114	[p6l1479t784r1669b843],
14	TLL	NN	O	tll	nn	15	SENT_114	[p6l1672t766r1780b842],
15	genotypes	NNS	O	genotype	conj_and	7	SENT_114	[p6l1824t802r2141b864],
16	were	VBD	O	be	auxpass	17	SENT_114	[p6l8t937r158b974],
17	analyzed	VBN	O	analyze	_	0	SENT_114	[p6l190t912r464b993],
18	concomitantly	RB	O	concomitantly	advmod	17	SENT_114	[p6l496t912r963b993],
19	for	IN	O	for	_	0	SENT_114	[p6l991t912r1082b974],
20	every	DT	O	every	det	21	SENT_114	[p6l1113t937r1281b993],
21	patient	NN	O	patient	prep_for	17	SENT_114	[p6l1309t916r1550b994],
22	.	.	O	.	_	0	SENT_114	[p6l1309t916r1550b994],

1	COMT	NNP	O	COMT	nn	4	SENT_115	[p6l17t1126r301b1196],
2	Activity	NNP	O	Activity	nn	4	SENT_115	[p6l324t1127r659b1216],
3	COMT	NNP	O	COMT	nn	4	SENT_115	[p6l13t1235r267b1296],
4	activity	NN	O	activity	nsubjpass	6	SENT_115	[p6l297t1238r532b1315],
5	was	VBD	O	be	auxpass	6	SENT_115	[p6l565t1260r680b1296],
6	measured	VBN	O	measure	_	0	SENT_115	[p6l721t1234r1027b1296],
7	on	IN	O	on	_	0	SENT_115	[p6l1066t1259r1148b1296],
8	red	JJ	O	red	amod	10	SENT_115	[p6l1188t1234r1289b1296],
9	blood	NN	O	blood	nn	10	SENT_115	[p6l1328t1234r1514b1296],
10	cells	NNS	O	cell	prep_on	6	SENT_115	[p6l1553t1234r1684b1296],
11	from	IN	O	from	_	0	SENT_115	[p6l1725t1234r1881b1296],
12	venous	JJ	O	venous	amod	13	SENT_115	[p6l1919t1259r2142b1296],
13	blood	NN	O	blood	prep_from	6	SENT_115	[p6l12t1336r213b1398],
14	.	.	O	.	_	0	SENT_115	[p6l12t1336r213b1398],

1	The	DT	O	the	det	3	SENT_116	[p6l258t1336r387b1397],
2	COMT	NN	O	comt	nn	3	SENT_116	[p6l430t1337r684b1398],
3	assay	NN	O	assay	nsubjpass	5	SENT_116	[p6l716t1361r875b1417],
4	was	VBD	O	be	auxpass	5	SENT_116	[p6l910t1361r1025b1397],
5	performed	VBN	O	perform	dep	38	SENT_116	[p6l1067t1336r1406b1418],
6	by	IN	O	by	_	0	SENT_116	[p6l1447t1336r1525b1417],
7	high-performance	JJ	O	high-performance	amod	11	SENT_116	[p6l1563t1336r2143b1419],
8	liquid	JJ	O	liquid	amod	11	SENT_116	[p6l11t1437r202b1519],
9	chromatography	NN	O	chromatography	nn	11	SENT_116	[p6l250t1437r785b1520],
10	(	CD	NUMBER	(	num	11	SENT_116	[p6l835t1438r1096b1511],
11	HPLC	NN	O	hplc	agent	5	SENT_116	[p6l835t1438r1096b1511],
12	)	CD	NUMBER	)	tmod	5	SENT_116	[p6l835t1438r1096b1511],
13	coupled	VBN	O	couple	dep	12	SENT_116	[p6l1150t1437r1405b1519],
14	with	IN	O	with	_	0	SENT_116	[p6l1449t1437r1595b1498],
15	electrochemical	JJ	O	electrochemical	amod	16	SENT_116	[p6l1644t1437r2142b1498],
16	detection	NN	O	detection	prep_with	13	SENT_116	[p6l12t1550r308b1612],
17	according	VBG	O	accord	_	0	SENT_116	[p6l348t1550r661b1633],
18	to	TO	O	to	prepc_according_to	13	SENT_116	[p6l699t1571r760b1612],
19	the	DT	O	the	det	20	SENT_116	[p6l801t1549r899b1612],
20	method	NN	O	method	pobj	13	SENT_116	[p6l938t1549r1188b1612],
21	of	IN	O	of	_	0	SENT_116	[p6l1226t1549r1299b1612],
22	Schultz	NNP	PERSON	Schultz	prep_of	20	SENT_116	[p6l1328t1549r1563b1612],
23	et	FW	O	et	nn	24	SENT_116	[p6l1601t1571r1658b1612],
24	al15	FW	O	al15	dep	22	SENT_116	[p6l1696t1535r1807b1612],
25	as	IN	O	as	_	0	SENT_116	[p6l1850t1575r1906b1612],
26	modified	VBN	O	modify	dep	12	SENT_116	[p6l1946t1550r2141b1612, p6l11t1651r131b1714],
27	by	IN	O	by	_	0	SENT_116	[p6l167t1652r246b1733],
28	Tuomainen	NNP	PERSON	Tuomainen	prep_by	26	SENT_116	[p6l277t1653r648b1714],
29	et	FW	O	et	nn	30	SENT_116	[p6l684t1673r741b1713],
30	al.	FW	O	al.	dobj	13	SENT_116	[p6l775t1636r911b1713],
31	16	CD	NUMBER	16	dep	12	SENT_116	[p6l775t1636r911b1713],
32	The	DT	O	the	det	34	SENT_116	[p6l946t1652r1076b1713],
33	specific	JJ	O	specific	amod	34	SENT_116	[p6l1112t1651r1348b1734],
34	activity	NN	O	activity	nsubjpass	38	SENT_116	[p6l1383t1656r1618b1733],
35	of	IN	O	of	_	0	SENT_116	[p6l1652t1651r1724b1713],
36	COMT	NNP	O	COMT	prep_of	34	SENT_116	[p6l1750t1653r2005b1714],
37	was	VBD	O	be	auxpass	38	SENT_116	[p6l2027t1677r2142b1714],
38	expressed	VBN	O	express	_	0	SENT_116	[p6l12t1753r313b1835],
39	as	IN	O	as	_	0	SENT_116	[p6l373t1778r430b1814],
40	Vanillic	JJ	O	vanillic	amod	42	SENT_116	[p6l489t1753r723b1815],
41	acid	NN	O	acid	nn	42	SENT_116	[p6l782t1753r912b1815],
42	(	NN	O	(	prep_as	38	SENT_116	[p6l976t1754r1061b1826],
43	in	IN	O	in	_	0	SENT_116	[p6l976t1754r1061b1826],
44	picomoles	NNS	O	picomole	prep_in	42	SENT_116	[p6l1121t1753r1469b1835],
45	)	CD	NUMBER	)	num	44	SENT_116	[p6l1121t1753r1469b1835],
46	formed	VBN	O	form	partmod	44	SENT_116	[p6l1535t1753r1769b1815],
47	during	IN	O	during	_	0	SENT_116	[p6l1830t1753r2045b1836],
48	1	CD	DURATION	1	num	49	SENT_116	[p6l2111t1759r2134b1813],
49	minute	NN	NUMBER	minute	prep_during	46	SENT_116	[p6l12t1869r242b1927],
50	per	IN	O	per	_	0	SENT_116	[p6l273t1889r376b1947],
51	milligram	NN	O	milligram	prep_per	49	SENT_116	[p6l406t1865r721b1948],
52	of	IN	O	of	_	0	SENT_116	[p6l753t1865r825b1927],
53	protein	NN	O	protein	prep_of	51	SENT_116	[p6l846t1869r1079b1947],
54	in	IN	O	in	_	0	SENT_116	[p6l1111t1869r1173b1926],
55	the	DT	O	the	det	56	SENT_116	[p6l1205t1865r1303b1927],
56	sample	NN	O	sample	prep_in	46	SENT_116	[p6l1334t1865r1573b1947],
57	.	.	O	.	_	0	SENT_116	[p6l1334t1865r1573b1947],

1	L-dopa	NN	MISC	l-dopa	nn	3	SENT_117	[p6l16t2076r311b2168],
2	Concentrations	NNS	MISC	concentration	nn	3	SENT_117	[p6l352t2079r1010b2149],
3	L-dopa	NN	MISC	l-dopa	nsubjpass	5	SENT_117	[p6l12t2199r245b2281],
4	was	VBD	O	be	auxpass	5	SENT_117	[p6l301t2224r416b2260],
5	measured	VBN	O	measure	_	0	SENT_117	[p6l478t2199r783b2261],
6	in	IN	O	in	_	0	SENT_117	[p6l844t2203r905b2259],
7	plasma	NN	O	plasma	prep_in	5	SENT_117	[p6l965t2199r1191b2281],
8	as	IN	O	as	mark	10	SENT_117	[p6l1250t2224r1306b2260],
9	previously	RB	DATE	previously	advmod	10	SENT_117	[p6l1367t2199r1699b2281],
10	described	VBN	O	describe	advcl	5	SENT_117	[p6l1757t2186r2142b2261],
11	.	.	O	.	_	0	SENT_117	[p6l1757t2186r2142b2261],

1	”	NN	O	”	nn	2	SENT_118	[p6l1757t2186r2142b2261],
2	Brieﬂy	NN	O	brieﬂy	nsubjpass	21	SENT_118	[p6l13t2299r234b2380],
3	,	,	O	,	_	0	SENT_118	[p6l13t2299r234b2380],
4	after	IN	O	after	_	0	SENT_118	[p6l283t2299r426b2360],
5	addition	NN	O	addition	prep_after	21	SENT_118	[p6l470t2299r741b2361],
6	of	IN	O	of	_	0	SENT_118	[p6l786t2299r859b2360],
7	dihydroxybenzylamine	NN	O	dihydroxybenzylamine	prep_of	5	SENT_118	[p6l893t2299r1627b2380],
8	as	IN	O	as	_	0	SENT_118	[p6l1673t2325r1729b2360],
9	an	DT	O	a	det	11	SENT_118	[p6l1775t2323r1850b2360],
10	internal	JJ	O	internal	amod	11	SENT_118	[p6l1895t2299r2142b2360],
11	standard	NN	O	standard	prep_as	7	SENT_118	[p6l11t2411r288b2473],
12	and	CC	O	and	_	0	SENT_118	[p6l322t2410r440b2473],
13	protein	NN	O	protein	nn	14	SENT_118	[p6l473t2415r707b2493],
14	precipitation	NN	O	precipitation	prep_as	7	SENT_118	[p6l742t2415r1155b2493],
15	with	IN	O	with	_	0	SENT_118	[p6l1188t2411r1333b2472],
16	perchloric	JJ	O	perchloric	amod	17	SENT_118	[p6l1367t2410r1692b2493],
17	acid	NN	O	acid	prep_with	11	SENT_118	[p6l1726t2411r1872b2481],
18	,	,	O	,	_	0	SENT_118	[p6l1726t2411r1872b2481],
19	L-dopa	NN	MISC	l-dopa	nsubjpass	21	SENT_118	[p6l1911t2410r2144b2493],
20	was	VBD	O	be	auxpass	21	SENT_118	[p6l8t2536r123b2572],
21	measured	VBN	O	measure	_	0	SENT_118	[p6l163t2511r468b2573],
22	in	IN	O	in	_	0	SENT_118	[p6l507t2515r568b2571],
23	the	DT	O	the	det	24	SENT_118	[p6l607t2510r705b2572],
24	supernatant	NN	O	supernatant	prep_in	21	SENT_118	[p6l743t2531r1122b2593],
25	by	IN	O	by	_	0	SENT_118	[p6l1159t2511r1238b2592],
26	HPLC	NN	O	hplc	agent	21	SENT_118	[p6l1273t2513r1487b2572],
27	coupled	VBN	O	couple	partmod	26	SENT_118	[p6l1526t2510r1780b2593],
28	with	IN	O	with	_	0	SENT_118	[p6l1815t2511r1960b2572],
29	electrochemical	JJ	O	electrochemical	amod	30	SENT_118	[p6l1998t2511r2141b2572, p6l12t2612r389b2673],
30	detection	NN	O	detection	prep_with	27	SENT_118	[p6l423t2612r720b2674],
31	at	IN	O	at	_	0	SENT_118	[p6l754t2633r811b2673],
32	O.	NNP	O	O.	nn	33	SENT_118	[p6l844t2616r1047b2674],
33	82V	NN	O	82v	prep_at	30	SENT_118	[p6l844t2616r1047b2674],
34	relative	JJ	O	relative	advmod	30	SENT_118	[p6l1071t2612r1300b2673],
35	to	TO	O	to	_	0	SENT_118	[p6l1334t2633r1395b2673],
36	an	DT	O	a	det	39	SENT_118	[p6l1430t2636r1504b2673],
37	Ag/AgCl	NN	O	ag/agcl	nn	39	SENT_118	[p6l1533t2612r1821b2695],
38	reference	NN	O	reference	nn	39	SENT_118	[p6l1855t2612r2142b2673],
39	electrode	NN	O	electrode	prep_to	34	SENT_118	[p6l12t2713r316b2775],
40	.	.	O	.	_	0	SENT_118	[p6l12t2713r316b2775],

1	The	DT	O	the	det	3	SENT_119	[p6l359t2712r489b2774],
2	lower	JJR	O	lower	amod	3	SENT_119	[p6l527t2713r703b2774],
3	limit	NN	O	limit	nsubj	8	SENT_119	[p6l742t2712r897b2774],
4	of	IN	O	of	_	0	SENT_119	[p6l935t2712r1007b2774],
5	quantitation	NN	O	quantitation	prep_of	3	SENT_119	[p6l1037t2717r1435b2795],
6	was	VBD	O	be	cop	8	SENT_119	[p6l1472t2738r1587b2774],
7	50	CD	NUMBER	50	num	8	SENT_119	[p6l1630t2718r1706b2778],
8	ng/ml	NN	O	ng/ml	_	0	SENT_119	[p6l1747t2712r1958b2795],
9	,	,	O	,	_	0	SENT_119	[p6l1747t2712r1958b2795],
10	with	IN	O	with	_	0	SENT_119	[p6l1997t2713r2143b2774],
11	a	DT	O	a	det	14	SENT_119	[p6l12t2836r44b2872],
12	relative	JJ	O	relative	amod	14	SENT_119	[p6l96t2810r325b2872],
13	standard	JJ	O	standard	amod	14	SENT_119	[p6l379t2810r653b2873],
14	deviation	NN	O	deviation	prep_with	8	SENT_119	[p6l707t2811r1004b2873],
15	of	IN	O	of	_	0	SENT_119	[p6l1057t2810r1130b2872],
16	<	JJR	O	<	prep_of	14	SENT_119	[p6l1177t2816r1363b2874],
17	8	CD	PERCENT	8	number	18	SENT_119	[p6l1177t2816r1363b2874],
18	%	NN	PERCENT	%	amod	16	SENT_119	[p6l1177t2816r1363b2874],
19	.	.	O	.	_	0	SENT_119	[p6l1177t2816r1363b2874],

1	The	DT	O	the	det	3	SENT_120	[p6l1419t2810r1549b2872],
2	pharmacokinetic	JJ	O	pharmacokinetic	amod	3	SENT_120	[p6l1601t2810r2144b2893],
3	parameters	NNS	O	parameter	nsubjpass	7	SENT_120	[p6l11t2932r360b2993],
4	for	IN	O	for	_	0	SENT_120	[p6l411t2911r503b2972],
5	L-dopa	NN	MISC	l-dopa	prep_for	3	SENT_120	[p6l552t2911r785b2993],
6	were	VBD	O	be	auxpass	7	SENT_120	[p6l830t2935r979b2973],
7	calculated	VBN	O	calculate	_	0	SENT_120	[p6l1030t2911r1349b2973],
8	by	IN	O	by	_	0	SENT_120	[p6l1398t2911r1476b2992],
9	Winonlin	NNP	PERSON	Winonlin	nn	11	SENT_120	[p6l1520t2911r1837b2973],
10	(	CD	NUMBER	(	num	11	SENT_120	[p6l1891t2912r2142b2984],
11	version	NN	O	version	agent	7	SENT_120	[p6l1891t2912r2142b2984],
12	5.2	CD	NUMBER	5.2	num	13	SENT_120	[p6l14t3014r135b3086],
13	)	NN	O	)	dobj	7	SENT_120	[p6l14t3014r135b3086],
14	with	IN	O	with	_	0	SENT_120	[p6l172t3012r317b3074],
15	a	DT	O	a	det	17	SENT_120	[p6l352t3038r384b3074],
16	noncompartmental	JJ	O	noncompartmental	amod	17	SENT_120	[p6l417t3013r1038b3095],
17	model	NN	O	model	prep_with	13	SENT_120	[p6l1073t3013r1291b3075],
18	.	.	O	.	_	0	SENT_120	[p6l1073t3013r1291b3075],

1	The	DT	O	the	det	3	SENT_121	[p6l1329t3013r1459b3074],
2	entacapone	NN	O	entacapone	nn	3	SENT_121	[p6l1494t3033r1855b3095],
3	concentrations	NNS	O	concentration	nsubjpass	5	SENT_121	[p6l1890t3037r2141b3074, p6l12t3116r254b3173],
4	were	VBD	O	be	auxpass	5	SENT_121	[p6l297t3136r447b3173],
5	determined	VBN	O	determine	_	0	SENT_121	[p6l492t3111r861b3174],
6	by	IN	O	by	_	0	SENT_121	[p6l906t3112r984b3193],
7	HPLC	NN	ORGANIZATION	hplc	agent	5	SENT_121	[p6l1026t3114r1241b3173],
8	with	IN	O	with	_	0	SENT_121	[p6l1283t3111r1428b3173],
9	ultraviolet	JJ	O	ultraviolet	amod	11	SENT_121	[p6l1474t3111r1801b3174],
10	detection	NN	O	detection	nn	11	SENT_121	[p6l1846t3111r2143b3174],
11	(	NN	O	(	prep_with	5	SENT_121	[p6l16t3213r159b3286],
12	310	CD	NUMBER	310	num	14	SENT_121	[p6l16t3213r159b3286],
13	nm	NN	O	nm	nn	14	SENT_121	[p6l193t3213r344b3286],
14	)	NN	O	)	dep	11	SENT_121	[p6l193t3213r344b3286],
15	.	.	O	.	_	0	SENT_121	[p6l193t3213r344b3286],

1	Entacapone	NNP	MISC	Entacapone	nn	3	SENT_122	[p6l16t3427r526b3515],
2	Concentrations	NNP	MISC	Concentrations	nn	3	SENT_122	[p6l566t3425r1223b3496],
3	Entacapone	NNP	MISC	Entacapone	nsubjpass	5	SENT_122	[p6l11t3549r389b3627],
4	was	VBD	O	be	auxpass	5	SENT_122	[p6l435t3571r550b3607],
5	measured	VBN	O	measure	_	0	SENT_122	[p6l600t3545r905b3608],
6	in	IN	O	in	_	0	SENT_122	[p6l954t3550r1015b3606],
7	plasma	NN	O	plasma	prep_in	5	SENT_122	[p6l1063t3545r1303b3627],
8	.	.	O	.	_	0	SENT_122	[p6l1063t3545r1303b3627],

1	Following	VBG	O	follow	_	0	SENT_123	[p6l1357t3545r1679b3628],
2	a	DT	O	a	det	5	SENT_123	[p6l1726t3571r1759b3607],
3	single	JJ	O	single	amod	5	SENT_123	[p6l1805t3545r2141b3628],
4	—	NN	O	—	nn	5	SENT_123	[p6l1805t3545r2141b3628],
5	step	NN	O	step	prep_following	25	SENT_123	[p6l1805t3545r2141b3628],
6	liquid	JJ	O	liquid	amod	9	SENT_123	[p6l11t3651r422b3734],
7	—	NN	O	—	nn	9	SENT_123	[p6l11t3651r422b3734],
8	liquid	NN	O	liquid	nn	9	SENT_123	[p6l11t3651r422b3734],
9	extraction	NN	O	extraction	dep	5	SENT_123	[p6l458t3656r777b3713],
10	with	IN	O	with	_	0	SENT_123	[p6l811t3652r957b3713],
11	ethyl	NN	O	ethyl	nn	12	SENT_123	[p6l994t3652r1149b3733],
12	acetate/n	NN	O	acetate/n	prep_with	9	SENT_123	[p6l1187t3652r1742b3722],
13	—	CD	NUMBER	—	num	14	SENT_123	[p6l1187t3652r1742b3722],
14	hexane	NN	O	hexane	dep	5	SENT_123	[p6l1187t3652r1742b3722],
15	,	,	O	,	_	0	SENT_123	[p6l1187t3652r1742b3722],
16	the	DT	O	the	det	17	SENT_123	[p6l1783t3651r1880b3713],
17	analyte	NN	O	analyte	appos	14	SENT_123	[p6l1917t3652r2142b3733],
18	and	CC	O	and	_	0	SENT_123	[p7l12t21r130b84],
19	internal	JJ	O	internal	amod	21	SENT_123	[p7l164t21r411b83],
20	standard	JJ	O	standard	amod	21	SENT_123	[p7l445t21r722b84],
21	(	NN	O	(	prep_following	25	SENT_123	[p7l759t21r1163b103],
22	probenecid	NN	O	probenecid	nn	23	SENT_123	[p7l759t21r1163b103],
23	)	NN	O	)	dep	21	SENT_123	[p7l759t21r1163b103],
24	were	VBD	O	be	auxpass	25	SENT_123	[p7l1200t46r1349b83],
25	separated	VBN	O	separate	_	0	SENT_123	[p7l1383t21r1682b103],
26	using	VBG	O	use	xcomp	25	SENT_123	[p7l1717t26r1888b104],
27	an	DT	O	a	det	30	SENT_123	[p7l1920t46r1994b83],
28	isocratic	JJ	O	isocratic	amod	30	SENT_123	[p7l2029t26r2141b83, p7l12t130r186b188],
29	mobile	JJ	O	mobile	amod	30	SENT_123	[p7l232t126r454b188],
30	phase	NN	O	phase	dobj	26	SENT_123	[p7l500t126r678b208],
31	of	IN	O	of	_	0	SENT_123	[p7l725t126r797b188],
32	30	CD	NUMBER	30	num	34	SENT_123	[p7l835t133r912b191],
33	mM	NN	O	mm	nn	34	SENT_123	[p7l961t130r1099b188],
34	phosphate	NN	O	phosphate	prep_of	30	SENT_123	[p7l1147t126r1478b208],
35	buffer	NN	O	buffer	nn	37	SENT_123	[p7l1525t126r1718b189],
36	(	NN	O	(	nn	37	SENT_123	[p7l1768t127r1896b208],
37	pH	NN	O	ph	nsubjpass	25	SENT_123	[p7l1768t127r1896b208],
38	2.75	CD	NUMBER	2.75	number	39	SENT_123	[p7l1944t127r2142b200],
39	)	CD	NUMBER	)	amod	37	SENT_123	[p7l1944t127r2142b200],
40	/	:	O	/	punct	41	SENT_123	[p7l1944t127r2142b200],
41	acetonitrile	NN	O	acetonitrile	dep	39	SENT_123	[p7l12t234r371b295],
42	on	IN	O	on	_	0	SENT_123	[p7l406t258r487b295],
43	a	DT	O	a	det	47	SENT_123	[p7l522t259r553b295],
44	reverse	JJ	O	reverse	amod	47	SENT_123	[p7l587t258r801b295],
45	phase	NN	O	phase	nn	47	SENT_123	[p7l835t233r1013b316],
46	C18	NN	O	c18	nn	47	SENT_123	[p7l1048t236r1183b295],
47	column	NN	O	column	prep_on	41	SENT_123	[p7l1221t233r1483b296],
48	.	.	O	.	_	0	SENT_123	[p7l1221t233r1483b296],

1	The	DT	O	the	det	3	SENT_124	[p7l1520t234r1650b295],
2	lower	JJR	O	lower	amod	3	SENT_124	[p7l1683t234r1861b295],
3	limit	NN	O	limit	_	0	SENT_124	[p7l1892t234r2047b295],
4	of	IN	O	of	prep	3	SENT_124	[p7l2081t233r2154b295],

1	January	NNP	DATE	January	_	0	SENT_125	[p7l6t485r245b558],
2	2011	CD	DATE	2011	dep	1	SENT_125	[p7l272t487r421b539],

1	Corvol	NNP	O	Corvol	nn	3	SENT_126	[p7l602t584r828b646],
2	et	FW	O	et	nn	3	SENT_126	[p7l864t596r932b645],
3	aI	NNP	O	aI	_	0	SENT_126	[p7l963t584r1036b645],
4	:	:	O	:	_	0	SENT_126	[p7l963t584r1036b645],
5	COMT	NNP	O	COMT	dep	3	SENT_126	[p7l1072t586r1309b646],
6	and	CC	O	and	_	0	SENT_126	[p7l1339t584r1464b645],
7	Entacapone	NNP	O	Entacapone	dep	3	SENT_126	[p7l1503t587r1917b663],
8	in	IN	O	in	_	0	SENT_126	[p7l1952t587r2005b645],
9	PD	NN	O	pd	prep_in	5	SENT_126	[p7l2044t587r2140b645],

1	quantitation	NN	O	quantitation	nsubj	3	SENT_127	[p7l11t836r409b914],
2	was	VBD	O	be	cop	3	SENT_127	[p7l442t858r557b894],
3	25ng/ml	CD	NUMBER	25ng/ml	_	0	SENT_127	[p7l594t832r888b915],
4	,	,	O	,	_	0	SENT_127	[p7l594t832r888b915],
5	with	IN	O	with	_	0	SENT_127	[p7l925t832r1070b894],
6	a	DT	O	a	det	9	SENT_127	[p7l1105t858r1137b894],
7	relative	JJ	O	relative	amod	9	SENT_127	[p7l1172t832r1401b894],
8	standard	JJ	O	standard	amod	9	SENT_127	[p7l1436t832r1713b895],
9	deviation	NN	O	deviation	prep_with	3	SENT_127	[p7l1747t832r2044b895],
10	of	IN	O	of	_	0	SENT_127	[p7l2080t832r2153b894],
11	<	JJR	O	<	prep_of	9	SENT_127	[p7l15t942r202b1000],
12	80/0	CD	NUMBER	80/0	dep	11	SENT_127	[p7l15t942r202b1000],
13	.	.	O	.	_	0	SENT_127	[p7l15t942r202b1000],

1	Statistical	JJ	O	statistical	amod	4	SENT_128	[p7l12t1169r435b1242],
2	Analysis	NN	O	analysis	nn	4	SENT_128	[p7l463t1169r817b1263],
3	Sample	NN	O	sample	nn	4	SENT_128	[p7l11t1287r246b1369],
4	size	NN	O	size	nsubjpass	6	SENT_128	[p7l283t1291r394b1349],
5	was	VBD	O	be	auxpass	6	SENT_128	[p7l428t1313r543b1349],
6	calculated	VBN	O	calculate	_	0	SENT_128	[p7l582t1287r901b1349],
7	to	TO	O	to	aux	8	SENT_128	[p7l938t1308r999b1349],
8	detect	VB	O	detect	xcomp	6	SENT_128	[p7l1039t1287r1231b1349],
9	a	DT	O	a	det	12	SENT_128	[p7l1268t1313r1300b1349],
10	50	CD	PERCENT	50	number	11	SENT_128	[p7l1338t1292r1486b1353],
11	%	NN	PERCENT	%	amod	12	SENT_128	[p7l1338t1292r1486b1353],
12	difference	NN	O	difference	dobj	8	SENT_128	[p7l1526t1287r1841b1349],
13	between	IN	O	between	_	0	SENT_128	[p7l1879t1287r2141b1349],
14	groups	NNS	O	group	prep_between	12	SENT_128	[p7l10t1423r226b1482],
15	(	CD	NUMBER	(	num	16	SENT_128	[p7l277t1400r663b1482],
16	genotypes	NNS	O	genotype	dep	17	SENT_128	[p7l277t1400r663b1482],
17	)	RB	O	)	amod	12	SENT_128	[p7l277t1400r663b1482],
18	,	,	O	,	_	0	SENT_128	[p7l277t1400r663b1482],
19	assuming	VBG	O	assume	partmod	12	SENT_128	[p7l714t1403r1013b1482],
20	a	DT	O	a	det	24	SENT_128	[p7l1058t1425r1090b1460],
21	mean	JJ	O	mean	amod	24	SENT_128	[p7l1135t1423r1309b1460],
22	30	CD	PERCENT	30	number	23	SENT_128	[p7l1356t1404r1505b1464],
23	%	NN	PERCENT	%	amod	24	SENT_128	[p7l1356t1404r1505b1464],
24	gain	NN	O	gain	dobj	19	SENT_128	[p7l1553t1403r1687b1482],
25	in	IN	O	in	_	0	SENT_128	[p7l1734t1403r1796b1460],
26	best	JJS	O	best	prep_in	24	SENT_128	[p7l1842t1399r1968b1460],
27	ON	IN	O	on	_	0	SENT_128	[p7l2014t1402r2141b1461],
28	time	NN	O	time	prep_on	26	SENT_128	[p7l10t1510r154b1568],
29	in	IN	O	in	_	0	SENT_128	[p7l208t1510r270b1567],
30	the	DT	O	the	det	33	SENT_128	[p7l323t1506r421b1568],
31	COM	NNP	O	COM	nn	33	SENT_128	[p7l479t1509r669b1568],
32	THH	NN	O	thh	nn	33	SENT_128	[p7l671t1491r816b1567],
33	group	NN	O	group	prep_in	28	SENT_128	[p7l861t1530r1067b1589],
34	,	,	O	,	_	0	SENT_128	[p7l861t1530r1067b1589],
35	with	IN	O	with	_	0	SENT_128	[p7l1120t1505r1266b1568],
36	a	DT	O	a	det	38	SENT_128	[p7l1319t1531r1351b1568],
37	standard	JJ	O	standard	amod	38	SENT_128	[p7l1401t1505r1678b1568],
38	deviation	NN	O	deviation	prep_with	12	SENT_128	[p7l1729t1505r2026b1568],
39	of	IN	O	of	_	0	SENT_128	[p7l2080t1505r2153b1568],
40	15	CD	PERCENT	15	num	41	SENT_128	[p7l18t1617r179b1678],
41	%	NN	PERCENT	%	prep_of	12	SENT_128	[p7l18t1617r179b1678],
42	.	.	O	.	_	0	SENT_128	[p7l18t1617r179b1678],

1	To	TO	O	to	aux	2	SENT_129	[p7l214t1614r297b1674],
2	obtain	VB	O	obtain	_	0	SENT_129	[p7l331t1612r535b1674],
3	a	DT	O	a	det	4	SENT_129	[p7l568t1638r599b1674],
4	power	NN	O	power	dobj	2	SENT_129	[p7l629t1636r828b1694],
5	of	IN	O	of	_	0	SENT_129	[p7l859t1612r932b1674],
6	0.8	CD	NUMBER	0.8	prep_of	4	SENT_129	[p7l953t1618r1051b1674],
7	and	CC	O	and	_	0	SENT_129	[p7l1087t1612r1205b1674],
8	for	IN	O	for	_	0	SENT_129	[p7l1235t1612r1327b1674],
9	a	DT	O	a	det	11	SENT_129	[p7l1358t1638r1390b1674],
10	risk	NN	O	risk	nn	11	SENT_129	[p7l1421t1612r1537b1674],
11	alpha	NN	O	alpha	prep_for	20	SENT_129	[p7l1566t1612r1740b1694],
12	of	IN	O	of	_	0	SENT_129	[p7l1771t1612r1843b1674],
13	0.05	CD	NUMBER	0.05	prep_of	11	SENT_129	[p7l1865t1617r2025b1683],
14	,	,	O	,	_	0	SENT_129	[p7l1865t1617r2025b1683],
15	17	CD	NUMBER	17	num	16	SENT_129	[p7l2068t1618r2141b1678],
16	patients	NNS	O	patient	nsubjpass	20	SENT_129	[p7l9t1728r260b1806],
17	per	IN	O	per	_	0	SENT_129	[p7l299t1748r402b1806],
18	group	NN	O	group	prep_per	16	SENT_129	[p7l440t1748r627b1807],
19	were	VBD	O	be	auxpass	20	SENT_129	[p7l665t1748r815b1785],
20	recruited	VBN	O	recruit	conj_and	2	SENT_129	[p7l854t1724r1156b1786],
21	.	.	O	.	_	0	SENT_129	[p7l854t1724r1156b1786],

1	The	DT	O	the	det	3	SENT_130	[p7l1198t1724r1327b1785],
2	primary	JJ	O	primary	amod	3	SENT_130	[p7l1366t1728r1626b1806],
3	endpoint	NN	O	endpoint	nsubjpass	18	SENT_130	[p7l1662t1724r1971b1806],
4	,	,	O	,	_	0	SENT_130	[p7l1662t1724r1971b1806],
5	percentage	NN	O	percentage	appos	3	SENT_130	[p7l2013t1748r2140b1806, p7l11t1876r248b1938],
6	of	IN	O	of	_	0	SENT_130	[p7l286t1855r358b1917],
7	best	JJS	O	best	prep_of	5	SENT_130	[p7l385t1855r511b1917],
8	ON	IN	O	on	_	0	SENT_130	[p7l548t1858r675b1917],
9	time	NN	O	time	prep_on	7	SENT_130	[p7l714t1859r857b1917],
10	gained	VBN	O	gain	partmod	9	SENT_130	[p7l895t1855r1106b1938],
11	with	IN	O	with	_	0	SENT_130	[p7l1139t1855r1285b1917],
12	entacapone	NN	O	entacapone	prep_with	10	SENT_130	[p7l1322t1876r1684b1937],
13	compared	VBN	O	compare	_	0	SENT_130	[p7l1722t1855r2042b1937],
14	to	TO	O	to	prepc_compared_to	10	SENT_130	[p7l2079t1876r2140b1917],
15	placebo	NN	O	placebo	pobj	10	SENT_130	[p7l9t1986r272b2068],
16	,	,	O	,	_	0	SENT_130	[p7l9t1986r272b2068],
17	was	VBD	O	be	auxpass	18	SENT_130	[p7l325t2012r440b2048],
18	compared	VBN	O	compare	_	0	SENT_130	[p7l493t1986r812b2068],
19	between	IN	O	between	_	0	SENT_130	[p7l863t1986r1126b2048],
20	genotypes	NNS	O	genotype	prep_between	18	SENT_130	[p7l1178t2007r1495b2069],
21	using	VBG	O	use	partmod	20	SENT_130	[p7l1549t1990r1720b2069],
22	the	DT	O	the	det	26	SENT_130	[p7l1770t1986r1868b2048],
23	Mann	NNP	O	Mann	nn	26	SENT_130	[p7l1919t1990r2140b2048, p7l7t2117r295b2198],
24	\	NNP	O	\	nn	26	SENT_130	[p7l1919t1990r2140b2048, p7l7t2117r295b2198],
25	Whitney	NNP	O	Whitney	nn	26	SENT_130	[p7l1919t1990r2140b2048, p7l7t2117r295b2198],
26	test	NN	O	test	dobj	21	SENT_130	[p7l332t2138r456b2178],
27	.	.	O	.	_	0	SENT_130	[p7l332t2138r456b2178],

1	The	DT	O	the	det	2	SENT_131	[p7l498t2117r628b2178],
2	treatment	NN	O	treatment	nsubjpass	7	SENT_131	[p7l668t2137r981b2178],
3	by	IN	O	by	_	0	SENT_131	[p7l1019t2117r1098b2198],
4	genotype	NN	O	genotype	nn	5	SENT_131	[p7l1134t2138r1425b2200],
5	interaction	NN	O	interaction	prep_by	2	SENT_131	[p7l1465t2121r1814b2178],
6	was	VBD	O	be	auxpass	7	SENT_131	[p7l1851t2142r1965b2179],
7	analyzed	VBN	O	analyze	_	0	SENT_131	[p7l2006t2141r2140b2178, p7l10t2223r173b2304],
8	by	IN	O	by	_	0	SENT_131	[p7l207t2223r286b2304],
9	repeated	VBN	O	repeat	amod	11	SENT_131	[p7l317t2223r587b2305],
10	measures	NNS	O	measure	nn	11	SENT_131	[p7l622t2247r909b2285],
11	analysis	NN	O	analysis	agent	7	SENT_131	[p7l945t2223r1187b2304],
12	of	IN	O	of	_	0	SENT_131	[p7l1223t2223r1295b2284],
13	variance	NN	O	variance	prep_of	7	SENT_131	[p7l1316t2227r1597b2285],
14	.	.	O	.	_	0	SENT_131	[p7l1316t2227r1597b2285],

1	For	IN	O	for	_	0	SENT_132	[p7l1636t2227r1745b2284],
2	all	DT	O	all	det	6	SENT_132	[p7l1779t2223r1851b2284],
3	primary	JJ	O	primary	amod	6	SENT_132	[p7l1885t2227r2144b2305],
4	and	CC	O	and	_	0	SENT_132	[p7l11t2335r129b2397],
5	secondary	JJ	O	secondary	conj_and	3	SENT_132	[p7l205t2335r527b2416],
6	endpoints	NNS	O	endpoint	prep_for	12	SENT_132	[p7l601t2335r937b2417],
7	,	,	O	,	_	0	SENT_132	[p7l601t2335r937b2417],
8	the	DT	O	the	det	10	SENT_132	[p7l1019t2335r1116b2397],
9	randomization	NN	O	randomization	nn	10	SENT_132	[p7l1194t2335r1667b2397],
10	period	NN	O	period	nsubjpass	12	SENT_132	[p7l1744t2335r1952b2417],
11	was	VBD	O	be	auxpass	12	SENT_132	[p7l2026t2361r2141b2397],
12	included	VBN	O	include	_	0	SENT_132	[p7l11t2442r290b2504],
13	in	IN	O	in	_	0	SENT_132	[p7l322t2446r384b2503],
14	the	DT	O	the	det	15	SENT_132	[p7l417t2442r515b2503],
15	model	NN	O	model	prep_in	12	SENT_132	[p7l547t2442r748b2504],
16	to	TO	O	to	aux	17	SENT_132	[p7l781t2463r842b2503],
17	control	VB	O	control	xcomp	12	SENT_132	[p7l877t2442r1106b2503],
18	for	IN	O	for	_	0	SENT_132	[p7l1139t2442r1230b2503],
19	a	DT	O	a	det	24	SENT_132	[p7l1262t2468r1294b2503],
20	potential	JJ	O	potential	amod	24	SENT_132	[p7l1324t2442r1610b2524],
21	carryover	NN	O	carryover	nn	24	SENT_132	[p7l1643t2466r1939b2523],
22	effect	NN	O	effect	nn	24	SENT_132	[p7l1971t2442r2143b2503],
23	(	NN	O	(	nn	24	SENT_132	[p7l15t2550r351b2623],
24	treatment	NN	O	treatment	prep_for	17	SENT_132	[p7l15t2550r351b2623],
25	by	IN	O	by	_	0	SENT_132	[p7l399t2549r478b2630],
26	randomization	NN	O	randomization	nn	28	SENT_132	[p7l524t2549r997b2611],
27	interaction	NN	O	interaction	nn	28	SENT_132	[p7l1046t2550r1439b2623],
28	)	NN	O	)	prep_by	17	SENT_132	[p7l1046t2550r1439b2623],
29	.	.	O	.	_	0	SENT_132	[p7l1046t2550r1439b2623],

1	For	IN	O	for	_	0	SENT_133	[p7l1493t2553r1602b2610],
2	other	JJ	O	other	amod	3	SENT_133	[p7l1650t2549r1818b2610],
3	analyses	NNS	O	analysis	prep_for	7	SENT_133	[p7l1866t2549r2138b2630],
4	,	,	O	,	_	0	SENT_133	[p7l1866t2549r2138b2630],
5	groups	NNS	O	group	nsubjpass	7	SENT_133	[p7l10t2686r226b2745],
6	were	VBD	O	be	auxpass	7	SENT_133	[p7l266t2687r415b2724],
7	compared	VBN	O	compare	_	0	SENT_133	[p7l457t2662r777b2744],
8	using	VBG	O	use	xcomp	7	SENT_133	[p7l818t2666r990b2745],
9	the	DT	O	the	det	14	SENT_133	[p7l1030t2662r1127b2724],
10	Mann	NNP	O	Mann	nn	14	SENT_133	[p7l1169t2662r1679b2743],
11	—	CD	NUMBER	—	num	14	SENT_133	[p7l1169t2662r1679b2743],
12	\	CD	NUMBER	\	num	14	SENT_133	[p7l1169t2662r1679b2743],
13	X/hitney	NN	O	x/hitney	nn	14	SENT_133	[p7l1169t2662r1679b2743],
14	test	NN	O	test	dobj	8	SENT_133	[p7l1718t2683r1827b2724],
15	for	IN	O	for	_	0	SENT_133	[p7l1868t2662r1959b2724],
16	continuous	JJ	O	continuous	amod	17	SENT_133	[p7l2000t2687r2140b2724, p7l11t2772r251b2830],
17	variables	NNS	O	variable	prep_for	8	SENT_133	[p7l281t2768r557b2830],
18	and	CC	O	and	_	0	SENT_133	[p7l590t2768r708b2830],
19	the	DT	O	the	det	22	SENT_133	[p7l739t2768r837b2830],
20	Fisher	NNP	O	Fisher	nn	22	SENT_133	[p7l869t2768r1062b2830],
21	exact	JJ	O	exact	amod	22	SENT_133	[p7l1093t2789r1252b2830],
22	test	NN	O	test	prep_for	8	SENT_133	[p7l1283t2789r1392b2830],
23	for	IN	O	for	_	0	SENT_133	[p7l1422t2768r1513b2829],
24	dichotomous	JJ	O	dichotomous	amod	25	SENT_133	[p7l1543t2768r1965b2830],
25	variable	NN	O	variable	prep_for	22	SENT_133	[p7l1995t2772r2140b2830, p7l11t2881r154b2942],
26	.	.	O	.	_	0	SENT_133	[p7l1995t2772r2140b2830, p7l11t2881r154b2942],

1	The	DT	O	the	det	3	SENT_134	[p7l188t2881r317b2942],
2	treatment	NN	O	treatment	nn	3	SENT_134	[p7l348t2902r661b2942],
3	effect	NN	O	effect	nsubjpass	12	SENT_134	[p7l691t2881r863b2942],
4	within	IN	O	within	_	0	SENT_134	[p7l890t2881r1100b2943],
5	groups	NNS	O	group	prep_within	3	SENT_134	[p7l1131t2905r1346b2964],
6	(	CD	NUMBER	(	num	7	SENT_134	[p7l1382t2882r1768b2963],
7	entacapone	NN	O	entacapone	dep	5	SENT_134	[p7l1382t2882r1768b2963],
8	versus	CC	O	versus	prep	7	SENT_134	[p7l1795t2905r1988b2943],
9	placebo	NN	O	placebo	nn	10	SENT_134	[p7l2019t2881r2141b2963, p7l11t2988r178b3062],
10	)	NN	O	)	dep	8	SENT_134	[p7l2019t2881r2141b2963, p7l11t2988r178b3062],
11	was	VBD	O	be	auxpass	12	SENT_134	[p7l214t3014r329b3050],
12	analyzed	VBN	O	analyze	_	0	SENT_134	[p7l362t2988r636b3069],
13	using	VBG	O	use	xcomp	12	SENT_134	[p7l669t2992r840b3071],
14	the	DT	O	the	det	17	SENT_134	[p7l871t2988r969b3050],
15	paired	JJ	O	paired	amod	17	SENT_134	[p7l1000t2988r1201b3070],
16	Wilkinson	NNP	PERSON	Wilkinson	nn	17	SENT_134	[p7l1229t2988r1571b3050],
17	test	NN	O	test	dobj	13	SENT_134	[p7l1603t3009r1727b3050],
18	.	.	O	.	_	0	SENT_134	[p7l1603t3009r1727b3050],

1	All	DT	O	all	det	2	SENT_135	[p7l1760t2988r1855b3049],
2	analyses	NNS	O	analysis	nsubjpass	4	SENT_135	[p7l1888t2988r2141b3069],
3	were	VBD	O	be	auxpass	4	SENT_135	[p7l7t3119r157b3156],
4	performed	VBN	O	perform	_	0	SENT_135	[p7l191t3094r531b3176],
5	on	IN	O	on	_	0	SENT_135	[p7l565t3118r647b3155],
6	an	DT	O	a	det	7	SENT_135	[p7l683t3118r757b3155],
7	intention	NN	O	intention	prep_on	4	SENT_135	[p7l793t3098r1089b3155],
8	to	TO	O	to	aux	9	SENT_135	[p7l1125t3115r1186b3155],
9	treat	VB	O	treat	infmod	7	SENT_135	[p7l1224t3114r1368b3155],
10	basis	NN	O	basis	dobj	9	SENT_135	[p7l1402t3094r1568b3164],
11	,	,	O	,	_	0	SENT_135	[p7l1402t3094r1568b3164],
12	with	IN	O	with	mark	15	SENT_135	[p7l1604t3094r1750b3156],
13	all	DT	O	all	det	14	SENT_135	[p7l1785t3094r1857b3155],
14	subjects	NNS	O	subject	nsubj	15	SENT_135	[p7l1892t3094r2141b3176],
15	included	VBD	O	include	advcl	4	SENT_135	[p7l11t3202r290b3264],
16	in	IN	O	in	_	0	SENT_135	[p7l340t3206r402b3263],
17	the	DT	O	the	det	22	SENT_135	[p7l452t3202r550b3263],
18	two	CD	NUMBER	two	num	22	SENT_135	[p7l601t3223r717b3263],
19	L	NN	O	l	nn	22	SENT_135	[p7l770t3202r1003b3284],
20	—	CD	NUMBER	—	num	22	SENT_135	[p7l770t3202r1003b3284],
21	dopa	NN	O	dopa	nn	22	SENT_135	[p7l770t3202r1003b3284],
22	challenges	NNS	O	challenge	prep_in	15	SENT_135	[p7l1052t3202r1392b3285],
23	.	.	O	.	_	0	SENT_135	[p7l1052t3202r1392b3285],

1	No	DT	O	no	det	3	SENT_136	[p7l1446t3206r1547b3263],
2	interim	NN	O	interim	nn	3	SENT_136	[p7l1599t3206r1836b3263],
3	analyses	NNS	O	analysis	nsubjpass	5	SENT_136	[p7l1888t3202r2141b3283],
4	were	VBD	O	be	auxpass	5	SENT_136	[p7l7t3333r157b3370],
5	performed	VBN	O	perform	_	0	SENT_136	[p7l198t3308r552b3390],
6	.	.	O	.	_	0	SENT_136	[p7l198t3308r552b3390],

1	Statistical	JJ	MISC	statistical	amod	2	SENT_137	[p7l599t3308r904b3370],
2	analysis	NN	O	analysis	nsubjpass	4	SENT_137	[p7l945t3308r1187b3389],
3	was	VBD	O	be	auxpass	4	SENT_137	[p7l1227t3334r1342b3370],
4	carried	VBN	O	carry	_	0	SENT_137	[p7l1385t3308r1603b3370],
5	out	RP	O	out	prt	4	SENT_137	[p7l1644t3329r1751b3370],
6	with	IN	O	with	_	0	SENT_137	[p7l1788t3308r1933b3370],
7	STATISTICA	NN	O	statistica	nn	8	SENT_137	[p7l1975t3309r2140b3370, p7l8t3417r329b3478],
8	software	NN	O	software	prep_with	4	SENT_137	[p7l384t3416r650b3477],
9	(	CD	NUMBER	(	num	10	SENT_137	[p7l711t3417r1022b3489],
10	Statistica	NNP	O	Statistica	dep	8	SENT_137	[p7l711t3417r1022b3489],
11	7.1	CD	NUMBER	7.1	num	10	SENT_137	[p7l1077t3422r1197b3486],
12	,	,	O	,	_	0	SENT_137	[p7l1077t3422r1197b3486],
13	Statsoft	NNP	LOCATION	Statsoft	nn	14	SENT_137	[p7l1259t3416r1499b3478],
14	France	NNP	LOCATION	France	appos	10	SENT_137	[p7l1556t3420r1785b3486],
15	,	,	O	,	_	0	SENT_137	[p7l1556t3420r1785b3486],
16	Maisons	NNP	PERSON	Maisons	nn	18	SENT_137	[p7l1845t3420r2140b3477],
17	—	NNP	PERSON	—	nn	18	SENT_137	[p7l1845t3420r2140b3477],
18	Alfort	NNP	PERSON	Alfort	appos	10	SENT_137	[p7l6t3522r217b3592],
19	,	,	O	,	_	0	SENT_137	[p7l6t3522r217b3592],
20	France	NNP	LOCATION	France	appos	10	SENT_137	[p7l259t3523r514b3596],
21	)	CD	NUMBER	)	num	20	SENT_137	[p7l259t3523r514b3596],
22	.	.	O	.	_	0	SENT_137	[p7l259t3523r514b3596],

1	Values	NNS	O	value	nsubjpass	3	SENT_138	[p7l553t3522r760b3584],
2	are	VBP	O	be	auxpass	3	SENT_138	[p7l798t3546r889b3583],
3	expressed	VBN	O	express	_	0	SENT_138	[p7l927t3522r1228b3604],
4	as	IN	O	as	_	0	SENT_138	[p7l1265t3548r1321b3583],
5	mean	JJ	O	mean	amod	6	SENT_138	[p7l1360t3546r1534b3583],
6	i	FW	O	i	prep_as	3	SENT_138	[p7l1579t3530r1629b3580],
7	standard	JJ	O	standard	amod	8	SENT_138	[p7l1675t3522r1951b3584],
8	error	NN	O	error	dobj	3	SENT_138	[p7l1987t3546r2143b3583],
9	of	IN	O	of	_	0	SENT_138	[p7l11t3629r83b3691],
10	the	DT	O	the	det	11	SENT_138	[p7l104t3629r202b3691],
11	mean	NN	O	mean	prep_of	8	SENT_138	[p7l234t3654r425b3691],
12	.	.	O	.	_	0	SENT_138	[p7l234t3654r425b3691],

1	Results	NNS	O	result	_	0	SENT_139	[p8l16t105r346b184],

1	Patients	NNS	O	patient	tmod	20	SENT_140	[p8l15t245r364b314],
2	Among	IN	O	among	_	0	SENT_140	[p8l6t370r278b458],
3	the	DT	O	the	det	5	SENT_140	[p8l339t366r448b434],
4	58	CD	NUMBER	58	num	5	SENT_140	[p8l513t371r596b440],
5	patients	NNS	O	patient	prep_among	11	SENT_140	[p8l661t371r940b458],
6	screened	VBN	O	screen	partmod	5	SENT_140	[p8l1003t366r1326b445],
7	,	,	O	,	_	0	SENT_140	[p8l1003t366r1326b445],
8	20	CD	NUMBER	20	nsubj	11	SENT_140	[p8l1391t373r1479b434],
9	were	VBD	O	be	cop	11	SENT_140	[p8l1540t394r1706b435],
10	COM	NNP	O	COM	nn	11	SENT_140	[p8l1776t370r1987b435],
11	THH	NNP	O	THH	rcmod	1	SENT_140	[p8l1990t350r2150b433],
12	(	CD	PERCENT	(	number	13	SENT_140	[p8l15t488r259b570],
13	34	CD	PERCENT	34	num	14	SENT_140	[p8l15t488r259b570],
14	%	NN	PERCENT	%	dep	11	SENT_140	[p8l15t488r259b570],
15	)	CD	NUMBER	)	dep	14	SENT_140	[p8l15t488r259b570],
16	,	,	O	,	_	0	SENT_140	[p8l15t488r259b570],
17	21	CD	NUMBER	21	nsubj	20	SENT_140	[p8l300t494r380b555],
18	were	VBD	O	be	cop	20	SENT_140	[p8l423t515r588b556],
19	COM	NNP	O	COM	nn	20	SENT_140	[p8l632t491r843b556],
20	THL	NNP	O	THL	dep	30	SENT_140	[p8l847t471r983b555],
21	(	CD	PERCENT	(	number	22	SENT_140	[p8l1023t488r1267b569],
22	36	CD	PERCENT	36	num	23	SENT_140	[p8l1023t488r1267b569],
23	%	NN	PERCENT	%	dep	20	SENT_140	[p8l1023t488r1267b569],
24	)	CD	NUMBER	)	dep	20	SENT_140	[p8l1023t488r1267b569],
25	,	,	O	,	_	0	SENT_140	[p8l1023t488r1267b569],
26	and	CC	O	and	_	0	SENT_140	[p8l1308t487r1439b557],
27	17	CD	NUMBER	17	conj_and	20	SENT_140	[p8l1483t494r1564b560],
28	were	VBD	O	be	cop	30	SENT_140	[p8l1597t515r1763b556],
29	COM	NNP	O	COM	nn	30	SENT_140	[p8l1807t491r2017b556],
30	Ta	NNP	O	Ta	_	0	SENT_140	[p8l2021t471r2142b555],
31	(	CD	PERCENT	(	number	32	SENT_140	[p8l15t610r233b691],
32	29	CD	PERCENT	29	dep	33	SENT_140	[p8l15t610r233b691],
33	%	NN	PERCENT	%	dep	30	SENT_140	[p8l15t610r233b691],
34	)	CD	NUMBER	)	tmod	30	SENT_140	[p8l15t610r233b691],
35	(	CD	NUMBER	(	num	38	SENT_140	[p8l307t610r444b701],
36	Fig	NN	O	fig	nn	38	SENT_140	[p8l307t610r444b701],
37	1	CD	NUMBER	1	num	38	SENT_140	[p8l513t610r596b691],
38	)	NN	O	)	nsubj	30	SENT_140	[p8l513t610r596b691],
39	.	.	O	.	_	0	SENT_140	[p8l513t610r596b691],

1	The	DT	O	the	det	7	SENT_141	[p8l661t609r805b677],
2	first	JJ	ORDINAL	first	quantmod	3	SENT_141	[p8l867t608r1006b677],
3	17	CD	NUMBER	17	num	7	SENT_141	[p8l1075t616r1156b682],
4	consecutive	JJ	O	consecutive	amod	7	SENT_141	[p8l1218t613r1628b678],
5	homozygous	JJ	O	homozygous	amod	7	SENT_141	[p8l1689t609r2139b701],
6	COM	NN	O	com	nn	7	SENT_141	[p8l17t734r228b799],
7	THH	NN	O	thh	nsubjpass	13	SENT_141	[p8l232t714r393b798],
8	and	CC	O	and	_	0	SENT_141	[p8l442t730r572b800],
9	COM	NN	O	com	nn	11	SENT_141	[p8l636t734r847b799],
10	Tu	NN	O	tu	nn	11	SENT_141	[p8l851t714r972b798],
11	patients	NNS	O	patient	nsubjpass	13	SENT_141	[p8l1028t735r1307b822],
12	were	VBD	O	be	auxpass	13	SENT_141	[p8l1363t758r1528b799],
13	randomized	VBN	O	randomize	_	0	SENT_141	[p8l1587t730r2013b800],
14	to	TO	O	to	aux	15	SENT_141	[p8l2072t753r2139b799],
15	receive	VB	O	receive	xcomp	13	SENT_141	[p8l11t854r250b918],
16	acute	JJ	O	acute	amod	17	SENT_141	[p8l309t873r493b919],
17	challenges	NNS	O	challenge	dobj	15	SENT_141	[p8l552t850r910b942],
18	of	IN	O	of	_	0	SENT_141	[p8l970t849r1051b918],
19	L	NN	O	l	nn	21	SENT_141	[p8l1098t849r1357b941],
20	—	CD	NUMBER	—	num	21	SENT_141	[p8l1098t849r1357b941],
21	dopa	NN	O	dopa	prep_of	17	SENT_141	[p8l1098t849r1357b941],
22	With	IN	O	with	_	0	SENT_141	[p8l1409t850r1571b918],
23	either	CC	O	either	preconj	25	SENT_141	[p8l1629t850r1832b918],
24	200mg	JJ	O	200mg	amod	25	SENT_141	[p8l1888t857r2143b942],
25	entacapone	NN	O	entacapone	prep_with	15	SENT_141	[p8l11t994r413b1062],
26	or	CC	O	or	_	0	SENT_141	[p8l451t998r524b1039],
27	placebo	NN	O	placebo	prep_with	15	SENT_141	[p8l559t971r850b1062],
28	.	.	O	.	_	0	SENT_141	[p8l559t971r850b1062],

1	One	CD	NUMBER	one	num	2	SENT_142	[p8l891t974r1046b1039],
2	patient	NN	O	patient	nsubj	7	SENT_142	[p8l1081t975r1332b1062],
3	(	CD	NUMBER	(	num	5	SENT_142	[p8l1372t972r1615b1053],
4	COM	NN	O	com	nn	5	SENT_142	[p8l1372t972r1615b1053],
5	TM	NN	O	tm	dep	2	SENT_142	[p8l1619t954r1763b1053],
6	)	CD	NUMBER	)	dep	2	SENT_142	[p8l1619t954r1763b1053],
7	withdrew	VBD	O	withdraw	_	0	SENT_142	[p8l1802t971r2144b1040],
8	consent	NN	O	consent	dobj	7	SENT_142	[p8l11t1114r284b1160],
9	before	IN	O	before	_	0	SENT_142	[p8l332t1091r553b1160],
10	the	DT	O	the	det	11	SENT_142	[p8l602t1091r711b1160],
11	challenge	NN	O	challenge	prep_before	7	SENT_142	[p8l760t1091r1108b1183],
12	.	.	O	.	_	0	SENT_142	[p8l760t1091r1108b1183],

1	Age	NNP	O	Age	nsubj	25	SENT_143	[p8l1157t1095r1316b1183],
2	,	,	O	,	_	0	SENT_143	[p8l1157t1095r1316b1183],
3	sex	NN	O	sex	nsubj	25	SENT_143	[p8l1368t1120r1490b1170],
4	,	,	O	,	_	0	SENT_143	[p8l1368t1120r1490b1170],
5	disease	NN	O	disease	nn	6	SENT_143	[p8l1544t1091r1784b1161],
6	duration	NN	O	duration	nsubj	25	SENT_143	[p8l1834t1091r2141b1161],
7	and	CC	O	and	_	0	SENT_143	[p8l11t1211r142b1280],
8	severity	NN	O	severity	conj_and	1	SENT_143	[p8l182t1215r460b1301],
9	,	,	O	,	_	0	SENT_143	[p8l182t1215r460b1301],
10	and	CC	O	and	_	0	SENT_143	[p8l505t1211r636b1280],
11	daily	JJ	SET	daily	amod	12	SENT_143	[p8l677t1211r850b1301],
12	dose	NN	O	dose	conj_and	1	SENT_143	[p8l889t1210r1044b1280],
13	of	IN	O	of	_	0	SENT_143	[p8l1087t1210r1167b1279],
14	treatment	NN	O	treatment	prep_of	12	SENT_143	[p8l1197t1234r1544b1279],
15	were	VBD	O	be	cop	25	SENT_143	[p8l1582t1238r1748b1279],
16	similar	JJ	O	similar	amod	25	SENT_143	[p8l1789t1210r2032b1279],
17	in	IN	O	in	_	0	SENT_143	[p8l2073t1215r2142b1278],
18	the	DT	O	the	det	20	SENT_143	[p8l11t1333r120b1401],
19	COM	NNP	O	COM	nn	20	SENT_143	[p8l175t1336r386b1401],
20	THH	NN	O	thh	prep_in	16	SENT_143	[p8l390t1317r550b1400],
21	and	CC	O	and	_	0	SENT_143	[p8l589t1333r720b1402],
22	COM	NN	O	com	amod	25	SENT_143	[p8l774t1336r984b1401],
23	7	CD	NUMBER	7	num	22	SENT_143	[p8l988t1317r1110b1400],
24	”	NN	O	”	nn	25	SENT_143	[p8l988t1317r1110b1400],
25	patients	NNS	O	patient	_	0	SENT_143	[p8l1156t1337r1434b1424],
26	(	RB	O	(	dep	27	SENT_143	[p8l1489t1332r1708b1415],
27	Table	NNP	O	Table	dep	25	SENT_143	[p8l1489t1332r1708b1415],
28	1	CD	NUMBER	1	number	29	SENT_143	[p8l1765t1334r1849b1415],
29	)	CD	NUMBER	)	num	27	SENT_143	[p8l1765t1334r1849b1415],
30	.	.	O	.	_	0	SENT_143	[p8l1765t1334r1849b1415],

1	Except	IN	O	except	_	0	SENT_144	[p8l1901t1337r2142b1424],

1	548	CD	NUMBER	548	num	2	SENT_145	[p8l580t1634r644b1682],
2	screenecl	NN	O	screenecl	_	0	SENT_145	[p8l661t1631r907b1682],
3	21	CD	NUMBER	21	num	4	SENT_145	[p8l590t1715r654b1763],
4	COMTHH	NNP	O	COMTHH	dep	2	SENT_145	[p8l674t1712r900b1763],
5	.20	CD	NUMBER	.20	num	4	SENT_145	[p8l594t1799r661b1844],
6	COM	NNP	O	COM	dep	4	SENT_145	[p8l678t1793r894b1844],
7	)	CD	NUMBER	)	num	6	SENT_145	[p8l678t1793r894b1844],
8	?	.	O	?	_	0	SENT_145	[p8l678t1793r894b1844],

1	”	NN	O	”	_	0	SENT_146	[p8l678t1793r894b1844],
2	1	CD	NUMBER	1	dep	1	SENT_146	[p8l603t1880r664b1927],
3	?	.	O	?	_	0	SENT_146	[p8l603t1880r664b1927],

1	COM	NN	O	com	_	0	SENT_147	[p8l681t1874r890b1927],
2	?	.	O	?	_	0	SENT_147	[p8l681t1874r890b1927],

1	“	NN	O	“	_	0	SENT_148	[p8l681t1874r890b1927],

1	1	CD	NUMBER	1	_	0	SENT_149	[p8l209t2408r270b2456],
2	?	.	O	?	_	0	SENT_149	[p8l209t2408r270b2456],

1	C-QMTHH	NN	O	c-qmthh	_	0	SENT_150	[p8l290t2405r516b2456],
2	1	CD	NUMBER	1	dep	1	SENT_150	[p8l1097t2392r1158b2439],
3	?	.	O	?	_	0	SENT_150	[p8l1097t2392r1158b2439],

1	COMFL	NNP	O	COMFL	_	0	SENT_151	[p8l1177t2388r1383b2439],
2	[	CD	NUMBER	[	num	1	SENT_151	[p8l199t2502r247b2537],
3	-3	CD	NUMBER	-3	num	4	SENT_151	[p8l199t2502r247b2537],
4	o͒	NN	O	o͒	dep	1	SENT_151	[p8l253t2489r318b2537],
5	*	CD	NUMBER	*	num	6	SENT_151	[p8l253t2489r318b2537],
6	an-1ﬁZE	NN	O	an-1ﬁze	dep	4	SENT_151	[p8l324t2489r523b2537],
7	.	.	O	.	_	0	SENT_151	[p8l324t2489r523b2537],

1	d	NN	O	d	nn	3	SENT_152	[p8l324t2489r523b2537],
2	Fa	NN	O	fa	nn	3	SENT_152	[p8l1076t2486r1124b2520],
3	ϒ	NN	O	ϒ	_	0	SENT_152	[p8l1131t2472r1286b2520],
4	*	CD	NUMBER	*	num	5	SENT_152	[p8l1131t2472r1286b2520],
5	lI	NN	O	li	dep	3	SENT_152	[p8l1295t2472r1400b2520],
6	.	.	O	.	_	0	SENT_152	[p8l1295t2472r1400b2520],

1	EI	NN	O	eus	_	0	SENT_153	[p8l1295t2472r1400b2520],
2	‘	NN	O	‘	dep	1	SENT_153	[p8l1295t2472r1400b2520],
3	.	.	O	.	_	0	SENT_153	[p8l1295t2472r1400b2520],

1	l	NN	O	l	_	0	SENT_154	[p8l1295t2472r1400b2520],

1	1	CD	NUMBER	1	nsubj	2	SENT_155	[p8l1703t2644r1731b2688],
2	withdraw	VBP	O	withdraw	_	0	SENT_155	[p8l1747t2640r2010b2688],
3	of	IN	O	of	_	0	SENT_155	[p8l2027t2640r2085b2688],
4	consent	NN	O	consent	prep_of	2	SENT_155	[p8l1784t2728r2000b2771],

1	1	CD	NUMBER	1	_	0	SENT_156	[p8l209t2899r270b2946],
2	?	.	O	?	_	0	SENT_156	[p8l209t2899r270b2946],

1	CDMTHH	JJ	O	cdmthh	_	0	SENT_157	[p8l290t2895r516b2946],
2	anallvzed	JJ	O	anallvzed	dep	1	SENT_157	[p8l240t2980r479b3041],

1	FIGURE	NN	O	figure	_	0	SENT_158	[p8l15t3190r276b3246],
2	1	CD	NUMBER	1	num	1	SENT_158	[p8l308t3192r364b3245],
3	:	:	O	:	_	0	SENT_158	[p8l308t3192r364b3245],
4	Flow	NN	O	flow	nn	5	SENT_158	[p8l412t3188r574b3246],
5	chart	NN	O	chart	dep	1	SENT_158	[p8l601t3188r774b3246],
6	of	IN	O	of	_	0	SENT_158	[p8l803t3187r873b3246],
7	the	DT	O	the	det	8	SENT_158	[p8l898t3188r1009b3246],
8	study	NN	O	study	prep_of	5	SENT_158	[p8l1038t3188r1244b3263],
9	.	.	O	.	_	0	SENT_158	[p8l1038t3188r1244b3263],

1	ANNALS	NN	O	annals	_	0	SENT_159	[p8l80t3569r241b3599],
2	of	IN	O	of	_	0	SENT_159	[p8l267t3562r314b3612],
3	Neurology	NNP	O	Neurology	prep_of	1	SENT_159	[p8l317t3562r516b3612],

1	TABLE	NN	O	table	dep	162	SENT_160	[p9l100t67r214b94],
2	1	CD	NUMBER	1	dep	162	SENT_160	[p9l230t67r259b94],
3	:	:	O	:	_	0	SENT_160	[p9l230t67r259b94],
4	Characteristics	NNS	O	characteristic	dep	162	SENT_160	[p9l275t65r528b95],
5	of	IN	O	of	dep	162	SENT_160	[p9l543t65r579b94],
6	PD	NN	O	pd	dep	162	SENT_160	[p9l593t67r641b94],
7	Patients	NNS	O	patient	dep	162	SENT_160	[p9l657t67r795b95],
8	with	IN	O	with	dep	162	SENT_160	[p9l809t65r882b94],
9	COMTHH	NN	O	comthh	dep	162	SENT_160	[p9l900t59r1052b95],
10	and	CC	O	and	dep	162	SENT_160	[p9l1065t65r1127b95],
11	COMT	NN	O	comt	dep	162	SENT_160	[p9l1145t59r1284b95],
12	”	NN	O	”	dep	162	SENT_160	[p9l1145t59r1284b95],
13	'	''	O	'	_	0	SENT_160	[p9l1145t59r1284b95],
14	Genotypes	NNPS	O	Genotypes	dep	162	SENT_160	[p9l1298t67r1487b103],
15	Characteristics	NNPS	O	Characteristics	dep	162	SENT_160	[p9l109t143r359b174],
16	COMI	NNP	O	COMI	dep	162	SENT_160	[p9l1050t136r1227b179],
17	””	CD	NUMBER	””	dep	162	SENT_160	[p9l1050t136r1227b179],
18	,	,	O	,	_	0	SENT_160	[p9l1050t136r1227b179],
19	n	NN	O	n	dep	162	SENT_160	[p9l1243t155r1265b174],
20	=	JJ	O	=	dep	162	SENT_160	[p9l1283t154r1309b167],
21	17	CD	NUMBER	17	dep	162	SENT_160	[p9l1331t146r1371b176],
22	c0M7	NN	O	c0m7	dep	162	SENT_160	[p9l1517t136r1682b179],
23	“	NN	O	“	dep	162	SENT_160	[p9l1517t136r1682b179],
24	,	,	O	,	_	0	SENT_160	[p9l1517t136r1682b179],
25	n	NN	O	n	dep	162	SENT_160	[p9l1698t155r1720b174],
26	=	JJ	O	=	dep	162	SENT_160	[p9l1739t154r1764b167],
27	16	CD	NUMBER	16	dep	162	SENT_160	[p9l1787t144r1825b174],
28	[	NN	O	[	dep	162	SENT_160	[p9l1964t153r1990b185],
29	2	CD	NUMBER	2	dep	162	SENT_160	[p9l1964t153r1990b185],
30	Age	NNP	O	Age	dep	162	SENT_160	[p9l118t224r189b263],
31	,	,	O	,	_	0	SENT_160	[p9l118t224r189b263],
32	yr	NN	DURATION	yr	dep	162	SENT_160	[p9l205t234r237b262],
33	64	CD	NUMBER	64	dep	162	SENT_160	[p9l1047t222r1086b253],
34	i	FW	O	i	dep	162	SENT_160	[p9l1106t226r1131b251],
35	10	CD	NUMBER	10	dep	162	SENT_160	[p9l1155t225r1190b253],
36	60	CD	NUMBER	60	dep	162	SENT_160	[p9l1515t223r1553b253],
37	i	FW	O	i	dep	162	SENT_160	[p9l1573t226r1598b251],
38	12	CD	NUMBER	12	dep	162	SENT_160	[p9l1622t225r1657b252],
39	0.35	CD	NUMBER	0.35	dep	162	SENT_160	[p9l1970t225r2038b255],
40	Sex	NN	O	sex	dep	162	SENT_160	[p9l121t290r174b319],
41	ratio	NN	O	ratio	dep	162	SENT_160	[p9l189t291r261b319],
42	(	CD	NUMBER	(	dep	162	SENT_160	[p9l280t289r493b326],
43	malezfemale	NN	O	malezfemale	dep	162	SENT_160	[p9l280t289r493b326],
44	)	NN	O	)	dep	162	SENT_160	[p9l280t289r493b326],
45	2.4	CD	NUMBER	2.4	dep	162	SENT_160	[p9l1047t289r1096b319],
46	(	CD	NUMBER	(	dep	162	SENT_160	[p9l1115t289r1208b326],
47	1225	CD	DATE	1225	dep	162	SENT_160	[p9l1115t289r1208b326],
48	)	NN	O	)	dep	162	SENT_160	[p9l1115t289r1208b326],
49	2.2	CD	NUMBER	2.2	dep	162	SENT_160	[p9l1514t292r1564b319],
50	(	NN	O	(	dep	162	SENT_160	[p9l1582t289r1676b325],
51	115	CD	NUMBER	115	dep	162	SENT_160	[p9l1582t289r1676b325],
52	)	CD	NUMBER	)	dep	162	SENT_160	[p9l1582t289r1676b325],
53	0.99	CD	NUMBER	0.99	dep	162	SENT_160	[p9l1970t292r2039b321],
54	Disease	NN	O	disease	dep	162	SENT_160	[p9l121t357r239b386],
55	duration	NN	O	duration	dep	162	SENT_160	[p9l255t355r401b390],
56	,	,	O	,	_	0	SENT_160	[p9l255t355r401b390],
57	yr	NN	DURATION	yr	dep	162	SENT_160	[p9l417t367r449b396],
58	11	CD	NUMBER	11	dep	162	SENT_160	[p9l1050t358r1083b385],
59	i	FW	O	i	dep	162	SENT_160	[p9l1106t359r1131b384],
60	5	CD	NUMBER	5	dep	162	SENT_160	[p9l1152t358r1168b388],
61	11	CD	NUMBER	11	dep	162	SENT_160	[p9l1518t358r1550b385],
62	i	FW	O	i	dep	162	SENT_160	[p9l1573t359r1598b384],
63	5	CD	NUMBER	5	dep	162	SENT_160	[p9l1620t358r1635b388],
64	0.54	CD	NUMBER	0.54	dep	162	SENT_160	[p9l1970t355r2040b388],
65	Treatment	NN	O	treatment	dep	162	SENT_160	[p9l120t423r285b452],
66	duration	NN	O	duration	dep	162	SENT_160	[p9l301t422r447b457],
67	,	,	O	,	_	0	SENT_160	[p9l301t422r447b457],
68	yr	NN	DURATION	yr	dep	162	SENT_160	[p9l463t434r495b462],
69	10	CD	NUMBER	10	dep	162	SENT_160	[p9l1050t425r1086b452],
70	i	FW	O	i	dep	162	SENT_160	[p9l1106t425r1131b451],
71	6	CD	NUMBER	6	dep	162	SENT_160	[p9l1151t423r1169b452],
72	10	CD	NUMBER	10	dep	162	SENT_160	[p9l1518t425r1553b452],
73	i	FW	O	i	dep	162	SENT_160	[p9l1573t425r1598b451],
74	5	CD	NUMBER	5	dep	162	SENT_160	[p9l1620t424r1635b454],
75	0.86	CD	NUMBER	0.86	dep	162	SENT_160	[p9l1970t423r2040b452],
76	UPDRS	NNS	O	updr	dep	162	SENT_160	[p9l121t490r252b519],
77	total	JJ	O	total	dep	162	SENT_160	[p9l268t488r339b519],
78	score	NN	NUMBER	score	dep	162	SENT_160	[p9l355t500r434b519],
79	44	CD	NUMBER	44	dep	162	SENT_160	[p9l1046t489r1086b518],
80	i	FW	O	i	dep	162	SENT_160	[p9l1106t492r1131b517],
81	21	CD	NUMBER	21	dep	162	SENT_160	[p9l1151t491r1187b518],
82	44	CD	NUMBER	44	dep	162	SENT_160	[p9l1514t488r1554b518],
83	i	FW	O	i	dep	162	SENT_160	[p9l1573t492r1598b517],
84	11	CD	NUMBER	11	dep	162	SENT_160	[p9l1622t491r1654b518],
85	0.71	CD	NUMBER	0.71	dep	162	SENT_160	[p9l1970t491r2036b521],
86	Hoehn	NNP	PERSON	Hoehn	dep	162	SENT_160	[p9l121t555r232b585],
87	and	CC	O	and	dep	162	SENT_160	[p9l248t555r306b586],
88	Yahr	NNP	O	Yahr	dep	162	SENT_160	[p9l320t555r393b585],
89	2.4	CD	NUMBER	2.4	dep	162	SENT_160	[p9l1047t555r1096b585],
90	i	FW	O	i	dep	162	SENT_160	[p9l1117t559r1142b584],
91	‘	FW	O	‘	dep	162	SENT_160	[p9l1117t559r1142b584],
92	0.6	CD	NUMBER	0.6	dep	162	SENT_160	[p9l1162t556r1211b585],
93	2.4	CD	NUMBER	2.4	dep	162	SENT_160	[p9l1514t555r1564b585],
94	i	FW	O	i	dep	162	SENT_160	[p9l1584t559r1609b584],
95	0.6	CD	NUMBER	0.6	dep	162	SENT_160	[p9l1629t556r1678b585],
96	0.86	CD	NUMBER	0.86	dep	162	SENT_160	[p9l1970t556r2040b585],
97	L-dopa	NN	O	l-dopa	dep	162	SENT_160	[p9l121t621r244b662],
98	,	,	O	,	_	0	SENT_160	[p9l121t621r244b662],
99	mg/day	NN	O	mg/day	dep	162	SENT_160	[p9l262t621r383b662],
100	635	CD	NUMBER	635	dep	162	SENT_160	[p9l1047t622r1105b654],
101	i	FW	O	i	dep	162	SENT_160	[p9l1127t625r1152b650],
102	275	CD	NUMBER	275	dep	162	SENT_160	[p9l1172t624r1231b654],
103	766	CD	NUMBER	766	dep	162	SENT_160	[p9l1514t622r1574b654],
104	i	FW	O	i	dep	162	SENT_160	[p9l1594t625r1619b650],
105	277	CD	NUMBER	277	dep	162	SENT_160	[p9l1639t624r1700b654],
106	0.14	CD	NUMBER	0.14	dep	162	SENT_160	[p9l1970t621r2040b652],
107	Dopamine	NN	O	dopamine	dep	162	SENT_160	[p9l121t690r292b729],
108	agonist	NN	O	agonist	dep	162	SENT_160	[p9l308t690r421b729],
109	(	CD	NUMBER	(	dep	162	SENT_160	[p9l438t688r565b729],
110	L-dopa	NN	MISC	l-dopa	dep	162	SENT_160	[p9l438t688r565b729],
111	equivalent	JJ	O	equivalent	dep	162	SENT_160	[p9l580t688r766b729],
112	)	NN	O	)	dep	162	SENT_160	[p9l580t688r766b729],
113	,	,	O	,	_	0	SENT_160	[p9l580t688r766b729],
114	mg/day	NN	O	mg/day	dep	162	SENT_160	[p9l783t688r904b729],
115	212	CD	NUMBER	212	dep	162	SENT_160	[p9l1047t691r1107b718],
116	i	FW	O	i	dep	162	SENT_160	[p9l1127t692r1152b717],
117	131	CD	NUMBER	131	dep	162	SENT_160	[p9l1176t691r1229b720],
118	164	CD	NUMBER	164	dep	162	SENT_160	[p9l1518t688r1574b718],
119	i	FW	O	i	dep	162	SENT_160	[p9l1594t692r1619b717],
120	125	CD	NUMBER	125	dep	162	SENT_160	[p9l1643t690r1698b721],
121	0.28	CD	NUMBER	0.28	dep	162	SENT_160	[p9l1970t691r2039b718],
122	Total	JJ	O	total	dep	162	SENT_160	[p9l120t754r202b785],
123	L-dopa	NN	MISC	l-dopa	dep	162	SENT_160	[p9l218t754r333b795],
124	equivalent	NN	O	equivalent	dep	162	SENT_160	[p9l348t754r520b795],
125	,	,	O	,	_	0	SENT_160	[p9l348t754r520b795],
126	mg/day	NN	O	mg/day	dep	162	SENT_160	[p9l538t754r659b795],
127	847	CD	NUMBER	847	dep	162	SENT_160	[p9l1048t754r1107b787],
128	i	FW	O	i	dep	162	SENT_160	[p9l1127t758r1152b783],
129	320	CD	NUMBER	320	dep	162	SENT_160	[p9l1172t757r1232b787],
130	930	CD	NUMBER	930	dep	162	SENT_160	[p9l1515t757r1574b787],
131	i	FW	O	i	dep	162	SENT_160	[p9l1594t758r1619b783],
132	329	CD	NUMBER	329	dep	162	SENT_160	[p9l1640t757r1699b787],
133	0.47	CD	NUMBER	0.47	dep	162	SENT_160	[p9l1970t754r2040b787],
134	Ongoing	JJ	O	ongoing	dep	162	SENT_160	[p9l121t822r265b862],
135	treatment	NN	O	treatment	dep	162	SENT_160	[p9l280t831r435b851],
136	with	IN	O	with	dep	162	SENT_160	[p9l449t821r521b851],
137	entacapone	NN	O	entacapone	dep	162	SENT_160	[p9l536t831r724b861],
138	,	,	O	,	_	0	SENT_160	[p9l536t831r724b861],
139	No.	NN	O	no.	dep	162	SENT_160	[p9l741t823r800b851],
140	(	CD	PERCENT	(	dep	162	SENT_160	[p9l819t821r875b857],
141	%	NN	PERCENT	%	dep	162	SENT_160	[p9l819t821r875b857],
142	)	CD	NUMBER	)	dep	162	SENT_160	[p9l819t821r875b857],
143	9	CD	NUMBER	9	dep	162	SENT_160	[p9l1047t824r1065b853],
144	(	NN	O	(	dep	162	SENT_160	[p9l1084t821r1181b857],
145	53	CD	PERCENT	53	dep	162	SENT_160	[p9l1084t821r1181b857],
146	%	NN	PERCENT	%	dep	162	SENT_160	[p9l1084t821r1181b857],
147	)	CD	NUMBER	)	dep	162	SENT_160	[p9l1084t821r1181b857],
148	7	CD	NUMBER	7	dep	162	SENT_160	[p9l1514t824r1533b853],
149	(	NN	O	(	dep	162	SENT_160	[p9l1551t821r1648b857],
150	44	CD	PERCENT	44	dep	162	SENT_160	[p9l1551t821r1648b857],
151	%	NN	PERCENT	%	dep	162	SENT_160	[p9l1551t821r1648b857],
152	)	CD	NUMBER	)	dep	162	SENT_160	[p9l1551t821r1648b857],
153	0.60	CD	NUMBER	0.60	dep	162	SENT_160	[p9l1970t822r2040b851],
154	Values	NNS	O	value	dep	162	SENT_160	[p9l107t885r199b913],
155	are	VBP	O	be	dep	162	SENT_160	[p9l214t896r254b913],
156	means	VBZ	O	mean	dep	162	SENT_160	[p9l268t896r358b913],
157	i	FW	O	i	dep	162	SENT_160	[p9l376t888r398b911],
158	standard	JJ	O	standard	dep	162	SENT_160	[p9l416t885r538b913],
159	error	NN	O	error	dep	162	SENT_160	[p9l552t896r622b913],
160	of	IN	O	of	dep	162	SENT_160	[p9l635t885r668b913],
161	the	DT	O	the	dep	162	SENT_160	[p9l677t885r721b913],
162	mean	NN	O	mean	_	0	SENT_160	[p9l735t896r820b913],
163	.	.	O	.	_	0	SENT_160	[p9l735t896r820b913],

1	p	NN	O	p	nn	2	SENT_161	[p9l831t894r851b922],
2	value	NN	O	value	_	0	SENT_161	[p9l864t885r946b913],
3	:	:	O	:	_	0	SENT_161	[p9l864t885r946b913],
4	Mann	NNP	PERSON	Mann	nn	5	SENT_161	[p9l961t887r1048b913],
5	Whitney	NNP	PERSON	Whitney	dep	2	SENT_161	[p9l1061t885r1189b922],
6	or	CC	O	or	_	0	SENT_161	[p9l1202t896r1231b913],
7	Fisher	NNP	O	Fisher	nn	9	SENT_161	[p9l1245t885r1331b913],
8	exact	JJ	O	exact	amod	9	SENT_161	[p9l1345t894r1416b913],
9	tests	NNS	O	test	dep	2	SENT_161	[p9l1430t894r1497b913],
10	.	.	O	.	_	0	SENT_161	[p9l1430t894r1497b913],

1	UPDRS	NN	O	updr	_	0	SENT_162	[p9l108t928r226b955],
2	=	JJ	O	=	amod	7	SENT_162	[p9l242t940r267b949],
3	Unified	NNP	O	Unified	nn	7	SENT_162	[p9l283t927r392b955],
4	Parkinson	NNP	O	Parkinson	nn	7	SENT_162	[p9l406t927r549b955],
5	Disease	NNP	O	Disease	nn	7	SENT_162	[p9l563t929r668b955],
6	Rating	NNP	O	Rating	nn	7	SENT_162	[p9l683t929r779b964],
7	Scale	NNP	O	Scale	dep	1	SENT_162	[p9l792t927r870b955],
8	.	.	O	.	_	0	SENT_162	[p9l792t927r870b955],

1	for	IN	O	for	_	0	SENT_163	[p9l10t1146r112b1215],
2	1	CD	NUMBER	1	num	4	SENT_163	[p9l175t1153r200b1214],
3	Asian	JJ	MISC	asian	amod	4	SENT_163	[p9l259t1149r461b1215],
4	patient	NN	O	patient	prep_for	14	SENT_163	[p9l516t1150r767b1238],
5	in	IN	O	in	_	0	SENT_163	[p9l822t1150r891b1214],
6	each	DT	O	each	det	8	SENT_163	[p9l946t1146r1103b1215],
7	genotype	NN	O	genotype	nn	8	SENT_163	[p9l1157t1169r1483b1239],
8	group	NN	O	group	prep_in	4	SENT_163	[p9l1538t1173r1769b1239],
9	,	,	O	,	_	0	SENT_163	[p9l1538t1173r1769b1239],
10	all	DT	O	all	det	12	SENT_163	[p9l1827t1146r1907b1215],
11	other	JJ	O	other	amod	12	SENT_163	[p9l1964t1146r2151b1215],
12	patients	NNS	O	patient	nsubj	14	SENT_163	[p9l10t1265r290b1353],
13	were	VBD	O	be	cop	14	SENT_163	[p9l329t1288r495b1329],
14	Caucasian	JJ	MISC	caucasian	_	0	SENT_163	[p9l537t1264r920b1330],
15	.	.	O	.	_	0	SENT_163	[p9l537t1264r920b1330],

1	As	IN	O	as	mark	2	SENT_164	[p9l960t1264r1050b1329],
2	expected	VBN	O	expect	advcl	14	SENT_164	[p9l1092t1260r1421b1353],
3	,	,	O	,	_	0	SENT_164	[p9l1092t1260r1421b1353],
4	COMT	NN	O	comt	nn	5	SENT_164	[p9l1467t1262r1750b1330],
5	activity	NN	O	activity	nsubj	14	SENT_164	[p9l1782t1265r2044b1352],
6	in	IN	O	in	_	0	SENT_164	[p9l2082t1265r2151b1328],
7	red	JJ	O	red	amod	9	SENT_164	[p9l11t1373r123b1442],
8	blood	NN	O	blood	nn	9	SENT_164	[p9l182t1373r389b1442],
9	cells	NNS	O	cell	prep_in	5	SENT_164	[p9l447t1373r593b1441],
10	at	IN	O	at	_	0	SENT_164	[p9l653t1396r717b1441],
11	baseline	NN	O	baseline	prep_at	9	SENT_164	[p9l774t1372r1058b1441],
12	was	VBD	O	be	cop	14	SENT_164	[p9l1113t1401r1241b1442],
13	signiﬁcantly	RB	O	signiﬁcantly	advmod	14	SENT_164	[p9l1301t1372r1739b1466],
14	higher	JJR	O	higher	_	0	SENT_164	[p9l1794t1373r2024b1466],
15	in	IN	O	in	_	0	SENT_164	[p9l2082t1377r2151b1441],
16	COMTHH	NNP	O	COMTHH	nn	30	SENT_164	[p9l17t1480r394b1564],
17	than	IN	O	than	amod	30	SENT_164	[p9l429t1496r588b1564],
18	in	IN	O	in	_	0	SENT_164	[p9l633t1500r703b1563],
19	COMTLL	NN	O	comtll	nn	20	SENT_164	[p9l754t1480r1091b1564],
20	patients	NNS	O	patient	prep_in	17	SENT_164	[p9l1134t1500r1414b1587],
21	(	IN	O	(	_	0	SENT_164	[p9l1465t1497r1600b1578],
22	1.3	CD	NUMBER	1.3	prep_(	17	SENT_164	[p9l1465t1497r1600b1578],
23	i	FW	O	i	dep	22	SENT_164	[p9l1657t1505r1713b1560],
24	0.1	CD	NUMBER	0.1	num	27	SENT_164	[p9l1769t1502r1871b1564],
25	VS	NN	O	v	amod	27	SENT_164	[p9l1923t1524r1991b1564],
26	0.8	CD	NUMBER	0.8	number	25	SENT_164	[p9l2038t1502r2146b1564],
27	ioLp	NN	O	iolp	dep	23	SENT_164	[p9l19t1609r678b1700],
28	=	JJ	O	=	amod	30	SENT_164	[p9l19t1609r678b1700],
29	oM	NN	O	om	nn	30	SENT_164	[p9l19t1609r678b1700],
30	)	NN	O	)	prep_in	14	SENT_164	[p9l19t1609r678b1700],

1	Effect	NN	O	effect	_	0	SENT_165	[p9l15t1869r271b1943],
2	of	IN	O	of	_	0	SENT_165	[p9l306t1869r401b1943],
3	Entacapone	NN	MISC	entacapone	prep_of	1	SENT_165	[p9l429t1875r941b1963],
4	on	IN	O	on	_	0	SENT_165	[p9l980t1895r1083b1943],
5	the	DT	O	the	det	7	SENT_165	[p9l1122t1870r1259b1943],
6	Motor	NNP	O	Motor	nn	7	SENT_165	[p9l1299t1875r1572b1943],
7	Response	NN	O	response	prep_on	3	SENT_165	[p9l1606t1875r2019b1964],
8	of	IN	O	of	_	0	SENT_165	[p9l15t1982r110b2056],
9	PD	NN	O	pd	nn	10	SENT_165	[p9l138t1988r261b2055],
10	Patients	NNS	O	patient	prep_of	1	SENT_165	[p9l298t1987r648b2056],
11	to	TO	O	to	_	0	SENT_165	[p9l685t1996r771b2056],
12	L-dopa	NN	O	l-dopa	prep_to	1	SENT_165	[p9l811t1983r1106b2076],
13	We	PRP	O	we	nsubj	14	SENT_165	[p9l7t2112r127b2177],
14	observed	VBD	O	observe	rcmod	12	SENT_165	[p9l173t2108r488b2178],
15	a	DT	O	a	det	17	SENT_165	[p9l532t2137r568b2177],
16	significant	JJ	O	significant	amod	17	SENT_165	[p9l611t2108r984b2201],
17	interaction	NN	O	interaction	dobj	14	SENT_165	[p9l1028t2113r1417b2177],
18	between	IN	O	between	_	0	SENT_165	[p9l1463t2108r1756b2177],
19	treatment	NN	O	treatment	prep_between	17	SENT_165	[p9l1802t2132r2151b2177],
20	and	CC	O	and	_	0	SENT_165	[p9l11t2229r142b2299],
21	genotype	NN	O	genotype	prep_between	17	SENT_165	[p9l194t2253r518b2322],
22	on	IN	O	on	_	0	SENT_165	[p9l572t2257r663b2298],
23	the	DT	O	the	det	24	SENT_165	[p9l714t2229r824b2298],
24	gain	NN	O	gain	prep_on	14	SENT_165	[p9l876t2234r1026b2322],
25	of	IN	O	of	_	0	SENT_165	[p9l1079t2229r1160b2298],
26	the	DT	O	the	det	27	SENT_165	[p9l1200t2229r1309b2298],
27	best	JJS	O	best	prep_of	24	SENT_165	[p9l1362t2229r1502b2298],
28	ON	IN	O	on	_	0	SENT_165	[p9l1554t2232r1696b2298],
29	time	NN	O	time	nn	31	SENT_165	[p9l1749t2234r1909b2298],
30	(	NN	O	(	nn	31	SENT_165	[p9l1966t2230r2030b2322],
31	p	NN	O	p	prep_on	27	SENT_165	[p9l1966t2230r2030b2322],
32	=	JJ	O	=	amod	1	SENT_165	[p9l2084t2262r2148b2285],
33	0.04	CD	NUMBER	0.04	tmod	32	SENT_165	[p9l12t2350r191b2429],
34	,	,	O	,	_	0	SENT_165	[p9l12t2350r191b2429],
35	adjusted	VBN	O	adjust	partmod	1	SENT_165	[p9l232t2350r530b2443],
36	for	IN	O	for	_	0	SENT_165	[p9l565t2350r667b2419],
37	the	DT	O	the	det	38	SENT_165	[p9l703t2350r813b2419],
38	dose	NN	O	dose	prep_for	35	SENT_165	[p9l850t2350r1007b2419],
39	of	IN	O	of	_	0	SENT_165	[p9l1044t2350r1125b2419],
40	L-dopa	NN	MISC	l-dopa	nn	41	SENT_165	[p9l1150t2350r1457b2442],
41	)	NN	O	)	prep_of	1	SENT_165	[p9l1150t2350r1457b2442],
42	.	.	O	.	_	0	SENT_165	[p9l1150t2350r1457b2442],

1	With	IN	O	with	_	0	SENT_166	[p9l1495t2350r1686b2419],
2	entacapone	NN	O	entacapone	prep_with	8	SENT_166	[p9l1723t2373r2146b2442],
3	,	,	O	,	_	0	SENT_166	[p9l1723t2373r2146b2442],
4	the	DT	O	the	det	7	SENT_166	[p9l11t2472r120b2540],
5	COM	NNP	O	COM	nn	7	SENT_166	[p9l165t2475r377b2541],
6	THH	NN	O	thh	nn	7	SENT_166	[p9l380t2456r541b2539],
7	group	NN	O	group	nsubj	8	SENT_166	[p9l570t2499r779b2564],
8	gained	VBD	O	gain	_	0	SENT_166	[p9l819t2472r1055b2564],
9	39	CD	NUMBER	39	nsubj	20	SENT_166	[p9l1093t2478r1179b2545],
10	i	FW	O	i	dep	9	SENT_166	[p9l1229t2481r1285b2536],
11	10	CD	NUMBER	10	num	13	SENT_166	[p9l1340t2478r1420b2540],
12	additional	JJ	O	additional	amod	13	SENT_166	[p9l1460t2472r1824b2541],
13	minutes	NNS	DURATION	minute	dep	9	SENT_166	[p9l1863t2476r2149b2541],
14	of	IN	O	of	_	0	SENT_166	[p9l11t2592r92b2661],
15	best	JJS	O	best	prep_of	13	SENT_166	[p9l131t2592r271b2661],
16	ON	IN	O	on	_	0	SENT_166	[p9l321t2596r463b2661],
17	time	NN	O	time	nn	19	SENT_166	[p9l514t2597r674b2661],
18	(	NN	O	(	nn	19	SENT_166	[p9l730t2593r794b2685],
19	p	NN	O	p	prep_on	15	SENT_166	[p9l730t2593r794b2685],
20	=	JJ	O	=	xcomp	8	SENT_166	[p9l845t2625r909b2648],
21	0.003	CD	NUMBER	0.003	tmod	20	SENT_166	[p9l964t2599r1166b2665],
22	between	IN	O	between	_	0	SENT_166	[p9l1220t2592r1514b2661],
23	entacapone	NN	O	entacapone	nn	26	SENT_166	[p9l1565t2616r1968b2684],
24	and	CC	O	and	_	0	SENT_166	[p9l2020t2592r2151b2662],
25	placebo	NN	O	placebo	nn	26	SENT_166	[p9l10t2713r334b2804],
26	)	NN	O	)	prep_between	20	SENT_166	[p9l10t2713r334b2804],
27	,	,	O	,	_	0	SENT_166	[p9l10t2713r334b2804],
28	whereas	IN	O	whereas	mark	35	SENT_166	[p9l370t2713r651b2781],
29	the	DT	O	the	det	34	SENT_166	[p9l689t2713r798b2781],
30	COM	NN	O	com	nn	34	SENT_166	[p9l840t2716r1052b2782],
31	7	CD	MONEY	7	num	34	SENT_166	[p9l1056t2696r1177b2780],
32	£	NN	MONEY	£	nn	34	SENT_166	[p9l1056t2696r1177b2780],
33	L	NN	O	l	nn	34	SENT_166	[p9l1056t2696r1177b2780],
34	group	NN	O	group	nsubj	35	SENT_166	[p9l1211t2740r1421b2805],
35	gained	VBD	O	gain	advcl	8	SENT_166	[p9l1458t2713r1694b2805],
36	only	RB	O	only	quantmod	37	SENT_166	[p9l1729t2713r1888b2803],
37	9	CD	NUMBER	9	dobj	35	SENT_166	[p9l1921t2720r1959b2786],
38	i	FW	O	i	dep	37	SENT_166	[p9l2006t2722r2062b2777],
39	9	CD	DURATION	9	num	40	SENT_166	[p9l2109t2720r2147b2785],
40	minutes	NNS	NUMBER	minute	tmod	37	SENT_166	[p9l10t2838r297b2903],
41	(	CD	NUMBER	(	num	42	SENT_166	[p9l343t2834r407b2926],
42	p	NN	O	p	tmod	35	SENT_166	[p9l343t2834r407b2926],
43	=	JJ	O	=	amod	42	SENT_166	[p9l448t2866r512b2888],
44	0.28	CD	NUMBER	0.28	tmod	43	SENT_166	[p9l555t2840r711b2902],
45	between	IN	O	between	_	0	SENT_166	[p9l755t2833r1048b2902],
46	entacapone	NN	O	entacapone	prep_between	42	SENT_166	[p9l1088t2857r1492b2925],
47	and	CC	O	and	_	0	SENT_166	[p9l1533t2833r1664b2903],
48	placebo	NN	O	placebo	prep_between	42	SENT_166	[p9l1702t2833r1996b2925],
49	,	,	O	,	_	0	SENT_166	[p9l1702t2833r1996b2925],
50	Fig	NN	O	fig	nn	52	SENT_166	[p9l2040t2838r2152b2926],
51	2	CD	NUMBER	2	num	52	SENT_166	[p9l10t2955r103b3037],
52	)	NN	O	)	appos	46	SENT_166	[p9l10t2955r103b3037],
53	.	.	O	.	_	0	SENT_166	[p9l10t2955r103b3037],

1	Entacapone	NNP	O	Entacapone	nsubj	2	SENT_167	[p9l158t2959r579b3046],
2	prolonged	VBD	O	prolong	_	0	SENT_167	[p9l629t2954r998b3047],
3	the	DT	O	the	det	4	SENT_167	[p9l1048t2954r1158b3023],
4	best	JJS	O	best	dobj	2	SENT_167	[p9l1208t2954r1349b3023],
5	ON	IN	O	on	_	0	SENT_167	[p9l1398t2958r1540b3023],
6	time	NN	O	time	prep_on	4	SENT_167	[p9l1591t2959r1752b3023],
7	by	IN	O	by	_	0	SENT_167	[p9l1802t2954r1889b3046],
8	74	CD	NUMBER	74	prep_by	2	SENT_167	[p9l1936t2955r2025b3028],
9	i	FW	O	i	tmod	2	SENT_167	[p9l2085t2963r2141b3020],
10	22	CD	PERCENT	22	number	11	SENT_167	[p9l10t3081r177b3146],
11	%	NN	PERCENT	%	amod	9	SENT_167	[p9l10t3081r177b3146],
12	in	IN	O	in	_	0	SENT_167	[p9l216t3080r285b3142],
13	the	DT	O	the	det	15	SENT_167	[p9l322t3075r431b3143],
14	COMTHH	NNP	O	COMTHH	nn	15	SENT_167	[p9l474t3059r850b3144],
15	group	NN	O	group	prep_in	2	SENT_167	[p9l877t3102r1107b3167],
16	,	,	O	,	_	0	SENT_167	[p9l877t3102r1107b3167],
17	but	CC	O	but	_	0	SENT_167	[p9l1147t3075r1267b3145],
18	only	RB	O	only	advmod	20	SENT_167	[p9l1303t3075r1461b3166],
19	15	CD	NUMBER	15	pobj	18	SENT_167	[p9l1502t3081r1579b3149],
20	i	FW	O	i	dep	31	SENT_167	[p9l1628t3084r1685b3140],
21	10	CD	PERCENT	10	number	22	SENT_167	[p9l1738t3081r1896b3146],
22	%	NN	PERCENT	%	amod	20	SENT_167	[p9l1738t3081r1896b3146],
23	in	IN	O	in	_	0	SENT_167	[p9l1936t3080r2005b3142],
24	the	DT	O	the	det	27	SENT_167	[p9l2041t3075r2150b3143],
25	COM	NNP	O	COM	nn	27	SENT_167	[p9l17t3198r229b3264],
26	Tu	NNP	O	Tu	nn	27	SENT_167	[p9l233t3178r355b3262],
27	group	NN	O	group	prep_in	20	SENT_167	[p9l432t3222r642b3287],
28	(	CD	NUMBER	(	num	29	SENT_167	[p9l729t3196r793b3287],
29	p	NN	O	p	dep	31	SENT_167	[p9l729t3196r793b3287],
30	=	JJ	O	=	amod	31	SENT_167	[p9l874t3227r937b3250],
31	0.04	CD	NUMBER	0.04	dep	34	SENT_167	[p9l1020t3196r1178b3264],
32	between	IN	O	between	_	0	SENT_167	[p9l1259t3195r1553b3264],
33	groups	NNS	O	group	prep_between	31	SENT_167	[p9l1632t3196r1923b3287],
34	)	CD	NUMBER	)	conj_but	2	SENT_167	[p9l1632t3196r1923b3287],
35	.	.	O	.	_	0	SENT_167	[p9l1632t3196r1923b3287],

1	The	DT	O	the	det	4	SENT_168	[p9l2005t3195r2150b3264],
2	COM	NNP	O	COM	nn	4	SENT_168	[p9l17t3319r229b3384],
3	THH	NNP	O	THH	nn	4	SENT_168	[p9l233t3299r394b3382],
4	genotype	NN	O	genotype	nsubj	8	SENT_168	[p9l426t3338r771b3407],
5	,	,	O	,	_	0	SENT_168	[p9l426t3338r771b3407],
6	therefore	RB	O	therefore	advmod	8	SENT_168	[p9l817t3315r1157b3393],
7	,	,	O	,	_	0	SENT_168	[p9l817t3315r1157b3393],
8	increases	VBZ	O	increase	_	0	SENT_168	[p9l1204t3320r1513b3383],
9	the	DT	O	the	det	10	SENT_168	[p9l1557t3315r1666b3383],
10	gain	NN	O	gain	dobj	8	SENT_168	[p9l1708t3320r1858b3407],
11	of	IN	O	of	_	0	SENT_168	[p9l1900t3315r1982b3383],
12	best	JJS	O	best	prep_of	10	SENT_168	[p9l2012t3315r2152b3383],
13	ON	IN	O	on	_	0	SENT_168	[p9l12t3438r154b3504],
14	time	NN	O	time	prep_on	12	SENT_168	[p9l198t3440r358b3504],
15	induced	VBN	O	induce	partmod	14	SENT_168	[p9l402t3435r690b3505],
16	by	IN	O	by	_	0	SENT_168	[p9l732t3435r820b3526],
17	entacapone	NN	O	entacapone	agent	15	SENT_168	[p9l860t3458r1263b3527],
18	in	IN	O	in	_	0	SENT_168	[p9l1308t3440r1377b3503],
19	PD	NN	O	pd	nn	20	SENT_168	[p9l1421t3439r1538b3503],
20	patients	NNS	O	patient	prep_in	17	SENT_168	[p9l1583t3440r1882b3527],
21	.	.	O	.	_	0	SENT_168	[p9l1583t3440r1882b3527],

1	In	IN	O	in	_	0	SENT_169	[p9l1931t3439r2007b3503],
2	accordance	NN	O	accordance	pobj	1	SENT_169	[p9l2049t3463r2149b3504, p9l11t3556r330b3626],

1	with	IN	O	with	_	0	SENT_170	[p9l387t3556r550b3625],
2	previous	JJ	O	previous	amod	3	SENT_170	[p9l609t3561r910b3647],
3	studies	NNS	O	study	prep_with	8	SENT_170	[p9l973t3556r1235b3635],
4	,	,	O	,	_	0	SENT_170	[p9l973t3556r1235b3635],
5	entacapone	NN	O	entacapone	nsubj	8	SENT_170	[p9l1388t3579r1792b3647],
6	did	VBD	O	do	aux	8	SENT_170	[p9l1854t3556r1971b3626],
7	not	RB	O	not	neg	8	SENT_170	[p9l2031t3579r2152b3625],
8	change	VB	O	change	_	0	SENT_170	[p9l11t3676r258b3769],
9	either	CC	O	either	prep	8	SENT_170	[p9l296t3676r500b3745],
10	the	DT	O	the	det	11	SENT_170	[p9l536t3676r646b3745],
11	magnitude	NN	O	magnitude	dep	9	SENT_170	[p9l684t3676r1069b3769],
12	of	IN	O	of	_	0	SENT_170	[p9l1107t3676r1189b3745],
13	the	DT	O	the	det	15	SENT_170	[p9l1214t3676r1323b3745],
14	motor	NN	O	motor	nn	15	SENT_170	[p9l1361t3700r1585b3745],
15	response	NN	O	response	prep_of	11	SENT_170	[p9l1622t3703r1926b3769],
16	to	TO	O	to	_	0	SENT_170	[p9l1965t3700r2033b3745],
17	Ldopa	NN	LOCATION	ldopa	prep_to	8	SENT_170	[p9l2073t3681r2149b3744, p10l11t21r189b113],

1	or	CC	O	or	cc	3	SENT_171	[p10l223t48r297b90],
2	the	DT	O	the	det	3	SENT_171	[p10l331t21r440b89],
3	time	NN	O	time	nsubj	10	SENT_171	[p10l476t26r636b90],
4	to	TO	O	to	dep	3	SENT_171	[p10l671t44r739b90],
5	peak	JJ	O	peak	amod	6	SENT_171	[p10l776t21r945b113],
6	response	NN	O	response	dep	3	SENT_171	[p10l976t48r1282b113],
7	(	CD	NUMBER	(	num	6	SENT_171	[p10l1322t20r1542b104],
8	Table	NNP	O	Table	dep	10	SENT_171	[p10l1322t20r1542b104],
9	2	CD	NUMBER	2	num	10	SENT_171	[p10l1577t22r1669b104],
10	)	CD	NUMBER	)	_	0	SENT_171	[p10l1577t22r1669b104],
11	.	.	O	.	_	0	SENT_171	[p10l1577t22r1669b104],

1	Effect	NN	O	effect	nsubj	10	SENT_172	[p10l15t282r272b356],
2	of	IN	O	of	_	0	SENT_172	[p10l306t282r401b356],
3	Entacapone	NN	MISC	entacapone	prep_of	1	SENT_172	[p10l429t287r941b376],
4	on	IN	O	on	_	0	SENT_172	[p10l980t308r1083b356],
5	the	DT	O	the	det	6	SENT_172	[p10l1122t283r1259b356],
6	Pharmacokinetics	NNS	MISC	pharmacokinetic	prep_on	3	SENT_172	[p10l1299t283r2059b356],
7	of	IN	MISC	of	_	0	SENT_172	[p10l15t394r110b468],
8	L-dopa	NN	MISC	l-dopa	prep_of	6	SENT_172	[p10l138t395r433b489],
9	There	EX	O	there	expl	10	SENT_172	[p10l8t514r222b582],
10	was	VBD	O	be	_	0	SENT_172	[p10l262t542r390b583],
11	a	DT	O	a	det	13	SENT_172	[p10l433t542r470b582],
12	signiﬁcant	JJ	O	signiﬁcant	amod	13	SENT_172	[p10l510t513r882b607],
13	interaction	NN	O	interaction	nn	31	SENT_172	[p10l924t519r1314b582],
14	between	IN	O	between	_	0	SENT_172	[p10l1356t514r1650b583],
15	the	DT	O	the	det	16	SENT_172	[p10l1693t514r1802b582],
16	response	NN	O	response	prep_between	13	SENT_172	[p10l1846t541r2150b606],
17	to	TO	O	to	_	0	SENT_172	[p10l11t653r79b699],
18	entacapone	NN	O	entacapone	prep_to	16	SENT_172	[p10l123t653r528b722],
19	and	CC	O	and	_	0	SENT_172	[p10l571t630r702b699],
20	the	DT	O	the	det	21	SENT_172	[p10l744t630r853b699],
21	genotype	NN	O	genotype	prep_between	13	SENT_172	[p10l895t653r1220b723],
22	on	IN	O	on	_	0	SENT_172	[p10l1263t657r1354b699],
23	the	DT	O	the	det	24	SENT_172	[p10l1397t630r1506b699],
24	AUC	NN	O	auc	prep_on	21	SENT_172	[p10l1543t633r1737b699],
25	of	IN	O	of	_	0	SENT_172	[p10l1780t630r1861b699],
26	L-dopa	NN	O	l-dopa	nn	28	SENT_172	[p10l1892t630r2152b722],
27	(	CD	NUMBER	(	num	28	SENT_172	[p10l15t747r79b839],
28	p	NN	O	p	prep_of	24	SENT_172	[p10l15t747r79b839],
29	=	JJ	O	=	amod	31	SENT_172	[p10l119t779r182b802],
30	0.04	CD	NUMBER	0.04	tmod	29	SENT_172	[p10l225t747r433b829],
31	)	NN	O	)	nsubj	10	SENT_172	[p10l225t747r433b829],
32	.	.	O	.	_	0	SENT_172	[p10l225t747r433b829],

1	Entacapone	NN	O	entacapone	nsubj	2	SENT_173	[p10l475t751r897b839],
2	increased	VBD	O	increase	_	0	SENT_173	[p10l936t746r1264b816],
3	the	DT	O	the	det	4	SENT_173	[p10l1302t746r1412b815],
4	AUC	NN	O	auc	dobj	2	SENT_173	[p10l1444t750r1639b816],
5	of	IN	O	of	_	0	SENT_173	[p10l1678t746r1759b815],
6	L-dopa	NN	O	l-dopa	prep_of	4	SENT_173	[p10l1785t746r2045b839],
7	in	IN	O	in	_	0	SENT_173	[p10l2082t751r2151b814],
8	both	CC	O	both	dep	11	SENT_173	[p10l10t862r176b930],
9	genotype	NN	O	genotype	nn	10	SENT_173	[p10l219t885r543b955],
10	groups	NNS	O	group	nsubj	11	SENT_173	[p10l587t889r827b955],
11	(	VBP	O	(	dep	2	SENT_173	[p10l876t863r1002b945],
12	see	VB	O	see	xcomp	11	SENT_173	[p10l876t863r1002b945],
13	Table	NNP	O	Table	dobj	12	SENT_173	[p10l1043t862r1239b930],
14	2	CD	NUMBER	2	number	15	SENT_173	[p10l1282t863r1374b945],
15	)	CD	NUMBER	)	prep_in	2	SENT_173	[p10l1282t863r1374b945],
16	.	.	O	.	_	0	SENT_173	[p10l1282t863r1374b945],

1	This	DT	O	this	det	2	SENT_174	[p10l1419t862r1580b930],
2	effect	NN	O	effect	nsubj	5	SENT_174	[p10l1625t861r1816b930],
3	was	VBD	O	be	cop	5	SENT_174	[p10l1855t890r1983b931],
4	significantly	RB	O	significantly	advmod	5	SENT_174	[p10l2027t867r2149b955, p10l11t984r354b1075],
5	higher	JJR	O	higher	_	0	SENT_174	[p10l388t985r618b1077],
6	in	IN	O	in	_	0	SENT_174	[p10l657t989r726b1052],
7	COM	NNP	O	COM	nn	8	SENT_174	[p10l772t988r984b1053],
8	THH	NN	O	thh	prep_in	5	SENT_174	[p10l988t969r1149b1052],
9	than	IN	O	than	prep	5	SENT_174	[p10l1179t984r1339b1053],
10	in	IN	O	in	pcomp	9	SENT_174	[p10l1379t989r1448b1052],
11	COM	NNP	O	COM	pobj	10	SENT_174	[p10l1494t988r1705b1053],
12	Tu	FW	O	tu	nn	13	SENT_174	[p10l1709t969r1831b1052],
13	patients	NNS	O	patient	npadvmod	10	SENT_174	[p10l1869t989r2149b1076],
14	(	IN	O	(	_	0	SENT_174	[p10l15t1101r201b1183],
15	+62	CD	NUMBER	+62	prep_(	10	SENT_174	[p10l15t1101r201b1183],
16	i	FW	O	i	dep	20	SENT_174	[p10l255t1109r311b1165],
17	6	CD	PERCENT	6	num	18	SENT_174	[p10l365t1102r483b1172],
18	%	NN	PERCENT	%	dep	16	SENT_174	[p10l365t1102r483b1172],
19	Vs	NNS	O	v	dep	20	SENT_174	[p10l527t1129r595b1169],
20	+34	CD	NUMBER	+34	dep	31	SENT_174	[p10l641t1101r800b1176],
21	i	FW	O	i	dep	20	SENT_174	[p10l853t1109r910b1165],
22	8	CD	PERCENT	8	num	23	SENT_174	[p10l965t1106r1104b1179],
23	%	NN	PERCENT	%	nsubj	31	SENT_174	[p10l965t1106r1104b1179],
24	,	,	O	,	_	0	SENT_174	[p10l965t1106r1104b1179],
25	p	NN	O	p	appos	23	SENT_174	[p10l1139t1123r1190b1193],
26	=	JJ	O	=	amod	25	SENT_174	[p10l1235t1133r1298b1155],
27	0.01	CD	NUMBER	0.01	tmod	26	SENT_174	[p10l1345t1107r1495b1169],
28	between	IN	O	between	_	0	SENT_174	[p10l1548t1100r1842b1169],
29	groups	NNS	O	group	prep_between	25	SENT_174	[p10l1885t1127r2146b1193],
30	,	,	O	,	_	0	SENT_174	[p10l1885t1127r2146b1193],
31	see	VBP	O	see	ccomp	5	SENT_174	[p10l10t1245r111b1285],
32	Table	NNP	O	Table	dobj	31	SENT_174	[p10l146t1217r341b1285],
33	2	CD	NUMBER	2	num	32	SENT_174	[p10l377t1224r419b1285],
34	and	CC	O	and	_	0	SENT_174	[p10l457t1217r588b1286],
35	Fig	NN	O	fig	nn	37	SENT_174	[p10l625t1221r737b1310],
36	3	CD	NUMBER	3	num	37	SENT_174	[p10l772t1218r863b1300],
37	)	NN	O	)	conj_and	32	SENT_174	[p10l772t1218r863b1300],
38	.	.	O	.	_	0	SENT_174	[p10l772t1218r863b1300],

1	Entacapone	NN	O	entacapone	nsubj	2	SENT_175	[p10l904t1221r1326b1309],
2	increased	VBD	O	increase	_	0	SENT_175	[p10l1363t1217r1692b1286],
3	the	DT	O	the	det	6	SENT_175	[p10l1729t1217r1838b1285],
4	half	NN	O	half	nn	6	SENT_175	[p10l1873t1216r2150b1285],
5	—	JJ	O	—	amod	6	SENT_175	[p10l1873t1216r2150b1285],
6	life	NN	O	life	dobj	2	SENT_175	[p10l1873t1216r2150b1285],
7	of	IN	O	of	_	0	SENT_175	[p10l10t1704r91b1772],
8	L-dopa	NN	MISC	l-dopa	prep_of	6	SENT_175	[p10l125t1704r385b1795],
9	to	TO	O	to	_	0	SENT_175	[p10l429t1727r497b1772],
10	the	DT	O	the	det	12	SENT_175	[p10l545t1704r654b1772],
11	same	JJ	O	same	amod	12	SENT_175	[p10l700t1731r876b1772],
12	extent	NN	O	extent	prep_to	2	SENT_175	[p10l922t1727r1139b1772],
13	in	IN	O	in	prep	2	SENT_175	[p10l1184t1708r1253b1771],
14	both	CC	O	both	dep	13	SENT_175	[p10l1299t1704r1465b1772],
15	genotype	NN	O	genotype	nn	16	SENT_175	[p10l1510t1727r1834b1796],
16	groups	NNS	O	group	conj	13	SENT_175	[p10l1880t1731r2142b1796],
17	,	,	O	,	_	0	SENT_175	[p10l1880t1731r2142b1796],
18	but	CC	O	but	_	0	SENT_175	[p10l9t1824r130b1894],
19	the	DT	O	the	det	20	SENT_175	[p10l165t1824r274b1893],
20	clearance	NN	O	clearance	nsubjpass	27	SENT_175	[p10l310t1824r634b1893],
21	of	IN	O	of	_	0	SENT_175	[p10l670t1824r751b1893],
22	L	NN	O	l	nn	24	SENT_175	[p10l775t1824r1035b1916],
23	—	CD	NUMBER	—	num	24	SENT_175	[p10l775t1824r1035b1916],
24	dopa	NN	O	dopa	prep_of	20	SENT_175	[p10l775t1824r1035b1916],
25	was	VBD	O	be	auxpass	27	SENT_175	[p10l1066t1853r1193b1893],
26	significantly	RB	O	significantly	advmod	27	SENT_175	[p10l1230t1824r1669b1916],
27	enhanced	VBN	O	enhance	conj_but	2	SENT_175	[p10l1702t1824r2041b1894],
28	in	IN	O	in	_	0	SENT_175	[p10l2077t1829r2146b1892],
29	the	DT	O	the	det	31	SENT_175	[p10l10t1944r119b2012],
30	COMTHH	NNP	O	COMTHH	nn	31	SENT_175	[p10l161t1927r537b2012],
31	group	NN	O	group	prep_in	27	SENT_175	[p10l564t1971r773b2036],
32	(	CD	NUMBER	(	num	33	SENT_175	[p10l816t1945r1048b2026],
33	-329	CD	NUMBER	-329	tmod	27	SENT_175	[p10l816t1945r1048b2026],
34	i	FW	O	i	dep	33	SENT_175	[p10l1096t1952r1152b2008],
35	35	CD	NUMBER	35	num	36	SENT_175	[p10l1199t1949r1282b2017],
36	Versus	NNP	O	Versus	xcomp	27	SENT_175	[p10l1320t1971r1535b2013],
37	-200	CD	NUMBER	-200	num	36	SENT_175	[p10l1577t1950r1779b2012],
38	i	FW	O	i	nn	39	SENT_175	[p10l1826t1952r1882b2008],
39	45ml	FW	O	45ml	dep	36	SENT_175	[p10l1927t1943r2144b2017],
40	/	:	O	/	punct	47	SENT_175	[p10l1927t1943r2144b2017],
41	min	NN	DURATION	min	nsubj	47	SENT_175	[p10l9t2068r173b2142],
42	,	,	O	,	_	0	SENT_175	[p10l9t2068r173b2142],
43	p	NN	O	p	appos	41	SENT_175	[p10l217t2086r268b2156],
44	=	JJ	O	=	amod	43	SENT_175	[p10l324t2096r387b2118],
45	0.05	CD	NUMBER	0.05	tmod	44	SENT_175	[p10l444t2069r623b2142],
46	,	,	O	,	_	0	SENT_175	[p10l444t2069r623b2142],
47	see	VBP	O	see	dep	36	SENT_175	[p10l680t2092r780b2132],
48	Table	NNP	O	Table	dobj	47	SENT_175	[p10l832t2064r1028b2132],
49	2	CD	NUMBER	2	num	50	SENT_175	[p10l1080t2065r1173b2146],
50	)	CD	NUMBER	)	dep	36	SENT_175	[p10l1080t2065r1173b2146],
51	.	.	O	.	_	0	SENT_175	[p10l1080t2065r1173b2146],

1	These	DT	O	these	det	2	SENT_176	[p10l1229t2064r1441b2132],
2	results	NNS	O	result	nsubj	3	SENT_176	[p10l1495t2064r1718b2133],
3	show	VBP	O	show	_	0	SENT_176	[p10l1772t2064r1958b2132],
4	that	IN	O	that	complm	13	SENT_176	[p10l2007t2064r2147b2132],
5	entacapone-induced	JJ	O	entacapone-induced	amod	6	SENT_176	[p10l10t2184r736b2275],
6	changes	NNS	O	change	nsubjpass	13	SENT_176	[p10l775t2184r1051b2276],
7	in	IN	O	in	_	0	SENT_176	[p10l1092t2189r1161b2251],
8	the	DT	O	the	det	9	SENT_176	[p10l1200t2184r1309b2252],
9	biodisponibility	NN	O	biodisponibility	prep_in	6	SENT_176	[p10l1348t2184r1924b2275],
10	of	IN	O	of	_	0	SENT_176	[p10l1960t2184r2041b2252],
11	Ldopa	NN	LOCATION	ldopa	prep_of	9	SENT_176	[p10l2068t2188r2144b2251, p10l10t2305r188b2396],
12	are	VBP	O	be	auxpass	13	SENT_176	[p10l226t2332r327b2373],
13	enhanced	VBN	O	enhance	ccomp	3	SENT_176	[p10l368t2304r708b2374],
14	in	IN	O	in	_	0	SENT_176	[p10l747t2309r816b2372],
15	COM	NNP	O	COM	nn	17	SENT_176	[p10l862t2308r1073b2373],
16	THH	NN	O	thh	nn	17	SENT_176	[p10l1077t2288r1238b2372],
17	patients	NNS	O	patient	prep_in	13	SENT_176	[p10l1267t2309r1566b2396],
18	.	.	O	.	_	0	SENT_176	[p10l1267t2309r1566b2396],

1	As	IN	O	as	_	0	SENT_177	[p10l1605t2308r1695b2373],
2	in	IN	O	in	pcomp	1	SENT_177	[p10l1736t2309r1805b2372],
3	previous	JJ	O	previous	amod	4	SENT_177	[p10l1844t2309r2144b2396],
4	p	NN	O	p	pobj	2	SENT_177	[p10l1045t2579r1082b2639],
5	=	JJ	O	=	amod	4	SENT_177	[p10l1106t2585r1146b2609],
6	0.04	CD	NUMBER	0.04	tmod	5	SENT_177	[p10l1169t2565r1319b2623],

1	@	IN	O	@	dep	3	SENT_178	[p10l645t2763r675b2765],
2	E	NN	O	e	pobj	1	SENT_178	[p10l645t2763r675b2765],
3	3	CD	NUMBER	3	_	0	SENT_178	[p10l645t2763r675b2765],
4	+	CC	O	+	cc	3	SENT_178	[p10l645t2763r675b2765],
5	0.00.3	CD	NUMBER	0.00.3	num	6	SENT_178	[p10l702t2743r895b2804],
6	[	CD	NUMBER	[	dep	3	SENT_178	[p10l1423t2760r1461b2817],
7	J	NN	O	j	prep	6	SENT_178	[p10l1423t2760r1461b2817],
8	=	JJ	O	=	amod	9	SENT_178	[p10l1484t2766r1521b2790],
9	0.2.8	CD	NUMBER	0.2.8	dep	7	SENT_178	[p10l1548t2743r1697b2804],
10	'	''	O	'	_	0	SENT_178	[p10l580t2760r618b2817],

1	5	CD	NUMBER	5	num	2	SENT_179	[p10l580t2760r618b2817],
2	II	CD	NUMBER	ii	_	0	SENT_179	[p10l641t2766r679b2790],

1	£	NN	MONEY	£	_	0	SENT_180	[p11l182t12r320b79],
2	1.50	CD	MONEY	1.50	dep	1	SENT_180	[p11l182t12r320b79],
3	`	``	O	`	_	0	SENT_180	[p11l382t53r406b105],
4	w	FW	O	w	nn	5	SENT_180	[p11l382t53r406b105],
5	*	FW	O	*	dep	2	SENT_180	[p11l382t53r406b105],

1	a	DT	O	a	det	2	SENT_181	[p11l405t106r406b161],
2	{	NN	O	{	_	0	SENT_181	[p11l405t106r406b161],
3	*	CD	NUMBER	*	dep	2	SENT_181	[p11l405t106r406b161],
4	Iii	NNP	O	Iii	nn	5	SENT_181	[p11l1575t110r1663b177],
5	Placebo	NNP	O	Placebo	dep	2	SENT_181	[p11l1713t107r2011b178],

1	140	CD	NUMBER	140	_	0	SENT_182	[p11l182t230r320b295],
2	I	PRP	O	I	nsubj	3	SENT_182	[p11l1575t244r1663b308],
3	Entacapone	VBP	O	entacapone	rcmod	1	SENT_182	[p11l1700t244r2153b326],

1	60	CD	NUMBER	60	_	0	SENT_183	[p11l229t1103r320b1170],
2	Best	JJS	O	best	dep	1	SENT_183	[p11l13t1160r77b1319],
3	ON	IN	O	on	_	0	SENT_183	[p11l13t1015r77b1133],
4	time	NN	O	time	nn	7	SENT_183	[p11l13t808r77b985],
5	(	CD	NUMBER	(	num	7	SENT_183	[p11l6t579r94b778],
6	min	NN	DURATION	min	nn	7	SENT_183	[p11l6t579r94b778],
7	)	NN	O	)	prep_on	2	SENT_183	[p11l6t579r94b778],

1	R	NN	O	r	_	0	SENT_184	[p11l226t1322r282b1386],
2	{	CD	NUMBER	{	number	3	SENT_184	[p11l226t1322r282b1386],
3	*	CD	NUMBER	*	dep	1	SENT_184	[p11l226t1322r282b1386],
4	E	NN	O	e	dep	3	SENT_184	[p11l276t1319r320b1387],

1	c	NN	O	c	_	0	SENT_185	[p11l651t1896r1024b1977],
2	»	CD	NUMBER	»	num	4	SENT_185	[p11l651t1896r1024b1977],
3	oMWH	NN	O	omwh	nn	4	SENT_185	[p11l651t1896r1024b1977],
4	comvu	NN	O	comvu	dep	1	SENT_185	[p11l1423t1896r1771b1977],

1	FIGURE	NN	O	figure	_	0	SENT_186	[p11l13t2040r273b2095],
2	2	CD	NUMBER	2	num	1	SENT_186	[p11l335t2040r393b2094],
3	:	:	O	:	_	0	SENT_186	[p11l335t2040r393b2094],
4	Pharmacodynamics	NNS	O	pharmacodynamic	dep	1	SENT_186	[p11l440t2037r1102b2112],
5	of	IN	O	of	_	0	SENT_186	[p11l1162t2037r1233b2095],
6	L-dopa	NN	O	l-dopa	prep_of	4	SENT_186	[p11l1292t2037r1547b2111],
7	.	.	O	.	_	0	SENT_186	[p11l1292t2037r1547b2111],

1	Best	JJS	O	best	_	0	SENT_187	[p11l1611t2041r1758b2095],
2	ON	IN	O	on	_	0	SENT_187	[p11l1817t2040r1931b2095],
3	time	NN	O	time	prep_on	1	SENT_187	[p11l1991t2040r2144b2095],
4	after	IN	O	after	_	0	SENT_187	[p11l9t2129r174b2188],
5	L-dopa	NN	O	l-dopa	prep_after	3	SENT_187	[p11l225t2130r458b2204],
6	+	CC	O	+	_	0	SENT_187	[p11l516t2141r562b2187],
7	placebo	NN	O	placebo	conj_+	1	SENT_187	[p11l620t2130r891b2204],
8	(	CD	NUMBER	(	num	10	SENT_187	[p11l943t2130r1174b2198],
9	white	JJ	O	white	amod	10	SENT_187	[p11l943t2130r1174b2198],
10	)	NN	O	)	dep	7	SENT_187	[p11l943t2130r1174b2198],
11	or	CC	O	or	_	0	SENT_187	[p11l1225t2150r1296b2188],
12	L-dopa	NN	O	l-dopa	conj_or	1	SENT_187	[p11l1347t2130r1580b2204],
13	+	CC	O	+	_	0	SENT_187	[p11l1637t2141r1684b2187],
14	entacapone	NN	O	entacapone	conj_+	12	SENT_187	[p11l1740t2140r2144b2204],
15	(	CD	NUMBER	(	num	17	SENT_187	[p11l10t2222r231b2292],
16	black	JJ	O	black	amod	17	SENT_187	[p11l10t2222r231b2292],
17	)	NN	O	)	dep	1	SENT_187	[p11l10t2222r231b2292],
18	in	IN	O	in	_	0	SENT_187	[p11l267t2226r321b2280],
19	COMTHH	NNP	O	COMTHH	nn	22	SENT_187	[p11l361t2210r666b2281],
20	and	CC	O	and	_	0	SENT_187	[p11l696t2222r820b2281],
21	COMTLL	NNP	O	COMTLL	conj_and	19	SENT_187	[p11l860t2210r1138b2281],
22	patients	NNS	O	patient	prep_in	17	SENT_187	[p11l1173t2226r1469b2297],
23	.	.	O	.	_	0	SENT_187	[p11l1173t2226r1469b2297],

1	Results	NNS	O	result	nsubj	3	SENT_188	[p11l1508t2222r1750b2281],
2	are	VBP	O	be	aux	3	SENT_188	[p11l1782t2243r1890b2281],
3	means	VBZ	O	mean	_	0	SENT_188	[p11l1926t2243r2145b2281],
4	1	CD	NUMBER	1	num	6	SENT_188	[p11l15t2328r61b2370],
5	standard	JJ	O	standard	amod	6	SENT_188	[p11l97t2315r399b2373],
6	error	NN	O	error	dobj	3	SENT_188	[p11l432t2335r604b2373],
7	of	IN	O	of	_	0	SENT_188	[p11l632t2315r703b2373],
8	the	DT	O	the	det	9	SENT_188	[p11l727t2315r839b2373],
9	mean	NN	O	mean	prep_of	6	SENT_188	[p11l871t2335r1076b2373],
10	.	.	O	.	_	0	SENT_188	[p11l871t2335r1076b2373],

1	p	NN	O	p	nn	2	SENT_189	[p11l1107t2335r1152b2389],
2	values	NNS	O	value	_	0	SENT_189	[p11l1177t2315r1394b2373],
3	for	IN	O	for	_	0	SENT_189	[p11l1421t2315r1521b2373],
4	treatment	NN	O	treatment	nn	5	SENT_189	[p11l1547t2326r1896b2373],
5	effect	NN	O	effect	prep_for	2	SENT_189	[p11l1925t2315r2143b2373],
6	:	:	O	:	_	0	SENT_189	[p11l1925t2315r2143b2373],
7	paired	JJ	O	paired	amod	9	SENT_189	[p11l12t2408r228b2483],
8	Wilcoxon	NNP	PERSON	Wilcoxon	nn	9	SENT_189	[p11l291t2408r611b2466],
9	test	NN	O	test	dep	2	SENT_189	[p11l674t2418r825b2466],
10	.	.	O	.	_	0	SENT_189	[p11l674t2418r825b2466],

1	p	NN	O	p	nn	2	SENT_190	[p11l891t2428r936b2483],
2	values	NNS	O	value	dep	13	SENT_190	[p11l995t2408r1211b2466],
3	for	IN	O	for	_	0	SENT_190	[p11l1272t2407r1373b2466],
4	genotype/treatment	JJ	O	genotype/treatment	amod	5	SENT_190	[p11l1435t2408r2146b2484],
5	interaction	NN	O	interaction	prep_for	2	SENT_190	[p11l10t2504r401b2559],
6	:	:	O	:	_	0	SENT_190	[p11l10t2504r401b2559],
7	analysis	NN	O	analysis	dep	2	SENT_190	[p11l433t2501r698b2577],
8	of	IN	O	of	_	0	SENT_190	[p11l728t2500r799b2559],
9	variance	NN	O	variance	prep_of	7	SENT_190	[p11l823t2504r1110b2559],
10	for	IN	O	for	_	0	SENT_190	[p11l1138t2500r1239b2559],
11	repeated	VBN	O	repeat	amod	12	SENT_190	[p11l1269t2501r1581b2576],
12	measures	NNS	O	measure	prep_for	9	SENT_190	[p11l1614t2521r1938b2559],
13	(	VBP	O	(	_	0	SENT_190	[p11l1969t2503r2136b2578],
14	F131	NN	O	f131	dobj	13	SENT_190	[p11l1969t2503r2136b2578],
15	=	JJ	O	=	amod	16	SENT_190	[p11l15t2616r61b2640],
16	4.8	CD	NUMBER	4.8	nsubj	13	SENT_190	[p11l96t2597r223b2661],
17	,	,	O	,	_	0	SENT_190	[p11l96t2597r223b2661],
18	p	NN	O	p	appos	16	SENT_190	[p11l254t2614r299b2669],
19	=	JJ	O	=	amod	21	SENT_190	[p11l332t2616r378b2640],
20	0.04	CD	NUMBER	0.04	tmod	19	SENT_190	[p11l414t2596r606b2663],
21	)	NN	O	)	dep	18	SENT_190	[p11l414t2596r606b2663],
22	.	.	O	.	_	0	SENT_190	[p11l414t2596r606b2663],

1	Volume	NN	O	volume	_	0	SENT_191	[p11l1568t2838r1808b2897],
2	69	CD	NUMBER	69	num	1	SENT_191	[p11l1839t2840r1931b2903],
3	,	,	O	,	_	0	SENT_191	[p11l1839t2840r1931b2903],
4	No.	NN	O	no.	appos	1	SENT_191	[p11l1964t2842r2076b2896],
5	1	CD	NUMBER	1	num	4	SENT_191	[p11l2117t2844r2138b2895],

1	Corvol	NNP	O	Corvol	nn	3	SENT_192	[p11l1394t2978r1495b3005],
2	et	NNP	O	et	nn	3	SENT_192	[p11l1511t2983r1541b3005],
3	al	NNP	O	al	_	0	SENT_192	[p11l1555t2978r1587b3005],
4	:	:	O	:	_	0	SENT_192	[p11l1555t2978r1587b3005],
5	COMT	NNP	O	COMT	dep	3	SENT_192	[p11l1604t2979r1709b3005],
6	and	CC	O	and	_	0	SENT_192	[p11l1722t2978r1778b3005],
7	Entacapone	NNP	O	Entacapone	dep	3	SENT_192	[p11l1795t2979r1980b3013],
8	in	IN	O	in	_	0	SENT_192	[p11l1995t2980r2019b3005],
9	PD	NN	O	pd	prep_in	5	SENT_192	[p11l2036t2979r2079b3005],

1	TABLE	NN	O	table	_	0	SENT_193	[p12l100t67r214b94],
2	2	CD	NUMBER	2	num	1	SENT_193	[p12l230t67r259b94],
3	:	:	O	:	_	0	SENT_193	[p12l230t67r259b94],
4	Pharmacodynamics	NNS	O	pharmacodynamic	dep	1	SENT_193	[p12l276t65r608b103],
5	and	CC	O	and	_	0	SENT_193	[p12l622t65r684b94],
6	Pharmacokinetics	NNS	O	pharmacokinetic	dep	1	SENT_193	[p12l701t65r1003b94],
7	of	IN	O	of	_	0	SENT_193	[p12l1018t65r1053b94],
8	L-dopa	NN	O	l-dopa	nn	11	SENT_193	[p12l1068t65r1184b103],
9	Pharmacodynamicsl	NN	O	pharmacodynamicsl	nn	11	SENT_193	[p12l133t143r479b184],
10	coMI	NN	O	comus	nn	11	SENT_193	[p12l744t136r921b179],
11	””	NN	O	””	prep_of	4	SENT_193	[p12l744t136r921b179],
12	,	,	O	,	_	0	SENT_193	[p12l744t136r921b179],
13	n	NN	O	n	appos	11	SENT_193	[p12l937t155r959b174],
14	=	JJ	O	=	amod	13	SENT_193	[p12l978t154r1004b167],
15	17	CD	NUMBER	17	num	16	SENT_193	[p12l1026t146r1066b176],
16	COMILL	NNP	O	COMILL	tmod	14	SENT_193	[p12l1359t136r1523b179],
17	,	,	O	,	_	0	SENT_193	[p12l1359t136r1523b179],
18	n	NN	O	n	appos	16	SENT_193	[p12l1539t155r1561b174],
19	=	JJ	O	=	advmod	13	SENT_193	[p12l1580t154r1606b167],
20	16	CD	NUMBER	16	num	22	SENT_193	[p12l1628t144r1667b174],
21	COMIHH	NNP	O	COMIHH	nn	22	SENT_193	[p12l1846t136r2018b174],
22	Pharmacokinetics	NNPS	O	Pharmacokinetics	dep	13	SENT_193	[p12l133t193r436b224],
23	versus	CC	O	versus	rcmod	22	SENT_193	[p12l1842t205r1945b224],

1	COMI	NNP	O	COMI	_	0	SENT_194	[p12l1846t236r2002b274],
2	”	CD	NUMBER	”	dep	1	SENT_194	[p12l1846t236r2002b274],

1	Placebo	NNP	O	Placebo	nn	5	SENT_195	[p12l627t348r759b379],
2	Entacapone	NNP	O	Entacapone	nn	5	SENT_195	[p12l824t350r1025b389],
3	pa	NN	O	pa	nn	5	SENT_195	[p12l1073t348r1112b389],
4	Placebo	NNP	O	Placebo	nn	5	SENT_195	[p12l1246t348r1378b379],
5	Entacapone	NNP	O	Entacapone	_	0	SENT_195	[p12l1443t350r1643b389],
6	pa	NN	O	pa	nn	7	SENT_195	[p12l1691t348r1730b389],
7	pb	NN	O	pb	dep	5	SENT_195	[p12l1838t340r1879b389],

1	Motor	NNP	O	Motor	_	0	SENT_196	[p12l120t426r224b454],
2	response	NN	O	response	nn	3	SENT_196	[p12l240t436r375b465],
3	Best	NN	O	best	dep	1	SENT_196	[p12l163t492r229b521],
4	ON	IN	O	on	_	0	SENT_196	[p12l245t492r307b521],
5	time	NN	O	time	prep_on	3	SENT_196	[p12l324t492r403b525],
6	,	,	O	,	_	0	SENT_196	[p12l324t492r403b525],
7	min	NN	DURATION	min	appos	5	SENT_196	[p12l421t492r485b520],
8	96	CD	NUMBER	96	number	9	SENT_196	[p12l616t491r654b523],
9	(	CD	NUMBER	(	dep	1	SENT_196	[p12l673t491r735b527],
10	11	CD	NUMBER	11	num	11	SENT_196	[p12l673t491r735b527],
11	)	NN	O	)	dep	9	SENT_196	[p12l673t491r735b527],
12	135	CD	NUMBER	135	number	13	SENT_196	[p12l861t493r916b523],
13	(	CD	NUMBER	(	dep	1	SENT_196	[p12l936t491r977b527],
14	9	CD	NUMBER	9	num	15	SENT_196	[p12l936t491r977b527],
15	)	NN	O	)	dep	13	SENT_196	[p12l936t491r977b527],
16	0.003	CD	NUMBER	0.003	number	17	SENT_196	[p12l1067t493r1157b523],
17	92	CD	NUMBER	92	num	18	SENT_196	[p12l1234t493r1273b523],
18	(	NN	O	(	dep	1	SENT_196	[p12l1291t491r1332b527],
19	7	CD	NUMBER	7	number	20	SENT_196	[p12l1291t491r1332b527],
20	)	NN	O	)	amod	18	SENT_196	[p12l1291t491r1332b527],
21	100	CD	NUMBER	100	number	22	SENT_196	[p12l1480t493r1536b521],
22	(	CD	NUMBER	(	dep	1	SENT_196	[p12l1555t491r1596b527],
23	9	CD	NUMBER	9	num	24	SENT_196	[p12l1555t491r1596b527],
24	)	NN	O	)	dep	22	SENT_196	[p12l1555t491r1596b527],
25	0.28	CD	NUMBER	0.28	num	26	SENT_196	[p12l1698t493r1767b521],
26	delta	NN	O	delta	dep	1	SENT_196	[p12l204t557r281b588],
27	+39	CD	NUMBER	+39	number	28	SENT_196	[p12l847t560r917b590],
28	(	CD	NUMBER	(	dep	26	SENT_196	[p12l936t557r998b594],
29	10	CD	NUMBER	10	num	30	SENT_196	[p12l936t557r998b594],
30	)	NN	O	)	dep	1	SENT_196	[p12l936t557r998b594],
31	--	:	O	--	_	0	SENT_196	[p12l1487t560r1536b589],
32	9	CD	NUMBER	9	number	33	SENT_196	[p12l1487t560r1536b589],
33	(	CD	NUMBER	(	dep	30	SENT_196	[p12l1554t557r1596b594],
34	9	CD	NUMBER	9	num	35	SENT_196	[p12l1554t557r1596b594],
35	)	NN	O	)	dep	33	SENT_196	[p12l1554t557r1596b594],
36	0.04	CD	NUMBER	0.04	dep	1	SENT_196	[p12l1844t557r1914b588],
37	UPDRS-I11	NN	O	updrs-i11	nn	63	SENT_196	[p12l162t625r359b658],
38	,	,	O	,	_	0	SENT_196	[p12l162t625r359b658],
39	%	NN	O	%	dep	63	SENT_196	[p12l377t626r408b655],
40	response	NN	O	response	nn	63	SENT_196	[p12l425t635r561b664],
41	68	CD	NUMBER	68	num	63	SENT_196	[p12l615t624r654b654],
42	(	NN	O	(	nn	63	SENT_196	[p12l673t623r714b660],
43	4	CD	NUMBER	4	num	63	SENT_196	[p12l673t623r714b660],
44	)	CD	NUMBER	)	num	63	SENT_196	[p12l673t623r714b660],
45	67	CD	NUMBER	67	num	63	SENT_196	[p12l879t624r918b656],
46	(	NN	O	(	nn	63	SENT_196	[p12l936t623r977b660],
47	4	CD	NUMBER	4	num	63	SENT_196	[p12l936t623r977b660],
48	)	CD	NUMBER	)	num	63	SENT_196	[p12l936t623r977b660],
49	0.87	CD	NUMBER	0.87	num	63	SENT_196	[p12l1067t626r1137b656],
50	66	CD	NUMBER	66	num	63	SENT_196	[p12l1234t624r1273b654],
51	(	NN	O	(	nn	63	SENT_196	[p12l1291t623r1332b660],
52	4	CD	NUMBER	4	num	63	SENT_196	[p12l1291t623r1332b660],
53	)	CD	NUMBER	)	num	63	SENT_196	[p12l1291t623r1332b660],
54	68	CD	NUMBER	68	num	63	SENT_196	[p12l1497t624r1535b654],
55	(	NN	O	(	nn	63	SENT_196	[p12l1555t624r1596b660],
56	3	CD	NUMBER	3	num	63	SENT_196	[p12l1555t624r1596b660],
57	)	NN	O	)	nn	63	SENT_196	[p12l1555t624r1596b660],
58	0.43	CD	NUMBER	0.43	num	63	SENT_196	[p12l1698t623r1767b656],
59	delta	NN	O	delta	nn	63	SENT_196	[p12l204t690r281b721],
60	-1	CD	NUMBER	-1	num	63	SENT_196	[p12l869t693r914b720],
61	(	NN	O	(	nn	63	SENT_196	[p12l936t690r977b726],
62	3	CD	NUMBER	3	num	63	SENT_196	[p12l936t690r977b726],
63	)	NN	O	)	rcmod	36	SENT_196	[p12l936t690r977b726],
64	.	.	O	.	_	0	SENT_196	[p12l1487t693r1536b720],

1	—	NN	O	—	_	0	SENT_197	[p12l1487t693r1536b720],
2	.	.	O	.	_	0	SENT_197	[p12l1487t693r1536b720],

1	.	.	O	.	_	0	SENT_198	[p12l1487t693r1536b720],

1	—	NN	O	—	_	0	SENT_199	[p12l1487t693r1536b720],
2	.	.	O	.	_	0	SENT_199	[p12l1487t693r1536b720],

1	2	CD	NUMBER	2	dep	4	SENT_200	[p12l1487t693r1536b720],
2	(	CD	NUMBER	(	dep	1	SENT_200	[p12l1554t690r1596b726],
3	3	CD	NUMBER	3	dep	4	SENT_200	[p12l1554t690r1596b726],
4	)	NN	O	)	dep	8	SENT_200	[p12l1554t690r1596b726],
5	0.28	CD	NUMBER	0.28	dep	4	SENT_200	[p12l1844t693r1913b720],
6	Time	NNP	O	Time	nsubj	8	SENT_200	[p12l161t757r247b787],
7	to	TO	O	to	aux	8	SENT_200	[p12l263t767r293b787],
8	peak	VB	O	peak	dep	38	SENT_200	[p12l309t756r391b797],
9	,	,	O	,	_	0	SENT_200	[p12l309t756r391b797],
10	min	NN	DURATION	min	dep	21	SENT_200	[p12l409t758r472b786],
11	83	CD	NUMBER	83	num	10	SENT_200	[p12l616t759r654b789],
12	(	CD	NUMBER	(	number	13	SENT_200	[p12l673t757r714b793],
13	9	CD	NUMBER	9	num	14	SENT_200	[p12l673t757r714b793],
14	)	NN	O	)	dep	10	SENT_200	[p12l673t757r714b793],
15	72	CD	NUMBER	72	num	16	SENT_200	[p12l878t759r917b789],
16	(	NN	O	(	dep	14	SENT_200	[p12l936t757r977b793],
17	7	CD	NUMBER	7	num	18	SENT_200	[p12l936t757r977b793],
18	)	NN	O	)	dep	21	SENT_200	[p12l936t757r977b793],
19	0.41	CD	NUMBER	0.41	number	20	SENT_200	[p12l1067t757r1133b787],
20	55	CD	NUMBER	55	num	21	SENT_200	[p12l1235t759r1271b789],
21	(	NN	O	(	dep	23	SENT_200	[p12l1291t757r1332b793],
22	3	CD	NUMBER	3	dep	21	SENT_200	[p12l1291t757r1332b793],
23	)	NN	O	)	dep	25	SENT_200	[p12l1291t757r1332b793],
24	64	CD	NUMBER	64	num	23	SENT_200	[p12l1497t757r1536b787],
25	(	CD	NUMBER	(	dep	27	SENT_200	[p12l1555t757r1596b793],
26	8	CD	NUMBER	8	num	27	SENT_200	[p12l1555t757r1596b793],
27	)	NN	O	)	dep	29	SENT_200	[p12l1555t757r1596b793],
28	0.40	CD	NUMBER	0.40	num	29	SENT_200	[p12l1698t756r1767b787],
29	delta	NN	O	delta	dep	38	SENT_200	[p12l204t823r281b854],
30	-11	CD	NUMBER	-11	dep	29	SENT_200	[p12l848t826r914b853],
31	(	CD	NUMBER	(	number	32	SENT_200	[p12l936t823r977b859],
32	9	CD	NUMBER	9	num	33	SENT_200	[p12l936t823r977b859],
33	)	NN	O	)	dep	30	SENT_200	[p12l936t823r977b859],
34	--	:	O	--	_	0	SENT_200	[p12l1487t826r1536b855],
35	9	CD	NUMBER	9	num	36	SENT_200	[p12l1487t826r1536b855],
36	(	NN	O	(	dep	30	SENT_200	[p12l1554t823r1596b859],
37	8	CD	NUMBER	8	dep	36	SENT_200	[p12l1554t823r1596b859],
38	)	NN	O	)	_	0	SENT_200	[p12l1554t823r1596b859],
39	0.14	CD	NUMBER	0.14	num	38	SENT_200	[p12l1844t823r1914b853],

1	Pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_201	[p12l121t889r403b920],
2	AUC	NN	O	auc	rcmod	1	SENT_201	[p12l160t957r256b991],
3	,	,	O	,	_	0	SENT_201	[p12l160t957r256b991],
4	,	,	O	,	_	0	SENT_201	[p12l273t956r445b997],
5	ug	NN	O	ug	dep	2	SENT_201	[p12l273t956r445b997],
6	.	.	O	.	_	0	SENT_201	[p12l273t956r445b997],

1	min/ml	NN	O	min/ml	_	0	SENT_202	[p12l273t956r445b997],
2	128	CD	NUMBER	128	num	3	SENT_202	[p12l619t959r674b986],
3	(	NN	O	(	dep	1	SENT_202	[p12l693t956r735b992],
4	7	CD	NUMBER	7	num	5	SENT_202	[p12l693t956r735b992],
5	)	NN	O	)	dep	3	SENT_202	[p12l693t956r735b992],
6	204	CD	NUMBER	204	num	7	SENT_202	[p12l857t956r918b986],
7	(	NN	O	(	dep	1	SENT_202	[p12l936t956r998b993],
8	12	CD	NUMBER	12	number	9	SENT_202	[p12l936t956r998b993],
9	)	CD	NUMBER	)	dep	7	SENT_202	[p12l936t956r998b993],
10	0.0003	CD	NUMBER	0.0003	number	11	SENT_202	[p12l1067t959r1178b988],
11	138	CD	NUMBER	138	dep	1	SENT_202	[p12l1237t959r1293b988],
12	(	NN	O	(	dep	11	SENT_202	[p12l1312t956r1374b993],
13	12	CD	NUMBER	12	num	14	SENT_202	[p12l1312t956r1374b993],
14	)	NN	O	)	dep	1	SENT_202	[p12l1312t956r1374b993],
15	178	CD	NUMBER	178	num	16	SENT_202	[p12l1480t959r1535b988],
16	(	NN	O	(	dep	14	SENT_202	[p12l1555t956r1617b993],
17	14	CD	NUMBER	14	number	18	SENT_202	[p12l1555t956r1617b993],
18	)	CD	NUMBER	)	dep	1	SENT_202	[p12l1555t956r1617b993],
19	0.007	CD	NUMBER	0.007	num	20	SENT_202	[p12l1698t959r1789b988],
20	delta	NN	O	delta	dep	18	SENT_202	[p12l204t1022r281b1053],
21	--	:	O	--	_	0	SENT_202	[p12l847t1026r918b1055],
22	77	CD	NUMBER	77	number	23	SENT_202	[p12l847t1026r918b1055],
23	(	CD	NUMBER	(	dep	18	SENT_202	[p12l936t1023r977b1059],
24	8	CD	NUMBER	8	num	25	SENT_202	[p12l936t1023r977b1059],
25	)	NN	O	)	dep	23	SENT_202	[p12l936t1023r977b1059],
26	.	.	O	.	_	0	SENT_202	[p12l1466t1022r1536b1053],

1	—	NN	O	—	_	0	SENT_203	[p12l1466t1022r1536b1053],
2	.	.	O	.	_	0	SENT_203	[p12l1466t1022r1536b1053],

1	.	.	O	.	_	0	SENT_204	[p12l1466t1022r1536b1053],

1	—	NN	O	—	_	0	SENT_205	[p12l1466t1022r1536b1053],
2	.	.	O	.	_	0	SENT_205	[p12l1466t1022r1536b1053],

1	40	CD	NUMBER	40	num	2	SENT_206	[p12l1466t1022r1536b1053],
2	(	CD	NUMBER	(	_	0	SENT_206	[p12l1554t1023r1617b1059],
3	13	CD	NUMBER	13	num	4	SENT_206	[p12l1554t1023r1617b1059],
4	)	NN	O	)	dep	2	SENT_206	[p12l1554t1023r1617b1059],
5	0.03	CD	NUMBER	0.03	num	6	SENT_206	[p12l1844t1025r1913b1054],
6	Ha1f	NN	O	ha1f	dep	4	SENT_206	[p12l163t1089r306b1124],
7	—	CD	NUMBER	—	dep	2	SENT_206	[p12l163t1089r306b1124],
8	1ife	NN	O	1ife	nn	29	SENT_206	[p12l163t1089r306b1124],
9	,	,	O	,	_	0	SENT_206	[p12l163t1089r306b1124],
10	min	NN	DURATION	min	dep	29	SENT_206	[p12l323t1091r387b1119],
11	68	CD	NUMBER	68	num	29	SENT_206	[p12l615t1090r653b1119],
12	(	NN	O	(	nn	29	SENT_206	[p12l673t1089r714b1126],
13	2	CD	NUMBER	2	num	29	SENT_206	[p12l673t1089r714b1126],
14	)	CD	NUMBER	)	num	29	SENT_206	[p12l673t1089r714b1126],
15	95	CD	NUMBER	95	num	29	SENT_206	[p12l879t1091r916b1122],
16	(	NN	O	(	nn	29	SENT_206	[p12l936t1089r977b1126],
17	6	CD	NUMBER	6	num	29	SENT_206	[p12l936t1089r977b1126],
18	)	NN	O	)	nn	29	SENT_206	[p12l936t1089r977b1126],
19	0.0005	CD	NUMBER	0.0005	num	29	SENT_206	[p12l1067t1091r1177b1122],
20	69	CD	NUMBER	69	num	29	SENT_206	[p12l1234t1090r1272b1121],
21	(	NN	O	(	nn	29	SENT_206	[p12l1291t1089r1332b1126],
22	3	CD	NUMBER	3	num	29	SENT_206	[p12l1291t1089r1332b1126],
23	)	NN	O	)	nn	29	SENT_206	[p12l1291t1089r1332b1126],
24	91	CD	NUMBER	91	num	29	SENT_206	[p12l1498t1092r1533b1121],
25	(	CD	NUMBER	(	num	29	SENT_206	[p12l1555t1089r1617b1126],
26	10	CD	NUMBER	10	num	29	SENT_206	[p12l1555t1089r1617b1126],
27	)	NN	O	)	nn	29	SENT_206	[p12l1555t1089r1617b1126],
28	0.001	CD	NUMBER	0.001	num	29	SENT_206	[p12l1698t1092r1785b1119],
29	delta	NN	O	delta	rcmod	7	SENT_206	[p12l204t1155r281b1186],
30	.	.	O	.	_	0	SENT_206	[p12l847t1158r917b1186],

1	—	NN	O	—	_	0	SENT_207	[p12l847t1158r917b1186],
2	.	.	O	.	_	0	SENT_207	[p12l847t1158r917b1186],

1	.	.	O	.	_	0	SENT_208	[p12l847t1158r917b1186],

1	—	NN	O	—	_	0	SENT_209	[p12l847t1158r917b1186],
2	.	.	O	.	_	0	SENT_209	[p12l847t1158r917b1186],

1	28	CD	NUMBER	28	num	2	SENT_210	[p12l847t1158r917b1186],
2	(	CD	NUMBER	(	_	0	SENT_210	[p12l936t1156r977b1192],
3	6	CD	NUMBER	6	num	4	SENT_210	[p12l936t1156r977b1192],
4	)	NN	O	)	dep	2	SENT_210	[p12l936t1156r977b1192],
5	.	.	O	.	_	0	SENT_210	[p12l1466t1158r1536b1185],

1	—	NN	O	—	_	0	SENT_211	[p12l1466t1158r1536b1185],
2	.	.	O	.	_	0	SENT_211	[p12l1466t1158r1536b1185],

1	.	.	O	.	_	0	SENT_212	[p12l1466t1158r1536b1185],

1	—	NN	O	—	_	0	SENT_213	[p12l1466t1158r1536b1185],
2	.	.	O	.	_	0	SENT_213	[p12l1466t1158r1536b1185],

1	22	CD	NUMBER	22	num	2	SENT_214	[p12l1466t1158r1536b1185],
2	(	CD	NUMBER	(	dep	27	SENT_214	[p12l1554t1156r1617b1192],
3	10	CD	NUMBER	10	num	4	SENT_214	[p12l1554t1156r1617b1192],
4	)	NN	O	)	dep	2	SENT_214	[p12l1554t1156r1617b1192],
5	0.59	CD	NUMBER	0.59	num	23	SENT_214	[p12l1844t1158r1914b1188],
6	Clearance	NNP	O	Clearance	nn	23	SENT_214	[p12l163t1222r328b1257],
7	,	,	O	,	_	0	SENT_214	[p12l163t1222r328b1257],
8	ml/min	JJ	O	ml/min	amod	23	SENT_214	[p12l345t1222r466b1252],
9	829	CD	NUMBER	829	num	23	SENT_214	[p12l616t1225r675b1254],
10	(	CD	NUMBER	(	num	23	SENT_214	[p12l693t1222r756b1258],
11	49	CD	NUMBER	49	num	23	SENT_214	[p12l693t1222r756b1258],
12	)	NN	O	)	nn	23	SENT_214	[p12l693t1222r756b1258],
13	500	CD	NUMBER	500	num	23	SENT_214	[p12l859t1224r917b1255],
14	(	NN	O	(	nn	23	SENT_214	[p12l936t1222r998b1258],
15	26	CD	NUMBER	26	num	23	SENT_214	[p12l936t1222r998b1258],
16	)	CD	NUMBER	)	num	23	SENT_214	[p12l936t1222r998b1258],
17	0.0003	CD	NUMBER	0.0003	num	23	SENT_214	[p12l1067t1225r1178b1254],
18	806	CD	NUMBER	806	num	23	SENT_214	[p12l1235t1223r1294b1252],
19	(	NN	O	(	nn	23	SENT_214	[p12l1312t1222r1374b1258],
20	69	CD	NUMBER	69	num	23	SENT_214	[p12l1312t1222r1374b1258],
21	)	NN	O	)	nn	23	SENT_214	[p12l1312t1222r1374b1258],
22	606	CD	NUMBER	606	num	23	SENT_214	[p12l1476t1223r1536b1252],
23	(	NN	O	(	rcmod	4	SENT_214	[p12l1555t1222r1617b1258],
24	53	CD	NUMBER	53	dep	27	SENT_214	[p12l1555t1222r1617b1258],
25	)	CD	NUMBER	)	num	27	SENT_214	[p12l1555t1222r1617b1258],
26	0.004	CD	NUMBER	0.004	num	27	SENT_214	[p12l1698t1222r1789b1252],
27	delta	NN	O	delta	dep	31	SENT_214	[p12l204t1288r281b1319],
28	-329	CD	NUMBER	-329	num	29	SENT_214	[p12l828t1291r917b1321],
29	(	CD	NUMBER	(	dep	27	SENT_214	[p12l936t1289r998b1325],
30	35	CD	NUMBER	35	num	31	SENT_214	[p12l936t1289r998b1325],
31	)	NN	O	)	dep	44	SENT_214	[p12l936t1289r998b1325],
32	-200	CD	NUMBER	-200	dep	31	SENT_214	[p12l1446t1291r1536b1319],
33	(	CD	NUMBER	(	number	34	SENT_214	[p12l1554t1289r1617b1325],
34	47	CD	NUMBER	47	num	35	SENT_214	[p12l1554t1289r1617b1325],
35	)	NN	O	)	rcmod	32	SENT_214	[p12l1554t1289r1617b1325],
36	0.05	CD	NUMBER	0.05	num	37	SENT_214	[p12l1844t1291r1913b1321],
37	Cmax	NN	O	cmax	dep	35	SENT_214	[p12l163t1356r266b1390],
38	,	,	O	,	_	0	SENT_214	[p12l163t1356r266b1390],
39	,	,	O	,	_	0	SENT_214	[p12l283t1355r380b1396],
40	ug/ml	JJ	O	ug/ml	amod	32	SENT_214	[p12l283t1355r380b1396],
41	3.7	CD	NUMBER	3.7	number	42	SENT_214	[p12l616t1358r665b1387],
42	(	CD	NUMBER	(	dep	40	SENT_214	[p12l683t1355r756b1391],
43	0.3	CD	NUMBER	0.3	num	44	SENT_214	[p12l683t1355r756b1391],
44	)	NN	O	)	dep	46	SENT_214	[p12l683t1355r756b1391],
45	3.8	CD	NUMBER	3.8	num	46	SENT_214	[p12l868t1358r917b1387],
46	(	NN	O	(	dep	52	SENT_214	[p12l936t1355r1009b1391],
47	0.3	CD	NUMBER	0.3	num	48	SENT_214	[p12l936t1355r1009b1391],
48	)	NN	O	)	dep	46	SENT_214	[p12l936t1355r1009b1391],
49	0.62	CD	NUMBER	0.62	number	50	SENT_214	[p12l1067t1356r1137b1385],
50	4.2	CD	NUMBER	4.2	num	51	SENT_214	[p12l1233t1355r1283b1385],
51	(	NN	O	(	dep	48	SENT_214	[p12l1302t1355r1374b1391],
52	0.4	CD	NUMBER	0.4	dep	59	SENT_214	[p12l1302t1355r1374b1391],
53	)	CD	NUMBER	)	number	54	SENT_214	[p12l1302t1355r1374b1391],
54	4.0	CD	NUMBER	4.0	num	55	SENT_214	[p12l1486t1355r1536b1385],
55	(	NN	O	(	dep	52	SENT_214	[p12l1555t1355r1627b1391],
56	0.4	CD	NUMBER	0.4	num	57	SENT_214	[p12l1555t1355r1627b1391],
57	)	CD	NUMBER	)	dep	55	SENT_214	[p12l1555t1355r1627b1391],
58	0.62	CD	NUMBER	0.62	num	59	SENT_214	[p12l1698t1356r1768b1385],
59	delta	NN	O	delta	dep	61	SENT_214	[p12l204t1421r281b1452],
60	+0.1	CD	NUMBER	+0.1	num	61	SENT_214	[p12l837t1424r914b1454],
61	(	NN	O	(	dep	63	SENT_214	[p12l936t1422r1009b1458],
62	0.3	CD	NUMBER	0.3	num	63	SENT_214	[p12l936t1422r1009b1458],
63	)	CD	NUMBER	)	dep	66	SENT_214	[p12l936t1422r1009b1458],
64	-0.2	CD	NUMBER	-0.2	num	65	SENT_214	[p12l1456t1424r1536b1452],
65	(	NN	O	(	dep	63	SENT_214	[p12l1554t1421r1627b1458],
66	0.4	CD	NUMBER	0.4	dep	91	SENT_214	[p12l1554t1421r1627b1458],
67	)	CD	NUMBER	)	num	68	SENT_214	[p12l1554t1421r1627b1458],
68	0.27	CD	NUMBER	0.27	dep	66	SENT_214	[p12l1844t1424r1915b1454],
69	Tmax	NN	O	tmax	nn	90	SENT_214	[p12l161t1488r259b1523],
70	,	,	O	,	_	0	SENT_214	[p12l161t1488r259b1523],
71	min	NN	DURATION	min	dep	90	SENT_214	[p12l277t1490r340b1518],
72	32	CD	NUMBER	32	num	90	SENT_214	[p12l616t1491r654b1520],
73	(	NN	O	(	nn	90	SENT_214	[p12l673t1488r714b1524],
74	3	CD	NUMBER	3	num	90	SENT_214	[p12l673t1488r714b1524],
75	)	NN	O	)	nn	90	SENT_214	[p12l673t1488r714b1524],
76	37	CD	NUMBER	37	num	90	SENT_214	[p12l879t1491r918b1520],
77	(	CD	NUMBER	(	num	90	SENT_214	[p12l936t1488r977b1524],
78	4	CD	NUMBER	4	num	90	SENT_214	[p12l936t1488r977b1524],
79	)	NN	O	)	nn	90	SENT_214	[p12l936t1488r977b1524],
80	0.16	CD	NUMBER	0.16	num	90	SENT_214	[p12l1067t1489r1137b1518],
81	31	CD	NUMBER	31	num	90	SENT_214	[p12l1234t1491r1269b1520],
82	(	NN	O	(	nn	90	SENT_214	[p12l1291t1488r1332b1524],
83	3	CD	NUMBER	3	num	90	SENT_214	[p12l1291t1488r1332b1524],
84	)	NN	O	)	nn	90	SENT_214	[p12l1291t1488r1332b1524],
85	33	CD	NUMBER	33	num	90	SENT_214	[p12l1497t1491r1535b1520],
86	(	NN	O	(	nn	90	SENT_214	[p12l1554t1488r1596b1524],
87	3	CD	NUMBER	3	num	90	SENT_214	[p12l1554t1488r1596b1524],
88	)	NN	O	)	nn	90	SENT_214	[p12l1554t1488r1596b1524],
89	0.74	CD	NUMBER	0.74	num	90	SENT_214	[p12l1698t1488r1768b1520],
90	delta	NN	O	delta	rcmod	68	SENT_214	[p12l204t1554r281b1585],
91	+5	CD	NUMBER	+5	dep	94	SENT_214	[p12l868t1556r916b1587],
92	(	CD	NUMBER	(	number	93	SENT_214	[p12l936t1555r977b1591],
93	3	CD	NUMBER	3	num	94	SENT_214	[p12l936t1555r977b1591],
94	)	NN	O	)	dep	98	SENT_214	[p12l936t1555r977b1591],
95	+1	CD	NUMBER	+1	number	96	SENT_214	[p12l1487t1557r1533b1588],
96	(	CD	NUMBER	(	num	94	SENT_214	[p12l1554t1555r1596b1591],
97	3	CD	NUMBER	3	dep	94	SENT_214	[p12l1554t1555r1596b1591],
98	)	NN	O	)	_	0	SENT_214	[p12l1554t1555r1596b1591],
99	0.44	CD	NUMBER	0.44	num	98	SENT_214	[p12l1844t1554r1914b1585],

1	Values	NNS	O	value	nsubj	2	SENT_215	[p12l107t1618r199b1646],
2	obtained	VBN	O	obtain	_	0	SENT_215	[p12l214t1618r339b1646],
3	during	IN	O	during	_	0	SENT_215	[p12l353t1618r449b1656],
4	L-dopa	NN	MISC	l-dopa	nn	5	SENT_215	[p12l462t1618r566b1655],
5	challenge	NN	O	challenge	prep_during	2	SENT_215	[p12l579t1618r711b1656],
6	with	IN	O	with	_	0	SENT_215	[p12l724t1618r789b1646],
7	placebo	NN	O	placebo	nn	10	SENT_215	[p12l802t1618r911b1655],
8	or	CC	O	or	_	0	SENT_215	[p12l926t1630r956b1646],
9	200mg	JJ	O	200mg	nn	10	SENT_215	[p12l969t1621r1071b1656],
10	entacapone	NN	O	entacapone	prep_with	2	SENT_215	[p12l1084t1628r1245b1655],
11	and	CC	O	and	_	0	SENT_215	[p12l1260t1618r1312b1646],
12	the	DT	O	the	det	18	SENT_215	[p12l1326t1618r1370b1646],
13	delta	NN	O	delta	nn	18	SENT_215	[p12l1384t1618r1453b1646],
14	(	NN	O	(	nn	18	SENT_215	[p12l1468t1619r1639b1655],
15	entacapone	NN	O	entacapone	nn	18	SENT_215	[p12l1468t1619r1639b1655],
16	—	CD	NUMBER	—	num	18	SENT_215	[p12l1655t1635r1678b1637],
17	placebo	NN	O	placebo	nn	18	SENT_215	[p12l1694t1618r1823b1655],
18	)	NN	O	)	conj_and	10	SENT_215	[p12l1694t1618r1823b1655],
19	,	,	O	,	_	0	SENT_215	[p12l1694t1618r1823b1655],
20	expressed	VBN	O	express	dep	2	SENT_215	[p12l1839t1618r1973b1655],
21	as	IN	O	as	_	0	SENT_215	[p12l1987t1630r2012b1646],
22	mean	JJ	O	mean	amod	25	SENT_215	[p12l108t1671r186b1688],
23	(	JJ	O	(	amod	25	SENT_215	[p12l201t1660r334b1693],
24	standard	JJ	O	standard	amod	25	SENT_215	[p12l201t1660r334b1693],
25	error	NN	O	error	prep_as	20	SENT_215	[p12l348t1671r418b1688],
26	of	IN	O	of	_	0	SENT_215	[p12l431t1660r464b1688],
27	the	DT	O	the	det	29	SENT_215	[p12l473t1660r517b1688],
28	mean	JJ	O	mean	amod	29	SENT_215	[p12l531t1661r628b1693],
29	)	NN	O	)	prep_of	25	SENT_215	[p12l531t1661r628b1693],
30	.	.	O	.	_	0	SENT_215	[p12l531t1661r628b1693],

1	IAUC	NN	O	iauc	nn	2	SENT_216	[p12l646t1654r734b1688],
2	values	NNS	O	value	nsubjpass	4	SENT_216	[p12l747t1660r832b1688],
3	were	VBD	O	be	auxpass	4	SENT_216	[p12l846t1671r912b1688],
4	adjusted	VBN	O	adjust	_	0	SENT_216	[p12l926t1660r1045b1697],
5	for	IN	O	for	mark	10	SENT_216	[p12l1059t1660r1100b1688],
6	the	DT	O	the	det	7	SENT_216	[p12l1113t1660r1157b1688],
7	dose	NN	O	dose	nsubj	10	SENT_216	[p12l1171t1660r1234b1688],
8	of	IN	O	of	_	0	SENT_216	[p12l1248t1660r1280b1688],
9	L-dopa	NN	MISC	l-dopa	prep_of	7	SENT_216	[p12l1289t1660r1393b1697],
10	received	VBD	O	receive	advcl	4	SENT_216	[p12l1407t1660r1522b1688],
11	for	IN	O	for	_	0	SENT_216	[p12l1536t1660r1577b1688],
12	the	DT	O	the	det	13	SENT_216	[p12l1590t1660r1634b1688],
13	challenge	NN	O	challenge	prep_for	10	SENT_216	[p12l1648t1660r1780b1697],
14	and	CC	O	and	_	0	SENT_216	[p12l1794t1660r1847b1688],
15	are	VBP	O	be	auxpass	16	SENT_216	[p12l1861t1671r1901b1688],
16	expressed	VBN	O	express	advcl	4	SENT_216	[p12l1916t1660r2050b1697],
17	relative	JJ	O	relative	advmod	16	SENT_216	[p12l108t1702r210b1729],
18	to	TO	O	to	_	0	SENT_216	[p12l225t1711r252b1729],
19	a	DT	O	a	det	20	SENT_216	[p12l267t1713r281b1729],
20	dose	NN	O	dose	prep_to	16	SENT_216	[p12l294t1702r357b1729],
21	of	IN	O	of	_	0	SENT_216	[p12l371t1702r404b1729],
22	100mg	NN	O	100mg	prep_of	20	SENT_216	[p12l416t1704r515b1739],
23	of	IN	O	of	_	0	SENT_216	[p12l528t1702r561b1729],
24	L-dopa	NN	O	l-dopa	prep_of	22	SENT_216	[p12l570t1702r680b1738],
25	.	.	O	.	_	0	SENT_216	[p12l570t1702r680b1738],

1	“	NN	O	“	nn	2	SENT_217	[p12l108t1743r229b1771],
2	Placebo	NN	O	placebo	_	0	SENT_217	[p12l108t1743r229b1771],
3	versus	CC	O	versus	prep	2	SENT_217	[p12l243t1754r328b1771],
4	entacapone	NN	O	entacapone	dep	3	SENT_217	[p12l343t1753r512b1780],
5	,	,	O	,	_	0	SENT_217	[p12l343t1753r512b1780],
6	paired	JJ	O	paired	amod	8	SENT_217	[p12l527t1743r617b1780],
7	Wilcoxon	NNP	PERSON	Wilcoxon	nn	8	SENT_217	[p12l629t1743r771b1771],
8	test	NN	O	test	appos	4	SENT_217	[p12l785t1753r840b1771],
9	.	.	O	.	_	0	SENT_217	[p12l785t1753r840b1771],

1	bGenotype	NN	O	bgenotype	nsubj	13	SENT_218	[p12l108t1777r263b1822],
2	by	IN	O	by	_	0	SENT_218	[p12l277t1785r312b1821],
3	treatment	NN	O	treatment	nn	4	SENT_218	[p12l325t1794r464b1813],
4	interaction	NN	O	interaction	prep_by	1	SENT_218	[p12l478t1787r641b1817],
5	,	,	O	,	_	0	SENT_218	[p12l478t1787r641b1817],
6	analysis	NN	O	analysis	appos	4	SENT_218	[p12l657t1785r764b1821],
7	of	IN	O	of	_	0	SENT_218	[p12l779t1785r811b1813],
8	variance	NN	O	variance	prep_of	6	SENT_218	[p12l819t1787r937b1813],
9	for	IN	O	for	_	0	SENT_218	[p12l951t1785r992b1813],
10	repeated	VBN	O	repeat	amod	11	SENT_218	[p12l1005t1785r1126b1822],
11	measure	NN	O	measure	prep_for	8	SENT_218	[p12l1139t1796r1256b1813],
12	(	CD	NUMBER	(	dep	11	SENT_218	[p12l1272t1786r1322b1818],
13	see	VBP	O	see	_	0	SENT_218	[p12l1272t1786r1322b1818],
14	Patients	NNS	O	patient	dobj	13	SENT_218	[p12l1337t1787r1448b1813],
15	and	CC	O	and	_	0	SENT_218	[p12l1462t1785r1515b1813],
16	Methods	NNS	O	method	dobj	13	SENT_218	[p12l1528t1785r1675b1818],
17	)	CD	NUMBER	)	tmod	13	SENT_218	[p12l1528t1785r1675b1818],
18	.	.	O	.	_	0	SENT_218	[p12l1528t1785r1675b1818],

1	UPDRS	NN	O	updr	_	0	SENT_219	[p12l108t1828r226b1855],
2	=	JJ	O	=	amod	7	SENT_219	[p12l242t1840r267b1849],
3	Unified	NNP	O	Unified	nn	7	SENT_219	[p12l283t1827r392b1855],
4	Parkinson	NNP	O	Parkinson	nn	7	SENT_219	[p12l406t1827r549b1854],
5	Disease	NNP	O	Disease	nn	7	SENT_219	[p12l563t1829r668b1854],
6	Rating	NNP	O	Rating	nn	7	SENT_219	[p12l683t1829r779b1864],
7	Scale	NNP	O	Scale	dep	1	SENT_219	[p12l792t1827r871b1858],
8	;	:	O	;	_	0	SENT_219	[p12l792t1827r871b1858],
9	AUC	NN	O	auc	nn	11	SENT_219	[p12l884t1828r962b1855],
10	=	JJ	O	=	amod	11	SENT_219	[p12l977t1840r1002b1849],
11	area	NN	O	area	dep	1	SENT_219	[p12l1018t1838r1075b1854],
12	under	IN	O	under	_	0	SENT_219	[p12l1088t1827r1172b1855],
13	the	DT	O	the	det	14	SENT_219	[p12l1185t1827r1229b1854],
14	curve	NN	O	curve	prep_under	11	SENT_219	[p12l1243t1838r1327b1855],
15	.	.	O	.	_	0	SENT_219	[p12l1243t1838r1327b1855],

1	studies	NNS	O	study	nsubjpass	11	SENT_220	[p12l13t2050r274b2128],
2	,	,	O	,	_	0	SENT_220	[p12l13t2050r274b2128],
3	the	DT	O	the	det	4	SENT_220	[p12l322t2050r431b2118],
4	Tmax	NN	O	tmax	appos	1	SENT_220	[p12l473t2051r675b2118],
5	and	CC	O	and	_	0	SENT_220	[p12l717t2050r848b2119],
6	Cmax	NN	O	cmax	appos	1	SENT_220	[p12l891t2053r1107b2118],
7	of	IN	O	of	_	0	SENT_220	[p12l1148t2050r1229b2118],
8	L-dopa	NN	O	l-dopa	prep_of	4	SENT_220	[p12l1260t2050r1521b2141],
9	were	VBD	O	be	auxpass	11	SENT_220	[p12l1558t2077r1725b2118],
10	not	RB	O	not	neg	11	SENT_220	[p12l1768t2073r1888b2118],
11	modiﬁed	VBN	O	modiﬁed	_	0	SENT_220	[p12l1930t2050r2148b2119, p12l13t2157r146b2227],
12	by	IN	O	by	_	0	SENT_220	[p12l221t2157r308b2248],
13	entacapone	NN	O	entacapone	agent	11	SENT_220	[p12l380t2181r782b2249],
14	and	CC	O	and	_	0	SENT_220	[p12l858t2157r989b2227],
15	did	VBD	O	do	aux	17	SENT_220	[p12l1063t2157r1180b2227],
16	not	RB	O	not	neg	17	SENT_220	[p12l1254t2181r1375b2226],
17	differ	VB	O	differ	conj_and	11	SENT_220	[p12l1448t2157r1640b2227],
18	significantly	RB	O	significantly	advmod	17	SENT_220	[p12l1714t2157r2153b2249],
19	between	IN	O	between	_	0	SENT_220	[p12l13t2265r306b2334],
20	genotype	NN	O	genotype	nn	21	SENT_220	[p12l341t2289r666b2357],
21	groups	NNS	O	group	prep_between	17	SENT_220	[p12l701t2292r961b2357],
22	.	.	O	.	_	0	SENT_220	[p12l701t2292r961b2357],

1	Is	VBZ	O	be	cop	4	SENT_221	[p12l17t2511r80b2579],
2	the	DT	O	the	det	3	SENT_221	[p12l116t2507r254b2579],
3	Entacapone-Induced	JJ	MISC	entacapone-induced	nsubj	4	SENT_221	[p12l293t2507r1188b2599],
4	Increase	NN	MISC	increase	_	0	SENT_221	[p12l1222t2511r1576b2579],
5	in	IN	O	in	_	0	SENT_221	[p12l1615t2510r1685b2578],
6	the	DT	O	the	det	7	SENT_221	[p12l1724t2507r1861b2579],
7	Pharmacodynamics	NNPS	O	Pharmacodynamics	prep_in	4	SENT_221	[p12l17t2619r851b2713],
8	and	CC	O	and	_	0	SENT_221	[p12l888t2619r1050b2692],
9	Pharmacokinetics	NNPS	O	Pharmacokinetics	prep_in	4	SENT_221	[p12l1085t2619r1844b2692],
10	of	IN	O	of	_	0	SENT_221	[p12l1880t2618r1975b2692],
11	L-dopa	NNP	O	L-dopa	nn	12	SENT_221	[p12l17t2735r313b2828],
12	Related	NNP	O	Related	prep_of	7	SENT_221	[p12l354t2735r686b2808],
13	to	TO	O	to	_	0	SENT_221	[p12l720t2748r807b2808],
14	Its	PRP$	O	its	poss	15	SENT_221	[p12l846t2740r945b2808],
15	Inhibition	NN	O	inhibition	prep_to	12	SENT_221	[p12l982t2735r1386b2808],
16	of	IN	O	of	_	0	SENT_221	[p12l1427t2734r1522b2808],
17	COMT	NNP	O	COMT	prep_of	15	SENT_221	[p12l1551t2738r1880b2809],
18	?	.	O	?	_	0	SENT_221	[p12l1551t2738r1880b2809],

1	To	TO	O	to	aux	2	SENT_222	[p12l11t2856r104b2922],
2	determine	VB	O	determine	purpcl	25	SENT_222	[p12l159t2854r520b2923],
3	whether	IN	O	whether	complm	16	SENT_222	[p12l570t2854r862b2923],
4	the	DT	O	the	det	5	SENT_222	[p12l914t2854r1023b2922],
5	effect	NN	O	effect	nsubjpass	16	SENT_222	[p12l1076t2854r1267b2922],
6	of	IN	O	of	_	0	SENT_222	[p12l1319t2854r1400b2922],
7	entacapone	NN	O	entacapone	prep_of	5	SENT_222	[p12l1441t2877r1843b2945],
8	on	IN	O	on	_	0	SENT_222	[p12l1897t2881r1987b2922],
9	the	DT	O	the	det	10	SENT_222	[p12l2040t2854r2149b2922],
10	pharmacodynamics	NNS	O	pharmacodynamic	prep_on	7	SENT_222	[p12l12t2975r711b3067],
11	and	CC	O	and	_	0	SENT_222	[p12l757t2975r888b3045],
12	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	10	SENT_222	[p12l930t2975r1563b3067],
13	of	IN	O	of	_	0	SENT_222	[p12l1609t2975r1689b3044],
14	L-dopa	NN	MISC	l-dopa	prep_of	10	SENT_222	[p12l1721t2975r1981b3067],
15	was	VBD	O	be	auxpass	16	SENT_222	[p12l2020t3004r2148b3044],
16	related	VBN	O	relate	ccomp	2	SENT_222	[p12l14t3091r253b3160],
17	to	TO	O	to	_	0	SENT_222	[p12l294t3114r362b3159],
18	its	PRP$	O	its	poss	19	SENT_222	[p12l406t3095r484b3159],
19	effect	NN	O	effect	prep_to	16	SENT_222	[p12l527t3091r718b3159],
20	on	IN	O	on	_	0	SENT_222	[p12l759t3118r849b3159],
21	COMT	NN	O	comt	nn	22	SENT_222	[p12l892t3092r1175b3159],
22	activity	NN	O	activity	prep_on	19	SENT_222	[p12l1207t3095r1476b3181],
23	,	,	O	,	_	0	SENT_222	[p12l1207t3095r1476b3181],
24	We	PRP	O	we	nsubj	25	SENT_222	[p12l1519t3119r1616b3159],
25	measured	VBD	O	measure	_	0	SENT_222	[p12l1658t3091r1999b3160],
26	the	DT	O	the	det	27	SENT_222	[p12l2040t3091r2149b3159],
27	activity	NN	O	activity	dobj	25	SENT_222	[p12l13t3209r274b3295],
28	of	IN	O	of	_	0	SENT_222	[p12l312t3205r393b3273],
29	this	DT	O	this	det	30	SENT_222	[p12l422t3205r547b3273],
30	enzyme	NN	O	enzyme	prep_of	27	SENT_222	[p12l590t3232r859b3295],
31	in	IN	O	in	_	0	SENT_222	[p12l900t3209r969b3273],
32	red	JJ	O	red	amod	34	SENT_222	[p12l1011t3205r1123b3274],
33	blood	NN	O	blood	nn	34	SENT_222	[p12l1163t3205r1370b3274],
34	cells	NNS	O	cell	prep_in	30	SENT_222	[p12l1411t3205r1556b3273],
35	90	CD	DURATION	90	num	36	SENT_222	[p12l1600t3212r1686b3277],
36	minutes	NNS	NUMBER	minute	tmod	30	SENT_222	[p12l1729t3209r2015b3274],
37	after	IN	O	after	_	0	SENT_222	[p12l2058t3205r2147b3273, p12l13t3343r107b3389],
38	administration	NN	O	administration	prep_after	25	SENT_222	[p12l166t3320r696b3390],
39	of	IN	O	of	_	0	SENT_222	[p12l756t3320r837b3389],
40	the	DT	O	the	det	41	SENT_222	[p12l886t3320r994b3389],
41	drug	NN	O	drug	prep_of	38	SENT_222	[p12l1055t3320r1238b3412],
42	.	.	O	.	_	0	SENT_222	[p12l1055t3320r1238b3412],

1	COMT	NN	O	comt	nn	2	SENT_223	[p12l1305t3322r1588b3389],
2	inhibition	NN	O	inhibition	dep	6	SENT_223	[p12l1645t3321r2005b3389],
3	by	IN	O	by	_	0	SENT_223	[p12l2065t3320r2153b3411],
4	entacapone	NN	O	entacapone	prep_by	6	SENT_223	[p12l13t3465r416b3533],
5	was	VBD	O	be	cop	6	SENT_223	[p12l466t3470r594b3510],
6	higher	JJR	O	higher	_	0	SENT_223	[p12l647t3442r876b3534],
7	in	IN	O	in	_	0	SENT_223	[p12l927t3446r996b3509],
8	COM	NNP	O	COM	nn	9	SENT_223	[p12l1055t3445r1266b3510],
9	THH	NN	O	thh	prep_in	6	SENT_223	[p12l1270t3425r1431b3509],
10	than	IN	O	than	advmod	17	SENT_223	[p12l1474t3442r1633b3510],
11	in	IN	O	in	_	0	SENT_223	[p12l1685t3446r1754b3509],
12	COM	NNP	O	COM	prep_in	10	SENT_223	[p12l1814t3445r2025b3510],
13	Tu	FW	O	tu	nn	14	SENT_223	[p12l2029t3425r2150b3509],
14	patients	NNS	O	patient	npadvmod	10	SENT_223	[p12l12t3560r292b3647],
15	(	IN	O	(	_	0	SENT_223	[p12l334t3556r591b3638],
16	-0.54	CD	NUMBER	-0.54	prep_(	10	SENT_223	[p12l334t3556r591b3638],
17	i	FW	O	i	rcmod	9	SENT_223	[p12l636t3565r692b3620],
18	0.07	CD	NUMBER	0.07	num	19	SENT_223	[p12l739t3563r898b3629],
19	VS.	NNP	O	VS.	dep	17	SENT_223	[p12l932t3584r1020b3624],
20	-0.31	CD	NUMBER	-0.31	num	19	SENT_223	[p12l1066t3563r1284b3628],
21	i	FW	O	i	dep	19	SENT_223	[p12l1338t3565r1394b3620],
22	0.06	CD	NUMBER	0.06	num	24	SENT_223	[p12l1441t3558r1599b3624],
23	pmol/min/mg	NN	O	pmol/min/mg	nn	24	SENT_223	[p12l1636t3556r2151b3648],
24	protein	NN	O	protein	nsubj	6	SENT_223	[p12l12t3682r292b3768],
25	,	,	O	,	_	0	SENT_223	[p12l12t3682r292b3768],
26	genotype	NN	O	genotype	appos	24	SENT_223	[p12l331t3700r656b3769],
27	by	IN	O	by	_	0	SENT_223	[p12l692t3677r780b3767],
28	treatment	NN	O	treatment	nn	29	SENT_223	[p12l812t3700r1160b3745],
29	interaction	NN	O	interaction	prep_by	26	SENT_223	[p12l1195t3682r1603b3755],
30	,	,	O	,	_	0	SENT_223	[p12l1195t3682r1603b3755],
31	p	NN	O	p	appos	29	SENT_223	[p12l1630t3699r1681b3769],
32	=	JJ	O	=	amod	26	SENT_223	[p12l1718t3709r1781b3732],
33	0.02	CD	NUMBER	0.02	tmod	32	SENT_223	[p12l1821t3684r2000b3755],
34	,	,	O	,	_	0	SENT_223	[p12l1821t3684r2000b3755],
35	Fig	NN	O	fig	appos	26	SENT_223	[p12l2040t3681r2151b3769],

1	4A	NN	O	4a	_	0	SENT_224	[p13l12t19r163b101],
2	)	NN	O	)	dep	1	SENT_224	[p13l12t19r163b101],
3	.	.	O	.	_	0	SENT_224	[p13l12t19r163b101],

1	The	DT	O	the	det	2	SENT_225	[p13l201t19r345b87],
2	relationship	NN	O	relationship	_	0	SENT_225	[p13l381t19r802b110],
3	between	IN	O	between	_	0	SENT_225	[p13l840t19r1133b87],
4	COMT	NN	O	comt	nn	5	SENT_225	[p13l1169t20r1452b87],
5	activity	NN	O	activity	prep_between	2	SENT_225	[p13l1477t23r1738b109],
6	at	IN	O	at	_	0	SENT_225	[p13l1770t42r1833b87],
7	baseline	NN	O	baseline	prep_at	2	SENT_225	[p13l1867t19r2149b87],

1	January	NNP	DATE	January	nsubj	33	SENT_226	[p13l7t279r246b352],
2	201	CD	DATE	201	num	1	SENT_226	[p13l274t281r382b333],
3	1	CD	DATE	1	dep	1	SENT_226	[p13l401t281r423b333],
4	and	CC	O	and	_	0	SENT_226	[p13l9t416r140b485],
5	after	IN	O	after	mark	8	SENT_226	[p13l180t416r339b484],
6	entacapone	NN	O	entacapone	nsubj	8	SENT_226	[p13l378t439r780b507],
7	was	VBD	O	be	cop	8	SENT_226	[p13l819t444r947b484],
8	linear	JJ	O	linear	nsubj	33	SENT_226	[p13l987t416r1202b494],
9	,	,	O	,	_	0	SENT_226	[p13l987t416r1202b494],
10	confirming	VBG	O	confirm	xcomp	8	SENT_226	[p13l1247t416r1648b508],
11	a	DT	O	a	det	13	SENT_226	[p13l1687t444r1723b484],
12	greater	JJR	O	greater	amod	13	SENT_226	[p13l1761t439r2003b508],
13	inhibition	NN	O	inhibition	dobj	10	SENT_226	[p13l2043t420r2141b483, p13l8t537r295b605],
14	in	IN	O	in	_	0	SENT_226	[p13l355t541r424b604],
15	subjects	NNS	O	subject	prep_in	10	SENT_226	[p13l482t536r759b628],
16	with	IN	O	with	_	0	SENT_226	[p13l816t537r977b605],
17	higher	JJR	O	higher	amod	20	SENT_226	[p13l1034t536r1263b628],
18	basal	JJ	O	basal	amod	20	SENT_226	[p13l1320t537r1493b605],
19	COMT	NN	O	comt	nn	20	SENT_226	[p13l1553t538r1836b605],
20	activity	NN	O	activity	prep_with	15	SENT_226	[p13l1885t541r2145b627],
21	(	CD	NUMBER	(	num	23	SENT_226	[p13l13t659r312b740],
22	Pearson	NNP	PERSON	Pearson	nn	23	SENT_226	[p13l13t659r312b740],
23	correlation	NN	O	correlation	dep	20	SENT_226	[p13l349t658r756b737],
24	,	,	O	,	_	0	SENT_226	[p13l349t658r756b737],
25	R2	NN	O	r2	nsubj	33	SENT_226	[p13l793t643r879b725],
26	=	JJ	O	=	amod	25	SENT_226	[p13l917t690r980b713],
27	0.75	CD	NUMBER	0.75	tmod	26	SENT_226	[p13l1019t664r1198b737],
28	,	,	O	,	_	0	SENT_226	[p13l1019t664r1198b737],
29	p	NN	O	p	dep	30	SENT_226	[p13l1224t681r1275b750],
30	<	JJR	O	<	appos	25	SENT_226	[p13l1315t674r1372b729],
31	0.001	CD	NUMBER	0.001	dep	30	SENT_226	[p13l1414t665r1640b737],
32	,	,	O	,	_	0	SENT_226	[p13l1414t665r1640b737],
33	see	VBP	O	see	_	0	SENT_226	[p13l1679t687r1779b727],
34	Fig	NN	O	fig	nn	36	SENT_226	[p13l1815t663r1927b750],
35	4B	NN	O	4b	nn	36	SENT_226	[p13l1958t659r2108b740],
36	)	NN	O	)	dobj	33	SENT_226	[p13l1958t659r2108b740],
37	.	.	O	.	_	0	SENT_226	[p13l1958t659r2108b740],

1	Effect	NN	O	effect	_	0	SENT_227	[p13l13t919r269b992],
2	of	IN	O	of	_	0	SENT_227	[p13l303t919r398b992],
3	Plasma	NN	O	plasma	nn	4	SENT_227	[p13l426t920r724b992],
4	Levels	NNS	O	level	prep_of	1	SENT_227	[p13l765t920r1030b992],
5	of	IN	O	of	_	0	SENT_227	[p13l1067t919r1163b992],
6	Entacapone	NN	O	entacapone	prep_of	4	SENT_227	[p13l1190t924r1700b1012],
7	on	IN	O	on	_	0	SENT_227	[p13l1739t945r1841b992],
8	COMT	NNP	O	COMT	nn	9	SENT_227	[p13l14t1035r298b1105],
9	Inhibition	NN	O	inhibition	prep_on	6	SENT_227	[p13l328t1032r732b1104],
10	The	DT	O	the	det	11	SENT_227	[p13l6t1149r151b1217],
11	concentration	NN	O	concentration	nsubj	20	SENT_227	[p13l193t1153r688b1217],
12	of	IN	O	of	_	0	SENT_227	[p13l729t1149r811b1217],
13	entacapone	NN	O	entacapone	prep_of	11	SENT_227	[p13l840t1172r1242b1240],
14	was	VBD	O	be	cop	20	SENT_227	[p13l1281t1177r1408b1217],
15	similar	JJ	O	similar	amod	20	SENT_227	[p13l1451t1149r1694b1217],
16	(	NN	O	(	nn	20	SENT_227	[p13l1738t1150r1802b1241],
17	p	NN	O	p	nn	20	SENT_227	[p13l1738t1150r1802b1241],
18	=	JJ	O	=	amod	20	SENT_227	[p13l1845t1181r1908b1203],
19	0.68	CD	NUMBER	0.68	num	20	SENT_227	[p13l1953t1150r2136b1231],
20	)	NN	O	)	rcmod	4	SENT_227	[p13l1953t1150r2136b1231],
21	in	IN	O	in	_	0	SENT_227	[p13l9t1275r77b1338],
22	COMIHH	NNP	O	COMIHH	prep_in	20	SENT_227	[p13l134t1254r509b1339],
23	(	CD	NUMBER	(	number	24	SENT_227	[p13l555t1272r712b1352],
24	285	CD	NUMBER	285	nn	31	SENT_227	[p13l555t1272r712b1352],
25	:	:	O	:	_	0	SENT_227	[p13l775t1279r831b1335],
26	45ng/ml	CD	NUMBER	45ng/ml	num	27	SENT_227	[p13l889t1270r1224b1362],
27	)	NN	O	)	dep	24	SENT_227	[p13l889t1270r1224b1362],
28	and	CC	O	and	_	0	SENT_227	[p13l1280t1270r1410b1340],
29	COMT	NN	O	comt	dep	24	SENT_227	[p13l1466t1254r1803b1339],
30	”	CD	NUMBER	”	num	29	SENT_227	[p13l1466t1254r1803b1339],
31	(	NN	O	(	dep	4	SENT_227	[p13l1856t1271r2017b1352],
32	322	CD	NUMBER	322	num	34	SENT_227	[p13l1856t1271r2017b1352],
33	:	:	O	:	_	0	SENT_227	[p13l2077t1279r2133b1335],
34	77ng/ml	CD	NUMBER	77ng/ml	dep	4	SENT_227	[p13l8t1392r391b1484],
35	,	,	O	,	_	0	SENT_227	[p13l8t1392r391b1484],
36	)	CD	NUMBER	)	appos	34	SENT_227	[p13l8t1392r391b1484],
37	,	,	O	,	_	0	SENT_227	[p13l8t1392r391b1484],
38	and	CC	O	and	_	0	SENT_227	[p13l446t1392r576b1461],
39	COMT	NN	O	comt	nn	40	SENT_227	[p13l627t1393r910b1460],
40	inhibition	NN	O	inhibition	prep_of	1	SENT_227	[p13l958t1392r1317b1460],
41	was	VBD	O	be	auxpass	43	SENT_227	[p13l1365t1420r1493b1460],
42	positively	RB	O	positively	advmod	43	SENT_227	[p13l1544t1392r1887b1483],
43	correlated	VBN	O	correlate	rcmod	40	SENT_227	[p13l1934t1419r2141b1460, p13l8t1513r180b1583],
44	with	IN	O	with	_	0	SENT_227	[p13l230t1513r392b1582],
45	entacapone	NN	O	entacapone	nn	46	SENT_227	[p13l446t1537r848b1605],
46	concentration	NN	O	concentration	prep_with	43	SENT_227	[p13l904t1518r1399b1582],
47	(	CD	NUMBER	(	num	48	SENT_227	[p13l1458t1499r1567b1596],
48	R2	NN	O	r2	dep	46	SENT_227	[p13l1458t1499r1567b1596],
49	=	JJ	O	=	amod	1	SENT_227	[p13l1625t1546r1687b1568],
50	0.43	CD	NUMBER	0.43	tmod	49	SENT_227	[p13l1746t1514r1924b1592],
51	,	,	O	,	_	0	SENT_227	[p13l1746t1514r1924b1592],
52	[	CD	NUMBER	[	number	53	SENT_227	[p13l1969t1536r2020b1606],
53	9	CD	NUMBER	9	num	54	SENT_227	[p13l1969t1536r2020b1606],
54	=	JJ	O	=	appos	1	SENT_227	[p13l2077t1546r2139b1568],
55	0.001	CD	NUMBER	0.001	num	56	SENT_227	[p13l9t1631r264b1711],
56	)	NN	O	)	dep	54	SENT_227	[p13l9t1631r264b1711],
57	.	.	O	.	_	0	SENT_227	[p13l9t1631r264b1711],

1	The	DT	O	the	det	2	SENT_228	[p13l305t1629r450b1698],
2	effect	NN	O	effect	nsubj	25	SENT_228	[p13l489t1629r680b1698],
3	of	IN	O	of	_	0	SENT_228	[p13l717t1629r798b1698],
4	the	DT	O	the	det	5	SENT_228	[p13l825t1630r933b1698],
5	genotype	NN	O	genotype	prep_of	2	SENT_228	[p13l971t1652r1295b1721],
6	on	IN	O	on	_	0	SENT_228	[p13l1335t1657r1425b1698],
7	COMT	NN	O	comt	nn	8	SENT_228	[p13l1464t1631r1747b1698],
8	inhibition	NN	O	inhibition	prep_on	5	SENT_228	[p13l1782t1629r2142b1698],
9	by	IN	O	by	_	0	SENT_228	[p13l8t1751r96b1841],
10	entacapone	NN	O	entacapone	prep_by	8	SENT_228	[p13l140t1774r542b1842],
11	remained	VBD	O	remain	cop	25	SENT_228	[p13l591t1751r925b1820],
12	significant	JJ	O	significant	amod	25	SENT_228	[p13l972t1751r1344b1843],
13	after	IN	O	after	_	0	SENT_228	[p13l1390t1751r1548b1819],
14	adjustment	NN	O	adjustment	prep_after	12	SENT_228	[p13l1595t1751r1996b1843],
15	for	IN	O	for	_	0	SENT_228	[p13l2042t1751r2143b1819],
16	the	DT	O	the	det	17	SENT_228	[p13l9t1865r118b1933],
17	concentration	NN	O	concentration	prep_for	14	SENT_228	[p13l176t1869r672b1933],
18	of	IN	O	of	_	0	SENT_228	[p13l729t1865r811b1933],
19	the	DT	O	the	det	22	SENT_228	[p13l857t1865r966b1933],
20	drug	NN	O	drug	nn	22	SENT_228	[p13l1023t1865r1190b1957],
21	(	NN	O	(	nn	22	SENT_228	[p13l1250t1866r1314b1957],
22	p	NN	O	p	prep_of	17	SENT_228	[p13l1250t1866r1314b1957],
23	=	JJ	O	=	amod	22	SENT_228	[p13l1374t1897r1436b1919],
24	0.02	CD	NUMBER	0.02	tmod	23	SENT_228	[p13l1498t1866r1706b1947],
25	)	NN	O	)	_	0	SENT_228	[p13l1498t1866r1706b1947],
26	.	.	O	.	_	0	SENT_228	[p13l1498t1866r1706b1947],

1	Thus	RB	O	thus	advmod	19	SENT_229	[p13l1767t1865r1972b1943],
2	,	,	O	,	_	0	SENT_229	[p13l1767t1865r1972b1943],
3	the	DT	O	the	det	4	SENT_229	[p13l2033t1865r2142b1933],
4	effect	NN	O	effect	nsubj	19	SENT_229	[p13l9t1980r200b2048],
5	of	IN	O	of	_	0	SENT_229	[p13l268t1980r348b2048],
6	the	DT	O	the	det	9	SENT_229	[p13l405t1980r514b2048],
7	COM	NN	O	com	nn	9	SENT_229	[p13l589t1983r800b2049],
8	T	NN	O	t	nn	9	SENT_229	[p13l804t1983r863b2047],
9	genotype	NN	O	genotype	prep_of	4	SENT_229	[p13l915t2003r1239b2072],
10	on	IN	O	on	_	0	SENT_229	[p13l1309t2008r1399b2048],
11	the	DT	O	the	det	12	SENT_229	[p13l1467t1980r1576b2048],
12	inhibition	NN	O	inhibition	prep_on	9	SENT_229	[p13l1644t1980r2005b2048],
13	of	IN	O	of	_	0	SENT_229	[p13l2074t1980r2154b2048],
14	COMT	NN	O	comt	nn	15	SENT_229	[p13l10t2097r292b2164],
15	activity	NN	O	activity	prep_of	12	SENT_229	[p13l333t2100r595b2186],
16	by	IN	O	by	_	0	SENT_229	[p13l643t2096r730b2186],
17	entacapone	NN	O	entacapone	prep_by	15	SENT_229	[p13l779t2119r1181b2187],
18	was	VBD	O	be	cop	19	SENT_229	[p13l1230t2124r1358b2164],
19	independent	JJ	O	independent	_	0	SENT_229	[p13l1411t2096r1861b2187],
20	of	IN	O	of	_	0	SENT_229	[p13l1913t2096r1993b2164],
21	the	DT	O	the	prep_of	19	SENT_229	[p13l2033t2096r2142b2164],

1	ANNALS	NN	O	annals	_	0	SENT_230	[p13l6t2479r369b2546],
2	of	IN	O	of	_	0	SENT_230	[p13l428t2463r534b2575],
3	Neurology	NNP	O	Neurology	prep_of	1	SENT_230	[p13l541t2463r990b2575],

1	La	NNP	O	La	_	0	SENT_231	[p14l6t534r100b1193],
2	:	:	O	:	_	0	SENT_231	[p14l6t534r100b1193],
3	D	NNP	O	D	nn	5	SENT_231	[p14l6t534r100b1193],
4	~	CD	NUMBER	~	num	5	SENT_231	[p14l6t534r100b1193],
5	AcJPA1ﬁgjmI	NN	O	acjpa1ﬁgjmi	dep	1	SENT_231	[p14l6t534r100b1193],
6	}	NN	O	}	dep	5	SENT_231	[p14l6t534r100b1193],
7	'	''	O	'	_	0	SENT_231	[p14l6t534r100b1193],
8	“	SYM	O	“	dep	1	SENT_231	[p14l8t416r19b450],

1	COMTHH	NN	O	comthh	_	0	SENT_232	[p14l1038t98r1421b179],

1	-	:	O	-	_	0	SENT_233	[p14l1404t443r1577b511],
2	E	NN	O	e	_	0	SENT_233	[p14l1404t443r1577b511],
3	-	:	O	-	_	0	SENT_233	[p14l1404t443r1577b511],
4	Pla	NN	O	plum	dep	2	SENT_233	[p14l1685t440r1993b511],
5	«	CD	PERCENT	«	number	6	SENT_233	[p14l1685t440r1993b511],
6	ce	CD	PERCENT	ce	num	7	SENT_233	[p14l1685t440r1993b511],
7	%	NN	PERCENT	%	dep	4	SENT_233	[p14l1685t440r1993b511],
8	1b0	CD	PERCENT	1b0	num	9	SENT_233	[p14l1685t440r1993b511],
9	%	NN	PERCENT	%	dep	4	SENT_233	[p14l1685t440r1993b511],

1	Entaca	NNP	O	Entaca	nsubj	2	SENT_234	[p14l1685t582r1942b649],
2	pone	NN	O	pone	_	0	SENT_234	[p14l1955t596r2153b666],
3	i	FW	O	i	dobj	2	SENT_234	[p14l1441t1315r1482b1359],
4	1	LS	NUMBER	1	dep	3	SENT_234	[p14l1546t1214r1739b1389],
5	.	.	O	.	_	0	SENT_234	[p14l1546t1214r1739b1389],

1	.	.	O	.	_	0	SENT_235	[p14l1546t1214r1739b1389],

1	Time	NNP	O	Time	_	0	SENT_236	[p14l1031t1799r1228b1867],
2	(	CD	NUMBER	(	num	1	SENT_236	[p14l1258t1796r1461b1881],
3	min	NN	DURATION	min	nn	5	SENT_236	[p14l1258t1796r1461b1881],
4	)	CD	NUMBER	)	num	5	SENT_236	[p14l1258t1796r1461b1881],
5	COM	NNP	O	COM	dep	1	SENT_236	[p14l1038t1955r1401b2036, p14l1255t3023r1336b3115],
6	?	.	O	?	_	0	SENT_236	[p14l1038t1955r1401b2036, p14l1255t3023r1336b3115],

1	“	NN	O	“	nn	2	SENT_237	[p14l1038t1955r1401b2036, p14l1255t3023r1336b3115],
2	A	NN	O	a	_	0	SENT_237	[p14l1038t1955r1401b2036, p14l1255t3023r1336b3115],

1	Q	NNP	O	Q	nn	2	SENT_238	[p14l1422t3054r1509b3161],
2	E	NNP	O	E	_	0	SENT_238	[p14l1526t3142r1560b3169],

1	Wu	NNP	O	Wu	nn	2	SENT_239	[p14l1553t3162r1614b3213],
2	lP	NNP	O	lP	dep	3	SENT_239	[p14l1651t2242r1959b2314],
3	‘	VBD	O	‘	_	0	SENT_239	[p14l1651t2242r1959b2314],
4	|	CD	NUMBER	|	dobj	3	SENT_239	[p14l1651t2242r1959b2314],
5	a	DT	O	a	det	7	SENT_239	[p14l1651t2242r1959b2314],
6	£	NN	O	£	nn	7	SENT_239	[p14l1651t2242r1959b2314],
7	EbD	NN	O	ebd	nsubj	3	SENT_239	[p14l1651t2242r1959b2314],

1	-	:	O	-	_	0	SENT_240	[p14l1404t2378r1526b2449],
2	O	NN	O	o	_	0	SENT_240	[p14l1404t2378r1526b2449],
3	-	:	O	-	_	0	SENT_240	[p14l1546t2408r1577b2419],
4	Entacapone	NNP	O	Entacapone	nn	5	SENT_240	[p14l1644t2382r2111b2466],
5	i.	NNP	O	i.	dep	2	SENT_240	[p14l1546t3203r1763b3276],
6	.	.	O	.	_	0	SENT_240	[p14l1546t3203r1763b3276],

1	T	NN	O	t	_	0	SENT_241	[p14l1546t3203r1763b3276],

1	T	NN	O	t	nn	2	SENT_242	[p14l473t3451r480b3453],
2	o	NN	O	o	_	0	SENT_242	[p14l533t3497r580b3565],
3	20	CD	PERCENT	20	number	4	SENT_242	[p14l692t3497r784b3565],
4	40	CD	PERCENT	40	dep	2	SENT_242	[p14l831t3460r966b3565],
5	60 90 120130	CD	PERCENT	60 90 120130	num	7	SENT_242	[p14l1393t3463r1715b3565],[p14l1052t3497r1147b3565],
6	240	CD	PERCENT	240	num	7	SENT_242	[p14l1752t3443r1918b3565],
7	%	NN	PERCENT	%	dep	4	SENT_242	[p14l1752t3443r1918b3565],

1	Time	NNP	O	Time	_	0	SENT_243	[p14l973t3605r1171b3673],
2	(	CD	NUMBER	(	num	4	SENT_243	[p14l1201t3602r1404b3690],
3	min	NN	DURATION	min	nn	4	SENT_243	[p14l1201t3602r1404b3690],
4	)	NN	O	)	dep	1	SENT_243	[p14l1201t3602r1404b3690],

1	FIGURE	NN	O	figure	_	0	SENT_244	[p15l11t39r272b95],
2	3	CD	NUMBER	3	num	1	SENT_244	[p15l364t39r423b94],
3	:	:	O	:	_	0	SENT_244	[p15l364t39r423b94],
4	Pharmacokinetics	NNS	O	pharmacokinetic	dep	1	SENT_244	[p15l471t36r1074b94],
5	of	IN	O	of	_	0	SENT_244	[p15l1164t36r1235b94],
6	L-dopa	NN	O	l-dopa	prep_of	4	SENT_244	[p15l1325t36r1580b110],
7	.	.	O	.	_	0	SENT_244	[p15l1325t36r1580b110],

1	Plasma	NN	O	plasma	nn	2	SENT_245	[p15l1675t36r1912b94],
2	concentrations	NNS	O	concentration	_	0	SENT_245	[p15l2004t56r2148b94, p15l9t133r395b187],
3	of	IN	O	of	_	0	SENT_245	[p15l438t128r509b187],
4	L-dopa	NN	MISC	l-dopa	prep_of	2	SENT_245	[p15l551t129r785b204],
5	versus	CC	O	versus	prep	2	SENT_245	[p15l827t149r1046b187],
6	time	NN	O	time	dep	5	SENT_245	[p15l1086t133r1240b187],
7	in	IN	O	in	_	0	SENT_245	[p15l1284t133r1339b187],
8	COMTHH	JJ	O	comthh	amod	9	SENT_245	[p15l1388t117r1693b188],
9	patients	NNS	O	patient	prep_in	2	SENT_245	[p15l1734t133r2012b204],
10	(	IN	O	(	_	0	SENT_245	[p15l2055t132r2146b198],
11	A	DT	O	a	det	12	SENT_245	[p15l2055t132r2146b198],
12	)	NN	O	)	prep_(	9	SENT_245	[p15l2055t132r2146b198],
13	and	CC	O	and	_	0	SENT_245	[p15l8t223r132b282],
14	COMT	NN	O	comt	conj_and	12	SENT_245	[p15l191t211r470b282],
15	"	''	O	"	punct	9	SENT_245	[p15l191t211r470b282],
16	"	``	O	"	punct	17	SENT_245	[p15l191t211r470b282],
17	patients	NNS	O	patient	dep	9	SENT_245	[p15l522t227r800b298],
18	(	CD	NUMBER	(	num	20	SENT_245	[p15l853t226r939b292],
19	B	NN	O	b	nn	20	SENT_245	[p15l853t226r939b292],
20	)	NN	O	)	dep	17	SENT_245	[p15l853t226r939b292],
21	after	IN	O	after	_	0	SENT_245	[p15l992t223r1158b282],
22	L-dopa	NN	O	l-dopa	prep_after	20	SENT_245	[p15l1211t223r1445b298],
23	+	CC	O	+	_	0	SENT_245	[p15l1505t235r1551b281],
24	placebo	NN	O	placebo	dep	17	SENT_245	[p15l1612t223r1883b298],
25	(	CD	NUMBER	(	num	27	SENT_245	[p15l1940t223r2150b292],
26	white	JJ	O	white	amod	27	SENT_245	[p15l1940t223r2150b292],
27	squares	NNS	O	square	dep	24	SENT_245	[p15l8t336r295b391],
28	,	,	O	,	_	0	SENT_245	[p15l8t336r295b391],
29	solid	JJ	O	solid	amod	31	SENT_245	[p15l332t317r498b374],
30	line	NN	O	line	nn	31	SENT_245	[p15l531t317r674b385],
31	)	NN	O	)	dep	17	SENT_245	[p15l531t317r674b385],
32	or	CC	O	or	_	0	SENT_245	[p15l707t336r779b374],
33	L-dopa	NN	O	l-dopa	dep	17	SENT_245	[p15l816t317r1050b391],
34	+	CC	O	+	_	0	SENT_245	[p15l1093t328r1140b374],
35	entacapone	NN	O	entacapone	dep	9	SENT_245	[p15l1182t327r1587b391],
36	(	CD	NUMBER	(	num	38	SENT_245	[p15l1627t317r1831b385],
37	black	JJ	O	black	amod	38	SENT_245	[p15l1627t317r1831b385],
38	squares	NNS	O	square	dep	35	SENT_245	[p15l1861t336r2147b391],
39	,	,	O	,	_	0	SENT_245	[p15l1861t336r2147b391],
40	dotted	VBN	O	dot	amod	42	SENT_245	[p15l11t410r250b468],
41	line	NN	O	line	nn	42	SENT_245	[p15l296t410r455b479],
42	)	NN	O	)	appos	17	SENT_245	[p15l296t410r455b479],
43	.	.	O	.	_	0	SENT_245	[p15l296t410r455b479],

1	Analysis	NN	O	analysis	_	0	SENT_246	[p15l505t410r785b486],
2	of	IN	O	of	_	0	SENT_246	[p15l835t409r906b468],
3	variance	NN	O	variance	prep_of	1	SENT_246	[p15l949t413r1237b468],
4	for	IN	O	for	_	0	SENT_246	[p15l1285t409r1386b468],
5	repeated	VBN	O	repeat	amod	6	SENT_246	[p15l1435t410r1748b485],
6	measures	NNS	O	measure	prep_for	3	SENT_246	[p15l1801t430r2145b468],
7	:	:	O	:	_	0	SENT_246	[p15l1801t430r2145b468],
8	F12	NN	O	f12	nn	9	SENT_246	[p15l11t508r163b581],
9	,5	NN	O	,5	dep	3	SENT_246	[p15l11t508r163b581],
10	=	JJ	O	=	quantmod	11	SENT_246	[p15l199t527r246b550],
11	53.3	CD	NUMBER	53.3	dep	9	SENT_246	[p15l283t507r453b571],
12	,	,	O	,	_	0	SENT_246	[p15l283t507r453b571],
13	p	NN	O	p	appos	3	SENT_246	[p15l485t524r530b579],
14	=	JJ	O	=	amod	13	SENT_246	[p15l563t527r610b550],
15	0.0002	CD	NUMBER	0.0002	tmod	14	SENT_246	[p15l647t507r884b563],
16	for	IN	O	for	_	0	SENT_246	[p15l914t503r1016b563],
17	the	DT	O	the	det	18	SENT_246	[p15l1042t504r1154b563],
18	effect	NN	O	effect	prep_for	14	SENT_246	[p15l1185t503r1385b563],
19	of	IN	O	of	_	0	SENT_246	[p15l1414t503r1485b563],
20	entacapone	NN	O	entacapone	prep_of	18	SENT_246	[p15l1513t514r1917b579],
21	in	IN	O	in	_	0	SENT_246	[p15l1950t507r2004b562],
22	the	DT	O	the	det	24	SENT_246	[p15l2035t504r2147b563],
23	COMTHH	NNP	O	COMTHH	nn	24	SENT_246	[p15l12t586r317b657],
24	group	NN	O	group	prep_in	20	SENT_246	[p15l359t618r585b673],
25	;	:	O	;	_	0	SENT_246	[p15l359t618r585b673],
26	F12	NN	O	f12	nn	27	SENT_246	[p15l635t602r788b674],
27	,4	NN	O	,4	dep	3	SENT_246	[p15l635t602r788b674],
28	=	JJ	O	=	amod	27	SENT_246	[p15l838t621r884b644],
29	10.5	CD	NUMBER	10.5	tmod	28	SENT_246	[p15l938t601r1106b665],
30	,	,	O	,	_	0	SENT_246	[p15l938t601r1106b665],
31	p	NN	O	p	appos	3	SENT_246	[p15l1153t618r1197b673],
32	=	JJ	O	=	amod	31	SENT_246	[p15l1246t621r1292b644],
33	0.02	CD	NUMBER	0.02	tmod	32	SENT_246	[p15l1343t601r1491b656],
34	for	IN	O	for	_	0	SENT_246	[p15l1536t597r1637b656],
35	the	DT	O	the	det	36	SENT_246	[p15l1678t598r1790b656],
36	effect	NN	O	effect	prep_for	1	SENT_246	[p15l1836t597r2035b656],
37	of	IN	O	of	_	0	SENT_246	[p15l2080t597r2151b656],
38	entacapone	NN	O	entacapone	prep_of	1	SENT_246	[p15l9t702r414b767],
39	in	IN	O	in	_	0	SENT_246	[p15l449t695r504b750],
40	the	DT	O	the	det	41	SENT_246	[p15l537t692r649b750],
41	COMT	NNP	MISC	COMT	prep_in	38	SENT_246	[p15l686t680r965b751],
42	"	``	O	"	punct	38	SENT_246	[p15l686t680r965b751],
43	"	``	O	"	punct	44	SENT_246	[p15l686t680r965b751],
44	group	NN	O	group	dep	38	SENT_246	[p15l997t712r1224b767],
45	;	:	O	;	_	0	SENT_246	[p15l997t712r1224b767],
46	F1	NN	O	f1	nn	47	SENT_246	[p15l1262t696r1404b769],
47	,31	NN	O	,31	dep	38	SENT_246	[p15l1262t696r1404b769],
48	=	JJ	O	=	amod	47	SENT_246	[p15l1452t714r1499b738],
49	4.5	CD	NUMBER	4.5	tmod	48	SENT_246	[p15l1538t696r1664b759],
50	,	,	O	,	_	0	SENT_246	[p15l1538t696r1664b759],
51	p	NN	O	p	appos	38	SENT_246	[p15l1699t712r1744b767],
52	=	JJ	O	=	amod	51	SENT_246	[p15l1781t714r1827b738],
53	0.04	CD	NUMBER	0.04	tmod	52	SENT_246	[p15l1867t695r2017b750],
54	for	IN	O	for	_	0	SENT_246	[p15l2048t691r2149b750],
55	genotype/treatment	JJ	O	genotype/treatment	amod	56	SENT_246	[p15l9t786r721b862],
56	interaction	NN	O	interaction	prep_for	1	SENT_246	[p15l751t789r1141b844],
57	.	.	O	.	_	0	SENT_246	[p15l751t789r1141b844],

1	plasma	NN	O	plasma	nn	2	SENT_247	[p15l8t1031r259b1123],
2	concentration	NN	O	concentration	_	0	SENT_247	[p15l304t1036r801b1100],
3	of	IN	O	of	_	0	SENT_247	[p15l847t1031r929b1100],
4	the	DT	O	the	det	5	SENT_247	[p15l963t1031r1072b1100],
5	drug	NN	O	drug	prep_of	2	SENT_247	[p15l1119t1031r1302b1124],
6	.	.	O	.	_	0	SENT_247	[p15l1119t1031r1302b1124],

1	It	PRP	O	it	nsubj	3	SENT_248	[p15l1354t1036r1408b1100],
2	is	VBZ	O	be	cop	3	SENT_248	[p15l1453t1036r1502b1100],
3	noteworthy	JJ	O	noteworthy	_	0	SENT_248	[p15l1550t1031r1966b1122],
4	that	IN	O	that	complm	12	SENT_248	[p15l2009t1031r2149b1100],
5	entacapone	NN	O	entacapone	nsubj	12	SENT_248	[p15l9t1166r432b1233],
6	,	,	O	,	_	0	SENT_248	[p15l9t1166r432b1233],
7	at	IN	O	at	_	0	SENT_248	[p15l497t1165r561b1211],
8	baseline	NN	O	baseline	prep_at	5	SENT_248	[p15l619t1142r921b1221],
9	,	,	O	,	_	0	SENT_248	[p15l619t1142r921b1221],
10	was	VBD	O	be	cop	12	SENT_248	[p15l983t1171r1111b1211],
11	not	RB	O	not	neg	12	SENT_248	[p15l1172t1165r1292b1211],
12	detectable	JJ	O	detectable	ccomp	3	SENT_248	[p15l1352t1142r1710b1212],
13	in	IN	O	in	_	0	SENT_248	[p15l1771t1147r1840b1210],
14	plasma	NN	O	plasma	nn	15	SENT_248	[p15l1898t1142r2150b1233],
15	(	NN	O	(	prep_in	12	SENT_248	[p15l13t1253r149b1335],
16	<	JJR	O	<	amod	18	SENT_248	[p15l13t1253r149b1335],
17	5	CD	NUMBER	5	num	18	SENT_248	[p15l13t1253r149b1335],
18	ng/ml	NN	O	ng/ml	nsubj	24	SENT_248	[p15l197t1252r435b1345],
19	)	CD	NUMBER	)	npadvmod	20	SENT_248	[p15l197t1252r435b1345],
20	even	RB	O	even	advmod	18	SENT_248	[p15l484t1279r643b1321],
21	in	IN	O	in	_	0	SENT_248	[p15l685t1257r754b1320],
22	patients	NNS	O	patient	prep_in	18	SENT_248	[p15l795t1257r1074b1344],
23	currently	RB	DATE	currently	advmod	24	SENT_248	[p15l1118t1252r1444b1343],
24	treated	VBN	O	treat	rcmod	15	SENT_248	[p15l1483t1252r1728b1322],
25	with	IN	O	with	_	0	SENT_248	[p15l1765t1252r1928b1321],
26	entacapone	NN	O	entacapone	prep_with	24	SENT_248	[p15l1969t1276r2146b1321, p15l9t1390r278b1455],
27	.	.	O	.	_	0	SENT_248	[p15l1969t1276r2146b1321, p15l9t1390r278b1455],

1	When	WRB	O	when	advmod	51	SENT_249	[p15l327t1363r551b1432],
2	adjusted	VBN	O	adjust	partmod	51	SENT_249	[p15l598t1363r895b1456],
3	for	IN	O	for	_	0	SENT_249	[p15l941t1363r1044b1432],
4	chronic	JJ	O	chronic	amod	6	SENT_249	[p15l1090t1363r1360b1432],
5	entacapone	NN	O	entacapone	nn	6	SENT_249	[p15l1406t1387r1809b1455],
6	use	NN	O	use	prep_for	2	SENT_249	[p15l1857t1392r1988b1442],
7	,	,	O	,	_	0	SENT_249	[p15l1857t1392r1988b1442],
8	the	DT	O	the	det	9	SENT_249	[p15l2039t1363r2148b1432],
9	interaction	NN	O	interaction	nsubj	51	SENT_249	[p15l9t1490r399b1554],
10	between	IN	O	between	_	0	SENT_249	[p15l462t1485r755b1554],
11	genotype	NN	O	genotype	prep_between	9	SENT_249	[p15l818t1509r1143b1578],
12	and	CC	O	and	_	0	SENT_249	[p15l1206t1485r1338b1555],
13	treatment	NN	O	treatment	conj_and	11	SENT_249	[p15l1400t1509r1750b1554],
14	remained	VBD	O	remain	cop	51	SENT_249	[p15l1812t1485r2149b1555],
15	signiﬁcant	JJ	O	signiﬁcant	dep	21	SENT_249	[p15l8t1596r382b1689],
16	for	IN	O	for	_	0	SENT_249	[p15l427t1596r529b1665],
17	the	DT	O	the	det	18	SENT_249	[p15l575t1596r684b1665],
18	motor	NN	O	motor	prep_for	15	SENT_249	[p15l732t1620r956b1665],
19	response	NN	O	response	dep	21	SENT_249	[p15l1002t1623r1307b1688],
20	(	CD	NUMBER	(	num	19	SENT_249	[p15l1360t1596r1526b1679],
21	best	JJS	O	best	dep	51	SENT_249	[p15l1360t1596r1526b1679],
22	ON	IN	O	on	_	0	SENT_249	[p15l1573t1599r1714b1665],
23	time	NN	O	time	prep_on	21	SENT_249	[p15l1763t1601r1943b1675],
24	,	,	O	,	_	0	SENT_249	[p15l1763t1601r1943b1675],
25	p	NN	O	p	appos	23	SENT_249	[p15l1981t1619r2032b1689],
26	=	JJ	O	=	amod	28	SENT_249	[p15l2082t1629r2145b1651],
27	0.04	CD	NUMBER	0.04	tmod	26	SENT_249	[p15l9t1708r219b1790],
28	)	NN	O	)	dep	25	SENT_249	[p15l9t1708r219b1790],
29	,	,	O	,	_	0	SENT_249	[p15l9t1708r219b1790],
30	the	DT	O	the	det	31	SENT_249	[p15l265t1707r375b1776],
31	AUC	NN	O	auc	appos	23	SENT_249	[p15l412t1710r607b1776],
32	of	IN	O	of	_	0	SENT_249	[p15l650t1707r730b1776],
33	L-dopa	NN	O	l-dopa	nn	35	SENT_249	[p15l761t1707r1021b1799],
34	(	CD	NUMBER	(	num	35	SENT_249	[p15l1066t1708r1130b1800],
35	p	NN	O	p	prep_of	31	SENT_249	[p15l1066t1708r1130b1800],
36	=	JJ	O	=	amod	35	SENT_249	[p15l1174t1740r1237b1763],
37	0.03	CD	NUMBER	0.03	num	38	SENT_249	[p15l1283t1708r1493b1790],
38	)	NN	O	)	tmod	36	SENT_249	[p15l1283t1708r1493b1790],
39	,	,	O	,	_	0	SENT_249	[p15l1283t1708r1493b1790],
40	and	CC	O	and	_	0	SENT_249	[p15l1539t1707r1670b1777],
41	the	DT	O	the	det	43	SENT_249	[p15l1712t1707r1821b1776],
42	COM	NN	O	com	nn	43	SENT_249	[p15l1865t1711r2084b1776],
43	activi	NN	O	activus	tmod	36	SENT_249	[p15l9t1834r197b1898],
44	=	JJ	O	=	amod	31	SENT_249	[p15l408t1862r471b1885],
45	0.02	CD	NUMBER	0.02	tmod	44	SENT_249	[p15l510t1836r667b1898],
46	,	,	O	,	_	0	SENT_249	[p15l706t1885r719b1908],
47	su	FW	O	su	nn	48	SENT_249	[p15l758t1858r833b1899],
48	estin	FW	O	estin	appos	31	SENT_249	[p15l922t1834r1087b1898],
49	that	WDT	O	that	dep	51	SENT_249	[p15l1164t1829r1305b1898],
50	chronic	JJ	O	chronic	amod	51	SENT_249	[p15l1338t1829r1609b1898],
51	use	NN	O	use	_	0	SENT_249	[p15l1643t1858r1754b1899],
52	of	IN	O	of	_	0	SENT_249	[p15l1789t1829r1870b1898],
53	entacagg	NN	O	entacagg	prep_of	51	SENT_249	[p15l1893t1853r2146b1898, p15l836t1858r920b1922],

1	8	CD	NUMBER	8	_	0	SENT_250	[p15l1090t1858r1131b1922],

1	one	PRP	NUMBER	one	nsubj	2	SENT_251	[p15l57t1967r184b2009],
2	has	VBZ	O	have	_	0	SENT_251	[p15l219t1940r331b2009],
3	little	JJ	O	little	amod	4	SENT_251	[p15l367t1940r529b2009],
4	effect	NN	O	effect	dobj	2	SENT_251	[p15l565t1940r756b2009],
5	on	IN	O	on	_	0	SENT_251	[p15l791t1967r881b2009],
6	this	DT	O	this	det	7	SENT_251	[p15l917t1940r1043b2009],
7	interaction	NN	O	interaction	prep_on	4	SENT_251	[p15l1079t1945r1488b2009],
8	.	.	O	.	_	0	SENT_251	[p15l1079t1945r1488b2009],

1	P	NN	O	p	_	0	SENT_252	[p15l8t1967r50b2031],

1	Adverse	JJ	O	adverse	amod	2	SENT_253	[p15l6t2160r367b2232],
2	Events	NNS	O	event	nsubj	9	SENT_253	[p15l406t2164r693b2232],
3	No	DT	O	no	dep	4	SENT_253	[p15l7t2280r120b2345],
4	serious	JJ	O	serious	dep	2	SENT_253	[p15l166t2281r408b2346],
5	or	CC	O	or	_	0	SENT_253	[p15l454t2304r527b2345],
6	unexpected	JJ	O	unexpected	amod	8	SENT_253	[p15l571t2276r976b2368],
7	adverse	JJ	O	adverse	amod	8	SENT_253	[p15l1020t2276r1278b2346],
8	event	NN	O	event	dep	2	SENT_253	[p15l1322t2300r1511b2345],
9	occurred	VBD	O	occur	_	0	SENT_253	[p15l1554t2276r1866b2346],
10	during	IN	O	during	_	0	SENT_253	[p15l1909t2276r2150b2369],
11	the	DT	O	the	det	13	SENT_253	[p15l9t2398r118b2466],
12	L-dopa	NN	MISC	l-dopa	nn	13	SENT_253	[p15l172t2398r432b2490],
13	challenges	NNS	O	challenge	prep_during	9	SENT_253	[p15l483t2398r863b2491],
14	.	.	O	.	_	0	SENT_253	[p15l483t2398r863b2491],

1	Four	CD	NUMBER	four	num	2	SENT_254	[p15l923t2402r1093b2467],
2	patients	NNS	O	patient	nsubj	3	SENT_254	[p15l1143t2403r1423b2490],
3	experienced	VBD	O	experience	_	0	SENT_254	[p15l1478t2398r1901b2490],
4	dizziness	NN	O	dizziness	dobj	3	SENT_254	[p15l1954t2398r2146b2467, p15l11t2913r152b2954],

1	(	NN	O	(	nn	3	SENT_255	[p15l211t2886r276b2967],
2	3	CD	NUMBER	3	num	3	SENT_255	[p15l211t2886r276b2967],
3	placebo	NN	O	placebo	nsubj	12	SENT_255	[p15l332t2885r625b2976],
4	,	,	O	,	_	0	SENT_255	[p15l332t2885r625b2976],
5	1	CD	NUMBER	1	num	7	SENT_255	[p15l691t2892r716b2953],
6	entacapone	NN	O	entacapone	nn	7	SENT_255	[p15l779t2886r1232b2976],
7	)	NN	O	)	conj_and	3	SENT_255	[p15l779t2886r1232b2976],
8	,	,	O	,	_	0	SENT_255	[p15l779t2886r1232b2976],
9	and	CC	O	and	_	0	SENT_255	[p15l1290t2885r1421b2955],
10	2	CD	NUMBER	2	num	11	SENT_255	[p15l1474t2892r1515b2953],
11	patients	NNS	O	patient	nsubj	12	SENT_255	[p15l1568t2890r1848b2976],
12	experienced	VBD	O	experience	_	0	SENT_255	[p15l1903t2890r2145b2976, p15l11t2983r216b3053],
13	headache	NN	O	headache	nsubj	16	SENT_255	[p15l267t2983r595b3053],
14	(	CD	NUMBER	(	num	16	SENT_255	[p15l654t2983r1001b3075],
15	placebo	NN	O	placebo	nn	16	SENT_255	[p15l654t2983r1001b3075],
16	)	NN	O	)	xcomp	12	SENT_255	[p15l654t2983r1001b3075],
17	.	.	O	.	_	0	SENT_255	[p15l654t2983r1001b3075],

1	In	IN	O	in	_	0	SENT_256	[p15l1060t2988r1135b3051],
2	accordance	NN	O	accordance	nsubj	7	SENT_256	[p15l1187t2983r1581b3053],
3	with	IN	O	with	_	0	SENT_256	[p15l1631t2983r1793b3052],
4	previous	JJ	O	previous	amod	6	SENT_256	[p15l1845t2988r2145b3075],
5	epidemiological	JJ	O	epidemiological	amod	6	SENT_256	[p15l11t3082r581b3176],
6	studies	NNS	O	study	prep_with	2	SENT_256	[p15l621t3083r862b3152],
7	suggesting	VBG	O	suggest	prepc_in	23	SENT_256	[p15l903t3088r1276b3176],
8	that	IN	O	that	complm	14	SENT_256	[p15l1314t3083r1453b3151],
9	the	DT	O	the	det	12	SENT_256	[p15l1492t3083r1600b3151],
10	COM	NN	O	com	nn	12	SENT_256	[p15l1647t3086r1859b3152],
11	T	NN	O	t	nn	12	SENT_256	[p15l1862t3085r1922b3151],
12	genotype	NN	O	genotype	nsubj	14	SENT_256	[p15l1946t3110r2145b3176, p15l11t3228r161b3296],
13	might	MD	O	might	aux	14	SENT_256	[p15l201t3205r416b3297],
14	inﬂuence	VB	O	inﬂuence	ccomp	7	SENT_256	[p15l454t3205r783b3274],
15	dyskinesia	NN	O	dyskinesium	dobj	14	SENT_256	[p15l823t3190r1278b3296],
16	,18	CD	NUMBER	,18	num	15	SENT_256	[p15l823t3190r1278b3296],
17	the	DT	O	the	det	18	SENT_256	[p15l1321t3205r1430b3273],
18	peak	NN	O	peak	nsubj	23	SENT_256	[p15l1469t3205r1638b3296],
19	of	IN	O	of	_	0	SENT_256	[p15l1674t3205r1755b3273],
20	dyskinesia	NN	O	dyskinesium	nn	21	SENT_256	[p15l1783t3205r2148b3296],
21	score	NN	NUMBER	score	prep_of	18	SENT_256	[p15l10t3353r188b3393],
22	was	VBD	O	be	cop	23	SENT_256	[p15l224t3354r353b3394],
23	higher	JJR	O	higher	_	0	SENT_256	[p15l392t3325r620b3417],
24	in	IN	O	in	_	0	SENT_256	[p15l659t3330r728b3392],
25	COM	NNP	O	COM	nn	26	SENT_256	[p15l774t3329r985b3394],
26	TLL	NN	O	tll	prep_in	23	SENT_256	[p15l989t3309r1110b3392],
27	than	IN	O	than	mark	32	SENT_256	[p15l1149t3325r1308b3393],
28	in	IN	O	in	_	0	SENT_256	[p15l1347t3330r1416b3392],
29	COM	NNP	O	COM	prep_in	32	SENT_256	[p15l1462t3329r1673b3394],
30	THH	NN	O	thh	nn	31	SENT_256	[p15l1677t3309r1837b3392],
31	patients	NNS	O	patient	nsubj	32	SENT_256	[p15l1866t3330r2146b3417],
32	(	VBP	O	(	advcl	23	SENT_256	[p15l15t3446r152b3528],
33	1.6	CD	NUMBER	1.6	dobj	32	SENT_256	[p15l15t3446r152b3528],
34	vs	CC	O	vs	_	0	SENT_256	[p15l191t3473r259b3514],
35	1.0	CD	NUMBER	1.0	dobj	32	SENT_256	[p15l308t3452r433b3523],
36	,	,	O	,	_	0	SENT_256	[p15l308t3452r433b3523],
37	p	NN	O	p	appos	35	SENT_256	[p15l463t3468r515b3538],
38	=	JJ	O	=	amod	40	SENT_256	[p15l556t3477r619b3500],
39	0.05	CD	NUMBER	0.05	tmod	38	SENT_256	[p15l663t3446r870b3528],
40	)	NN	O	)	dep	37	SENT_256	[p15l663t3446r870b3528],
41	.	.	O	.	_	0	SENT_256	[p15l663t3446r870b3528],

1	The	DT	O	the	det	2	SENT_257	[p15l913t3445r1057b3513],
2	peak	NN	O	peak	nsubj	6	SENT_257	[p15l1096t3445r1265b3537],
3	of	IN	O	of	_	0	SENT_257	[p15l1301t3444r1382b3513],
4	dyskinesia	NN	O	dyskinesium	nn	5	SENT_257	[p15l1410t3445r1775b3536],
5	score	NN	NUMBER	score	prep_of	2	SENT_257	[p15l1813t3472r1991b3513],
6	did	VBD	O	do	_	0	SENT_257	[p15l2031t3445r2148b3514],
7	not	RB	O	not	neg	9	SENT_257	[p16l11t44r131b90],
8	signiﬁcantly	JJ	O	signiﬁcantly	amod	9	SENT_257	[p16l176t21r613b113],
9	change	NN	O	change	dobj	6	SENT_257	[p16l656t21r903b113],
10	after	IN	O	after	_	0	SENT_257	[p16l949t21r1108b90],
11	entacapone	NN	O	entacapone	prep_after	6	SENT_257	[p16l1153t44r1575b112],
12	;	:	O	;	_	0	SENT_257	[p16l1153t44r1575b112],
13	the	DT	O	the	det	14	SENT_257	[p16l1627t21r1735b90],
14	mean	NN	O	mean	nsubj	15	SENT_257	[p16l1781t49r1975b90],
15	was	VBD	O	be	parataxis	6	SENT_257	[p16l2018t50r2146b90],
16	slightly	RB	O	slightly	advmod	17	SENT_257	[p16l10t141r271b233],
17	higher	JJR	O	higher	advmod	15	SENT_257	[p16l305t141r533b233],
18	in	IN	O	in	_	0	SENT_257	[p16l571t146r640b208],
19	the	DT	O	the	det	22	SENT_257	[p16l678t141r787b209],
20	COM	NNP	O	COM	nn	22	SENT_257	[p16l832t145r1043b210],
21	THH	NN	O	thh	nn	22	SENT_257	[p16l1047t125r1207b208],
22	group	NN	O	group	prep_in	17	SENT_257	[p16l1236t168r1445b233],
23	(	CD	NUMBER	(	num	24	SENT_257	[p16l1489t142r1626b224],
24	1.0	CD	NUMBER	1.0	dep	29	SENT_257	[p16l1489t142r1626b224],
25	i	FW	O	i	dep	24	SENT_257	[p16l1675t150r1731b206],
26	0.7	CD	NUMBER	0.7	number	27	SENT_257	[p16l1779t148r1891b214],
27	VS	NN	O	v	amod	25	SENT_257	[p16l1926t170r1994b210],
28	1.2	CD	NUMBER	1.2	dep	29	SENT_257	[p16l2042t148r2145b209],
29	i	FW	O	i	dep	44	SENT_257	[p16l19t269r75b325],
30	0.7	CD	NUMBER	0.7	dep	29	SENT_257	[p16l123t267r255b339],
31	,	,	O	,	_	0	SENT_257	[p16l123t267r255b339],
32	p	NN	O	p	appos	30	SENT_257	[p16l283t283r334b353],
33	=	JJ	O	=	amod	42	SENT_257	[p16l373t293r436b315],
34	0.07	CD	NUMBER	0.07	num	35	SENT_257	[p16l478t262r661b343],
35	)	NN	O	)	nn	42	SENT_257	[p16l478t262r661b343],
36	but	CC	O	but	_	0	SENT_257	[p16l704t261r825b330],
37	totally	RB	O	totally	advmod	38	SENT_257	[p16l861t260r1089b351],
38	unchanged	JJ	O	unchanged	conj_but	35	SENT_257	[p16l1123t260r1515b353],
39	in	IN	O	in	_	0	SENT_257	[p16l1552t265r1621b328],
40	the	DT	O	the	det	41	SENT_257	[p16l1658t260r1767b329],
41	COM	NNP	O	COM	prep_in	38	SENT_257	[p16l1812t264r2022b329],
42	TH	NN	O	th	dep	32	SENT_257	[p16l2026t244r2148b328],
43	‘	CD	NUMBER	‘	num	44	SENT_257	[p16l2026t244r2148b328],
44	group	NN	O	group	dep	48	SENT_257	[p16l10t408r219b473],
45	(	CD	NUMBER	(	number	46	SENT_257	[p16l266t382r403b463],
46	1.6	CD	NUMBER	1.6	dep	44	SENT_257	[p16l266t382r403b463],
47	i	FW	O	i	dep	46	SENT_257	[p16l453t390r509b445],
48	0.7	CD	NUMBER	0.7	dep	49	SENT_257	[p16l559t388r671b454],
49	VS	NN	O	v	dep	51	SENT_257	[p16l708t409r776b449],
50	1.6	CD	NUMBER	1.6	num	49	SENT_257	[p16l825t383r929b449],
51	i	FW	O	i	dep	15	SENT_257	[p16l978t390r1034b445],
52	0.7	CD	NUMBER	0.7	dep	51	SENT_257	[p16l1085t388r1217b459],
53	,	,	O	,	_	0	SENT_257	[p16l1085t388r1217b459],
54	p	NN	O	p	appos	52	SENT_257	[p16l1247t403r1298b473],
55	=	JJ	O	=	amod	57	SENT_257	[p16l1340t413r1402b435],
56	0.59	CD	NUMBER	0.59	tmod	55	SENT_257	[p16l1446t382r1654b463],
57	)	NN	O	)	dep	54	SENT_257	[p16l1446t382r1654b463],
58	.	.	O	.	_	0	SENT_257	[p16l1446t382r1654b463],

1	This	DT	O	this	nsubj	3	SENT_258	[p16l1697t381r1858b449],
2	is	VBZ	O	be	cop	3	SENT_258	[p16l1899t385r1948b449],
3	consistent	JJ	O	consistent	_	0	SENT_258	[p16l1989t408r2145b449, p16l10t506r236b569],
4	With	IN	O	with	_	0	SENT_258	[p16l270t501r432b570],
5	the	DT	O	the	det	7	SENT_258	[p16l470t501r579b569],
6	greater	JJR	O	greater	amod	7	SENT_258	[p16l616t524r859b593],
7	response	NN	O	response	prep_with	3	SENT_258	[p16l897t528r1201b593],
8	of	IN	O	of	_	0	SENT_258	[p16l1240t501r1322b569],
9	COM	NNP	O	COM	nn	11	SENT_258	[p16l1354t505r1565b570],
10	THH	NN	O	thh	nn	11	SENT_258	[p16l1569t485r1730b568],
11	patients	NNS	O	patient	prep_of	7	SENT_258	[p16l1758t506r2037b593],
12	to	TO	O	to	_	0	SENT_258	[p16l2077t524r2145b569],
13	entacapone	NN	O	entacapone	prep_to	3	SENT_258	[p16l11t623r433b692],
14	.	.	O	.	_	0	SENT_258	[p16l11t623r433b692],

1	COM	NN	O	com	nn	3	SENT_259	[p16l619t871r984b949],
2	"	''	O	"	punct	3	SENT_259	[p16l619t871r984b949],
3	T	NN	O	t	_	0	SENT_259	[p16l619t871r984b949],
4	”“	CD	NUMBER	”“	num	5	SENT_259	[p16l619t871r984b949],
5	cormit	NN	O	cormit	dep	3	SENT_259	[p16l1147t871r1485b949],

1	D	NN	O	d	nn	2	SENT_260	[p16l1526t1770r1590b1834],
2	Placebo	NN	O	placebo	_	0	SENT_260	[p16l1644t1769r1938b1837],

1	CQMIT	NN	O	cqmit	nn	3	SENT_261	[p16l20t1698r78b1912],
2	activity	NN	O	activity	nn	3	SENT_261	[p16l24t1429r92b1675],
3	change	NN	O	change	_	0	SENT_261	[p16l17t1162r92b1405],
4	(	CD	NUMBER	(	num	5	SENT_261	[p16l115t1435r193b1939],
5	pmnlfmin/mg	NN	O	pmnlfmin/mg	dep	3	SENT_261	[p16l115t1435r193b1939],
6	protein	NN	O	protein	nn	7	SENT_261	[p16l118t1135r193b1405],
7	}	NN	O	}	dep	3	SENT_261	[p16l118t1135r193b1405],

1	-	:	O	-	_	0	SENT_262	[p16l230t1915r372b1979],
2	o_5	NN	O	o_5	_	0	SENT_262	[p16l230t1915r372b1979],
3	I	PRP	O	I	nsubj	4	SENT_262	[p16l1526t1901r1590b1965],
4	Entacapoane	VBP	O	entacapoane	rcmod	2	SENT_262	[p16l1634t1905r2083b1983],
5	ip	NN	O	ip	nsubj	6	SENT_262	[p16l568t2161r606b2219],
6	=	JJ	O	=	ccomp	4	SENT_262	[p16l629t2165r666b2189],
7	0.0002	CD	NUMBER	0.0002	num	8	SENT_262	[p16l690t2145r923b2202],
8	p	NN	O	p	iobj	6	SENT_262	[p16l1130t2161r1168b2219],
9	=	JJ	O	=	amod	10	SENT_262	[p16l1191t2165r1228b2189],
10	E1001	NN	O	e1001	dobj	6	SENT_262	[p16l1252t2145r1441b2202],

1	In	IN	O	in	dep	2	SENT_263	[p16l808t2246r1303b2303],
2	p	NN	O	p	_	0	SENT_263	[p16l916t2360r1184b2431],
3	:	:	O	:	_	0	SENT_263	[p16l916t2360r1184b2431],
4	Uﬂ3	NN	O	uﬂ3	dep	2	SENT_263	[p16l916t2360r1184b2431],

1	2.5	CD	NUMBER	2.5	_	0	SENT_264	[p17l230t13r321b64],
2	e	LS	O	e	dep	1	SENT_264	[p17l382t34r386b35],
3	,	,	O	,	_	0	SENT_264	[p17l2063t40r2107b77, p17l470t125r531b185],
4	R1	NN	O	r1	appos	1	SENT_264	[p17l2063t40r2107b77, p17l470t125r531b185],

1	=	JJ	O	=	amod	2	SENT_265	[p17l551t151r585b172],
2	0.75	CD	NUMBER	0.75	_	0	SENT_265	[p17l605t134r754b195],
3	,	,	O	,	_	0	SENT_265	[p17l605t134r754b195],
4	p	NN	O	p	appos	2	SENT_265	[p17l778t145r811b199],
5	-	:	O	-	_	0	SENT_265	[p17l832t145r866b179],
6	=	JJ	O	=	dep	2	SENT_265	[p17l832t145r866b179],
7	:	:	O	:	_	0	SENT_265	[p17l832t145r866b179],
8	0.001	CD	NUMBER	0.001	dep	6	SENT_265	[p17l889t134r1059b185],

1	COMT	NN	O	comt	nn	2	SENT_266	[p17l10t1313r68b1526],
2	activity	NN	O	activity	_	0	SENT_266	[p17l10t1046r82b1293],
3	90	CD	DURATION	90	num	4	SENT_266	[p17l10t941r68b1023],
4	min	NN	DURATION	min	dep	2	SENT_266	[p17l10t793r68b915],
5	after	IN	O	after	_	0	SENT_266	[p17l7t600r68b765],
6	entacapone	NN	O	entacapone	nn	7	SENT_266	[p17l17t175r82b580],
7	lpmol	NN	O	lpmol	prep_after	4	SENT_266	[p17l105t748r186b1252],
8	/	:	O	/	punct	2	SENT_266	[p17l105t748r186b1252],
9	‘	CD	NUMBER	‘	num	10	SENT_266	[p17l105t748r186b1252],
10	min/mg	NN	O	min/mg	dep	2	SENT_266	[p17l105t748r186b1252],
11	protein	NN	O	protein	nn	12	SENT_266	[p17l108t448r186b718],
12	}	NN	O	}	dep	10	SENT_266	[p17l108t448r186b718],

1	COMT	NN	O	comt	nn	2	SENT_267	[p17l771t1692r984b1752],
2	activliity	NN	O	activliity	_	0	SENT_267	[p17l1004t1691r1252b1766],
3	at	IN	O	at	_	0	SENT_267	[p17l1279t1698r1343b1752],
4	baseline	NN	O	baseline	nn	8	SENT_267	[p17l1367t1688r1644b1752],
5	(	CD	NUMBER	(	num	8	SENT_267	[p17l805t1782r1310b1860],
6	pmol/min/mg	NN	O	pmol/min/mg	nn	8	SENT_267	[p17l805t1782r1310b1860],
7	protein	NN	O	protein	nn	8	SENT_267	[p17l1340t1782r1610b1860],
8	)	NN	O	)	prep_at	2	SENT_267	[p17l1340t1782r1610b1860],

1	FIGURE	NN	O	figure	_	0	SENT_268	[p17l14t1890r274b1945],
2	4	CD	NUMBER	4	num	1	SENT_268	[p17l316t1891r376b1944],
3	:	:	O	:	_	0	SENT_268	[p17l316t1891r376b1944],
4	COMT	NN	O	comt	nn	5	SENT_268	[p17l420t1890r645b1945],
5	activity	NN	O	activity	dep	1	SENT_268	[p17l683t1890r932b1962],
6	after	IN	O	after	_	0	SENT_268	[p17l971t1887r1136b1945],
7	the	DT	O	the	det	9	SENT_268	[p17l1173t1887r1285b1945],
8	two	CD	NUMBER	two	num	9	SENT_268	[p17l1325t1898r1455b1945],
9	challenges	NNS	O	challenge	prep_after	5	SENT_268	[p17l1498t1887r1860b1962],
10	with	IN	O	with	_	0	SENT_268	[p17l1899t1887r2045b1945],
11	Ldopa	NN	PERSON	ldopa	prep_with	9	SENT_268	[p17l2092t1891r2147b1944, p17l11t1980r184b2054],
12	and	CC	O	and	_	0	SENT_268	[p17l230t1980r354b2038],
13	entacapone	NN	O	entacapone	prep_with	9	SENT_268	[p17l401t1990r805b2054],
14	or	CC	O	or	_	0	SENT_268	[p17l852t2000r923b2038],
15	placebo	NN	O	placebo	prep_with	9	SENT_268	[p17l968t1980r1259b2054],
16	.	.	O	.	_	0	SENT_268	[p17l968t1980r1259b2054],

1	(	NN	O	(	nn	2	SENT_269	[p17l1306t1982r1397b2048],
2	A	NN	O	a	_	0	SENT_269	[p17l1306t1982r1397b2048],
3	)	CD	NUMBER	)	num	5	SENT_269	[p17l1306t1982r1397b2048],
4	Absolute	JJ	O	absolute	amod	5	SENT_269	[p17l1440t1980r1752b2038],
5	change	NN	O	change	dep	2	SENT_269	[p17l1797t1980r2044b2055],
6	in	IN	O	in	_	0	SENT_269	[p17l2090t1983r2144b2037],
7	COMT	NN	O	comt	nn	8	SENT_269	[p17l11t2075r235b2132],
8	activity	NN	O	activity	prep_in	5	SENT_269	[p17l291t2076r539b2149],
9	(	CD	NUMBER	(	number	10	SENT_269	[p17l596t2075r701b2142],
10	90	CD	DURATION	90	num	11	SENT_269	[p17l596t2075r701b2142],
11	minutes	NNS	NUMBER	minute	dep	12	SENT_269	[p17l762t2076r1031b2132],
12	—	RB	O	—	amod	14	SENT_269	[p17l1096t2104r1142b2112],
13	baseline	JJ	O	baseline	amod	14	SENT_269	[p17l1209t2073r1512b2142],
14	)	NN	O	)	dep	2	SENT_269	[p17l1209t2073r1512b2142],
15	after	IN	O	after	_	0	SENT_269	[p17l1571t2072r1735b2132],
16	L-dopa	NN	O	l-dopa	prep_after	14	SENT_269	[p17l1796t2073r2028b2148],
17	+	CC	O	+	_	0	SENT_269	[p17l2094t2084r2141b2131],
18	placebo	NN	O	placebo	prep_after	14	SENT_269	[p17l13t2167r283b2241],
19	(	CD	NUMBER	(	num	18	SENT_269	[p17l362t2167r593b2236],
20	white	JJ	O	white	amod	21	SENT_269	[p17l362t2167r593b2236],
21	)	NN	O	)	dep	2	SENT_269	[p17l362t2167r593b2236],
22	or	CC	O	or	_	0	SENT_269	[p17l672t2187r743b2225],
23	L-dopa	NN	O	l-dopa	conj_or	21	SENT_269	[p17l821t2167r1054b2241],
24	+	CC	O	+	_	0	SENT_269	[p17l1138t2178r1185b2224],
25	entacapone	NN	O	entacapone	conj_+	21	SENT_269	[p17l1268t2178r1672b2241],
26	(	CD	NUMBER	(	num	28	SENT_269	[p17l1751t2167r1972b2236],
27	black	JJ	O	black	amod	28	SENT_269	[p17l1751t2167r1972b2236],
28	)	NN	O	)	dep	2	SENT_269	[p17l1751t2167r1972b2236],
29	for	IN	O	for	_	0	SENT_269	[p17l2047t2167r2148b2225],
30	COMTHH	NNP	O	COMTHH	nn	34	SENT_269	[p17l14t2248r319b2319],
31	and	CC	O	and	_	0	SENT_269	[p17l376t2260r500b2319],
32	COMT	NNP	O	COMT	conj_and	30	SENT_269	[p17l566t2248r845b2319],
33	”	CD	NUMBER	”	num	34	SENT_269	[p17l566t2248r845b2319],
34	patients	NNS	O	patient	prep_for	28	SENT_269	[p17l906t2264r1203b2335],
35	.	.	O	.	_	0	SENT_269	[p17l906t2264r1203b2335],

1	p	NN	O	p	nn	2	SENT_270	[p17l1265t2280r1310b2335],
2	values	NNS	O	value	_	0	SENT_270	[p17l1367t2260r1583b2319],
3	for	IN	O	for	_	0	SENT_270	[p17l1641t2259r1742b2318],
4	treatment	NN	O	treatment	nn	5	SENT_270	[p17l1799t2271r2148b2319],
5	effect	NN	O	effect	prep_for	2	SENT_270	[p17l11t2353r229b2413],
6	:	:	O	:	_	0	SENT_270	[p17l11t2353r229b2413],
7	paired	JJ	O	paired	amod	9	SENT_270	[p17l307t2354r523b2429],
8	Wilcoxon	NNP	PERSON	Wilcoxon	nn	9	SENT_270	[p17l596t2354r914b2413],
9	test	NN	O	test	dep	2	SENT_270	[p17l988t2364r1139b2413],
10	.	.	O	.	_	0	SENT_270	[p17l988t2364r1139b2413],

1	p	NN	O	p	nn	2	SENT_271	[p17l1214t2374r1259b2429],
2	values	NNS	O	value	_	0	SENT_271	[p17l1327t2354r1544b2413],
3	for	IN	O	for	_	0	SENT_271	[p17l1614t2353r1715b2413],
4	genotype	NN	O	genotype	prep_for	2	SENT_271	[p17l1787t2354r2148b2430],
5	/	:	O	/	punct	7	SENT_271	[p17l1787t2354r2148b2430],
6	treatment	NN	O	treatment	nn	7	SENT_271	[p17l8t2459r357b2506],
7	interaction	NN	O	interaction	dep	4	SENT_271	[p17l418t2451r808b2506],
8	:	:	O	:	_	0	SENT_271	[p17l418t2451r808b2506],
9	analysis	NN	O	analysis	dep	2	SENT_271	[p17l872t2448r1136b2523],
10	of	IN	O	of	_	0	SENT_271	[p17l1198t2448r1269b2506],
11	variance	NN	O	variance	prep_of	9	SENT_271	[p17l1324t2451r1611b2506],
12	for	IN	O	for	_	0	SENT_271	[p17l1671t2448r1771b2506],
13	repeated	VBN	O	repeat	amod	14	SENT_271	[p17l1832t2448r2144b2522],
14	measures	NNS	O	measure	prep_for	11	SENT_271	[p17l12t2561r356b2599],
15	.	.	O	.	_	0	SENT_271	[p17l12t2561r356b2599],

1	(	NN	O	(	nn	2	SENT_272	[p17l433t2543r519b2609],
2	B	NN	O	b	dep	25	SENT_272	[p17l433t2543r519b2609],
3	)	CD	NUMBER	)	num	4	SENT_272	[p17l433t2543r519b2609],
4	Relationship	NN	O	relationship	dobj	2	SENT_272	[p17l596t2541r1018b2615],
5	between	IN	O	between	_	0	SENT_272	[p17l1094t2541r1392b2599],
6	COMT	NN	O	comt	nn	7	SENT_272	[p17l1467t2543r1691b2599],
7	activity	NN	O	activity	prep_between	4	SENT_272	[p17l1761t2544r2010b2616],
8	at	IN	O	at	_	0	SENT_272	[p17l2081t2551r2147b2599],
9	baseline	NN	O	baseline	nn	12	SENT_272	[p17l13t2634r294b2692],
10	and	CC	O	and	_	0	SENT_272	[p17l342t2634r466b2692],
11	COMT	NN	O	comt	nn	12	SENT_272	[p17l516t2636r739b2693],
12	activity	NN	O	activity	prep_at	7	SENT_272	[p17l785t2637r1033b2710],
13	90	CD	DURATION	90	num	14	SENT_272	[p17l1079t2637r1163b2692],
14	minutes	NNS	NUMBER	minute	tmod	7	SENT_272	[p17l1212t2637r1483b2692],
15	after	IN	O	after	_	0	SENT_272	[p17l1530t2633r1695b2692],
16	entacapone	NN	O	entacapone	nn	19	SENT_272	[p17l1742t2644r2145b2709],
17	(	CD	NUMBER	(	num	19	SENT_272	[p17l11t2731r377b2803],
18	Spearman	NNP	PERSON	Spearman	nn	19	SENT_272	[p17l11t2731r377b2803],
19	correlation	NN	O	correlation	prep_after	2	SENT_272	[p17l409t2729r781b2786],
20	coefficient	NN	O	coefficient	nn	23	SENT_272	[p17l814t2728r1177b2786],
21	and	CC	O	and	_	0	SENT_272	[p17l1205t2729r1329b2786],
22	p	NN	O	p	nn	23	SENT_272	[p17l1361t2748r1405b2803],
23	value	NN	O	value	nsubjpass	25	SENT_272	[p17l1430t2729r1612b2786],
24	are	VBP	O	be	auxpass	25	SENT_272	[p17l1642t2748r1749b2786],
25	indicated	VBN	O	indicate	_	0	SENT_272	[p17l1781t2729r2140b2797],
26	)	NN	O	)	dobj	25	SENT_272	[p17l1781t2729r2140b2797],
27	.	.	O	.	_	0	SENT_272	[p17l1781t2729r2140b2797],

1	Volume	NN	O	volume	_	0	SENT_273	[p17l1569t2972r1809b3031],
2	69	CD	NUMBER	69	num	1	SENT_273	[p17l1840t2974r1932b3037],
3	,	,	O	,	_	0	SENT_273	[p17l1840t2974r1932b3037],
4	No.	NN	O	no.	appos	1	SENT_273	[p17l1965t2976r2078b3030],
5	1	CD	NUMBER	1	num	4	SENT_273	[p17l2118t2978r2140b3029],

1	Discussion	NN	O	discussion	nsubj	4	SENT_274	[p17l17t3205r502b3280],
2	Our	PRP$	O	we	poss	3	SENT_274	[p17l13t3347r162b3413],
3	study	NN	O	study	dep	1	SENT_274	[p17l222t3343r417b3434],
4	demonstrates	VBZ	O	demonstrate	_	0	SENT_274	[p17l476t3343r946b3413],
5	that	IN	O	that	complm	10	SENT_274	[p17l1011t3343r1150b3412],
6	the	DT	O	the	det	9	SENT_274	[p17l1212t3343r1320b3412],
7	COM	NNP	O	COM	nn	9	SENT_274	[p17l1388t3347r1599b3412],
8	THH	NNP	O	THH	nn	9	SENT_274	[p17l1602t3327r1763b3411],
9	genotype	NN	O	genotype	nsubj	10	SENT_274	[p17l1815t3367r2138b3436],
10	increases	VBZ	O	increase	ccomp	4	SENT_274	[p17l12t3470r320b3534],
11	the	DT	O	the	det	13	SENT_274	[p17l404t3465r512b3534],
12	positive	JJ	O	positive	amod	13	SENT_274	[p17l594t3470r868b3556],
13	effect	NN	O	effect	dobj	10	SENT_274	[p17l951t3465r1141b3534],
14	of	IN	O	of	_	0	SENT_274	[p17l1223t3465r1303b3534],
15	entacapone	NN	O	entacapone	prep_of	13	SENT_274	[p17l1374t3488r1775b3556],
16	on	IN	O	on	_	0	SENT_274	[p17l1858t3493r1948b3534],
17	the	DT	O	the	det	18	SENT_274	[p17l2030t3465r2139b3534],
18	response	NN	O	response	prep_on	15	SENT_274	[p17l12t3613r315b3677],
19	of	IN	O	of	_	0	SENT_274	[p17l370t3586r450b3654],
20	PD	NN	O	pd	nn	21	SENT_274	[p17l493t3590r610b3654],
21	patients	NNS	O	patient	prep_of	18	SENT_274	[p17l665t3590r943b3677],
22	to	TO	O	to	_	0	SENT_274	[p17l999t3609r1067b3654],
23	L-dopa	NN	O	l-dopa	prep_to	10	SENT_274	[p17l1122t3586r1397b3677],
24	.	.	O	.	_	0	SENT_274	[p17l1122t3586r1397b3677],

1	The	DT	O	the	det	4	SENT_275	[p17l1454t3586r1599b3654],
2	main	JJ	O	main	amod	4	SENT_275	[p17l1652t3590r1833b3654],
3	clinical	JJ	O	clinical	amod	4	SENT_275	[p17l1887t3586r2138b3654],
4	response	NN	O	response	nsubj	18	SENT_275	[p18l12t49r315b114],
5	to	TO	O	to	_	0	SENT_275	[p18l356t46r424b91],
6	entacapone	NN	O	entacapone	prep_to	4	SENT_275	[p18l466t46r887b114],
7	,	,	O	,	_	0	SENT_275	[p18l466t46r887b114],
8	a	DT	O	a	det	9	SENT_275	[p18l932t51r967b91],
9	gain	NN	O	gain	appos	4	SENT_275	[p18l1004t27r1154b114],
10	in	IN	O	in	_	0	SENT_275	[p18l1195t27r1263b90],
11	best	JJS	O	best	prep_in	9	SENT_275	[p18l1303t22r1442b91],
12	ON	IN	O	on	_	0	SENT_275	[p18l1482t26r1623b91],
13	time	NN	O	time	prep_on	11	SENT_275	[p18l1665t27r1824b91],
14	after	IN	O	after	_	0	SENT_275	[p18l1864t22r2022b91],
15	Ldopa	NNP	PERSON	Ldopa	prep_after	13	SENT_275	[p18l2062t27r2137b90, p18l12t144r206b235],
16	,	,	O	,	_	0	SENT_275	[p18l2062t27r2137b90, p18l12t144r206b235],
17	was	VBD	O	be	cop	18	SENT_275	[p18l248t172r375b212],
18	>	JJR	O	>	_	0	SENT_275	[p18l423t149r656b217],
19	75	CD	PERCENT	75	num	20	SENT_275	[p18l423t149r656b217],
20	%	NN	PERCENT	%	npadvmod	21	SENT_275	[p18l423t149r656b217],
21	higher	JJR	O	higher	advmod	18	SENT_275	[p18l698t143r927b236],
22	in	IN	O	in	_	0	SENT_275	[p18l966t148r1035b211],
23	COM	NNP	MISC	COM	nn	24	SENT_275	[p18l1083t147r1293b212],
24	Tu	NNP	MISC	Tu	prep_in	18	SENT_275	[p18l1297t127r1418b211],
25	than	IN	O	than	prep	18	SENT_275	[p18l1458t143r1617b211],
26	in	IN	O	in	pcomp	25	SENT_275	[p18l1658t148r1726b210],
27	COM	NNP	O	COM	nn	29	SENT_275	[p18l1774t147r1985b212],
28	THH	NN	O	thh	nn	29	SENT_275	[p18l1988t127r2148b210],
29	patients	NNS	O	patient	pobj	26	SENT_275	[p18l11t247r290b333],
30	(	IN	O	(	_	0	SENT_275	[p18l359t243r424b324],
31	9	CD	NUMBER	9	prep_(	18	SENT_275	[p18l359t243r424b324],
32	vs	CC	O	vs	cc	31	SENT_275	[p18l487t271r555b311],
33	39	CD	DURATION	39	num	34	SENT_275	[p18l621t249r707b315],
34	minutes	NNS	NUMBER	minute	tmod	31	SENT_275	[p18l773t243r1107b324],
35	)	CD	NUMBER	)	tmod	18	SENT_275	[p18l773t243r1107b324],
36	.	.	O	.	_	0	SENT_275	[p18l773t243r1107b324],

1	The	DT	O	the	det	3	SENT_276	[p18l1175t242r1318b311],
2	average	JJ	O	average	amod	3	SENT_276	[p18l1383t270r1641b334],
3	gain	NN	O	gain	dep	16	SENT_276	[p18l1704t247r1853b334],
4	of	IN	O	of	_	0	SENT_276	[p18l1917t242r1998b311],
5	25	CD	DURATION	25	num	6	SENT_276	[p18l2049t248r2134b315],
6	minutes	NNS	NUMBER	minute	prep_of	3	SENT_276	[p18l12t367r297b432],
7	in	IN	O	in	_	0	SENT_276	[p18l376t367r445b430],
8	ON	NNP	O	ON	nn	9	SENT_276	[p18l523t366r663b432],
9	time	NN	O	time	prep_in	6	SENT_276	[p18l742t367r901b431],
10	in	IN	O	in	_	0	SENT_276	[p18l979t367r1047b430],
11	the	DT	O	the	det	13	SENT_276	[p18l1125t363r1233b431],
12	combined	JJ	O	combined	amod	13	SENT_276	[p18l1311t363r1669b432],
13	population	NN	O	population	prep_in	9	SENT_276	[p18l1744t363r2139b454],
14	(	CD	NUMBER	(	dep	16	SENT_276	[p18l16t486r259b567],
15	COM	NNP	O	COM	nn	16	SENT_276	[p18l16t486r259b567],
16	Ta	NNP	O	Ta	dep	21	SENT_276	[p18l263t469r384b553],
17	-1	CD	NUMBER	-1	dep	16	SENT_276	[p18l429t497r491b560],
18	-	:	O	-	_	0	SENT_276	[p18l429t497r491b560],
19	COM	NN	O	com	nn	21	SENT_276	[p18l540t489r751b554],
20	THH	NN	O	thh	nn	21	SENT_276	[p18l754t469r929b568],
21	)	NN	O	)	_	0	SENT_276	[p18l754t469r929b568],
22	was	VBD	O	be	cop	23	SENT_276	[p18l975t514r1102b554],
23	similar	JJ	O	similar	rcmod	21	SENT_276	[p18l1146t485r1389b554],
24	to	TO	O	to	_	0	SENT_276	[p18l1431t508r1499b554],
25	What	WP	MISC	what	nsubjpass	27	SENT_276	[p18l1540t485r1716b554],
26	Was	VBD	MISC	be	auxpass	27	SENT_276	[p18l1754t514r1882b554],
27	found	VBN	O	find	prepc_to	23	SENT_276	[p18l1925t485r2140b555],
28	in	IN	O	in	_	0	SENT_276	[p18l12t611r81b673],
29	a	DT	O	a	det	31	SENT_276	[p18l132t634r167b674],
30	previous	JJ	O	previous	amod	31	SENT_276	[p18l214t611r514b697],
31	study	NN	O	study	prep_in	27	SENT_276	[p18l565t588r806b696],
32	,6	CD	NUMBER	,6	num	31	SENT_276	[p18l565t588r806b696],
33	suggesting	VBG	O	suggest	partmod	31	SENT_276	[p18l856t611r1227b698],
34	that	IN	O	that	complm	38	SENT_276	[p18l1276t606r1415b674],
35	the	DT	O	the	det	37	SENT_276	[p18l1464t606r1572b674],
36	COMT	NNP	O	COMT	nn	37	SENT_276	[p18l1623t608r1905b675],
37	polymorphism	NN	O	polymorphism	nsubj	38	SENT_276	[p18l1954t606r2137b697, p18l12t727r382b818],
38	explains	VBZ	O	explain	ccomp	33	SENT_276	[p18l422t727r705b818],
39	most	JJS	O	most	dobj	38	SENT_276	[p18l745t750r920b796],
40	of	IN	O	of	_	0	SENT_276	[p18l959t727r1039b796],
41	the	DT	O	the	det	43	SENT_276	[p18l1066t727r1174b796],
42	interindividual	JJ	O	interindividual	amod	43	SENT_276	[p18l1214t727r1744b796],
43	variability	NN	O	variability	prep_of	39	SENT_276	[p18l1780t727r2142b817],
44	in	IN	O	in	_	0	SENT_276	[p18l12t852r81b915],
45	the	DT	O	the	det	46	SENT_276	[p18l120t848r228b916],
46	response	NN	O	response	prep_in	43	SENT_276	[p18l267t874r570b939],
47	to	TO	O	to	_	0	SENT_276	[p18l609t871r677b916],
48	entacapone	NN	O	entacapone	prep_to	38	SENT_276	[p18l717t871r1138b939],
49	.	.	O	.	_	0	SENT_276	[p18l717t871r1138b939],

1	The	DT	O	the	det	2	SENT_277	[p18l1179t848r1323b916],
2	fact	NN	O	fact	nsubj	35	SENT_277	[p18l1361t847r1489b916],
3	that	IN	O	that	complm	9	SENT_277	[p18l1526t848r1665b916],
4	the	DT	O	the	det	6	SENT_277	[p18l1703t848r1811b916],
5	2	CD	NUMBER	2	num	6	SENT_277	[p18l1850t855r1891b915],
6	alleles	NNS	O	allele	nsubjpass	9	SENT_277	[p18l1931t848r2137b916],
7	are	VBP	O	be	auxpass	9	SENT_277	[p18l12t997r114b1038],
8	equally	RB	O	equally	advmod	9	SENT_277	[p18l162t969r418b1060],
9	distributed	VBN	O	distribute	dep	2	SENT_277	[p18l462t969r852b1039],
10	in	IN	O	in	_	0	SENT_277	[p18l900t975r968b1037],
11	Caucasian	JJ	O	caucasian	amod	13	SENT_277	[p18l1017t973r1378b1039],
12	PD	NN	O	pd	nn	13	SENT_277	[p18l1427t974r1544b1037],
13	patients12	NN	O	patients12	prep_in	9	SENT_277	[p18l1593t955r1942b1060],
14	may	MD	O	may	aux	15	SENT_277	[p18l1990t997r2142b1060],
15	have	VB	O	have	parataxis	35	SENT_277	[p18l11t1090r170b1158],
16	consequences	NNS	O	consequence	dobj	15	SENT_277	[p18l229t1117r706b1181],
17	for	IN	O	for	_	0	SENT_277	[p18l765t1090r866b1158],
18	the	DT	O	the	det	19	SENT_277	[p18l923t1090r1032b1158],
19	management	NN	O	management	prep_for	16	SENT_277	[p18l1090t1113r1554b1182],
20	of	IN	O	of	_	0	SENT_277	[p18l1611t1090r1691b1158],
21	entacapone	NN	O	entacapone	nn	22	SENT_277	[p18l1737t1113r2138b1181],
22	therapy	NN	O	therapy	prep_of	19	SENT_277	[p18l12t1212r298b1303],
23	;	:	O	;	_	0	SENT_277	[p18l12t1212r298b1303],
24	about	IN	O	about	_	0	SENT_277	[p18l353t1212r556b1281],
25	25	CD	PERCENT	25	num	26	SENT_277	[p18l606t1217r772b1285],
26	%	NN	PERCENT	%	prep_about	16	SENT_277	[p18l606t1217r772b1285],
27	of	IN	O	of	_	0	SENT_277	[p18l825t1212r906b1280],
28	PD	NN	O	pd	nn	29	SENT_277	[p18l945t1216r1062b1280],
29	patients	NNS	O	patient	prep_of	26	SENT_277	[p18l1114t1216r1392b1303],
30	(	CD	NUMBER	(	num	33	SENT_277	[p18l1449t1213r1692b1294],
31	COM	NN	O	com	nn	33	SENT_277	[p18l1449t1213r1692b1294],
32	7	CD	NUMBER	7	num	33	SENT_277	[p18l1695t1196r1840b1294],
33	“	NN	O	“	nsubj	15	SENT_277	[p18l1695t1196r1840b1294],
34	)	CD	NUMBER	)	nsubj	35	SENT_277	[p18l1695t1196r1840b1294],
35	have	VBP	O	have	_	0	SENT_277	[p18l1895t1212r2054b1281],
36	a	DT	O	a	det	39	SENT_277	[p18l2106t1240r2141b1281],
37	very	RB	O	very	advmod	38	SENT_277	[p18l9t1360r161b1423],
38	weak	JJ	O	weak	amod	39	SENT_277	[p18l209t1333r392b1401],
39	response	NN	O	response	dobj	35	SENT_277	[p18l443t1360r746b1424],
40	to	TO	O	to	_	0	SENT_277	[p18l801t1356r869b1401],
41	entacapone	NN	O	entacapone	prep_to	39	SENT_277	[p18l925t1356r1344b1424],
42	.	.	O	.	_	0	SENT_277	[p18l925t1356r1344b1424],

1	In	IN	O	in	_	0	SENT_278	[p18l1405t1337r1480b1400],
2	clinical	JJ	O	clinical	amod	3	SENT_278	[p18l1533t1332r1784b1401],
3	practice	NN	O	practice	prep_in	20	SENT_278	[p18l1838t1337r2135b1424],
4	,	,	O	,	_	0	SENT_278	[p18l1838t1337r2135b1424],
5	however	RB	O	however	advmod	20	SENT_278	[p18l11t1454r322b1533],
6	,	,	O	,	_	0	SENT_278	[p18l11t1454r322b1533],
7	the	DT	O	the	det	8	SENT_278	[p18l366t1454r474b1523],
8	efficacy	NN	O	efficacy	nsubj	20	SENT_278	[p18l514t1454r781b1545],
9	of	IN	O	of	_	0	SENT_278	[p18l818t1454r899b1523],
10	entacapone	NN	O	entacapone	prep_of	8	SENT_278	[p18l927t1477r1328b1545],
11	in	IN	O	in	_	0	SENT_278	[p18l1369t1459r1437b1522],
12	acute	JJ	O	acute	amod	13	SENT_278	[p18l1477t1477r1660b1524],
13	challenge	NN	O	challenge	prep_in	10	SENT_278	[p18l1701t1454r2030b1546],
14	of	IN	O	of	_	0	SENT_278	[p18l2071t1454r2151b1523],
15	L	NN	O	l	nn	17	SENT_278	[p18l12t1575r271b1666],
16	—	CD	NUMBER	—	num	17	SENT_278	[p18l12t1575r271b1666],
17	dopa	NN	O	dopa	prep_of	13	SENT_278	[p18l12t1575r271b1666],
18	may	MD	O	may	aux	20	SENT_278	[p18l304t1602r457b1665],
19	not	RB	O	not	neg	20	SENT_278	[p18l488t1598r608b1643],
20	reflect	VB	O	reflect	_	0	SENT_278	[p18l643t1575r861b1643],
21	What	WP	O	what	nsubj	22	SENT_278	[p18l892t1575r1067b1643],
22	happens	VBZ	O	happen	ccomp	20	SENT_278	[p18l1101t1575r1393b1666],
23	when	WRB	O	when	advmod	26	SENT_278	[p18l1427t1575r1620b1644],
24	it	PRP	O	it	nsubjpass	26	SENT_278	[p18l1656t1579r1706b1643],
25	is	VBZ	O	be	auxpass	26	SENT_278	[p18l1740t1579r1789b1643],
26	administered	VBN	O	administer	advcl	22	SENT_278	[p18l1826t1575r2137b1644, p18l12t1676r190b1746],
27	chronically	RB	O	chronically	advmod	26	SENT_278	[p18l245t1676r648b1767],
28	.	.	O	.	_	0	SENT_278	[p18l245t1676r648b1767],

1	A	DT	O	a	det	3	SENT_279	[p18l703t1680r766b1744],
2	previous	JJ	O	previous	amod	3	SENT_279	[p18l816t1681r1114b1768],
3	study	NN	O	study	nsubj	4	SENT_279	[p18l1171t1676r1366b1767],
4	failed	VBD	O	fail	_	0	SENT_279	[p18l1417t1676r1611b1746],
5	to	TO	O	to	aux	6	SENT_279	[p18l1666t1700r1733b1745],
6	detect	VB	O	detect	xcomp	4	SENT_279	[p18l1791t1676r2003b1746],
7	an	DT	O	a	det	8	SENT_279	[p18l2057t1704r2139b1745],
8	effect	NN	O	effect	dobj	6	SENT_279	[p18l12t1796r202b1865],
9	of	IN	O	of	_	0	SENT_279	[p18l238t1796r319b1865],
10	the	DT	O	the	det	12	SENT_279	[p18l344t1796r452b1865],
11	COMT	NNP	O	COMT	nn	12	SENT_279	[p18l490t1798r772b1865],
12	genotype	NN	O	genotype	prep_of	8	SENT_279	[p18l807t1820r1130b1889],
13	on	IN	O	on	_	0	SENT_279	[p18l1168t1824r1258b1865],
14	the	DT	O	the	det	15	SENT_279	[p18l1294t1797r1403b1865],
15	response	NN	O	response	prep_on	6	SENT_279	[p18l1440t1824r1743b1888],
16	to	TO	O	to	_	0	SENT_279	[p18l1780t1820r1848b1865],
17	entacapone	NN	O	entacapone	prep_to	15	SENT_279	[p18l1886t1820r2137b1865, p18l11t1945r187b2009],
18	when	WRB	O	when	advmod	19	SENT_279	[p18l224t1918r418b1987],
19	administered	VBN	O	administer	advcl	6	SENT_279	[p18l458t1918r923b1988],
20	repeatedly	RB	O	repeatedly	advmod	19	SENT_279	[p18l963t1904r1410b2009],
21	.	.	O	.	_	0	SENT_279	[p18l963t1904r1410b2009],

1	”	NN	O	”	nsubjpass	7	SENT_280	[p18l963t1904r1410b2009],
2	However	RB	O	however	advmod	7	SENT_280	[p18l1453t1923r1787b1997],
3	,	,	O	,	_	0	SENT_280	[p18l1453t1923r1787b1997],
4	this	DT	O	this	det	5	SENT_280	[p18l1832t1918r1957b1987],
5	trial	NN	O	trial	nsubjpass	7	SENT_280	[p18l1998t1919r2138b1987],
6	Was	VBD	O	be	auxpass	7	SENT_280	[p18l8t2067r136b2107],
7	conducted	VBN	O	conduct	_	0	SENT_280	[p18l179t2039r553b2108],
8	in	IN	O	in	_	0	SENT_280	[p18l594t2043r662b2106],
9	an	DT	O	a	det	11	SENT_280	[p18l704t2066r787b2107],
10	Asian	JJ	LOCATION	asian	amod	11	SENT_280	[p18l823t2042r1024b2107],
11	population	NN	O	population	prep_in	7	SENT_280	[p18l1065t2039r1459b2130],
12	in	IN	O	in	_	0	SENT_280	[p18l1501t2043r1570b2106],
13	Which	WDT	O	which	rel	22	SENT_280	[p18l1608t2039r1826b2108],
14	the	DT	O	the	det	15	SENT_280	[p18l1867t2039r1975b2107],
15	frequency	NN	O	frequency	nsubj	22	SENT_280	[p18l2017t2039r2137b2107, p18l12t2189r269b2253],
16	of	IN	O	of	_	0	SENT_280	[p18l327t2161r407b2230],
17	the	DT	O	the	det	20	SENT_280	[p18l455t2161r564b2230],
18	COM	NNP	O	COM	nn	20	SENT_280	[p18l630t2165r841b2230],
19	TL	NN	O	tl	nn	20	SENT_280	[p18l844t2145r927b2229],
20	allele	NN	O	allele	prep_of	15	SENT_280	[p18l987t2161r1164b2230],
21	is	VBZ	O	be	cop	22	SENT_280	[p18l1225t2166r1274b2230],
22	low	JJ	O	low	rcmod	11	SENT_280	[p18l1334t2161r1480b2240],
23	;	:	O	;	_	0	SENT_280	[p18l1334t2161r1480b2240],
24	only	RB	O	only	advmod	30	SENT_280	[p18l1544t2161r1701b2252],
25	7	CD	NUMBER	7	num	26	SENT_280	[p18l1758t2169r1800b2234],
26	patients	NNS	O	patient	pobj	24	SENT_280	[p18l1859t2166r2138b2253],
27	(	IN	O	(	_	0	SENT_280	[p18l16t2283r234b2364],
28	11	CD	PERCENT	11	num	29	SENT_280	[p18l16t2283r234b2364],
29	%	NN	PERCENT	%	prep_(	24	SENT_280	[p18l16t2283r234b2364],
30	)	CD	NUMBER	)	nsubjpass	37	SENT_280	[p18l16t2283r234b2364],
31	with	IN	O	with	_	0	SENT_280	[p18l283t2281r445b2350],
32	the	DT	O	the	det	35	SENT_280	[p18l490t2281r598b2350],
33	COM	NNP	MISC	COM	nn	35	SENT_280	[p18l650t2285r861b2350],
34	Tu	NNP	MISC	Tu	nn	35	SENT_280	[p18l864t2265r985b2349],
35	genotype	NN	O	genotype	prep_with	30	SENT_280	[p18l1030t2305r1352b2374],
36	were	VBD	O	be	auxpass	37	SENT_280	[p18l1396t2309r1561b2350],
37	included	VBN	O	include	parataxis	7	SENT_280	[p18l1607t2281r1934b2351],
38	.	.	O	.	_	0	SENT_280	[p18l1607t2281r1934b2351],

1	Furthermore	RB	O	furthermore	advmod	31	SENT_281	[p18l1986t2286r2137b2351, p18l12t2403r360b2482],
2	,	,	O	,	_	0	SENT_281	[p18l1986t2286r2137b2351, p18l12t2403r360b2482],
3	because	IN	O	because	mark	6	SENT_281	[p18l410t2403r678b2473],
4	OFF	NN	O	off	nn	5	SENT_281	[p18l726t2406r892b2472],
5	periods	NNS	O	period	nsubj	6	SENT_281	[p18l940t2403r1200b2494],
6	persist	VBP	O	persist	parataxis	31	SENT_281	[p18l1245t2408r1472b2494],
7	in	IN	O	in	_	0	SENT_281	[p18l1518t2408r1587b2471],
8	some	DT	O	some	det	9	SENT_281	[p18l1632t2430r1814b2472],
9	patients	NNS	O	patient	prep_in	6	SENT_281	[p18l1859t2408r2138b2494],
10	despite	IN	O	despite	_	0	SENT_281	[p18l12t2524r260b2615],
11	entacapone	NN	O	entacapone	nn	12	SENT_281	[p18l303t2548r704b2615],
12	treatment	NN	O	treatment	prep_despite	6	SENT_281	[p18l747t2510r1186b2602],
13	,	,	O	,	_	0	SENT_281	[p18l747t2510r1186b2602],
14	”	IN	O	”	_	0	SENT_281	[p18l747t2510r1186b2602],
15	the	DT	O	the	det	16	SENT_281	[p18l1229t2524r1338b2592],
16	effect	NN	O	effect	prep_”	31	SENT_281	[p18l1380t2524r1571b2592],
17	of	IN	O	of	_	0	SENT_281	[p18l1612t2524r1693b2592],
18	the	DT	O	the	det	21	SENT_281	[p18l1723t2524r1832b2592],
19	COM	NN	O	com	nn	21	SENT_281	[p18l1880t2528r2091b2593],
20	T	NN	O	t	nn	21	SENT_281	[p18l2095t2527r2154b2592],
21	genotype	NN	O	genotype	prep_of	16	SENT_281	[p18l11t2669r335b2737],
22	on	IN	O	on	_	0	SENT_281	[p18l373t2673r463b2714],
23	the	DT	O	the	det	25	SENT_281	[p18l500t2645r609b2714],
24	long	JJ	O	long	amod	25	SENT_281	[p18l645t2645r1001b2737],
25	—	NN	O	—	prep_on	21	SENT_281	[p18l645t2645r1001b2737],
26	term	NN	O	term	nn	27	SENT_281	[p18l645t2645r1001b2737],
27	response	NN	O	response	nsubj	31	SENT_281	[p18l1040t2672r1343b2737],
28	to	TO	O	to	_	0	SENT_281	[p18l1381t2669r1449b2714],
29	the	DT	O	the	det	30	SENT_281	[p18l1488t2645r1597b2714],
30	drug	NN	O	drug	prep_to	27	SENT_281	[p18l1634t2645r1800b2737],
31	needs	VBZ	O	need	_	0	SENT_281	[p18l1836t2645r2031b2715],
32	to	TO	O	to	aux	34	SENT_281	[p18l2070t2668r2137b2714],
33	be	VB	O	be	auxpass	34	SENT_281	[p18l12t2766r91b2835],
34	studied	VBN	O	study	xcomp	31	SENT_281	[p18l127t2766r404b2836],
35	.	.	O	.	_	0	SENT_281	[p18l127t2766r404b2836],

1	The	DT	O	the	det	2	SENT_282	[p18l215t2888r359b2956],
2	gain	NN	O	gain	nsubjpass	26	SENT_282	[p18l412t2893r560b2980],
3	in	IN	O	in	_	0	SENT_282	[p18l613t2893r682b2955],
4	ON	NNP	O	ON	nn	5	SENT_282	[p18l735t2891r876b2957],
5	time	NN	O	time	prep_in	2	SENT_282	[p18l929t2893r1089b2956],
6	induced	VBN	O	induce	partmod	2	SENT_282	[p18l1141t2888r1427b2957],
7	by	IN	O	by	_	0	SENT_282	[p18l1480t2888r1567b2978],
8	entacapone	NN	O	entacapone	agent	6	SENT_282	[p18l1616t2911r2017b2979],
9	in	IN	O	in	_	0	SENT_282	[p18l2071t2893r2139b2955],
10	PD	NN	O	pd	prep_in	8	SENT_282	[p18l13t3013r130b3077],
11	is	VBZ	O	be	auxpass	26	SENT_282	[p18l186t3013r236b3077],
12	related	VBN	O	relate	acomp	26	SENT_282	[p18l292t3009r530b3078],
13	to	TO	O	to	_	0	SENT_282	[p18l585t3032r652b3077],
14	the	DT	O	the	det	15	SENT_282	[p18l709t3009r817b3077],
15	inhibition	NN	O	inhibition	prep_to	12	SENT_282	[p18l872t3008r1231b3077],
16	of	IN	O	of	_	0	SENT_282	[p18l1286t3008r1367b3077],
17	L	NN	O	l	nn	20	SENT_282	[p18l1409t3008r1668b3100],
18	—	CD	NUMBER	—	num	20	SENT_282	[p18l1409t3008r1668b3100],
19	dopa	NN	O	dopa	nn	20	SENT_282	[p18l1409t3008r1668b3100],
20	metabolism	NN	O	metabolism	prep_of	15	SENT_282	[p18l1721t3009r2138b3077],
21	through	IN	O	through	_	0	SENT_282	[p18l12t3130r299b3222],
22	the	DT	O	the	det	24	SENT_282	[p18l346t3130r455b3198],
23	COMT	NN	O	comt	nn	24	SENT_282	[p18l503t3132r785b3198],
24	pathway	NN	O	pathway	prep_through	26	SENT_282	[p18l830t3130r1141b3221],
25	,	,	O	,	_	0	SENT_282	[p18l830t3130r1141b3221],
26	leading	VBG	O	lead	ccomp	49	SENT_282	[p18l1191t3130r1451b3222],
27	to	TO	O	to	_	0	SENT_282	[p18l1497t3153r1564b3198],
28	an	DT	O	a	det	29	SENT_282	[p18l1614t3157r1696b3198],
29	increase	NN	O	increase	prep_to	26	SENT_282	[p18l1743t3134r2023b3198],
30	in	IN	O	in	_	0	SENT_282	[p18l2071t3134r2139b3197],
31	the	DT	O	the	det	32	SENT_282	[p18l12t3252r121b3321],
32	bioavailability	NN	O	bioavailability	prep_in	29	SENT_282	[p18l164t3252r670b3343],
33	of	IN	O	of	_	0	SENT_282	[p18l711t3252r792b3321],
34	L	NN	O	l	nn	36	SENT_282	[p18l824t3237r1136b3344],
35	—	CD	NUMBER	—	num	36	SENT_282	[p18l824t3237r1136b3344],
36	dopa	NN	O	dopa	prep_of	32	SENT_282	[p18l824t3237r1136b3344],
37	.5	CD	NUMBER	.5	num	36	SENT_282	[p18l824t3237r1136b3344],
38	Indeed	RB	O	indeed	advmod	26	SENT_282	[p18l1183t3252r1446b3331],
39	,	,	O	,	_	0	SENT_282	[p18l1183t3252r1446b3331],
40	L	NN	O	l	nn	43	SENT_282	[p18l1494t3252r1752b3344],
41	—	CD	NUMBER	—	num	43	SENT_282	[p18l1494t3252r1752b3344],
42	dopa	NN	O	dopa	nn	43	SENT_282	[p18l1494t3252r1752b3344],
43	bioavailability	NN	O	bioavailability	nsubj	49	SENT_282	[p18l1794t3252r2137b3321, p18l12t3373r199b3463],
44	in	IN	O	in	_	0	SENT_282	[p18l256t3378r325b3441],
45	the	DT	O	the	det	46	SENT_282	[p18l385t3373r493b3442],
46	presence	NN	O	presence	prep_in	43	SENT_282	[p18l552t3400r854b3464],
47	of	IN	O	of	_	0	SENT_282	[p18l916t3373r997b3442],
48	entacapone	NN	O	entacapone	prep_of	46	SENT_282	[p18l1045t3396r1445b3464],
49	increased	VBD	O	increase	_	0	SENT_282	[p18l1507t3373r1833b3442],
50	less	RBR	O	less	advmod	49	SENT_282	[p18l1892t3373r2008b3442],
51	in	IN	O	in	_	0	SENT_282	[p18l2071t3378r2139b3441],
52	COM	NNP	O	COM	nn	53	SENT_282	[p18l18t3499r229b3565],
53	Ta	NNP	O	Ta	prep_in	49	SENT_282	[p18l233t3480r354b3564],
54	than	IN	O	than	prep	49	SENT_282	[p18l393t3496r551b3565],
55	in	IN	O	in	pcomp	54	SENT_282	[p18l590t3501r659b3564],
56	COM	NNP	O	COM	nn	58	SENT_282	[p18l706t3499r916b3565],
57	THH	NN	O	thh	nn	58	SENT_282	[p18l919t3480r1079b3564],
58	patients	NNS	O	patient	pobj	55	SENT_282	[p18l1108t3501r1407b3587],
59	.	.	O	.	_	0	SENT_282	[p18l1108t3501r1407b3587],

1	Because	IN	O	because	_	0	SENT_283	[p18l1452t3500r1730b3566],
2	COMT	NNP	O	COMT	prep_because	5	SENT_283	[p18l1771t3498r2052b3565],
3	is	VBZ	O	be	cop	5	SENT_283	[p18l2089t3501r2138b3565],
4	ex	FW	O	ex	nn	5	SENT_283	[p18l12t3648r87b3688],
5	ressed	FW	O	ressed	_	0	SENT_283	[p18l137t3620r346b3689],
6	in	IN	O	in	_	0	SENT_283	[p18l382t3624r451b3687],
7	several	JJ	O	several	amod	8	SENT_283	[p18l486t3620r719b3688],
8	tissues	NNS	O	tissue	prep_in	5	SENT_283	[p18l755t3624r998b3698],
9	,	,	O	,	_	0	SENT_283	[p18l755t3624r998b3698],
10	includin	NN	O	includin	nn	11	SENT_283	[p18l1038t3620r1335b3689],
11	blood	NN	O	blood	appos	8	SENT_283	[p18l1414t3620r1638b3698],
12	,	,	O	,	_	0	SENT_283	[p18l1414t3620r1638b3698],
13	liver	NN	O	liver	appos	8	SENT_283	[p18l1677t3620r1845b3698],
14	,	,	O	,	_	0	SENT_283	[p18l1677t3620r1845b3698],
15	kidne	NN	O	kidne	appos	8	SENT_283	[p18l1883t3620r2082b3689],
16	,	,	O	,	_	0	SENT_283	[p18l2121t3675r2135b3698],
17	P	NN	O	p	appos	8	SENT_283	[p18l88t3647r131b3711],
18	8	CD	NUMBER	8	num	19	SENT_283	[p18l1339t3648r1379b3712],
19	Y	NN	O	y	nsubj	5	SENT_283	[p18l2083t3649r2126b3710],

1	and	CC	O	and	dep	3	SENT_284	[p19l12t21r143b90],
2	gastrointestinal	JJ	O	gastrointestinal	amod	3	SENT_284	[p19l181t21r723b113],
3	tract	NN	O	tract	dep	7	SENT_284	[p19l763t44r940b99],
4	,	,	O	,	_	0	SENT_284	[p19l763t44r940b99],
5	it	PRP	O	it	nsubj	7	SENT_284	[p19l983t26r1032b89],
6	is	VBZ	O	be	cop	7	SENT_284	[p19l1070t26r1120b89],
7	difficult	JJ	O	difficult	dep	14	SENT_284	[p19l1160t21r1443b90],
8	to	TO	O	to	aux	9	SENT_284	[p19l1482t44r1549b89],
9	know	VB	O	know	xcomp	7	SENT_284	[p19l1589t21r1789b90],
10	at	IN	O	at	_	0	SENT_284	[p19l1825t44r1888b89],
11	which	WDT	O	which	dobj	13	SENT_284	[p19l1922t21r2140b90],
12	levels	NNS	O	level	nsubj	13	SENT_284	[p19l11t142r197b211],
13	entacapone	VBP	O	entacapone	prepc_at	9	SENT_284	[p19l239t165r641b234],
14	acts	VBZ	O	act	_	0	SENT_284	[p19l681t127r866b211],
15	.5	CD	NUMBER	.5	num	17	SENT_284	[p19l681t127r866b211],
16	Previous	JJ	O	previous	amod	17	SENT_284	[p19l911t147r1210b212],
17	studies	NNS	O	study	nsubj	19	SENT_284	[p19l1251t142r1491b212],
18	have	VBP	O	have	aux	19	SENT_284	[p19l1532t142r1692b211],
19	shown	VBN	O	show	ccomp	14	SENT_284	[p19l1732t142r1960b211],
20	that	IN	O	that	complm	22	SENT_284	[p19l2001t142r2140b211],
21	entacapone	NN	O	entacapone	nsubj	22	SENT_284	[p19l12t287r413b355],
22	increases	VBZ	O	increase	ccomp	19	SENT_284	[p19l467t269r774b333],
23	the	DT	O	the	det	26	SENT_284	[p19l829t264r937b333],
24	half	NN	O	half	nn	26	SENT_284	[p19l989t264r1265b333],
25	—	JJ	O	—	amod	26	SENT_284	[p19l989t264r1265b333],
26	life	NN	O	life	dobj	22	SENT_284	[p19l989t264r1265b333],
27	of	IN	O	of	_	0	SENT_284	[p19l1317t264r1398b333],
28	L	NN	O	l	nn	30	SENT_284	[p19l1438t264r1714b355],
29	—	CD	NUMBER	—	num	30	SENT_284	[p19l1438t264r1714b355],
30	dopa	NN	O	dopa	prep_of	26	SENT_284	[p19l1438t264r1714b355],
31	,	,	O	,	_	0	SENT_284	[p19l1438t264r1714b355],
32	suggesting	VBG	O	suggest	partmod	22	SENT_284	[p19l1771t269r2141b356],
33	that	IN	O	that	complm	45	SENT_284	[p19l12t385r151b454],
34	the	DT	O	the	det	36	SENT_284	[p19l193t385r301b454],
35	relative	JJ	O	relative	amod	36	SENT_284	[p19l344t385r599b454],
36	increase	NN	O	increase	nsubjpass	45	SENT_284	[p19l641t390r921b454],
37	in	IN	O	in	_	0	SENT_284	[p19l964t390r1032b453],
38	the	DT	O	the	det	39	SENT_284	[p19l1075t385r1183b454],
39	bioavailability	NN	O	bioavailability	prep_in	36	SENT_284	[p19l1225t385r1732b476],
40	of	IN	O	of	_	0	SENT_284	[p19l1771t385r1851b454],
41	L	NN	O	l	nn	43	SENT_284	[p19l1882t385r2141b476],
42	—	CD	NUMBER	—	num	43	SENT_284	[p19l1882t385r2141b476],
43	dopa	NN	O	dopa	prep_of	39	SENT_284	[p19l1882t385r2141b476],
44	is	VBZ	O	be	auxpass	45	SENT_284	[p19l12t510r61b574],
45	related	VBN	O	relate	ccomp	32	SENT_284	[p19l117t506r356b574],
46	to	TO	O	to	_	0	SENT_284	[p19l410t529r477b574],
47	a	DT	O	a	det	48	SENT_284	[p19l534t534r569b574],
48	decrease	NN	O	decrease	prep_to	45	SENT_284	[p19l622t506r912b574],
49	in	IN	O	in	_	0	SENT_284	[p19l967t510r1036b573],
50	its	PRP$	O	its	poss	53	SENT_284	[p19l1091t510r1168b574],
51	elimination	NN	O	elimination	nn	53	SENT_284	[p19l1224t488r1828b574],
52	.6	CD	NUMBER	.6	num	53	SENT_284	[p19l1224t488r1828b574],
53	’	NN	O	’	prep_in	48	SENT_284	[p19l1224t488r1828b574],
54	8	CD	NUMBER	8	number	55	SENT_284	[p19l1224t488r1828b574],
55	’21	CD	NUMBER	’21	nsubj	14	SENT_284	[p19l1224t488r1828b574],
56	In	IN	O	in	_	0	SENT_284	[p19l1890t510r1965b573],
57	our	PRP$	O	we	poss	58	SENT_284	[p19l2018t533r2140b574],
58	study	NN	O	study	prep_in	61	SENT_284	[p19l12t627r215b717],
59	,	,	O	,	_	0	SENT_284	[p19l12t627r215b717],
60	entacapone	NN	O	entacapone	nsubj	71	SENT_284	[p19l268t650r670b718],
61	increased	VBD	O	increase	rcmod	55	SENT_284	[p19l721t627r1048b696],
62	the	DT	O	the	det	65	SENT_284	[p19l1099t627r1207b696],
63	half	NN	O	half	nn	65	SENT_284	[p19l1256t627r1532b696],
64	—	JJ	O	—	amod	65	SENT_284	[p19l1256t627r1532b696],
65	life	NN	O	life	dobj	61	SENT_284	[p19l1256t627r1532b696],
66	of	IN	O	of	_	0	SENT_284	[p19l1583t627r1663b696],
67	L	NN	O	l	nn	69	SENT_284	[p19l1702t627r1960b718],
68	—	CD	NUMBER	—	num	69	SENT_284	[p19l1702t627r1960b718],
69	dopa	NN	O	dopa	prep_of	65	SENT_284	[p19l1702t627r1960b718],
70	and	CC	O	and	_	0	SENT_284	[p19l2009t627r2140b697],
71	decreased	VBD	O	decrease	conj_and	61	SENT_284	[p19l12t748r352b817],
72	its	PRP$	O	its	poss	73	SENT_284	[p19l401t752r478b816],
73	clearance	NN	O	clearance	dobj	71	SENT_284	[p19l529t747r870b816],
74	.	.	O	.	_	0	SENT_284	[p19l529t747r870b816],

1	Only	RB	O	only	advmod	3	SENT_285	[p19l926t748r1111b838],
2	the	DT	O	the	det	3	SENT_285	[p19l1158t748r1266b816],
3	clearance	NN	O	clearance	nsubjpass	5	SENT_285	[p19l1316t748r1638b816],
4	was	VBD	O	be	auxpass	5	SENT_285	[p19l1685t776r1813b816],
5	affected	VBN	O	affect	_	0	SENT_285	[p19l1864t747r2139b817],
6	in	IN	O	in	_	0	SENT_285	[p19l12t874r81b936],
7	COM	NNP	MISC	COM	prep_in	5	SENT_285	[p19l134t872r344b938],
8	Tu	FW	MISC	tu	nn	9	SENT_285	[p19l348t852r469b936],
9	patients	NNS	O	patient	dep	5	SENT_285	[p19l513t874r811b960],
10	.	.	O	.	_	0	SENT_285	[p19l513t874r811b960],

1	We	PRP	O	we	nsubj	2	SENT_286	[p19l858t873r977b938],
2	found	VBD	O	find	_	0	SENT_286	[p19l1023t869r1237b939],
3	no	DT	O	no	det	5	SENT_286	[p19l1283t896r1371b938],
4	significant	JJ	O	significant	amod	5	SENT_286	[p19l1419t869r1790b961],
5	effect	NN	O	effect	dobj	2	SENT_286	[p19l1835t869r2025b938],
6	of	IN	O	of	_	0	SENT_286	[p19l2071t869r2151b938],
7	the	DT	O	the	det	10	SENT_286	[p19l12t990r121b1059],
8	COM	NN	O	com	nn	10	SENT_286	[p19l175t994r385b1059],
9	T	NN	O	t	nn	10	SENT_286	[p19l389t993r448b1058],
10	genotype	NN	O	genotype	prep_of	5	SENT_286	[p19l480t1014r803b1082],
11	on	IN	O	on	_	0	SENT_286	[p19l852t1018r942b1059],
12	the	DT	O	the	det	14	SENT_286	[p19l989t990r1098b1059],
13	motor	NN	O	motor	nn	14	SENT_286	[p19l1145t1013r1367b1059],
14	response	NN	O	response	prep_on	10	SENT_286	[p19l1414t1017r1717b1082],
15	to	TO	O	to	_	0	SENT_286	[p19l1766t1013r1833b1059],
16	L	NN	O	l	nn	18	SENT_286	[p19l1882t990r2141b1082],
17	—	CD	NUMBER	—	num	18	SENT_286	[p19l1882t990r2141b1082],
18	dopa	NN	O	dopa	prep_to	2	SENT_286	[p19l1882t990r2141b1082],
19	alone	RB	O	alone	advmod	21	SENT_286	[p19l12t1111r200b1180],
20	(	RB	O	(	advmod	21	SENT_286	[p19l246t1111r624b1193],
21	associated	VBN	O	associate	partmod	18	SENT_286	[p19l246t1111r624b1193],
22	with	IN	O	with	_	0	SENT_286	[p19l661t1111r823b1180],
23	placebo	NN	O	placebo	nn	24	SENT_286	[p19l861t1111r1183b1202],
24	)	NN	O	)	prep_with	21	SENT_286	[p19l861t1111r1183b1202],
25	.	.	O	.	_	0	SENT_286	[p19l861t1111r1183b1202],

1	Similarly	RB	O	similarly	advmod	19	SENT_287	[p19l1228t1111r1560b1201],
2	,	,	O	,	_	0	SENT_287	[p19l1228t1111r1560b1201],
3	the	DT	O	the	det	4	SENT_287	[p19l1604t1111r1712b1180],
4	pharmacokinetics	NNS	O	pharmacokinetic	dep	10	SENT_287	[p19l1752t1111r2137b1202, p19l11t1232r281b1301],
5	of	IN	O	of	_	0	SENT_287	[p19l320t1232r401b1301],
6	L	NN	O	l	prep_of	4	SENT_287	[p19l426t1232r685b1323],
7	—	CD	NUMBER	—	num	8	SENT_287	[p19l426t1232r685b1323],
8	dopa	NN	O	dopa	dep	10	SENT_287	[p19l426t1232r685b1323],
9	(	CD	NUMBER	(	num	10	SENT_287	[p19l725t1233r958b1314],
10	AUC	NN	O	auc	dep	19	SENT_287	[p19l725t1233r958b1314],
11	,	,	O	,	_	0	SENT_287	[p19l725t1233r958b1314],
12	Tmax	NN	O	tmax	conj_and	10	SENT_287	[p19l997t1234r1216b1310],
13	,	,	O	,	_	0	SENT_287	[p19l997t1234r1216b1310],
14	and	CC	O	and	_	0	SENT_287	[p19l1258t1232r1388b1301],
15	Cmax	NN	O	cmax	conj_and	10	SENT_287	[p19l1426t1233r1662b1314],
16	)	NN	O	)	nsubj	19	SENT_287	[p19l1426t1233r1662b1314],
17	did	VBD	O	do	aux	19	SENT_287	[p19l1705t1232r1822b1301],
18	not	RB	O	not	neg	19	SENT_287	[p19l1858t1255r1977b1301],
19	differ	VB	O	differ	_	0	SENT_287	[p19l2014t1232r2137b1302, p19l12t1352r104b1421],
20	signiﬁcantly	RB	O	signiﬁcantly	advmod	19	SENT_287	[p19l165t1352r601b1445],
21	between	IN	O	between	_	0	SENT_287	[p19l660t1352r952b1421],
22	genotype	NN	O	genotype	nn	23	SENT_287	[p19l1014t1376r1336b1445],
23	groups	NNS	O	group	prep_between	19	SENT_287	[p19l1398t1380r1657b1445],
24	.	.	O	.	_	0	SENT_287	[p19l1398t1380r1657b1445],

1	This	DT	O	this	det	2	SENT_288	[p19l1722t1353r1883b1421],
2	result	NN	O	result	nsubj	3	SENT_288	[p19l1945t1353r2140b1422],
3	confirms	VBZ	O	confirm	_	0	SENT_288	[p19l12t1474r326b1543],
4	the	DT	O	the	det	8	SENT_288	[p19l396t1474r504b1543],
5	previously	RB	DATE	previously	advmod	6	SENT_288	[p19l573t1474r941b1566],
6	reported	VBN	O	report	amod	8	SENT_288	[p19l1008t1474r1310b1566],
7	small	JJ	O	small	amod	8	SENT_288	[p19l1379t1474r1563b1543],
8	effect	NN	O	effect	dobj	3	SENT_288	[p19l1633t1474r1824b1543],
9	of	IN	O	of	_	0	SENT_288	[p19l1893t1474r1973b1543],
10	the	DT	O	the	det	12	SENT_288	[p19l2030t1474r2138b1543],
11	COMT	NNP	ORGANIZATION	COMT	nn	12	SENT_288	[p19l13t1576r295b1643],
12	polymorphism	NN	O	polymorphism	prep_of	8	SENT_288	[p19l335t1574r864b1666],
13	on	IN	O	on	_	0	SENT_288	[p19l907t1602r997b1643],
14	pharmacodynamics	NNS	O	pharmacodynamic	prep_on	12	SENT_288	[p19l1038t1574r1732b1666],
15	and	CC	O	and	_	0	SENT_288	[p19l1777t1574r1908b1644],
16	pharmacokinetics	NNS	O	pharmacokinetic	conj_and	14	SENT_288	[p19l1947t1574r2137b1666, p19l12t1695r476b1764],

1	of	IN	O	of	csubj	10	SENT_289	[p19l543t1695r624b1764],
2	L	NN	O	l	nn	4	SENT_289	[p19l678t1681r969b1786],
3	—	CD	NUMBER	—	num	4	SENT_289	[p19l678t1681r969b1786],
4	dopa2	NN	O	dopa2	pobj	1	SENT_289	[p19l678t1681r969b1786],
5	and	CC	O	and	_	0	SENT_289	[p19l1159t1695r1289b1764],
6	remains	VBZ	O	remain	csubj	10	SENT_289	[p19l1355t1700r1633b1764],
7	to	TO	O	to	aux	8	SENT_289	[p19l1700t1719r1767b1764],
8	be	VB	O	be	xcomp	6	SENT_289	[p19l1835t1695r1914b1764],
9	fully	RB	O	fully	advmod	8	SENT_289	[p19l1980t1695r2142b1785],
10	explained	VBN	O	explain	_	0	SENT_289	[p19l12t1816r370b1907],
11	.	.	O	.	_	0	SENT_289	[p19l12t1816r370b1907],

1	It	PRP	O	it	nsubj	2	SENT_290	[p19l431t1821r485b1885],
2	suggests	VBZ	O	suggest	_	0	SENT_290	[p19l538t1839r840b1908],
3	,	,	O	,	_	0	SENT_290	[p19l538t1839r840b1908],
4	however	RB	O	however	advmod	2	SENT_290	[p19l899t1816r1210b1895],
5	,	,	O	,	_	0	SENT_290	[p19l899t1816r1210b1895],
6	that	IN	O	that	_	0	SENT_290	[p19l1268t1816r1408b1885],
7	mechanisms	NNS	O	mechanism	prep_that	2	SENT_290	[p19l1461t1816r1897b1885],
8	other	JJ	O	other	advmod	7	SENT_290	[p19l1953t1816r2140b1885],

1	January	NNP	DATE	January	_	0	SENT_291	[p19l6t2076r244b2149],
2	2011	CD	DATE	2011	dep	1	SENT_291	[p19l272t2078r420b2130],

1	Corvol	NNP	O	Corvol	nn	3	SENT_292	[p19l602t2175r828b2237],
2	et	FW	O	et	nn	3	SENT_292	[p19l864t2187r932b2236],
3	aI	NNP	O	aI	_	0	SENT_292	[p19l963t2175r1036b2236],
4	:	:	O	:	_	0	SENT_292	[p19l963t2175r1036b2236],
5	COMT	NNP	O	COMT	dep	3	SENT_292	[p19l1072t2177r1309b2237],
6	and	CC	O	and	_	0	SENT_292	[p19l1339t2175r1464b2236],
7	Entacapone	NNP	O	Entacapone	dep	3	SENT_292	[p19l1503t2178r1917b2254],
8	in	IN	O	in	_	0	SENT_292	[p19l1952t2178r2005b2236],
9	PD	NN	O	pd	prep_in	5	SENT_292	[p19l2044t2178r2140b2236],

1	than	IN	O	than	_	0	SENT_293	[p19l11t2423r169b2492],
2	the	DT	O	the	det	4	SENT_293	[p19l248t2423r357b2492],
3	COMT	NN	O	comt	nn	4	SENT_293	[p19l437t2425r719b2492],
4	pathway	NN	O	pathway	prep_than	6	SENT_293	[p19l796t2423r1098b2514],
5	are	VBP	O	be	auxpass	6	SENT_293	[p19l1174t2451r1276b2492],
6	involved	VBN	O	involve	_	0	SENT_293	[p19l1355t2423r1659b2493],
7	in	IN	O	in	_	0	SENT_293	[p19l1737t2428r1805b2491],
8	L	NN	O	l	prep_in	6	SENT_293	[p19l1884t2423r2143b2514],
9	—	CD	NUMBER	—	num	11	SENT_293	[p19l1884t2423r2143b2514],
10	dopa	NN	O	dopa	nn	11	SENT_293	[p19l1884t2423r2143b2514],
11	metabolism	NN	O	metabolism	nsubjpass	6	SENT_293	[p19l10t2539r448b2608],
12	.	.	O	.	_	0	SENT_293	[p19l10t2539r448b2608],

1	In	IN	O	in	_	0	SENT_294	[p19l217t2667r292b2730],
2	this	DT	O	this	det	3	SENT_294	[p19l327t2663r452b2731],
3	proof	NN	O	proof	prep_in	15	SENT_294	[p19l487t2663r694b2754],
4	of	IN	O	of	_	0	SENT_294	[p19l717t2663r798b2731],
5	concept	NN	O	concept	nn	6	SENT_294	[p19l821t2686r1099b2754],
6	study	NN	O	study	prep_of	3	SENT_294	[p19l1133t2663r1337b2753],
7	,	,	O	,	_	0	SENT_294	[p19l1133t2663r1337b2753],
8	the	DT	O	the	det	9	SENT_294	[p19l1375t2663r1484b2731],
9	response	NN	O	response	nsubjpass	15	SENT_294	[p19l1520t2690r1823b2754],
10	to	TO	O	to	_	0	SENT_294	[p19l1859t2686r1926b2731],
11	entacapone	NN	O	entacapone	prep_to	9	SENT_294	[p19l1963t2686r2140b2731, p19l11t2840r261b2904],
12	of	IN	O	of	prep	11	SENT_294	[p19l308t2813r389b2882],
13	was	VBD	O	be	auxpass	15	SENT_294	[p19l420t2841r548b2882],
14	not	RB	O	not	neg	15	SENT_294	[p19l597t2836r716b2882],
15	assessed	VBN	O	assess	_	0	SENT_294	[p19l762t2813r1039b2883],
16	in	IN	O	in	_	0	SENT_294	[p19l1085t2818r1154b2881],
17	patients	NNS	O	patient	prep_in	15	SENT_294	[p19l1200t2818r1479b2904],
18	with	IN	O	with	_	0	SENT_294	[p19l1524t2813r1685b2882],
19	a	DT	O	a	det	21	SENT_294	[p19l1731t2841r1767b2882],
20	heterozygous	JJ	O	heterozygous	amod	21	SENT_294	[p19l1811t2813r2139b2903, p19l10t2987r171b3050],
21	genotype	NN	O	genotype	prep_with	17	SENT_294	[p19l218t2981r560b3050],
22	.	.	O	.	_	0	SENT_294	[p19l218t2981r560b3050],

1	Because	IN	O	because	mark	8	SENT_295	[p19l613t2963r891b3028],
2	the	DT	O	the	det	6	SENT_295	[p19l938t2958r1047b3027],
3	COM	NN	O	com	nn	6	SENT_295	[p19l1100t2961r1310b3027],
4	T	NN	O	t	nn	6	SENT_295	[p19l1314t2961r1374b3025],
5	gene	NN	O	gene	nn	6	SENT_295	[p19l1404t2986r1565b3050],
6	polymorphism	NN	O	polymorphism	nsubj	8	SENT_295	[p19l1611t2958r2140b3049],
7	is	VBZ	O	be	cop	8	SENT_295	[p19l11t3115r60b3179],
8	codominant	JJ	O	codominant	advcl	15	SENT_295	[p19l136t3110r589b3189],
9	,	,	O	,	_	0	SENT_295	[p19l136t3110r589b3189],
10	an	DT	O	a	det	12	SENT_295	[p19l703t3137r786b3179],
11	intermediate	JJ	O	intermediate	amod	12	SENT_295	[p19l861t3110r1312b3180],
12	response	NN	O	response	nsubjpass	15	SENT_295	[p19l1387t3137r1691b3201],
13	would	MD	O	would	aux	15	SENT_295	[p19l1762t3110r1988b3180],
14	be	VB	O	be	auxpass	15	SENT_295	[p19l2061t3110r2141b3179],
15	expected	VBN	O	expect	_	0	SENT_295	[p19l11t3251r320b3343],
16	in	IN	O	in	_	0	SENT_295	[p19l374t3256r443b3319],
17	COM	NNP	O	COM	nn	19	SENT_295	[p19l505t3255r715b3320],
18	THL	NNP	ORGANIZATION	THL	nn	19	SENT_295	[p19l719t3235r855b3319],
19	patients	NNS	O	patient	prep_in	15	SENT_295	[p19l908t3256r1207b3343],
20	.	.	O	.	_	0	SENT_295	[p19l908t3256r1207b3343],

1	Indeed	RB	O	indeed	advmod	4	SENT_296	[p19l1268t3251r1531b3330],
2	,	,	O	,	_	0	SENT_296	[p19l1268t3251r1531b3330],
3	we	PRP	O	we	nsubj	4	SENT_296	[p19l1587t3280r1684b3320],
4	observed	VBD	O	observe	_	0	SENT_296	[p19l1740t3251r2053b3321],
5	a	DT	O	a	det	7	SENT_296	[p19l2108t3280r2143b3320],
6	linear	JJ	O	linear	amod	7	SENT_296	[p19l10t3367r210b3435],
7	relationship	NN	O	relationship	dobj	4	SENT_296	[p19l250t3367r670b3458],
8	between	IN	O	between	_	0	SENT_296	[p19l712t3367r1006b3435],
9	COMT	NN	O	comt	nn	10	SENT_296	[p19l1046t3368r1328b3435],
10	inhibition	NN	O	inhibition	prep_between	7	SENT_296	[p19l1365t3367r1724b3435],
11	by	IN	O	by	_	0	SENT_296	[p19l1764t3367r1852b3457],
12	entacapone	NN	O	entacapone	prep_by	4	SENT_296	[p19l1888t3390r2139b3435, p19l10t3510r186b3574],
13	and	CC	O	and	_	0	SENT_296	[p19l233t3483r363b3552],
14	the	DT	O	the	det	16	SENT_296	[p19l409t3483r517b3551],
15	basal	JJ	O	basal	amod	16	SENT_296	[p19l564t3483r736b3551],
16	activity	NN	O	activity	prep_by	4	SENT_296	[p19l783t3487r1043b3573],
17	of	IN	O	of	_	0	SENT_296	[p19l1087t3482r1168b3551],
18	the	DT	O	the	det	19	SENT_296	[p19l1202t3483r1311b3551],
19	enzyme	NN	O	enzyme	prep_of	16	SENT_296	[p19l1357t3510r1644b3573],
20	.	.	O	.	_	0	SENT_296	[p19l1357t3510r1644b3573],

1	In	IN	O	in	_	0	SENT_297	[p19l1696t3487r1771b3550],
2	addition	NN	O	addition	prep_in	7	SENT_297	[p19l1817t3483r2137b3561],
3	,	,	O	,	_	0	SENT_297	[p19l1817t3483r2137b3561],
4	COMT	NN	O	comt	nn	5	SENT_297	[p19l12t3601r294b3668],
5	inhibition	NN	O	inhibition	nsubjpass	7	SENT_297	[p19l339t3599r699b3667],
6	was	VBD	O	be	auxpass	7	SENT_297	[p19l744t3627r872b3667],
7	correlated	VBN	O	correlate	_	0	SENT_297	[p19l922t3599r1276b3668],
8	with	IN	O	with	_	0	SENT_297	[p19l1320t3599r1482b3667],
9	the	DT	O	the	det	11	SENT_297	[p19l1530t3599r1639b3667],
10	plasma	NN	O	plasma	nn	11	SENT_297	[p19l1686t3599r1936b3690],
11	concentration	NN	O	concentration	prep_with	7	SENT_297	[p19l1983t3626r2139b3667, p19l11t3726r375b3789],
12	of	IN	O	of	_	0	SENT_297	[p19l416t3721r496b3789],
13	entacapone	NN	O	entacapone	prep_of	11	SENT_297	[p19l525t3744r946b3812],
14	,	,	O	,	_	0	SENT_297	[p19l525t3744r946b3812],
15	suggesting	VBG	O	suggest	xcomp	7	SENT_297	[p19l991t3726r1362b3813],
16	that	IN	O	that	complm	26	SENT_297	[p19l1401t3721r1540b3789],
17	higher	JJR	O	higher	amod	18	SENT_297	[p19l1578t3721r1806b3813],
18	doses	NNS	O	dose	nsubj	26	SENT_297	[p19l1845t3721r2030b3790],
19	of	IN	O	of	_	0	SENT_297	[p19l2073t3721r2153b3789],
20	the	DT	O	the	det	21	SENT_297	[p20l11t56r119b124],
21	drug	NN	O	drug	prep_of	18	SENT_297	[p20l174t56r341b148],
22	might	MD	O	might	aux	26	SENT_297	[p20l393t56r607b148],
23	have	VB	O	have	aux	26	SENT_297	[p20l658t56r818b125],
24	been	VBN	O	be	cop	26	SENT_297	[p20l873t56r1038b124],
25	more	RBR	O	more	advmod	26	SENT_297	[p20l1092t83r1277b124],
26	effective	JJ	O	effective	ccomp	15	SENT_297	[p20l1331t56r1622b124],
27	in	IN	O	in	_	0	SENT_297	[p20l1677t60r1746b123],
28	COM	NNP	O	COM	prep_in	26	SENT_297	[p20l1807t59r2017b124],
29	Tu	FW	O	tu	nn	30	SENT_297	[p20l2021t40r2142b123],
30	patients	NNS	O	patient	dep	26	SENT_297	[p20l10t177r308b263],
31	.	.	O	.	_	0	SENT_297	[p20l10t177r308b263],

1	In	IN	O	in	_	0	SENT_298	[p20l354t177r430b240],
2	our	PRP$	O	we	poss	3	SENT_298	[p20l470t200r591b242],
3	study	NN	O	study	prep_in	11	SENT_298	[p20l630t172r833b263],
4	,	,	O	,	_	0	SENT_298	[p20l630t172r833b263],
5	the	DT	O	the	det	7	SENT_298	[p20l878t172r987b241],
6	recommended	VBN	O	recommend	amod	7	SENT_298	[p20l1028t172r1541b242],
7	dose	NN	O	dose	nsubjpass	11	SENT_298	[p20l1582t172r1739b242],
8	of	IN	O	of	_	0	SENT_298	[p20l1780t172r1861b241],
9	200mg	NN	O	200mg	prep_of	7	SENT_298	[p20l1889t179r2143b264],
10	was	VBD	O	be	auxpass	11	SENT_298	[p20l7t317r135b357],
11	used	VBN	O	use	_	0	SENT_298	[p20l184t288r360b358],
12	.	.	O	.	_	0	SENT_298	[p20l184t288r360b358],

1	Although	IN	O	although	dep	118	SENT_299	[p20l407t288r750b380],
2	a	DT	O	a	dep	118	SENT_299	[p20l797t317r832b357],
3	dose	NN	O	dose	dep	118	SENT_299	[p20l877t288r1446b380],
4	—	NN	O	—	dep	118	SENT_299	[p20l877t288r1446b380],
5	dependent	JJ	O	dependent	dep	118	SENT_299	[p20l877t288r1446b380],
6	effect	NN	O	effect	dep	118	SENT_299	[p20l1492t288r1682b357],
7	with	IN	O	with	dep	118	SENT_299	[p20l1725t288r1887b357],
8	up	RB	O	up	dep	118	SENT_299	[p20l1934t315r2023b380],
9	to	TO	O	to	dep	118	SENT_299	[p20l2072t312r2140b357],
10	800mg	CD	NUMBER	800mg	dep	118	SENT_299	[p20l13t411r265b496],
11	of	IN	O	of	dep	118	SENT_299	[p20l317t404r398b473],
12	entacapone	NN	O	entacapone	dep	118	SENT_299	[p20l439t428r841b496],
13	was	VBD	O	be	dep	118	SENT_299	[p20l892t433r1020b473],
14	previously	RB	DATE	previously	dep	118	SENT_299	[p20l1073t404r1442b496],
15	found	VBN	O	find	dep	118	SENT_299	[p20l1493t404r1707b474],
16	in	IN	O	in	dep	118	SENT_299	[p20l1760t409r1829b472],
17	healthy	JJ	O	healthy	dep	118	SENT_299	[p20l1881t404r2145b495],
18	VOlL1I1t	NN	O	voll1i1t	dep	118	SENT_299	[p20l8t508r469b605],
19	€	CD	NUMBER	€	dep	118	SENT_299	[p20l8t508r469b605],
20	€	NN	MONEY	€	dep	118	SENT_299	[p20l8t508r469b605],
21	1	CD	MONEY	1	dep	118	SENT_299	[p20l8t508r469b605],
22	‘	CD	MONEY	‘	dep	118	SENT_299	[p20l8t508r469b605],
23	S	NN	O	s	dep	118	SENT_299	[p20l8t508r469b605],
24	,24	CD	NUMBER	,24	dep	118	SENT_299	[p20l8t508r469b605],
25	in	IN	O	in	dep	118	SENT_299	[p20l521t531r590b594],
26	PD	NN	O	pd	dep	118	SENT_299	[p20l641t531r758b594],
27	patients	NNS	O	patient	dep	118	SENT_299	[p20l811t531r1111b618],
28	,	,	O	,	_	0	SENT_299	[p20l811t531r1111b618],
29	doses	NNS	O	dose	dep	118	SENT_299	[p20l1165t527r1350b596],
30	higher	JJR	O	higher	dep	118	SENT_299	[p20l1401t527r1630b619],
31	than	IN	O	than	dep	118	SENT_299	[p20l1680t527r1839b595],
32	200mg	CD	NUMBER	200mg	dep	118	SENT_299	[p20l1888t534r2143b619],
33	failed	VBD	O	fail	dep	118	SENT_299	[p20l10t643r205b712],
34	to	TO	O	to	dep	118	SENT_299	[p20l241t666r309b711],
35	further	JJ	O	further	dep	118	SENT_299	[p20l347t643r595b712],
36	increase	NN	O	increase	dep	118	SENT_299	[p20l631t647r910b711],
37	the	DT	O	the	dep	118	SENT_299	[p20l947t643r1056b711],
38	bioavailability	NN	O	bioavailability	dep	118	SENT_299	[p20l1092t643r1599b733],
39	of	IN	O	of	dep	118	SENT_299	[p20l1632t643r1713b711],
40	L	NN	O	l	dep	118	SENT_299	[p20l1738t625r2138b734],
41	—	CD	NUMBER	—	dep	118	SENT_299	[p20l1738t625r2138b734],
42	dopa	NN	O	dopa	dep	118	SENT_299	[p20l1738t625r2138b734],
43	.6	CD	NUMBER	.6	dep	118	SENT_299	[p20l1738t625r2138b734],
44	’25	CD	NUMBER	’25	dep	118	SENT_299	[p20l1738t625r2138b734],
45	The	DT	O	the	dep	118	SENT_299	[p20l8t759r153b828],
46	cause	NN	O	cause	dep	118	SENT_299	[p20l188t788r373b829],
47	of	IN	O	of	dep	118	SENT_299	[p20l408t759r489b828],
48	this	DT	O	this	dep	118	SENT_299	[p20l512t759r637b828],
49	lack	NN	O	lack	dep	118	SENT_299	[p20l672t759r816b828],
50	of	IN	O	of	dep	118	SENT_299	[p20l847t759r928b828],
51	dose	NN	O	dose	dep	118	SENT_299	[p20l951t759r1107b829],
52	dependency	NN	O	dependency	dep	118	SENT_299	[p20l1143t759r1571b851],
53	in	IN	O	in	dep	118	SENT_299	[p20l1604t764r1673b827],
54	PD	NN	O	pd	dep	118	SENT_299	[p20l1708t764r1825b827],
55	remains	VBZ	O	remain	dep	118	SENT_299	[p20l1862t764r2140b828],
56	unknown	JJ	O	unknown	dep	118	SENT_299	[p20l11t875r372b953],
57	,	,	O	,	_	0	SENT_299	[p20l11t875r372b953],
58	but	CC	O	but	dep	118	SENT_299	[p20l412t875r532b944],
59	may	MD	O	may	dep	118	SENT_299	[p20l567t902r719b965],
60	be	VB	O	be	dep	118	SENT_299	[p20l753t875r833b943],
61	due	JJ	O	due	dep	118	SENT_299	[p20l869t875r997b944],
62	to	TO	O	to	dep	118	SENT_299	[p20l1034t898r1102b943],
63	an	DT	O	a	dep	118	SENT_299	[p20l1141t902r1223b943],
64	effect	NN	O	effect	dep	118	SENT_299	[p20l1260t874r1450b943],
65	on	IN	O	on	dep	118	SENT_299	[p20l1486t902r1576b943],
66	the	DT	O	the	dep	118	SENT_299	[p20l1612t874r1721b943],
67	absorption	NN	O	absorption	dep	118	SENT_299	[p20l1758t874r2141b966],
68	of	IN	O	of	dep	118	SENT_299	[p20l11t990r92b1059],
69	L	NN	O	l	dep	118	SENT_299	[p20l124t991r383b1082],
70	—	CD	NUMBER	—	dep	118	SENT_299	[p20l124t991r383b1082],
71	dopa	NN	O	dopa	dep	118	SENT_299	[p20l124t991r383b1082],
72	by	IN	O	by	dep	118	SENT_299	[p20l425t990r512b1081],
73	the	DT	O	the	dep	118	SENT_299	[p20l553t991r661b1059],
74	gut	NN	O	gut	dep	118	SENT_299	[p20l704t1014r820b1083],
75	or	CC	O	or	dep	118	SENT_299	[p20l862t1018r936b1059],
76	gastrointestinal	JJ	O	gastrointestinal	dep	118	SENT_299	[p20l979t991r1522b1083],
77	motility	NN	O	motility	dep	118	SENT_299	[p20l1566t972r2036b1081],
78	.5	CD	NUMBER	.5	dep	118	SENT_299	[p20l1566t972r2036b1081],
79	’	NN	O	’	dep	118	SENT_299	[p20l1566t972r2036b1081],
80	6	CD	NUMBER	6	dep	118	SENT_299	[p20l1566t972r2036b1081],
81	’21	CD	NUMBER	’21	dep	118	SENT_299	[p20l1566t972r2036b1081],
82	If	IN	O	if	dep	118	SENT_299	[p20l2087t990r2153b1058],
83	the	DT	O	the	dep	118	SENT_299	[p20l11t1107r119b1175],
84	COMT	NNP	O	COMT	dep	118	SENT_299	[p20l158t1109r441b1175],
85	genotype	NN	O	genotype	dep	118	SENT_299	[p20l478t1130r801b1199],
86	is	VBZ	O	be	dep	118	SENT_299	[p20l839t1111r888b1175],
87	to	TO	O	to	dep	118	SENT_299	[p20l927t1130r995b1175],
88	be	VB	O	be	dep	118	SENT_299	[p20l1034t1107r1114b1175],
89	used	VBN	O	use	dep	118	SENT_299	[p20l1152t1107r1311b1176],
90	to	TO	O	to	dep	118	SENT_299	[p20l1348t1130r1416b1175],
91	personalize	VB	O	personalize	dep	118	SENT_299	[p20l1454t1107r1850b1198],
92	entaca	NN	O	entaca	dep	118	SENT_299	[p20l1888t1130r2139b1175],
93	—	NN	O	—	dep	118	SENT_299	[p20l1888t1130r2139b1175],
94	pone	NN	O	pone	dep	118	SENT_299	[p20l10t1250r186b1314],
95	therapy	NN	O	therapy	dep	118	SENT_299	[p20l221t1223r492b1314],
96	in	IN	O	in	dep	118	SENT_299	[p20l524t1228r592b1290],
97	PD	NN	O	pd	dep	118	SENT_299	[p20l628t1227r767b1301],
98	,	,	O	,	_	0	SENT_299	[p20l628t1227r767b1301],
99	it	PRP	O	it	dep	118	SENT_299	[p20l807t1228r856b1291],
100	would	MD	O	would	dep	118	SENT_299	[p20l887t1223r1113b1292],
101	be	VB	O	be	dep	118	SENT_299	[p20l1147t1223r1227b1291],
102	of	IN	O	of	dep	118	SENT_299	[p20l1262t1223r1343b1291],
103	interest	NN	O	interest	dep	118	SENT_299	[p20l1366t1228r1628b1291],
104	to	TO	O	to	dep	118	SENT_299	[p20l1662t1246r1730b1291],
105	investigate	VB	O	investigate	dep	118	SENT_299	[p20l1767t1228r2141b1315],
106	the	DT	O	the	dep	118	SENT_299	[p20l11t1346r119b1414],
107	response	NN	O	response	dep	118	SENT_299	[p20l161t1373r464b1437],
108	of	IN	O	of	dep	118	SENT_299	[p20l507t1346r588b1414],
109	COM	NN	ORGANIZATION	com	dep	118	SENT_299	[p20l623t1349r834b1414],
110	7	CD	NUMBER	7	dep	118	SENT_299	[p20l837t1330r958b1413],
111	“	NN	O	“	dep	118	SENT_299	[p20l837t1330r958b1413],
112	subjects	NNS	O	subject	dep	118	SENT_299	[p20l998t1346r1275b1438],
113	to	TO	O	to	dep	118	SENT_299	[p20l1317t1369r1385b1414],
114	higher	JJR	O	higher	dep	118	SENT_299	[p20l1427t1346r1655b1438],
115	doses	NNS	O	dose	dep	118	SENT_299	[p20l1694t1346r1880b1415],
116	of	IN	O	of	dep	118	SENT_299	[p20l1923t1346r2003b1414],
117	the	DT	O	the	dep	118	SENT_299	[p20l2033t1346r2141b1414],
118	drug	NN	O	drug	_	0	SENT_299	[p20l11t1494r194b1586],
119	.	.	O	.	_	0	SENT_299	[p20l11t1494r194b1586],

1	In	IN	O	in	_	0	SENT_300	[p20l217t1615r292b1678],
2	conclusion	NN	O	conclusion	prep_in	6	SENT_300	[p20l329t1611r734b1689],
3	,	,	O	,	_	0	SENT_300	[p20l329t1611r734b1689],
4	our	PRP$	O	we	poss	5	SENT_300	[p20l775t1638r897b1680],
5	study	NN	O	study	nsubj	6	SENT_300	[p20l933t1611r1127b1701],
6	shows	VBZ	O	show	_	0	SENT_300	[p20l1160t1611r1371b1680],
7	that	IN	O	that	complm	20	SENT_300	[p20l1409t1611r1548b1679],
8	the	DT	O	the	det	9	SENT_300	[p20l1584t1611r1692b1679],
9	response	NN	O	response	nsubjpass	20	SENT_300	[p20l1730t1638r2034b1702],
10	to	TO	O	to	_	0	SENT_300	[p20l2072t1634r2139b1679],
11	entacapone	NN	O	entacapone	prep_to	9	SENT_300	[p20l11t1755r413b1823],
12	during	IN	O	during	_	0	SENT_300	[p20l458t1732r697b1824],
13	an	DT	O	a	det	18	SENT_300	[p20l740t1759r822b1800],
14	acute	JJ	O	acute	dep	15	SENT_300	[p20l867t1755r1050b1801],
15	L	NN	O	l	amod	18	SENT_300	[p20l1095t1732r1354b1823],
16	—	CD	NUMBER	—	num	18	SENT_300	[p20l1095t1732r1354b1823],
17	dopa	NN	O	dopa	nn	18	SENT_300	[p20l1095t1732r1354b1823],
18	challenge	NN	O	challenge	prep_during	11	SENT_300	[p20l1397t1732r1726b1824],
19	is	VBZ	O	be	auxpass	20	SENT_300	[p20l1771t1737r1820b1800],
20	affected	VBN	O	affect	ccomp	6	SENT_300	[p20l1866t1732r2142b1801],
21	by	IN	O	by	_	0	SENT_300	[p20l10t1848r98b1939],
22	a	DT	O	a	det	25	SENT_300	[p20l132t1877r168b1917],
23	frequent	JJ	O	frequent	amod	25	SENT_300	[p20l202t1848r505b1939],
24	Val158Met	NN	O	val158met	nn	25	SENT_300	[p20l538t1848r945b1921],
25	polymorphism	NN	O	polymorphism	agent	20	SENT_300	[p20l980t1848r1509b1939],
26	in	IN	O	in	_	0	SENT_300	[p20l1548t1853r1617b1916],
27	its	PRP$	O	its	poss	28	SENT_300	[p20l1655t1853r1732b1917],
28	target	NN	O	target	prep_in	25	SENT_300	[p20l1771t1871r1991b1940],
29	,	,	O	,	_	0	SENT_300	[p20l1771t1871r1991b1940],
30	the	DT	O	the	det	31	SENT_300	[p20l2033t1848r2141b1917],
31	enzyme	NN	O	enzyme	appos	28	SENT_300	[p20l11t1991r279b2054],
32	COMT	NNP	O	COMT	dep	31	SENT_300	[p20l319t1966r609b2032],
33	.	.	O	.	_	0	SENT_300	[p20l319t1966r609b2032],

1	Pharmacogenetics	NNS	O	pharmacogenetic	nsubj	4	SENT_301	[p20l653t1964r1296b2056],
2	may	MD	O	may	aux	4	SENT_301	[p20l1335t1991r1488b2054],
3	therefore	RB	O	therefore	advmod	4	SENT_301	[p20l1524t1964r1842b2032],
4	help	VB	O	help	_	0	SENT_301	[p20l1880t1964r2031b2055],
5	to	TO	O	to	aux	6	SENT_301	[p20l2072t1987r2139b2032],
6	understand	VB	O	understand	xcomp	4	SENT_301	[p20l11t2080r413b2149],
7	the	DT	O	the	det	9	SENT_301	[p20l454t2080r563b2149],
8	interindividual	JJ	O	interindividual	amod	9	SENT_301	[p20l605t2080r1136b2150],
9	Variability	NN	O	variability	dobj	6	SENT_301	[p20l1175t2080r1538b2170],
10	in	IN	O	in	_	0	SENT_301	[p20l1576t2085r1645b2148],
11	the	DT	O	the	det	12	SENT_301	[p20l1687t2080r1796b2149],
12	response	NN	O	response	prep_in	9	SENT_301	[p20l1837t2107r2141b2171],
13	to	TO	O	to	_	0	SENT_301	[p20l11t2220r79b2265],
14	treatment	NN	O	treatment	prep_to	6	SENT_301	[p20l137t2219r485b2265],
15	in	IN	O	in	_	0	SENT_301	[p20l540t2201r608b2264],
16	PD	NN	O	pd	nn	17	SENT_301	[p20l665t2201r782b2264],
17	patients	NNS	O	patient	prep_in	14	SENT_301	[p20l840t2201r1138b2287],
18	.	.	O	.	_	0	SENT_301	[p20l840t2201r1138b2287],

1	The	DT	O	the	det	3	SENT_302	[p20l1197t2196r1341b2265],
2	potential	JJ	O	potential	amod	3	SENT_302	[p20l1396t2196r1714b2287],
3	benefit	NN	O	benefit	nsubj	15	SENT_302	[p20l1771t2196r2017b2265],
4	of	IN	O	of	_	0	SENT_302	[p20l2073t2196r2153b2265],
5	genotyping	NN	O	genotyping	nn	6	SENT_302	[p20l10t2323r414b2410],
6	patients	NNS	O	patient	prep_of	3	SENT_302	[p20l452t2323r730b2409],
7	for	IN	O	for	_	0	SENT_302	[p20l771t2318r872b2386],
8	the	DT	O	the	det	9	SENT_302	[p20l911t2318r1019b2386],
9	management	NN	O	management	prep_for	6	SENT_302	[p20l1059t2341r1523b2410],
10	of	IN	O	of	_	0	SENT_302	[p20l1562t2318r1642b2386],
11	drug	NN	O	drug	nn	12	SENT_302	[p20l1671t2318r1836b2410],
12	therapy	NN	O	therapy	prep_of	9	SENT_302	[p20l1874t2318r2145b2409],
13	in	IN	O	in	_	0	SENT_302	[p20l11t2439r79b2502],
14	PD	NN	O	pd	prep_in	12	SENT_302	[p20l136t2439r253b2502],
15	needs	VBZ	O	need	_	0	SENT_302	[p20l311t2434r506b2504],
16	to	TO	O	to	aux	18	SENT_302	[p20l563t2458r631b2503],
17	be	VB	O	be	auxpass	18	SENT_302	[p20l688t2434r767b2503],
18	confirmed	VBN	O	confirm	conj_and	18	SENT_302	[p20l823t2434r1193b2504],
19	in	IN	O	in	_	0	SENT_302	[p20l1247t2439r1316b2502],
20	independent	JJ	O	independent	amod	21	SENT_302	[p20l1372t2434r1822b2525],
21	studies	NNS	O	study	prep_in	18	SENT_302	[p20l1876t2434r2137b2513],
22	,	,	O	,	_	0	SENT_302	[p20l1876t2434r2137b2513],
23	particularly	RB	O	particularly	advmod	18	SENT_302	[p20l10t2550r421b2642],
24	after	IN	O	after	_	0	SENT_302	[p20l460t2550r618b2619],
25	chronic	JJ	O	chronic	amod	26	SENT_302	[p20l660t2550r928b2619],
26	administration	NN	O	administration	prep_after	18	SENT_302	[p20l969t2550r1498b2620],
27	of	IN	O	of	_	0	SENT_302	[p20l1539t2550r1620b2619],
28	the	DT	O	the	det	30	SENT_302	[p20l1650t2550r1758b2619],
29	therapeutic	JJ	O	therapeutic	amod	30	SENT_302	[p20l1800t2550r2139b2642, p20l11t2676r98b2740],
30	agent	NN	O	agent	prep_of	26	SENT_302	[p20l134t2695r325b2764],
31	and	CC	O	and	_	0	SENT_302	[p20l361t2672r492b2741],
32	in	IN	O	in	_	0	SENT_302	[p20l529t2676r598b2739],
33	the	DT	O	the	det	35	SENT_302	[p20l635t2672r744b2740],
34	Whole	JJ	O	whole	amod	35	SENT_302	[p20l778t2672r993b2740],
35	population	NN	O	population	prep_in	18	SENT_302	[p20l1029t2672r1444b2763],
36	,	,	O	,	_	0	SENT_302	[p20l1029t2672r1444b2763],
37	including	VBG	O	include	_	0	SENT_302	[p20l1485t2672r1826b2764],
38	patients	NNS	O	patient	prep_including	35	SENT_302	[p20l1862t2676r2140b2763],
39	with	IN	O	with	_	0	SENT_302	[p20l7t2788r169b2857],
40	a	DT	O	a	det	42	SENT_302	[p20l204t2817r240b2857],
41	heterozygous	JJ	O	heterozygous	amod	42	SENT_302	[p20l272t2788r736b2880],
42	genotype	NN	O	genotype	prep_with	38	SENT_302	[p20l772t2811r1115b2880],
43	.	.	O	.	_	0	SENT_302	[p20l772t2811r1115b2880],

1	Acknowledgment	NNP	O	Acknowledgment	nsubjpass	5	SENT_303	[p20l8t3132r851b3235],
2	This	DT	O	this	det	3	SENT_303	[p20l8t3253r169b3322],
3	trial	NN	O	trial	dep	1	SENT_303	[p20l224t3253r364b3322],
4	was	VBD	O	be	auxpass	5	SENT_303	[p20l415t3282r542b3322],
5	funded	VBN	O	fund	_	0	SENT_303	[p20l596t3253r849b3323],
6	by	IN	O	by	_	0	SENT_303	[p20l902t3253r989b3344],
7	a	DT	O	a	det	8	SENT_303	[p20l1038t3282r1074b3322],
8	grant	NN	O	grant	agent	5	SENT_303	[p20l1125t3276r1311b3345],
9	from	IN	O	from	_	0	SENT_303	[p20l1363t3253r1536b3322],
10	the	DT	O	the	det	14	SENT_303	[p20l1590t3253r1699b3322],
11	AssistancePublique	NNP	O	AssistancePublique	nn	14	SENT_303	[p20l1747t3257r2139b3322, p20l11t3363r330b3455],
12	Hopitaux	NNP	O	Hopitaux	nn	14	SENT_303	[p20l373t3364r716b3455],
13	de	IN	O	de	amod	14	SENT_303	[p20l755t3363r835b3433],
14	Paris	NNP	LOCATION	Paris	prep_from	8	SENT_303	[p20l878t3368r1043b3432],
15	(	CD	NUMBER	(	num	16	SENT_303	[p20l1091t3365r1352b3445],
16	API-IP	NN	O	api-ip	tmod	8	SENT_303	[p20l1091t3365r1352b3445],
17	,	,	O	,	_	0	SENT_303	[p20l1091t3365r1352b3445],
18	grant	NN	O	grant	nn	20	SENT_303	[p20l1396t3387r1582b3455],
19	CRC_05170	NN	O	crc_05170	nn	20	SENT_303	[p20l1624t3364r2136b3446],
20	)	NN	O	)	appos	16	SENT_303	[p20l1624t3364r2136b3446],
21	.	.	O	.	_	0	SENT_303	[p20l1624t3364r2136b3446],

1	The	DT	O	the	det	2	SENT_304	[p20l8t3473r153b3541],
2	APHP	NNP	ORGANIZATION	APHP	nsubj	3	SENT_304	[p20l194t3476r429b3540],
3	promoted	VBD	O	promote	_	0	SENT_304	[p20l476t3473r831b3564],
4	the	DT	O	the	det	5	SENT_304	[p20l877t3473r986b3541],
5	study	NN	O	study	dobj	3	SENT_304	[p20l1032t3473r1226b3563],
6	and	CC	O	and	_	0	SENT_304	[p20l1269t3473r1400b3542],
7	participated	VBD	O	participate	conj_and	3	SENT_304	[p20l1444t3473r1871b3564],
8	in	IN	O	in	_	0	SENT_304	[p20l1918t3477r1987b3540],
9	the	DT	O	the	det	10	SENT_304	[p20l2033t3473r2141b3541],
10	design	NN	O	design	prep_in	7	SENT_304	[p20l11t3594r236b3686],
11	of	IN	O	of	_	0	SENT_304	[p20l273t3594r353b3663],
12	the	DT	O	the	det	16	SENT_304	[p20l377t3594r486b3663],
13	study	NN	O	study	nn	16	SENT_304	[p20l521t3594r716b3685],
14	and	CC	O	and	_	0	SENT_304	[p20l748t3594r879b3664],
15	data	NNS	O	datum	nn	16	SENT_304	[p20l914t3594r1064b3664],
16	monitoring	NN	O	monitoring	prep_of	10	SENT_304	[p20l1097t3599r1525b3686],
17	.	.	O	.	_	0	SENT_304	[p20l1097t3599r1525b3686],

1	Authorship	NN	O	authorship	nn	5	SENT_305	[p21l8t82r534b184],
2	Max	NN	PERSON	max	nn	5	SENT_305	[p21l10t237r172b301],
3	Dujardin	NNP	PERSON	Dujardin	nn	5	SENT_305	[p21l214t233r562b325],
4	,	,	O	,	_	0	SENT_305	[p21l214t233r562b325],
5	MD	NNP	O	MD	nsubj	6	SENT_305	[p21l609t237r761b300],
6	participated	VBD	O	participate	_	0	SENT_305	[p21l807t233r1234b324],
7	in	IN	O	in	_	0	SENT_305	[p21l1279t237r1348b300],
8	the	DT	O	the	det	9	SENT_305	[p21l1391t233r1500b301],
9	initiation	NN	O	initiation	prep_in	6	SENT_305	[p21l1545t237r1876b301],
10	of	IN	O	of	_	0	SENT_305	[p21l1920t233r2000b301],
11	the	DT	O	the	det	12	SENT_305	[p21l2033t233r2141b301],
12	study	NN	O	study	prep_of	9	SENT_305	[p21l10t343r213b434],
13	.	.	O	.	_	0	SENT_305	[p21l10t343r213b434],

1	Placebo	NN	O	placebo	nn	4	SENT_306	[p21l255t343r528b412],
2	and	CC	O	and	_	0	SENT_306	[p21l568t343r699b413],
3	entacapone	NN	O	entacapone	conj_and	1	SENT_306	[p21l736t367r1137b435],
4	stability	NN	O	stability	nsubjpass	6	SENT_306	[p21l1175t343r1459b434],
5	was	VBD	O	be	auxpass	6	SENT_306	[p21l1490t372r1618b412],
6	controlled	VBN	O	control	_	0	SENT_306	[p21l1656t343r2021b413],
7	by	IN	O	by	_	0	SENT_306	[p21l2057t343r2145b434],
8	the	DT	O	the	det	10	SENT_306	[p21l11t465r119b533],
9	French	JJ	MISC	french	amod	10	SENT_306	[p21l176t465r421b533],
10	agency	NN	O	agency	agent	6	SENT_306	[p21l477t492r719b557],
11	of	IN	O	of	_	0	SENT_306	[p21l772t464r852b533],
12	health	NN	O	health	nn	13	SENT_306	[p21l894t464r1115b533],
13	products	NNS	O	product	prep_of	10	SENT_306	[p21l1169t465r1480b556],
14	and	CC	O	and	_	0	SENT_306	[p21l1537t465r1668b534],
15	equipments	NNS	O	equipment	conj_and	10	SENT_306	[p21l1723t469r2140b556],
16	(	CD	NUMBER	(	num	15	SENT_306	[p21l15t576r297b667],
17	Agence	NNP	O	Agence	nn	20	SENT_306	[p21l15t576r297b667],
18	Générale	NNP	O	Générale	nn	20	SENT_306	[p21l339t575r656b643],
19	des	FW	O	des	nn	20	SENT_306	[p21l697t575r806b644],
20	Equipements	NNP	O	Equipements	dep	15	SENT_306	[p21l847t579r1319b666],
21	et	FW	O	et	nn	24	SENT_306	[p21l1362t598r1424b643],
22	Produits	FW	O	produits	nn	24	SENT_306	[p21l1463t575r1762b644],
23	de	FW	O	de	nn	24	SENT_306	[p21l1804t575r1884b644],
24	Santé	FW	O	santé	dep	10	SENT_306	[p21l1926t576r2138b653],
25	,	,	O	,	_	0	SENT_306	[p21l1926t576r2138b653],
26	Paris	NNP	LOCATION	Paris	nn	27	SENT_306	[p21l11t686r202b767],
27	)	NN	O	)	appos	24	SENT_306	[p21l11t686r202b767],
28	and	CC	O	and	_	0	SENT_306	[p21l249t685r380b754],
29	the	DT	O	the	det	30	SENT_306	[p21l420t685r529b753],
30	Department	NNP	ORGANIZATION	Department	agent	6	SENT_306	[p21l570t689r1009b776],
31	of	IN	ORGANIZATION	of	_	0	SENT_306	[p21l1050t684r1131b753],
32	Pharmacy	NNP	ORGANIZATION	Pharmacy	nn	34	SENT_306	[p21l1160t685r1526b775],
33	,	,	O	,	_	0	SENT_306	[p21l1160t685r1526b775],
34	Pitié	NNP	O	Pitié	prep_of	30	SENT_306	[p21l1571t685r2141b776],
35	.	.	O	.	_	0	SENT_306	[p21l1571t685r2141b776],

1	—	NN	O	—	_	0	SENT_307	[p21l1571t685r2141b776],
2	.	.	O	.	_	0	SENT_307	[p21l1571t685r2141b776],

1	Salpétriere	NNP	LOCATION	Salpétriere	nn	2	SENT_308	[p21l1571t685r2141b776],
2	Hospital	NNP	LOCATION	Hospital	_	0	SENT_308	[p21l11t795r338b886],
3	.	.	O	.	_	0	SENT_308	[p21l11t795r338b886],

1	ANNALS	NN	O	annals	_	0	SENT_309	[p21l6t1178r370b1245],
2	of	IN	O	of	_	0	SENT_309	[p21l429t1162r535b1274],
3	Neurology	NNP	O	Neurology	prep_of	1	SENT_309	[p21l542t1162r991b1274],

1	Potential	JJ	O	potential	amod	2	SENT_310	[p21l14t1445r434b1525],
2	Conflicts	NNS	O	conflict	_	0	SENT_310	[p21l480t1444r894b1525],
3	of	IN	O	of	_	0	SENT_310	[p21l936t1444r1033b1525],
4	Interest	NN	O	interest	prep_of	2	SENT_310	[p21l1074t1450r1438b1525],

1	Nothing	NN	O	nothing	_	0	SENT_311	[p21l7t1597r316b1690],
2	to	TO	O	to	aux	3	SENT_311	[p21l350t1621r419b1666],
3	report	VB	O	report	dep	1	SENT_311	[p21l457t1621r693b1689],
4	.	.	O	.	_	0	SENT_311	[p21l457t1621r693b1689],

1	References	NNS	O	reference	_	0	SENT_312	[p21l14t1968r537b2049],

1	Fahn	NNP	PERSON	Fahn	nn	4	SENT_313	[p21l177t2114r309b2165],
2	S.	NNP	PERSON	S.	nn	4	SENT_313	[p21l349t2116r395b2166],
3	Parkinson	NNP	PERSON	Parkinson	nn	4	SENT_313	[p21l438t2114r709b2165],
4	disease	NN	O	disease	_	0	SENT_313	[p21l748t2114r979b2174],
5	,	,	O	,	_	0	SENT_313	[p21l748t2114r979b2174],
6	the	DT	O	the	det	7	SENT_313	[p21l1016t2114r1108b2165],
7	effect	NN	O	effect	appos	4	SENT_313	[p21l1145t2113r1307b2165],
8	of	IN	O	of	_	0	SENT_313	[p21l1342t2113r1399b2165],
9	levodopa	NN	O	levodopa	prep_of	7	SENT_313	[p21l1434t2114r1721b2183],
10	,	,	O	,	_	0	SENT_313	[p21l1434t2114r1721b2183],
11	and	CC	O	and	_	0	SENT_313	[p21l1759t2114r1863b2165],
12	the	DT	O	the	det	14	SENT_313	[p21l1900t2114r1992b2165],
13	ELLDOPA	NN	O	elldopa	nn	14	SENT_313	[p21l2031t2117r2151b2165, p21l176t2200r358b2250],
14	trial	NN	O	trial	appos	4	SENT_313	[p21l411t2198r533b2249],
15	.	.	O	.	_	0	SENT_313	[p21l411t2198r533b2249],

1	Earlier	RBR	O	earlier	dep	4	SENT_314	[p21l597t2198r777b2249],
2	vs	CC	O	vs	_	0	SENT_314	[p21l831t2216r888b2249],
3	Later	RBR	O	later	conj_vs	1	SENT_314	[p21l948t2201r1090b2249],
4	L-DOPA	NN	O	l-dopa	_	0	SENT_314	[p21l1148t2200r1397b2249],
5	.	.	O	.	_	0	SENT_314	[p21l1148t2200r1397b2249],

1	Arch	NNP	O	Arch	nn	2	SENT_315	[p21l1455t2198r1586b2249],
2	Neurol	NNP	O	Neurol	_	0	SENT_315	[p21l1649t2198r1839b2249],
3	1999	CD	DATE	1999	num	2	SENT_315	[p21l1904t2200r2147b2258],
4	;	:	O	;	_	0	SENT_315	[p21l1904t2200r2147b2258],
5	56	CD	NUMBER	56	num	7	SENT_315	[p21l1904t2200r2147b2258],
6	:	:	O	:	_	0	SENT_315	[p21l1904t2200r2147b2258],
7	529-535	CD	NUMBER	529-535	dep	2	SENT_315	[p21l174t2284r436b2333],
8	.	.	O	.	_	0	SENT_315	[p21l174t2284r436b2333],

1	Jankovic	JJ	PERSON	jankovic	amod	2	SENT_316	[p21l172t2409r422b2460],
2	J	NN	PERSON	j	nsubj	11	SENT_316	[p21l446t2412r491b2468],
3	,	,	O	,	_	0	SENT_316	[p21l446t2412r491b2468],
4	Stacy	NNP	PERSON	Stacy	nn	7	SENT_316	[p21l521t2411r673b2475],
5	M.	NNP	PERSON	M.	nn	7	SENT_316	[p21l702t2412r767b2459],
6	Medical	NNP	PERSON	Medical	nn	7	SENT_316	[p21l800t2409r1022b2460],
7	management	NN	O	management	appos	2	SENT_316	[p21l1053t2419r1438b2475],
8	of	IN	O	of	_	0	SENT_316	[p21l1465t2408r1523b2460],
9	levodopa	NN	O	levodopa	nn	10	SENT_316	[p21l1547t2409r2148b2478],
10	—	NN	O	—	prep_of	7	SENT_316	[p21l1547t2409r2148b2478],
11	associated	VBN	O	associate	_	0	SENT_316	[p21l1547t2409r2148b2478],
12	motor	NN	O	motor	nn	13	SENT_316	[p21l175t2502r350b2543],
13	complications	NNS	O	complication	dobj	11	SENT_316	[p21l393t2492r795b2562],
14	in	IN	O	in	_	0	SENT_316	[p21l843t2496r885b2543],
15	patients	NNS	O	patient	prep_in	11	SENT_316	[p21l936t2496r1165b2562],
16	with	IN	O	with	_	0	SENT_316	[p21l1209t2492r1325b2543],
17	Parkinson	NNP	O	Parkinson	poss	19	SENT_316	[p21l1377t2492r1696b2543],
18	's	POS	O	's	_	0	SENT_316	[p21l1377t2492r1696b2543],
19	disease	NN	O	disease	prep_with	11	SENT_316	[p21l1741t2492r1971b2543],
20	.	.	O	.	_	0	SENT_316	[p21l1741t2492r1971b2543],

1	CNS	NNS	O	cn	nn	2	SENT_317	[p21l2021t2494r2150b2544],
2	Drugs	NNS	O	drug	_	0	SENT_317	[p21l176t2579r345b2642],
3	2007	CD	DATE	2007	dep	2	SENT_317	[p21l372t2579r889b2635],
4	;	:	O	;	_	0	SENT_317	[p21l372t2579r889b2635],
5	21:677	CD	NUMBER	21:677	num	6	SENT_317	[p21l372t2579r889b2635],
6	-692	CD	NUMBER	-692	dep	2	SENT_317	[p21l372t2579r889b2635],
7	.	.	O	.	_	0	SENT_317	[p21l372t2579r889b2635],

1	Pahwa	NN	PERSON	pahwa	nn	2	SENT_318	[p21l177t2662r357b2713],
2	R	NN	PERSON	r	_	0	SENT_318	[p21l400t2665r447b2721],
3	,	,	O	,	_	0	SENT_318	[p21l400t2665r447b2721],
4	Lyons	NNP	PERSON	Lyons	nn	5	SENT_318	[p21l491t2665r651b2728],
5	KE	NNP	PERSON	KE	appos	2	SENT_318	[p21l692t2665r778b2713],
6	.	.	O	.	_	0	SENT_318	[p21l692t2665r778b2713],

1	Levodopa	NN	O	levodopa	nn	4	SENT_319	[p21l823t2662r1337b2731],
2	—	CD	NUMBER	—	num	4	SENT_319	[p21l823t2662r1337b2731],
3	re	NN	O	re	nn	4	SENT_319	[p21l823t2662r1337b2731],
4	|	NN	O	|	_	0	SENT_319	[p21l823t2662r1337b2731],
5	ated	VBD	O	ate	rcmod	4	SENT_319	[p21l823t2662r1337b2731],
6	wearing	VBG	O	wear	xcomp	5	SENT_319	[p21l1376t2661r1710b2728],
7	—	CD	NUMBER	—	dobj	6	SENT_319	[p21l1376t2661r1710b2728],
8	off	RP	O	off	prt	6	SENT_319	[p21l1376t2661r1710b2728],
9	in	IN	O	in	_	0	SENT_319	[p21l1745t2666r1787b2712],
10	Parkinson	NNP	O	Parkinson	poss	12	SENT_319	[p21l1831t2662r2151b2713],
11	's	POS	O	's	_	0	SENT_319	[p21l1831t2662r2151b2713],
12	disease	NN	O	disease	prep_in	6	SENT_319	[p21l173t2746r403b2797],
13	:	:	O	:	_	0	SENT_319	[p21l173t2746r403b2797],
14	identification	NN	O	identification	dep	4	SENT_319	[p21l461t2745r832b2797],
15	and	CC	O	and	_	0	SENT_319	[p21l887t2746r991b2797],
16	management	NN	O	management	dep	4	SENT_319	[p21l1047t2756r1446b2812],
17	.	.	O	.	_	0	SENT_319	[p21l1047t2756r1446b2812],

1	Curr	NNP	O	Curr	nn	4	SENT_320	[p21l1501t2748r1625b2798],
2	Med	NNP	O	Med	nn	4	SENT_320	[p21l1678t2746r1803b2797],
3	Res	NNP	O	Res	nn	4	SENT_320	[p21l1860t2749r1956b2797],
4	Opin	NNP	O	Opin	_	0	SENT_320	[p21l2008t2748r2148b2815],
5	2009	CD	DATE	2009	num	4	SENT_320	[p21l173t2832r691b2890],
6	;	:	O	;	_	0	SENT_320	[p21l173t2832r691b2890],
7	25:841	CD	NUMBER	25:841	number	8	SENT_320	[p21l173t2832r691b2890],
8	-849	CD	NUMBER	-849	dep	4	SENT_320	[p21l173t2832r691b2890],
9	.	.	O	.	_	0	SENT_320	[p21l173t2832r691b2890],

1	Nutt	NNP	PERSON	Nutt	nn	2	SENT_321	[p21l177t2960r302b3008],
2	JG	NNP	O	JG	_	0	SENT_321	[p21l333t2959r429b3016],
3	,	,	O	,	_	0	SENT_321	[p21l333t2959r429b3016],
4	Fellman	NNP	O	Fellman	nn	5	SENT_321	[p21l468t2957r689b3008],
5	JH	NNP	O	JH	appos	2	SENT_321	[p21l723t2960r815b3008],
6	.	.	O	.	_	0	SENT_321	[p21l723t2960r815b3008],

1	Pharmacokinetics	NNS	O	pharmacokinetic	_	0	SENT_322	[p21l855t2957r1358b3008],
2	of	IN	O	of	_	0	SENT_322	[p21l1391t2956r1449b3008],
3	levodopa	NN	O	levodopa	prep_of	1	SENT_322	[p21l1482t2957r1767b3026],
4	.	.	O	.	_	0	SENT_322	[p21l1482t2957r1767b3026],

1	Clin	NNP	O	Clin	nn	2	SENT_323	[p21l1804t2957r1911b3008],
2	Neuropharmacol	NNP	O	Neuropharmacol	_	0	SENT_323	[p21l1951t2960r2151b3008, p21l175t3041r476b3110],
3	1984	CD	DATE	1984	num	2	SENT_323	[p21l511t3043r915b3100],
4	;	:	O	;	_	0	SENT_323	[p21l511t3043r915b3100],
5	7:35	CD	TIME	7:35	number	6	SENT_323	[p21l511t3043r915b3100],
6	—	CD	NUMBER	—	dep	2	SENT_323	[p21l511t3043r915b3100],
7	49	CD	NUMBER	49	dep	6	SENT_323	[p21l511t3043r915b3100],
8	.	.	O	.	_	0	SENT_323	[p21l511t3043r915b3100],

1	Bonifati	NNP	MISC	Bonifati	nn	4	SENT_324	[p21l177t3130r391b3182],
2	V	NNP	O	V	nn	4	SENT_324	[p21l426t3134r481b3191],
3	,	,	O	,	_	0	SENT_324	[p21l426t3134r481b3191],
4	Meco	NNP	PERSON	Meco	_	0	SENT_324	[p21l523t3134r680b3182],
5	(	CD	NUMBER	(	number	6	SENT_324	[p21l717t3133r779b3183],
6	3	CD	NUMBER	3	num	4	SENT_324	[p21l717t3133r779b3183],
7	.	.	O	.	_	0	SENT_324	[p21l717t3133r779b3183],

1	New	NNP	O	New	_	0	SENT_325	[p21l822t3134r965b3191],
2	,	,	O	,	_	0	SENT_325	[p21l822t3134r965b3191],
3	selective	JJ	O	selective	amod	5	SENT_325	[p21l1004t3131r1254b3182],
4	catechol-O-methyltransferase	NN	O	catechol-o-methyltransferase	nn	5	SENT_325	[p21l1291t3130r2150b3197],
5	inhibitors	NNS	O	inhibitor	appos	1	SENT_325	[p21l175t3215r441b3266],
6	as	IN	O	as	_	0	SENT_325	[p21l473t3233r531b3266],
7	therapeutic	JJ	O	therapeutic	amod	8	SENT_325	[p21l560t3215r892b3285],
8	agents	NNS	O	agent	prep_as	5	SENT_325	[p21l924t3225r1117b3281],
9	in	IN	O	in	_	0	SENT_325	[p21l1150t3219r1193b3266],
10	Parkinson	NNP	O	Parkinson	poss	12	SENT_325	[p21l1231t3215r1550b3266],
11	's	POS	O	's	_	0	SENT_325	[p21l1231t3215r1550b3266],
12	disease	NN	O	disease	prep_in	8	SENT_325	[p21l1581t3215r1812b3266],
13	.	.	O	.	_	0	SENT_325	[p21l1581t3215r1812b3266],

1	Pharmacol	NNP	O	Pharmacol	nn	2	SENT_326	[p21l1851t3215r2147b3266],
2	Ther	NNP	O	Ther	_	0	SENT_326	[p21l171t3299r304b3350],
3	1999	CD	DATE	1999	num	2	SENT_326	[p21l333t3301r737b3358],
4	;	:	O	;	_	0	SENT_326	[p21l333t3301r737b3358],
5	81:1	CD	NUMBER	81:1	number	6	SENT_326	[p21l333t3301r737b3358],
6	—	CD	NUMBER	—	dep	2	SENT_326	[p21l333t3301r737b3358],
7	36	CD	NUMBER	36	dep	6	SENT_326	[p21l333t3301r737b3358],
8	.	.	O	.	_	0	SENT_326	[p21l333t3301r737b3358],

1	Ruottinen	NNP	PERSON	Ruottinen	nn	2	SENT_327	[p21l177t3428r450b3476],
2	HM	NNS	O	hm	_	0	SENT_327	[p21l501t3428r615b3485],
3	,	,	O	,	_	0	SENT_327	[p21l501t3428r615b3485],
4	Rinne	NNP	PERSON	Rinne	nn	5	SENT_327	[p21l666t3428r821b3476],
5	UK	NNP	LOCATION	UK	appos	2	SENT_327	[p21l869t3428r963b3477],
6	.	.	O	.	_	0	SENT_327	[p21l869t3428r963b3477],

1	A	DT	O	a	dep	3	SENT_328	[p21l1010t3428r1055b3476],
2	double-blind	JJ	O	double-blind	amod	3	SENT_328	[p21l1098t3425r1471b3476],
3	pharmacokinetic	JJ	O	pharmacokinetic	_	0	SENT_328	[p21l1520t3425r2000b3495],
4	and	CC	O	and	_	0	SENT_328	[p21l2044t3425r2148b3476],
5	clinical	JJ	O	clinical	amod	7	SENT_328	[p21l174t3510r362b3561],
6	dose	NN	O	dose	nn	7	SENT_328	[p21l392t3509r821b3579],
7	—	NN	O	—	conj_and	3	SENT_328	[p21l392t3509r821b3579],
8	response	NN	O	response	nn	9	SENT_328	[p21l392t3509r821b3579],
9	study	NN	O	study	dep	3	SENT_328	[p21l848t3509r1003b3576],
10	of	IN	O	of	_	0	SENT_328	[p21l1028t3509r1086b3561],
11	entacapone	NN	O	entacapone	prep_of	9	SENT_328	[p21l1109t3520r1451b3579],
12	as	IN	O	as	_	0	SENT_328	[p21l1478t3528r1536b3561],
13	an	DT	O	a	det	17	SENT_328	[p21l1562t3528r1625b3561],
14	adjuvant	JJ	O	adjuvant	amod	17	SENT_328	[p21l1655t3509r1902b3576],
15	to	TO	O	to	_	0	SENT_328	[p21l1926t3520r1983b3561],
16	levodopa	NN	O	levodopa	prep_to	14	SENT_328	[p21l2013t3509r2150b3561, p21l173t3594r320b3663],
17	therapy	NN	O	therapy	prep_as	11	SENT_328	[p21l348t3594r570b3663],
18	in	IN	O	in	_	0	SENT_328	[p21l597t3597r640b3644],
19	advanced	JJ	O	advanced	amod	20	SENT_328	[p21l669t3594r948b3645],
20	Parkinson	NNP	O	Parkinson	poss	22	SENT_328	[p21l981t3594r1300b3645],
21	's	POS	O	's	_	0	SENT_328	[p21l981t3594r1300b3645],
22	disease	NN	O	disease	prep_in	17	SENT_328	[p21l1326t3594r1556b3645],
23	.	.	O	.	_	0	SENT_328	[p21l1326t3594r1556b3645],

1	Clin	NNP	O	Clin	nn	2	SENT_329	[p21l1587t3594r1694b3645],
2	Neuropharmacol	NNP	O	Neuropharmacol	_	0	SENT_329	[p21l1727t3594r2151b3663, p21l174t3678r252b3729],
3	1996	CD	DATE	1996	num	2	SENT_329	[p21l287t3680r800b3737],
4	;	:	O	;	_	0	SENT_329	[p21l287t3680r800b3737],
5	19:283	CD	NUMBER	19:283	number	6	SENT_329	[p21l287t3680r800b3737],
6	-296	CD	NUMBER	-296	dep	2	SENT_329	[p21l287t3680r800b3737],
7	.	.	O	.	_	0	SENT_329	[p21l287t3680r800b3737],

1	Ruottinen	NNP	PERSON	Ruottinen	nn	2	SENT_330	[p22l177t44r450b92],
2	HM	NNS	O	hm	_	0	SENT_330	[p22l483t44r597b101],
3	,	,	O	,	_	0	SENT_330	[p22l483t44r597b101],
4	Rinne	NNP	PERSON	Rinne	nn	5	SENT_330	[p22l630t44r785b92],
5	UK	NNP	LOCATION	UK	appos	2	SENT_330	[p22l815t44r909b93],
6	.	.	O	.	_	0	SENT_330	[p22l815t44r909b93],

1	Effect	NN	O	effect	_	0	SENT_331	[p22l944t40r1104b92],
2	of	IN	O	of	_	0	SENT_331	[p22l1130t40r1188b92],
3	one	CD	DURATION	one	num	4	SENT_331	[p22l1210t59r1317b92],
4	month	NN	NUMBER	month	poss	6	SENT_331	[p22l1346t41r1576b92],
5	's	POS	O	's	_	0	SENT_331	[p22l1346t41r1576b92],
6	treatment	NN	O	treatment	prep_of	1	SENT_331	[p22l1600t51r1887b92],
7	with	IN	O	with	_	0	SENT_331	[p22l1911t41r2027b92],
8	peripherally	RB	O	peripherally	advmod	9	SENT_331	[p22l2058t59r2150b110, p22l175t125r441b195],
9	acting	VBG	O	act	prepc_with	6	SENT_331	[p22l491t129r663b191],
10	catechol	NN	O	catechol	dobj	9	SENT_331	[p22l718t125r1578b191],
11	.	.	O	.	_	0	SENT_331	[p22l718t125r1578b191],

1	—	NN	O	—	_	0	SENT_332	[p22l718t125r1578b191],
2	.	.	O	.	_	0	SENT_332	[p22l718t125r1578b191],

1	O-methyltransferase	JJ	MISC	o-methyltransferase	amod	2	SENT_333	[p22l718t125r1578b191],
2	inhibitor	NN	O	inhibitor	_	0	SENT_333	[p22l1631t125r1884b185],
3	,	,	O	,	_	0	SENT_333	[p22l1631t125r1884b185],
4	entacapone	NN	O	entacapone	appos	2	SENT_333	[p22l1938t135r2150b176, p22l175t229r337b280],
5	,	,	O	,	_	0	SENT_333	[p22l1938t135r2150b176, p22l175t229r337b280],
6	on	IN	O	on	_	0	SENT_333	[p22l379t229r447b262],
7	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	2	SENT_333	[p22l490t211r997b280],
8	and	CC	O	and	_	0	SENT_333	[p22l1036t211r1140b262],
9	motor	NN	O	motor	nn	10	SENT_333	[p22l1183t221r1358b262],
10	response	NN	O	response	prep_on	2	SENT_333	[p22l1396t229r1656b280],
11	to	TO	O	to	_	0	SENT_333	[p22l1694t221r1751b262],
12	levodopa	NN	O	levodopa	prep_to	2	SENT_333	[p22l1794t211r2061b280],
13	in	IN	O	in	_	0	SENT_333	[p22l2105t215r2148b261],
14	advanced	JJ	O	advanced	amod	16	SENT_333	[p22l174t295r452b346],
15	parkinsonian	JJ	O	parkinsonian	amod	16	SENT_333	[p22l502t295r864b364],
16	patients	NNS	O	patient	prep_in	12	SENT_333	[p22l914t299r1158b364],
17	.	.	O	.	_	0	SENT_333	[p22l914t299r1158b364],

1	Clin	NNP	O	Clin	nn	2	SENT_334	[p22l1207t295r1314b347],
2	Neuropharmacol	NNP	O	Neuropharmacol	_	0	SENT_334	[p22l1366t295r1851b364],
3	1996	CD	DATE	1996	num	2	SENT_334	[p22l1904t297r2147b355],
4	;	:	O	;	_	0	SENT_334	[p22l1904t297r2147b355],
5	19	CD	NUMBER	19	num	7	SENT_334	[p22l1904t297r2147b355],
6	:	:	O	:	_	0	SENT_334	[p22l1904t297r2147b355],
7	222-233	CD	NUMBER	222-233	dep	2	SENT_334	[p22l173t383r436b432],
8	.	.	O	.	_	0	SENT_334	[p22l173t383r436b432],

1	Rinne	NNP	PERSON	Rinne	nn	2	SENT_335	[p22l177t511r332b559],
2	UK	NNP	LOCATION	UK	_	0	SENT_335	[p22l383t511r479b567],
3	,	,	O	,	_	0	SENT_335	[p22l383t511r479b567],
4	Larsen	NNP	PERSON	Larsen	nn	5	SENT_335	[p22l533t511r712b559],
5	JP	NNP	O	JP	appos	2	SENT_335	[p22l761t511r843b567],
6	,	,	O	,	_	0	SENT_335	[p22l761t511r843b567],
7	Siden	NNP	PERSON	Siden	nn	8	SENT_335	[p22l895t508r1052b559],
8	A	NNP	O	A	appos	2	SENT_335	[p22l1100t511r1160b567],
9	,	,	O	,	_	0	SENT_335	[p22l1100t511r1160b567],
10	Worm	NNP	O	Worm	appos	2	SENT_335	[p22l1207t511r1660b559],
11	.	.	O	.	_	0	SENT_335	[p22l1207t511r1660b559],

1	—	NN	O	—	_	0	SENT_336	[p22l1207t511r1660b559],
2	.	.	O	.	_	0	SENT_336	[p22l1207t511r1660b559],

1	Petersen	NNP	PERSON	Petersen	nn	3	SENT_337	[p22l1207t511r1660b559],
2	J.	NNP	PERSON	J.	nn	3	SENT_337	[p22l1710t511r1753b559],
3	Entacapone	NNP	PERSON	Entacapone	nsubj	4	SENT_337	[p22l1807t511r2150b577],
4	enhances	VBZ	O	enhance	_	0	SENT_337	[p22l174t592r446b643],
5	the	DT	O	the	det	6	SENT_337	[p22l476t592r567b643],
6	response	NN	O	response	dobj	4	SENT_337	[p22l603t610r862b661],
7	to	TO	O	to	_	0	SENT_337	[p22l894t602r951b643],
8	levodopa	NN	O	levodopa	prep_to	4	SENT_337	[p22l988t592r1255b661],
9	in	IN	O	in	_	0	SENT_337	[p22l1293t596r1335b642],
10	parkinsonian	JJ	O	parkinsonian	amod	11	SENT_337	[p22l1372t592r1735b661],
11	patients	NNS	O	patient	prep_in	8	SENT_337	[p22l1772t595r2001b661],
12	with	IN	O	with	_	0	SENT_337	[p22l2032t592r2148b643],
13	motor	NN	O	motor	nn	14	SENT_337	[p22l175t686r350b727],
14	fluctuations	NNS	O	fluctuation	prep_with	11	SENT_337	[p22l379t675r728b727],
15	.	.	O	.	_	0	SENT_337	[p22l379t675r728b727],

1	Nomecomt	NNP	O	Nomecomt	nn	3	SENT_338	[p22l768t678r1094b727],
2	Study	NNP	O	Study	nn	3	SENT_338	[p22l1127t676r1290b742],
3	Group	NNP	O	Group	_	0	SENT_338	[p22l1322t677r1521b745],
4	.	.	O	.	_	0	SENT_338	[p22l1322t677r1521b745],

1	Neurology	NN	O	neurology	_	0	SENT_339	[p22l1562t676r1867b742],
2	1998	CD	DATE	1998	num	1	SENT_339	[p22l1904t678r2147b735],
3	;	:	O	;	_	0	SENT_339	[p22l1904t678r2147b735],
4	51	CD	NUMBER	51	num	6	SENT_339	[p22l1904t678r2147b735],
5	:	:	O	:	_	0	SENT_339	[p22l1904t678r2147b735],
6	1309-1314	CD	DATE	1309-1314	dep	1	SENT_339	[p22l178t762r508b811],
7	.	.	O	.	_	0	SENT_339	[p22l178t762r508b811],

1	Weinshilboum	NNP	O	Weinshilboum	_	0	SENT_340	[p22l171t886r586b937],
2	RM	NN	O	rm	dep	1	SENT_340	[p22l627t889r731b937],
3	.	.	O	.	_	0	SENT_340	[p22l627t889r731b937],

1	Human	JJ	O	human	amod	2	SENT_341	[p22l772t889r972b937],
2	pharmacogenetics	NNS	O	pharmacogenetic	_	0	SENT_341	[p22l1012t886r1548b955],
3	of	IN	O	of	_	0	SENT_341	[p22l1582t885r1640b937],
4	methyl	NN	O	methyl	nn	5	SENT_341	[p22l1672t886r1861b952],
5	conjugation	NN	O	conjugation	prep_of	2	SENT_341	[p22l1899t890r2150b952, p22l171t974r297b1021],
6	.	.	O	.	_	0	SENT_341	[p22l1899t890r2150b952, p22l171t974r297b1021],

1	Fed	NNP	O	Fed	nn	2	SENT_342	[p22l331t970r434b1021],
2	Proc	NNP	O	Proc	_	0	SENT_342	[p22l466t973r589b1021],
3	1984	CD	DATE	1984	num	2	SENT_342	[p22l620t972r1206b1030],
4	;	:	O	;	_	0	SENT_342	[p22l620t972r1206b1030],
5	43:2303	CD	NUMBER	43:2303	number	6	SENT_342	[p22l620t972r1206b1030],
6	—	CD	NUMBER	—	dep	2	SENT_342	[p22l620t972r1206b1030],
7	2307	CD	DATE	2307	dep	6	SENT_342	[p22l620t972r1206b1030],
8	.	.	O	.	_	0	SENT_342	[p22l620t972r1206b1030],

1	Floderus	NNP	O	Floderus	nn	2	SENT_343	[p22l177t1096r423b1148],
2	Y	NN	O	y	_	0	SENT_343	[p22l457t1099r509b1156],
3	,	,	O	,	_	0	SENT_343	[p22l457t1099r509b1156],
4	Wetterberg	NNP	PERSON	Wetterberg	nn	7	SENT_343	[p22l545t1096r882b1163],
5	L.	NNP	O	L.	nn	7	SENT_343	[p22l924t1099r964b1147],
6	The	NNP	O	The	nn	7	SENT_343	[p22l1002t1096r1109b1148],
7	inheritance	NN	O	inheritance	appos	2	SENT_343	[p22l1148t1097r1465b1148],
8	of	IN	O	of	_	0	SENT_343	[p22l1502t1096r1560b1148],
9	human	JJ	O	human	amod	11	SENT_343	[p22l1594t1096r1785b1148],
10	erythrocyte	NN	O	erythrocyte	nn	11	SENT_343	[p22l1824t1097r2150b1163],
11	catechol-O	NN	O	catechol-o	prep_of	7	SENT_343	[p22l174t1180r1033b1247],
12	—	CD	NUMBER	—	num	14	SENT_343	[p22l174t1180r1033b1247],
13	methyltransferase	NN	O	methyltransferase	nn	14	SENT_343	[p22l174t1180r1033b1247],
14	activity	NN	O	activity	dep	7	SENT_343	[p22l1056t1185r1271b1247],
15	.	.	O	.	_	0	SENT_343	[p22l1056t1185r1271b1247],

1	Clin	NNP	PERSON	Clin	nn	2	SENT_344	[p22l1297t1181r1404b1232],
2	Genet	NNP	PERSON	Genet	_	0	SENT_344	[p22l1429t1183r1608b1232],
3	1981	CD	DATE	1981	num	2	SENT_344	[p22l1633t1183r2146b1240],
4	;	:	O	;	_	0	SENT_344	[p22l1633t1183r2146b1240],
5	19:392	CD	NUMBER	19:392	number	6	SENT_344	[p22l1633t1183r2146b1240],
6	-395	CD	NUMBER	-395	dep	2	SENT_344	[p22l1633t1183r2146b1240],
7	.	.	O	.	_	0	SENT_344	[p22l1633t1183r2146b1240],

1	Weinshilboum	NNP	O	Weinshilboum	nn	2	SENT_345	[p22l171t1266r586b1317],
2	R	NNP	O	R	_	0	SENT_345	[p22l641t1269r688b1326],
3	,	,	O	,	_	0	SENT_345	[p22l641t1269r688b1326],
4	Raymond	NNP	PERSON	Raymond	nn	6	SENT_345	[p22l742t1266r1009b1332],
5	F.	NNP	PERSON	F.	nn	6	SENT_345	[p22l1064t1269r1107b1317],
6	Variations	NNP	PERSON	Variations	appos	2	SENT_345	[p22l1157t1269r1443b1317],
7	in	IN	O	in	_	0	SENT_345	[p22l1494t1270r1536b1317],
8	catechol	NN	O	catechol	prep_in	6	SENT_345	[p22l1588t1266r2151b1332],
9	.	.	O	.	_	0	SENT_345	[p22l1588t1266r2151b1332],

1	—	NN	O	—	_	0	SENT_346	[p22l1588t1266r2151b1332],
2	.	.	O	.	_	0	SENT_346	[p22l1588t1266r2151b1332],

1	O	NN	O	o	_	0	SENT_347	[p22l1588t1266r2151b1332],
2	.	.	O	.	_	0	SENT_347	[p22l1588t1266r2151b1332],

1	—	NN	O	—	_	0	SENT_348	[p22l1588t1266r2151b1332],
2	.	.	O	.	_	0	SENT_348	[p22l1588t1266r2151b1332],

1	methyl	NN	O	methyl	nn	3	SENT_349	[p22l1588t1266r2151b1332],
2	transferase	NN	O	transferase	nn	3	SENT_349	[p22l171t1350r488b1401],
3	activity	NN	O	activity	_	0	SENT_349	[p22l527t1354r728b1416],
4	in	IN	O	in	_	0	SENT_349	[p22l767t1354r810b1401],
5	inbred	JJ	O	inbred	amod	6	SENT_349	[p22l853t1350r1036b1401],
6	strains	NNS	O	strain	prep_in	3	SENT_349	[p22l1076t1354r1259b1401],
7	of	IN	O	of	_	0	SENT_349	[p22l1297t1350r1355b1401],
8	rats	NNS	O	rat	prep_of	3	SENT_349	[p22l1391t1360r1506b1401],
9	.	.	O	.	_	0	SENT_349	[p22l1391t1360r1506b1401],

1	Neuropharmacology	NNP	O	Neuropharmacology	_	0	SENT_350	[p22l1551t1350r2152b1420],
2	1977	CD	DATE	1977	num	1	SENT_350	[p22l178t1436r691b1494],
3	;	:	O	;	_	0	SENT_350	[p22l178t1436r691b1494],
4	16:703	CD	NUMBER	16:703	number	5	SENT_350	[p22l178t1436r691b1494],
5	-706	CD	NUMBER	-706	dep	1	SENT_350	[p22l178t1436r691b1494],
6	.	.	O	.	_	0	SENT_350	[p22l178t1436r691b1494],

1	Hernan	NNP	PERSON	Hernan	nn	2	SENT_351	[p22l177t1564r379b1612],
2	MA	NNP	PERSON	MA	_	0	SENT_351	[p22l415t1564r527b1620],
3	,	,	O	,	_	0	SENT_351	[p22l415t1564r527b1620],
4	Checkoway	NNP	PERSON	Checkoway	nn	5	SENT_351	[p22l560t1561r891b1627],
5	H	NNP	PERSON	H	appos	2	SENT_351	[p22l924t1564r979b1620],
6	,	,	O	,	_	0	SENT_351	[p22l924t1564r979b1620],
7	O'Brien	NNP	PERSON	O'Brien	nn	8	SENT_351	[p22l1013t1563r1229b1612],
8	R	NNP	O	R	appos	2	SENT_351	[p22l1265t1564r1312b1620],
9	,	,	O	,	_	0	SENT_351	[p22l1265t1564r1312b1620],
10	et	FW	O	et	nn	11	SENT_351	[p22l1345t1571r1400b1612],
11	al.	FW	O	al.	appos	2	SENT_351	[p22l1429t1561r1489b1612],
12	.	.	O	.	_	0	SENT_351	[p22l1429t1561r1489b1612],

1	MAOB	NNP	ORGANIZATION	MAOB	_	0	SENT_352	[p22l1526t1563r1717b1612],
2	intron	NN	O	intron	dep	1	SENT_352	[p22l1750t1564r1913b1612],
3	13	CD	NUMBER	13	num	2	SENT_352	[p22l1950t1563r2012b1612],
4	and	CC	O	and	_	0	SENT_352	[p22l2044t1561r2148b1612],
5	COMT	NNP	O	COMT	dep	1	SENT_352	[p22l174t1646r368b1696],
6	codon	NN	O	codon	dep	1	SENT_352	[p22l395t1645r574b1696],
7	158	CD	NUMBER	158	num	8	SENT_352	[p22l610t1647r709b1696],
8	polymorphisms	NNS	O	polymorphism	dep	6	SENT_352	[p22l739t1644r1199b1714],
9	,	,	O	,	_	0	SENT_352	[p22l739t1644r1199b1714],
10	cigarette	NN	O	cigarette	nn	11	SENT_352	[p22l1230t1648r1486b1711],
11	smoking	NN	O	smoking	conj_and	1	SENT_352	[p22l1514t1645r1774b1711],
12	,	,	O	,	_	0	SENT_352	[p22l1514t1645r1774b1711],
13	and	CC	O	and	_	0	SENT_352	[p22l1805t1645r1909b1696],
14	the	DT	O	the	det	15	SENT_352	[p22l1937t1645r2029b1696],
15	risk	NN	O	risk	conj_and	1	SENT_352	[p22l2060t1644r2153b1696],
16	of	IN	O	of	_	0	SENT_352	[p22l174t1728r232b1780],
17	PD	NN	O	pd	prep_of	15	SENT_352	[p22l258t1731r351b1779],
18	.	.	O	.	_	0	SENT_352	[p22l258t1731r351b1779],

1	Neurology	NNP	O	Neurology	_	0	SENT_353	[p22l384t1729r690b1795],
2	2002	CD	DATE	2002	num	1	SENT_353	[p22l716t1731r1307b1788],
3	;	:	O	;	_	0	SENT_353	[p22l716t1731r1307b1788],
4	58:1381	CD	NUMBER	58:1381	number	5	SENT_353	[p22l716t1731r1307b1788],
5	—	CD	NUMBER	—	dep	1	SENT_353	[p22l716t1731r1307b1788],
6	1387	CD	DATE	1387	dep	5	SENT_353	[p22l716t1731r1307b1788],
7	.	.	O	.	_	0	SENT_353	[p22l716t1731r1307b1788],

1	Esteguy	NNP	O	Esteguy	nn	2	SENT_354	[p22l174t2054r402b2118],
2	M	NNP	O	M	_	0	SENT_354	[p22l431t2054r497b2111],
3	,	,	O	,	_	0	SENT_354	[p22l431t2054r497b2111],
4	Bonnet	NNP	ORGANIZATION	Bonnet	nn	5	SENT_354	[p22l530t2054r735b2103],
5	AM	NNP	ORGANIZATION	AM	appos	2	SENT_354	[p22l758t2054r875b2111],
6	,	,	O	,	_	0	SENT_354	[p22l758t2054r875b2111],
7	Kefalos	NNP	PERSON	Kefalos	nn	8	SENT_354	[p22l908t2051r1114b2103],
8	J	NNP	PERSON	J	appos	2	SENT_354	[p22l1139t2054r1184b2111],
9	,	,	O	,	_	0	SENT_354	[p22l1139t2054r1184b2111],
10	et	FW	O	et	nn	11	SENT_354	[p22l1214t2062r1268b2103],
11	al.	FW	O	al.	appos	2	SENT_354	[p22l1294t2052r1354b2103],
12	.	.	O	.	_	0	SENT_354	[p22l1294t2052r1354b2103],

1	The	DT	O	the	det	5	SENT_355	[p22l1382t2052r1490b2103],
2	L	NN	O	l	nn	5	SENT_355	[p22l1520t2052r1719b2121],
3	—	CD	NUMBER	—	num	5	SENT_355	[p22l1520t2052r1719b2121],
4	dopa	NN	O	dopa	nn	5	SENT_355	[p22l1520t2052r1719b2121],
5	test	NN	O	test	_	0	SENT_355	[p22l1746t2062r1854b2103],
6	in	IN	O	in	_	0	SENT_355	[p22l1881t2055r1924b2102],
7	Parkinson	NNP	O	Parkinson	poss	10	SENT_355	[p22l1956t2052r2149b2103, p22l171t2140r316b2188],
8	's	POS	O	's	_	0	SENT_355	[p22l1956t2052r2149b2103, p22l171t2140r316b2188],
9	disease	NN	O	disease	nn	10	SENT_355	[p22l342t2137r557b2188],
10	[	NN	O	[	prep_in	5	SENT_355	[p22l585t2138r646b2197],
11	in	IN	O	in	_	0	SENT_355	[p22l585t2138r646b2197],
12	French	JJ	MISC	french	amod	13	SENT_355	[p22l679t2137r903b2197],
13	]	NN	O	]	prep_in	5	SENT_355	[p22l679t2137r903b2197],
14	.	.	O	.	_	0	SENT_355	[p22l679t2137r903b2197],

1	Rev	NN	PERSON	rev	nn	2	SENT_356	[p22l936t2140r1037b2188],
2	Neurol	NN	PERSON	neurol	_	0	SENT_356	[p22l1066t2137r1256b2188],
3	(	CD	NUMBER	(	num	4	SENT_356	[p22l1286t2138r1452b2197],
4	Paris	NNP	LOCATION	Paris	dep	2	SENT_356	[p22l1286t2138r1452b2197],
5	)	CD	NUMBER	)	num	4	SENT_356	[p22l1286t2138r1452b2197],
6	1985	CD	DATE	1985	dep	2	SENT_356	[p22l1485t2139r2035b2196],
7	;	:	O	;	_	0	SENT_356	[p22l1485t2139r2035b2196],
8	141:413	CD	NUMBER	141:413	num	9	SENT_356	[p22l1485t2139r2035b2196],
9	—	NN	O	—	dep	2	SENT_356	[p22l1485t2139r2035b2196],
10	415	CD	NUMBER	415	dep	9	SENT_356	[p22l1485t2139r2035b2196],
11	.	.	O	.	_	0	SENT_356	[p22l1485t2139r2035b2196],

1	Goetz	NNP	PERSON	Goetz	nn	2	SENT_357	[p22l171t2267r344b2317],
2	CG	NNP	O	CG	_	0	SENT_357	[p22l380t2267r490b2325],
3	,	,	O	,	_	0	SENT_357	[p22l380t2267r490b2325],
4	Stebbins	NNP	PERSON	Stebbins	nn	5	SENT_357	[p22l529t2265r780b2317],
5	GT	NN	O	gt	appos	2	SENT_357	[p22l816t2267r917b2325],
6	,	,	O	,	_	0	SENT_357	[p22l816t2267r917b2325],
7	Shale	NNP	O	Shale	nn	8	SENT_357	[p22l956t2265r1109b2317],
8	HM	NNS	O	hm	appos	2	SENT_357	[p22l1149t2268r1263b2325],
9	,	,	O	,	_	0	SENT_357	[p22l1149t2268r1263b2325],
10	et	FW	O	et	nn	11	SENT_357	[p22l1302t2276r1357b2317],
11	al.	FW	O	al.	appos	2	SENT_357	[p22l1392t2265r1452b2317],
12	.	.	O	.	_	0	SENT_357	[p22l1392t2265r1452b2317],

1	Utility	NN	O	utility	_	0	SENT_358	[p22l1494t2265r1657b2332],
2	of	IN	O	of	_	0	SENT_358	[p22l1692t2265r1750b2317],
3	an	DT	O	a	det	7	SENT_358	[p22l1781t2284r1844b2317],
4	objective	JJ	O	objective	amod	7	SENT_358	[p22l1884t2265r2148b2332],
5	dyskinesia	NN	O	dyskinesium	nn	7	SENT_358	[p22l171t2349r463b2416],
6	rating	NN	O	rating	nn	7	SENT_358	[p22l496t2353r657b2416],
7	scale	NN	O	scale	prep_of	1	SENT_358	[p22l688t2349r829b2401],
8	for	IN	O	for	_	0	SENT_358	[p22l855t2349r935b2401],
9	Parkinson	NNP	O	Parkinson	poss	11	SENT_358	[p22l964t2349r1283b2401],
10	's	POS	O	's	_	0	SENT_358	[p22l964t2349r1283b2401],
11	disease	NN	O	disease	prep_for	7	SENT_358	[p22l1311t2350r1541b2401],
12	:	:	O	:	_	0	SENT_358	[p22l1311t2350r1541b2401],
13	inter	NN	O	inter	nn	14	SENT_358	[p22l1575t2353r1723b2401],
14	—	NN	O	—	dep	1	SENT_358	[p22l1575t2353r1723b2401],
15	and	CC	O	and	_	0	SENT_358	[p22l1751t2350r1855b2401],
16	intrarater	NN	O	intrarater	nn	18	SENT_358	[p22l1887t2353r2151b2401],
17	reliability	NN	O	reliability	nn	18	SENT_358	[p22l173t2433r434b2500],
18	assessment	NN	O	assessment	dep	1	SENT_358	[p22l460t2443r805b2484],
19	.	.	O	.	_	0	SENT_358	[p22l460t2443r805b2484],

1	Mov	NNP	O	Mov	nn	2	SENT_359	[p22l838t2436r960b2484],
2	Disord	NNP	O	Disord	_	0	SENT_359	[p22l989t2433r1173b2484],
3	1994	CD	DATE	1994	num	2	SENT_359	[p22l1207t2436r1684b2493],
4	;	:	O	;	_	0	SENT_359	[p22l1207t2436r1684b2493],
5	9:390	CD	NUMBER	9:390	num	6	SENT_359	[p22l1207t2436r1684b2493],
6	—	NN	O	—	dep	2	SENT_359	[p22l1207t2436r1684b2493],
7	394	CD	NUMBER	394	dep	6	SENT_359	[p22l1207t2436r1684b2493],
8	.	.	O	.	_	0	SENT_359	[p22l1207t2436r1684b2493],

1	Schultz	NNP	PERSON	Schultz	nn	2	SENT_360	[p22l172t2563r374b2614],
2	E	NNP	O	E	_	0	SENT_360	[p22l415t2566r462b2623],
3	,	,	O	,	_	0	SENT_360	[p22l415t2566r462b2623],
4	Nissinen	NNP	PERSON	Nissinen	nn	5	SENT_360	[p22l505t2566r743b2614],
5	E	NNP	PERSON	E	appos	2	SENT_360	[p22l788t2566r835b2623],
6	,	,	O	,	_	0	SENT_360	[p22l788t2566r835b2623],
7	Kaakkola	NNP	LOCATION	Kaakkola	nn	9	SENT_360	[p22l879t2563r1130b2614],
8	S.	NNP	O	S.	nn	9	SENT_360	[p22l1172t2565r1218b2614],
9	Determination	NNP	O	Determination	appos	2	SENT_360	[p22l1262t2566r1674b2614],
10	of	IN	O	of	_	0	SENT_360	[p22l1715t2562r1773b2614],
11	catechol	NN	O	catechol	prep_of	9	SENT_360	[p22l1806t2563r2148b2615],
12	.	.	O	.	_	0	SENT_360	[p22l1806t2563r2148b2615],

1	—	NN	O	—	_	0	SENT_361	[p22l1806t2563r2148b2615],
2	.	.	O	.	_	0	SENT_361	[p22l1806t2563r2148b2615],

1	O	NN	O	o	nn	3	SENT_362	[p22l1806t2563r2148b2615],
2	methyltransferase	NN	O	methyltransferase	nn	3	SENT_362	[p22l173t2646r684b2713],
3	activity	NN	O	activity	_	0	SENT_362	[p22l735t2651r936b2713],
4	in	IN	O	in	_	0	SENT_362	[p22l987t2651r1030b2698],
5	erythrocytes	NNS	O	erythrocyte	prep_in	3	SENT_362	[p22l1082t2647r1437b2713],
6	by	IN	O	by	_	0	SENT_362	[p22l1488t2647r1555b2713],
7	high	JJ	O	high	amod	10	SENT_362	[p22l1606t2647r1726b2713],
8	performance	NN	O	performance	nn	10	SENT_362	[p22l1780t2646r2148b2716],
9	liquid	JJ	O	liquid	amod	10	SENT_362	[p22l174t2731r328b2801],
10	chromatography	NN	O	chromatography	prep_by	5	SENT_362	[p22l380t2731r863b2801],
11	with	IN	O	with	_	0	SENT_362	[p22l908t2731r1024b2782],
12	electrochemical	JJ	O	electrochemical	amod	13	SENT_362	[p22l1075t2731r1529b2782],
13	detection	NN	O	detection	prep_with	3	SENT_362	[p22l1581t2731r1871b2782],
14	.	.	O	.	_	0	SENT_362	[p22l1581t2731r1871b2782],

1	Biomed	NNP	O	Biomed	nn	2	SENT_363	[p22l1927t2731r2146b2782],
2	Chromatogr	NNP	O	Chromatogr	_	0	SENT_363	[p22l171t2815r528b2882],
3	1989	CD	DATE	1989	num	2	SENT_363	[p22l557t2818r961b2875],
4	;	:	O	;	_	0	SENT_363	[p22l557t2818r961b2875],
5	3:64	CD	NUMBER	3:64	number	6	SENT_363	[p22l557t2818r961b2875],
6	—	CD	NUMBER	—	dep	2	SENT_363	[p22l557t2818r961b2875],
7	67	CD	NUMBER	67	dep	6	SENT_363	[p22l557t2818r961b2875],
8	.	.	O	.	_	0	SENT_363	[p22l557t2818r961b2875],

1	Tuomainen	NN	PERSON	tuomainen	nn	2	SENT_364	[p22l169t2948r493b2996],
2	P	NN	PERSON	p	_	0	SENT_364	[p22l531t2948r576b3005],
3	,	,	O	,	_	0	SENT_364	[p22l531t2948r576b3005],
4	Reenila	NN	O	reenilum	nn	5	SENT_364	[p22l614t2945r817b2996],
5	I	NN	O	i	appos	2	SENT_364	[p22l855t2948r880b3005],
6	,	,	O	,	_	0	SENT_364	[p22l855t2948r880b3005],
7	Mannisto	NNP	O	Mannisto	nn	8	SENT_364	[p22l917t2948r1178b2996],
8	PT	NN	O	pt	appos	5	SENT_364	[p22l1215t2948r1297b2996],
9	.	.	O	.	_	0	SENT_364	[p22l1215t2948r1297b2996],

1	Validation	NN	O	validation	_	0	SENT_365	[p22l1329t2945r1618b2996],
2	of	IN	O	of	_	0	SENT_365	[p22l1653t2945r1711b2996],
3	assay	NN	O	assay	prep_of	1	SENT_365	[p22l1739t2963r1892b3012],
4	of	IN	O	of	_	0	SENT_365	[p22l1922t2945r1980b2996],
5	catechol	NN	O	catechol	prep_of	1	SENT_365	[p22l2007t2955r2148b2996, p22l171t3028r907b3095],
6	.	.	O	.	_	0	SENT_365	[p22l2007t2955r2148b2996, p22l171t3028r907b3095],

1	—	NN	O	—	_	0	SENT_366	[p22l2007t2955r2148b2996, p22l171t3028r907b3095],
2	.	.	O	.	_	0	SENT_366	[p22l2007t2955r2148b2996, p22l171t3028r907b3095],

1	O	NN	O	o	_	0	SENT_367	[p22l2007t2955r2148b2996, p22l171t3028r907b3095],
2	.	.	O	.	_	0	SENT_367	[p22l2007t2955r2148b2996, p22l171t3028r907b3095],

1	—	NN	O	—	_	0	SENT_368	[p22l2007t2955r2148b2996, p22l171t3028r907b3095],
2	.	.	O	.	_	0	SENT_368	[p22l2007t2955r2148b2996, p22l171t3028r907b3095],

1	methyltransferase	NN	O	methyltransferase	nn	2	SENT_369	[p22l2007t2955r2148b2996, p22l171t3028r907b3095],
2	activity	NN	O	activity	_	0	SENT_369	[p22l944t3033r1144b3095],
3	in	IN	O	in	_	0	SENT_369	[p22l1181t3033r1223b3079],
4	human	JJ	O	human	amod	5	SENT_369	[p22l1264t3029r1455b3080],
5	erythrocytes	NNS	O	erythrocyte	prep_in	2	SENT_369	[p22l1494t3029r1864b3095],
6	.	.	O	.	_	0	SENT_369	[p22l1494t3029r1864b3095],

1	J	NNP	O	J	nn	4	SENT_370	[p22l1902t3032r1927b3081],
2	Pharm	NNP	O	Pharm	nn	4	SENT_370	[p22l1970t3029r2144b3080],
3	Biomed	NNP	O	Biomed	nn	4	SENT_370	[p22l174t3113r393b3164],
4	Anal	NNP	O	Anal	_	0	SENT_370	[p22l421t3113r547b3164],
5	1996	CD	DATE	1996	num	4	SENT_370	[p22l581t3115r1094b3173],
6	;	:	O	;	_	0	SENT_370	[p22l581t3115r1094b3173],
7	14:515	CD	NUMBER	14:515	number	8	SENT_370	[p22l581t3115r1094b3173],
8	-523	CD	NUMBER	-523	dep	4	SENT_370	[p22l581t3115r1094b3173],
9	.	.	O	.	_	0	SENT_370	[p22l581t3115r1094b3173],

1	Rondot	NNP	PERSON	Rondot	nn	2	SENT_371	[p22l174t3242r385b3293],
2	P	NN	O	p	_	0	SENT_371	[p22l415t3245r460b3301],
3	,	,	O	,	_	0	SENT_371	[p22l415t3245r460b3301],
4	Ziegler	NNP	PERSON	Ziegler	nn	5	SENT_371	[p22l490t3242r692b3308],
5	M	NNP	O	M	appos	2	SENT_371	[p22l721t3245r788b3301],
6	,	,	O	,	_	0	SENT_371	[p22l721t3245r788b3301],
7	Aymard	NNP	ORGANIZATION	Aymard	nn	8	SENT_371	[p22l816t3242r1042b3308],
8	N	NNP	ORGANIZATION	N	appos	2	SENT_371	[p22l1076t3245r1136b3301],
9	,	,	O	,	_	0	SENT_371	[p22l1076t3245r1136b3301],
10	Teinturier	NNP	O	Teinturier	nn	12	SENT_371	[p22l1164t3245r1446b3293],
11	A.	NNP	O	A.	nn	12	SENT_371	[p22l1468t3245r1527b3292],
12	Effect	NN	O	effect	appos	2	SENT_371	[p22l1562t3241r1723b3293],
13	of	IN	O	of	_	0	SENT_371	[p22l1751t3241r1808b3293],
14	controlledrelease	NN	O	controlledrelease	nn	15	SENT_371	[p22l1832t3242r2148b3293, p22l173t3326r375b3377],
15	carbidopa/levodopa	NN	O	carbidopa/levodopa	prep_of	12	SENT_371	[p22l415t3326r1009b3395],
16	on	IN	O	on	_	0	SENT_371	[p22l1051t3344r1118b3377],
17	motor	NN	O	motor	nn	18	SENT_371	[p22l1162t3336r1336b3377],
18	performance	NN	O	performance	prep_on	15	SENT_371	[p22l1374t3325r1742b3395],
19	in	IN	O	in	_	0	SENT_371	[p22l1783t3330r1826b3376],
20	advanced	JJ	O	advanced	amod	21	SENT_371	[p22l1867t3326r2145b3377],
21	Parkinson	NNP	O	Parkinson	poss	23	SENT_371	[p22l174t3410r494b3461],
22	's	POS	O	's	_	0	SENT_371	[p22l174t3410r494b3461],
23	disease	NN	O	disease	prep_in	18	SENT_371	[p22l520t3410r751b3461],
24	.	.	O	.	_	0	SENT_371	[p22l520t3410r751b3461],

1	Neurology	NN	O	neurology	_	0	SENT_372	[p22l785t3410r1090b3476],
2	1989	CD	DATE	1989	num	1	SENT_372	[p22l1120t3412r1562b3470],
3	;	:	O	;	_	0	SENT_372	[p22l1120t3412r1562b3470],
4	39:74	CD	NUMBER	39:74	number	5	SENT_372	[p22l1120t3412r1562b3470],
5	—	CD	NUMBER	—	dep	1	SENT_372	[p22l1120t3412r1562b3470],
6	77	CD	NUMBER	77	dep	5	SENT_372	[p22l1120t3412r1562b3470],
7	;	:	O	;	_	0	SENT_372	[p22l1120t3412r1562b3470],
8	discussion	NN	O	discussion	dep	1	SENT_372	[p22l1591t3410r1884b3461],
9	95	CD	NUMBER	95	dep	8	SENT_372	[p22l1914t3412r1997b3461],
10	.	.	O	.	_	0	SENT_372	[p22l1914t3412r1997b3461],

1	Watanabe	NNP	PERSON	Watanabe	nn	2	SENT_373	[p22l169t3540r467b3591],
2	M	NNP	O	M	_	0	SENT_373	[p22l504t3543r571b3600],
3	,	,	O	,	_	0	SENT_373	[p22l504t3543r571b3600],
4	Harada	NNP	PERSON	Harada	nn	5	SENT_373	[p22l610t3540r812b3591],
5	S	NNP	PERSON	S	appos	2	SENT_373	[p22l849t3542r896b3599],
6	,	,	O	,	_	0	SENT_373	[p22l849t3542r896b3599],
7	Nakamura	NNP	PERSON	Nakamura	nn	8	SENT_373	[p22l936t3540r1226b3591],
8	T	NN	O	t	appos	2	SENT_373	[p22l1260t3543r1311b3599],
9	,	,	O	,	_	0	SENT_373	[p22l1260t3543r1311b3599],
10	et	FW	O	et	nn	11	SENT_373	[p22l1348t3550r1403b3591],
11	al.	FW	O	al.	appos	2	SENT_373	[p22l1435t3540r1495b3591],
12	.	.	O	.	_	0	SENT_373	[p22l1435t3540r1495b3591],

1	Association	NNP	O	Association	_	0	SENT_374	[p22l1530t3543r1860b3591],
2	between	IN	O	between	_	0	SENT_374	[p22l1899t3540r2145b3591],
3	catechol-O	NN	O	catechol-o	prep_between	1	SENT_374	[p23l171t18r1031b85],
4	—	CD	NUMBER	—	num	7	SENT_374	[p23l171t18r1031b85],
5	methyltransferase	NN	O	methyltransferase	nn	7	SENT_374	[p23l171t18r1031b85],
6	gene	NN	O	gene	nn	7	SENT_374	[p23l1074t37r1219b85],
7	polymorphisms	NNS	O	polymorphism	dep	1	SENT_374	[p23l1263t19r1707b88],
8	and	CC	O	and	_	0	SENT_374	[p23l1749t19r1853b70],
9	wearingoff	NN	O	wearingoff	dep	1	SENT_374	[p23l1896t23r2148b85, p23l171t102r248b154],
10	and	CC	O	and	_	0	SENT_374	[p23l293t103r396b154],
11	dyskinesia	NN	O	dyskinesium	conj_and	9	SENT_374	[p23l446t103r738b169],
12	in	IN	O	in	_	0	SENT_374	[p23l791t106r833b153],
13	Parkinson	NNP	O	Parkinson	poss	15	SENT_374	[p23l888t103r1207b154],
14	's	POS	O	's	_	0	SENT_374	[p23l888t103r1207b154],
15	disease	NN	O	disease	prep_in	9	SENT_374	[p23l1255t103r1485b154],
16	.	.	O	.	_	0	SENT_374	[p23l1255t103r1485b154],

1	Neuropsychobiology	NNP	O	Neuropsychobiology	_	0	SENT_375	[p23l1540t102r2149b172],
2	2003	CD	DATE	2003	num	1	SENT_375	[p23l171t189r689b245],
3	;	:	O	;	_	0	SENT_375	[p23l171t189r689b245],
4	48:190	CD	NUMBER	48:190	number	5	SENT_375	[p23l171t189r689b245],
5	-193	CD	NUMBER	-193	dep	1	SENT_375	[p23l171t189r689b245],
6	.	.	O	.	_	0	SENT_375	[p23l171t189r689b245],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_376	[p23l174t318r272b367],
2	MS	NN	O	m	_	0	SENT_376	[p23l311t317r414b375],
3	,	,	O	,	_	0	SENT_376	[p23l311t317r414b375],
4	Kim	NNP	PERSON	Kim	nn	5	SENT_376	[p23l455t318r557b366],
5	HS	NN	O	h	appos	2	SENT_376	[p23l598t317r690b375],
6	,	,	O	,	_	0	SENT_376	[p23l598t317r690b375],
7	Cho	NNP	PERSON	Cho	nn	8	SENT_376	[p23l728t315r845b367],
8	EK	NNP	PERSON	EK	appos	2	SENT_376	[p23l884t318r972b375],
9	,	,	O	,	_	0	SENT_376	[p23l884t318r972b375],
10	et	FW	O	et	nn	11	SENT_376	[p23l1010t326r1065b367],
11	al.	FW	O	al.	appos	2	SENT_376	[p23l1099t316r1159b367],
12	.	.	O	.	_	0	SENT_376	[p23l1099t316r1159b367],

1	COMT	NNP	O	COMT	nn	2	SENT_377	[p23l1199t317r1393b367],
2	genotype	NN	O	genotype	_	0	SENT_377	[p23l1427t326r1704b385],
3	and	CC	O	and	_	0	SENT_377	[p23l1740t316r1844b367],
4	effectiveness	NN	O	effectiveness	conj_and	2	SENT_377	[p23l1883t315r2148b367, p23l173t418r296b451],
5	of	IN	O	of	_	0	SENT_377	[p23l337t399r395b451],
6	entacapone	NN	O	entacapone	prep_of	2	SENT_377	[p23l432t410r774b469],
7	in	IN	O	in	_	0	SENT_377	[p23l818t404r860b450],
8	patients	NNS	O	patient	prep_in	6	SENT_377	[p23l907t404r1136b469],
9	with	IN	O	with	_	0	SENT_377	[p23l1176t400r1291b451],
10	fluctuating	VBG	O	fluctuate	prepc_with	8	SENT_377	[p23l1334t399r1638b466],
11	Parkinson	NNP	O	Parkinson	poss	13	SENT_377	[p23l1686t400r2005b451],
12	's	POS	O	's	_	0	SENT_377	[p23l1686t400r2005b451],
13	disease	NN	O	disease	dobj	10	SENT_377	[p23l2046t400r2148b451, p23l171t502r317b535],
14	.	.	O	.	_	0	SENT_377	[p23l2046t400r2148b451, p23l171t502r317b535],

1	Neurology	NNP	O	Neurology	_	0	SENT_378	[p23l351t484r656b550],
2	2002	CD	DATE	2002	num	1	SENT_378	[p23l682t486r1200b543],
3	;	:	O	;	_	0	SENT_378	[p23l682t486r1200b543],
4	58:564	CD	NUMBER	58:564	number	5	SENT_378	[p23l682t486r1200b543],
5	-567	CD	NUMBER	-567	dep	1	SENT_378	[p23l682t486r1200b543],
6	.	.	O	.	_	0	SENT_378	[p23l682t486r1200b543],

1	Canesi	NN	MISC	canesus	nn	2	SENT_379	[p23l171t615r362b665],
2	M	NN	O	m	_	0	SENT_379	[p23l406t616r473b673],
3	,	,	O	,	_	0	SENT_379	[p23l406t616r473b673],
4	Zecchinelli	NNP	ORGANIZATION	Zecchinelli	nn	5	SENT_379	[p23l511t613r814b665],
5	AL	NNP	ORGANIZATION	AL	appos	2	SENT_379	[p23l852t616r945b673],
6	,	,	O	,	_	0	SENT_379	[p23l852t616r945b673],
7	Pezzoli	NNP	LOCATION	Pezzoli	nn	8	SENT_379	[p23l989t614r1179b665],
8	G	NNP	LOCATION	G	appos	2	SENT_379	[p23l1221t615r1284b673],
9	,	,	O	,	_	0	SENT_379	[p23l1221t615r1284b673],
10	Antonini	NNP	PERSON	Antonini	nn	13	SENT_379	[p23l1321t616r1564b665],
11	A.	NNP	O	A.	nn	13	SENT_379	[p23l1603t616r1660b664],
12	Clinical	JJ	O	clinical	amod	13	SENT_379	[p23l1703t614r1907b665],
13	experience	NN	O	experience	appos	2	SENT_379	[p23l1949t617r2148b683, p23l171t716r307b749],
14	of	IN	O	of	_	0	SENT_379	[p23l350t697r407b749],
15	tolcapone	NN	O	tolcapone	prep_of	13	SENT_379	[p23l443t698r735b767],
16	in	IN	O	in	_	0	SENT_379	[p23l779t702r822b748],
17	advanced	JJ	O	advanced	amod	18	SENT_379	[p23l867t698r1145b749],
18	Parkinson	NNP	O	Parkinson	poss	20	SENT_379	[p23l1193t698r1513b749],
19	's	POS	O	's	_	0	SENT_379	[p23l1193t698r1513b749],
20	disease	NN	O	disease	prep_in	15	SENT_379	[p23l1555t698r1785b749],
21	.	.	O	.	_	0	SENT_379	[p23l1555t698r1785b749],

1	Neurol	NNP	O	Neurol	nn	2	SENT_380	[p23l1834t698r2024b749],
2	Sci	NNP	O	Sci	_	0	SENT_380	[p23l2070t700r2146b749],
3	2008	CD	DATE	2008	num	2	SENT_380	[p23l171t781r579b851],
4	;	:	O	;	_	0	SENT_380	[p23l171t781r579b851],
5	29	CD	NUMBER	29	number	6	SENT_380	[p23l171t781r579b851],
6	(	CD	NUMBER	(	num	7	SENT_380	[p23l171t781r579b851],
7	suppl	NN	O	suppl	dep	2	SENT_380	[p23l171t781r579b851],
8	5	CD	NUMBER	5	num	9	SENT_380	[p23l610t783r1016b842],
9	)	NN	O	)	dep	7	SENT_380	[p23l610t783r1016b842],
10	:	:	O	:	_	0	SENT_380	[p23l610t783r1016b842],
11	S380	NN	O	s380	dep	7	SENT_380	[p23l610t783r1016b842],
12	.	.	O	.	_	0	SENT_380	[p23l610t783r1016b842],

1	—	NN	O	—	_	0	SENT_381	[p23l610t783r1016b842],
2	.	.	O	.	_	0	SENT_381	[p23l610t783r1016b842],

1	S382	NN	O	s382	_	0	SENT_382	[p23l610t783r1016b842],
2	.	.	O	.	_	0	SENT_382	[p23l610t783r1016b842],

1	Ahtila	NNP	ORGANIZATION	Ahtila	nn	2	SENT_383	[p23l169t868r333b919],
2	S	NNP	ORGANIZATION	S	_	0	SENT_383	[p23l380t870r427b928],
3	,	,	O	,	_	0	SENT_383	[p23l380t870r427b928],
4	Kaakkola	NNP	LOCATION	Kaakkola	nn	5	SENT_383	[p23l475t868r726b919],
5	S	NNP	LOCATION	S	appos	2	SENT_383	[p23l773t870r820b928],
6	,	,	O	,	_	0	SENT_383	[p23l773t870r820b928],
7	Gordin	NNP	PERSON	Gordin	nn	8	SENT_383	[p23l865t868r1063b920],
8	A	NNP	O	A	appos	2	SENT_383	[p23l1105t871r1165b928],
9	,	,	O	,	_	0	SENT_383	[p23l1105t871r1165b928],
10	et	FW	O	et	nn	11	SENT_383	[p23l1210t878r1265b919],
11	al.	FW	O	al.	appos	2	SENT_383	[p23l1306t868r1366b919],
12	.	.	O	.	_	0	SENT_383	[p23l1306t868r1366b919],

1	Effect	NN	O	effect	_	0	SENT_384	[p23l1416t867r1577b919],
2	of	IN	O	of	_	0	SENT_384	[p23l1619t867r1676b919],
3	entacapone	NN	O	entacapone	prep_of	1	SENT_384	[p23l1715t878r2074b937],
4	,	,	O	,	_	0	SENT_384	[p23l1715t878r2074b937],
5	a	DT	O	a	det	7	SENT_384	[p23l2119t886r2145b919],
6	COMT	NNP	O	COMT	nn	7	SENT_384	[p23l171t954r366b1004],
7	inhibitor	NN	O	inhibitor	appos	3	SENT_384	[p23l394t952r647b1012],
8	,	,	O	,	_	0	SENT_384	[p23l394t952r647b1012],
9	on	IN	O	on	_	0	SENT_384	[p23l676t970r744b1003],
10	the	DT	O	the	det	11	SENT_384	[p23l772t952r864b1003],
11	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	1	SENT_384	[p23l893t952r1399b1022],
12	and	CC	O	and	_	0	SENT_384	[p23l1426t952r1530b1003],
13	metabolism	NN	O	metabolism	prep_on	1	SENT_384	[p23l1561t952r1897b1003],
14	of	IN	O	of	_	0	SENT_384	[p23l1928t952r1986b1003],
15	levo	NN	O	levo	nn	17	SENT_384	[p23l2011t952r2148b1003],
16	—	CD	NUMBER	—	num	17	SENT_384	[p23l2011t952r2148b1003],
17	dopa	NN	O	dopa	prep_of	11	SENT_384	[p23l171t1036r318b1106],
18	after	IN	O	after	_	0	SENT_384	[p23l370t1036r501b1087],
19	administration	NN	O	administration	prep_after	17	SENT_384	[p23l547t1036r959b1087],
20	of	IN	O	of	_	0	SENT_384	[p23l1010t1036r1068b1087],
21	controlled-release	NN	O	controlled-release	nn	22	SENT_384	[p23l1113t1036r1638b1087],
22	levodopacarbidopa	NN	O	levodopacarbidopa	prep_of	1	SENT_384	[p23l1690t1036r2148b1106, p23l171t1121r318b1190],
23	in	IN	O	in	_	0	SENT_384	[p23l350t1124r393b1171],
24	volunteers	NNS	O	volunteer	prep_in	22	SENT_384	[p23l421t1121r737b1172],
25	.	.	O	.	_	0	SENT_384	[p23l421t1121r737b1172],

1	Clin	NNP	O	Clin	nn	2	SENT_385	[p23l768t1121r874b1172],
2	Neuropharmacol	NNP	O	Neuropharmacol	_	0	SENT_385	[p23l908t1120r1392b1190],
3	1995	CD	DATE	1995	num	2	SENT_385	[p23l1427t1123r1867b1180],
4	;	:	O	;	_	0	SENT_385	[p23l1427t1123r1867b1180],
5	18:46	CD	TIME	18:46	number	6	SENT_385	[p23l1427t1123r1867b1180],
6	—	CD	NUMBER	—	dep	2	SENT_385	[p23l1427t1123r1867b1180],
7	57	CD	NUMBER	57	dep	6	SENT_385	[p23l1427t1123r1867b1180],
8	.	.	O	.	_	0	SENT_385	[p23l1427t1123r1867b1180],

1	Contin	NN	O	contin	nn	2	SENT_386	[p23l171t1209r360b1259],
2	M	NN	O	m	_	0	SENT_386	[p23l399t1210r466b1267],
3	,	,	O	,	_	0	SENT_386	[p23l399t1210r466b1267],
4	Martinelli	NNP	PERSON	Martinelli	nn	5	SENT_386	[p23l504t1207r767b1258],
5	P	NN	PERSON	p	appos	2	SENT_386	[p23l806t1210r852b1267],
6	,	,	O	,	_	0	SENT_386	[p23l806t1210r852b1267],
7	Mochi	NNP	O	Mochi	nn	8	SENT_386	[p23l891t1207r1062b1258],
8	M	NNP	O	M	appos	2	SENT_386	[p23l1100t1210r1167b1267],
9	,	,	O	,	_	0	SENT_386	[p23l1100t1210r1167b1267],
10	et	FW	O	et	nn	11	SENT_386	[p23l1202t1217r1257b1258],
11	al.	FW	O	al.	appos	2	SENT_386	[p23l1289t1207r1349b1258],
12	.	.	O	.	_	0	SENT_386	[p23l1289t1207r1349b1258],

1	Genetic	JJ	O	genetic	amod	2	SENT_387	[p23l1386t1209r1612b1259],
2	polymorphism	NN	O	polymorphism	_	0	SENT_387	[p23l1646t1207r2058b1277],
3	of	IN	O	of	_	0	SENT_387	[p23l2095t1207r2153b1258],
4	catechol-O	NN	O	catechol-o	nn	6	SENT_387	[p23l171t1290r1031b1357],
5	—	CD	NUMBER	—	num	6	SENT_387	[p23l171t1290r1031b1357],
6	methyltransferase	NN	O	methyltransferase	prep_of	2	SENT_387	[p23l171t1290r1031b1357],
7	and	CC	O	and	_	0	SENT_387	[p23l1059t1291r1162b1342],
8	levodopa	NN	O	levodopa	nn	10	SENT_387	[p23l1194t1291r1461b1360],
9	pharmacokineticpharmacodynamic	JJ	O	pharmacokineticpharmacodynamic	amod	10	SENT_387	[p23l1493t1291r2148b1360, p23l173t1375r576b1441],
10	pattern	NN	O	pattern	conj_and	6	SENT_387	[p23l617t1385r823b1444],
11	in	IN	O	in	_	0	SENT_387	[p23l868t1379r911b1426],
12	patients	NNS	O	patient	prep_in	2	SENT_387	[p23l956t1379r1186b1444],
13	with	IN	O	with	_	0	SENT_387	[p23l1225t1375r1341b1426],
14	Parkinson	NNP	O	Parkinson	poss	16	SENT_387	[p23l1389t1375r1708b1426],
15	's	POS	O	's	_	0	SENT_387	[p23l1389t1375r1708b1426],
16	disease	NN	O	disease	prep_with	12	SENT_387	[p23l1748t1375r1979b1426],
17	.	.	O	.	_	0	SENT_387	[p23l1748t1375r1979b1426],

1	Mov	NNP	O	Mov	nn	2	SENT_388	[p23l2027t1378r2150b1426],
2	Disord	NNP	O	Disord	_	0	SENT_388	[p23l174t1459r358b1510],
3	2005	CD	DATE	2005	num	2	SENT_388	[p23l388t1461r906b1519],
4	;	:	O	;	_	0	SENT_388	[p23l388t1461r906b1519],
5	20:734	CD	NUMBER	20:734	number	6	SENT_388	[p23l388t1461r906b1519],
6	-739	CD	NUMBER	-739	dep	2	SENT_388	[p23l388t1461r906b1519],
7	.	.	O	.	_	0	SENT_388	[p23l388t1461r906b1519],

1	Lee	NNP	PERSON	Lee	nn	2	SENT_389	[p23l174t1591r272b1639],
2	MS	NN	O	m	_	0	SENT_389	[p23l316t1590r419b1647],
3	,	,	O	,	_	0	SENT_389	[p23l316t1590r419b1647],
4	Lyoo	NNP	PERSON	Lyoo	nn	5	SENT_389	[p23l465t1591r599b1654],
5	CH	NN	O	ch	appos	2	SENT_389	[p23l640t1590r745b1648],
6	,	,	O	,	_	0	SENT_389	[p23l640t1590r745b1648],
7	Ulmanen	NN	O	ulmanen	nn	8	SENT_389	[p23l791t1588r1041b1639],
8	I	NN	O	i	appos	2	SENT_389	[p23l1088t1591r1114b1647],
9	,	,	O	,	_	0	SENT_389	[p23l1088t1591r1114b1647],
10	et	FW	O	et	nn	11	SENT_389	[p23l1157t1598r1212b1639],
11	al.	FW	O	al.	appos	2	SENT_389	[p23l1251t1588r1311b1639],
12	.	.	O	.	_	0	SENT_389	[p23l1251t1588r1311b1639],

1	Genotypes	NNS	O	genotype	_	0	SENT_390	[p23l1355t1590r1672b1657],
2	of	IN	O	of	_	0	SENT_390	[p23l1713t1587r1771b1639],
3	catecholOmethyltransferase	NN	O	catecholomethyltransferase	prep_of	1	SENT_390	[p23l1806t1588r2148b1639, p23l173t1671r684b1738],
4	and	CC	O	and	_	0	SENT_390	[p23l714t1672r818b1723],
5	response	NN	O	response	prep_of	1	SENT_390	[p23l851t1690r1111b1741],
6	to	TO	O	to	_	0	SENT_390	[p23l1139t1682r1197b1723],
7	levodopa	NN	O	levodopa	nn	8	SENT_390	[p23l1230t1672r1497b1741],
8	treatment	NN	O	treatment	prep_to	1	SENT_390	[p23l1527t1682r1813b1723],
9	in	IN	O	in	_	0	SENT_390	[p23l1843t1676r1886b1723],
10	patients	NNS	O	patient	prep_in	1	SENT_390	[p23l1919t1676r2148b1741],
11	with	IN	O	with	_	0	SENT_390	[p23l170t1755r285b1806],
12	Parkinson	NNP	O	Parkinson	poss	14	SENT_390	[p23l318t1755r638b1806],
13	's	POS	O	's	_	0	SENT_390	[p23l318t1755r638b1806],
14	disease	NN	O	disease	prep_with	10	SENT_390	[p23l664t1755r894b1806],
15	.	.	O	.	_	0	SENT_390	[p23l664t1755r894b1806],

1	Neurosci	NNP	PERSON	Neurosci	nn	2	SENT_391	[p23l928t1758r1179b1806],
2	Lett	NNP	PERSON	Lett	_	0	SENT_391	[p23l1212t1758r1318b1806],
3	2001	CD	DATE	2001	num	2	SENT_391	[p23l1344t1758r1898b1815],
4	;	:	O	;	_	0	SENT_391	[p23l1344t1758r1898b1815],
5	298:131	CD	NUMBER	298:131	num	6	SENT_391	[p23l1344t1758r1898b1815],
6	—	NN	O	—	dep	2	SENT_391	[p23l1344t1758r1898b1815],
7	134	CD	NUMBER	134	dep	6	SENT_391	[p23l1344t1758r1898b1815],
8	.	.	O	.	_	0	SENT_391	[p23l1344t1758r1898b1815],

1	Keranen	JJ	PERSON	keranen	amod	2	SENT_392	[p23l174t1887r407b1935],
2	T	NN	PERSON	t	_	0	SENT_392	[p23l440t1887r491b1944],
3	,	,	O	,	_	0	SENT_392	[p23l440t1887r491b1944],
4	Gordin	NNP	PERSON	Gordin	nn	5	SENT_392	[p23l525t1884r724b1936],
5	A	NNP	O	A	appos	2	SENT_392	[p23l755t1887r814b1944],
6	,	,	O	,	_	0	SENT_392	[p23l755t1887r814b1944],
7	Harjola	NNP	O	Harjola	nn	8	SENT_392	[p23l852t1884r1050b1950],
8	VP	NNP	O	VP	appos	2	SENT_392	[p23l1083t1887r1175b1944],
9	,	,	O	,	_	0	SENT_392	[p23l1083t1887r1175b1944],
10	et	FW	O	et	nn	11	SENT_392	[p23l1209t1894r1264b1935],
11	al.	FW	O	al.	appos	2	SENT_392	[p23l1295t1884r1355b1935],
12	.	.	O	.	_	0	SENT_392	[p23l1295t1884r1355b1935],

1	The	DT	O	the	det	2	SENT_393	[p23l1389t1884r1496b1935],
2	effect	NN	O	effect	_	0	SENT_393	[p23l1529t1883r1690b1935],
3	of	IN	O	of	_	0	SENT_393	[p23l1721t1883r1779b1935],
4	catecholOmethyl	NN	O	catecholomethyl	nn	6	SENT_393	[p23l1806t1884r2148b1936, p23l173t1968r362b2034],
5	transferase	NN	O	transferase	nn	6	SENT_393	[p23l401t1967r718b2019],
6	inhibition	NN	O	inhibition	prep_of	2	SENT_393	[p23l758t1968r1023b2019],
7	by	IN	O	by	_	0	SENT_393	[p23l1066t1968r1133b2034],
8	entacapone	NN	O	entacapone	prep_by	6	SENT_393	[p23l1170t1978r1513b2037],
9	on	IN	O	on	_	0	SENT_393	[p23l1552t1986r1619b2019],
10	the	DT	O	the	det	11	SENT_393	[p23l1658t1968r1750b2019],
11	pharmacokinetics	NNS	O	pharmacokinetic	prep_on	2	SENT_393	[p23l1790t1968r2148b2037, p23l173t2056r337b2103],
12	and	CC	O	and	_	0	SENT_393	[p23l381t2052r485b2103],
13	metabolism	NN	O	metabolism	prep_on	2	SENT_393	[p23l534t2052r868b2103],
14	of	IN	O	of	_	0	SENT_393	[p23l917t2051r975b2103],
15	levodopa	NN	O	levodopa	prep_of	11	SENT_393	[p23l1017t2052r1284b2121],
16	in	IN	O	in	_	0	SENT_393	[p23l1334t2056r1376b2102],
17	healthy	JJ	O	healthy	amod	18	SENT_393	[p23l1425t2052r1632b2118],
18	volunteers	NNS	O	volunteer	prep_in	2	SENT_393	[p23l1674t2052r1991b2103],
19	.	.	O	.	_	0	SENT_393	[p23l1674t2052r1991b2103],

1	Clin	NNP	O	Clin	nn	2	SENT_394	[p23l2039t2052r2145b2103],
2	Neuropharmacol	NNP	O	Neuropharmacol	_	0	SENT_394	[p23l174t2136r659b2205],
3	1993	CD	DATE	1993	num	2	SENT_394	[p23l694t2138r1207b2196],
4	;	:	O	;	_	0	SENT_394	[p23l694t2138r1207b2196],
5	16:145	CD	NUMBER	16:145	number	6	SENT_394	[p23l694t2138r1207b2196],
6	-156	CD	NUMBER	-156	dep	2	SENT_394	[p23l694t2138r1207b2196],
7	.	.	O	.	_	0	SENT_394	[p23l694t2138r1207b2196],

1	Merello	NNP	O	Merello	nn	2	SENT_395	[p23l174t2223r390b2274],
2	M	NNP	O	M	_	0	SENT_395	[p23l414t2226r480b2282],
3	,	,	O	,	_	0	SENT_395	[p23l414t2226r480b2282],
4	Lees	NNP	PERSON	Lees	nn	5	SENT_395	[p23l505t2226r631b2274],
5	AJ	NNP	PERSON	AJ	appos	2	SENT_395	[p23l648t2226r738b2282],
6	,	,	O	,	_	0	SENT_395	[p23l648t2226r738b2282],
7	Webster	NNP	PERSON	Webster	nn	8	SENT_395	[p23l758t2223r1007b2274],
8	R	NNP	O	R	appos	2	SENT_395	[p23l1028t2226r1075b2282],
9	,	,	O	,	_	0	SENT_395	[p23l1028t2226r1075b2282],
10	et	FW	O	et	nn	11	SENT_395	[p23l1097t2233r1152b2274],
11	al.	FW	O	al.	appos	2	SENT_395	[p23l1170t2223r1230b2274],
12	.	.	O	.	_	0	SENT_395	[p23l1170t2223r1230b2274],

1	Effect	NN	O	effect	_	0	SENT_396	[p23l1257t2222r1417b2274],
2	of	IN	O	of	_	0	SENT_396	[p23l1436t2222r1494b2274],
3	entacapone	NN	O	entacapone	prep_of	1	SENT_396	[p23l1509t2233r1868b2292],
4	,	,	O	,	_	0	SENT_396	[p23l1509t2233r1868b2292],
5	a	DT	O	a	det	8	SENT_396	[p23l1891t2241r1917b2274],
6	peripherally	RB	O	peripherally	advmod	7	SENT_396	[p23l1941t2223r2149b2292, p23l171t2307r323b2373],
7	acting	VBG	O	act	amod	8	SENT_396	[p23l355t2311r528b2373],
8	catechol	NN	O	catechol	appos	1	SENT_396	[p23l564t2306r1424b2373],
9	.	.	O	.	_	0	SENT_396	[p23l564t2306r1424b2373],

1	—	NN	O	—	_	0	SENT_397	[p23l564t2306r1424b2373],
2	.	.	O	.	_	0	SENT_397	[p23l564t2306r1424b2373],

1	O	NN	O	o	_	0	SENT_398	[p23l564t2306r1424b2373],
2	.	.	O	.	_	0	SENT_398	[p23l564t2306r1424b2373],

1	—	NN	O	—	_	0	SENT_399	[p23l564t2306r1424b2373],
2	.	.	O	.	_	0	SENT_399	[p23l564t2306r1424b2373],

1	methyltransferase	NN	O	methyltransferase	nn	2	SENT_400	[p23l564t2306r1424b2373],
2	inhibitor	NN	O	inhibitor	_	0	SENT_400	[p23l1459t2307r1713b2367],
3	,	,	O	,	_	0	SENT_400	[p23l1459t2307r1713b2367],
4	on	IN	O	on	dep	2	SENT_400	[p23l1748t2325r1816b2358],
5	the	DT	O	the	det	7	SENT_400	[p23l1850t2307r1941b2358],
6	motor	NN	O	motor	nn	7	SENT_400	[p23l1976t2317r2151b2358],
7	response	NN	O	response	pobj	4	SENT_400	[p23l173t2409r433b2460],
8	to	TO	O	to	_	0	SENT_400	[p23l458t2401r516b2442],
9	acute	JJ	O	acute	amod	10	SENT_400	[p23l544t2401r699b2442],
10	treatment	NN	O	treatment	prep_to	4	SENT_400	[p23l724t2401r1010b2442],
11	with	IN	O	with	_	0	SENT_400	[p23l1034t2390r1150b2442],
12	levodopa	NN	O	levodopa	prep_with	10	SENT_400	[p23l1182t2391r1449b2460],
13	in	IN	O	in	_	0	SENT_400	[p23l1480t2394r1523b2441],
14	patients	NNS	O	patient	prep_in	4	SENT_400	[p23l1554t2394r1783b2460],
15	with	IN	O	with	_	0	SENT_400	[p23l1808t2390r1924b2442],
16	Parkinson	NNP	O	Parkinson	poss	18	SENT_400	[p23l1956t2391r2148b2442, p23l171t2478r316b2526],
17	's	POS	O	's	_	0	SENT_400	[p23l1956t2391r2148b2442, p23l171t2478r316b2526],
18	disease	NN	O	disease	prep_with	14	SENT_400	[p23l336t2475r565b2526],
19	.	.	O	.	_	0	SENT_400	[p23l336t2475r565b2526],

1	J	NNP	O	J	nn	4	SENT_401	[p23l588t2478r613b2526],
2	Neurol	NNP	O	Neurol	nn	4	SENT_401	[p23l639t2475r830b2526],
3	Neurosurg	NNP	O	Neurosurg	nn	4	SENT_401	[p23l856t2478r1158b2541],
4	Psychiatry	NNP	O	Psychiatry	_	0	SENT_401	[p23l1184t2475r1469b2541],
5	1994	CD	DATE	1994	num	4	SENT_401	[p23l1492t2477r2005b2534],
6	;	:	O	;	_	0	SENT_401	[p23l1492t2477r2005b2534],
7	57:186	CD	NUMBER	57:186	number	8	SENT_401	[p23l1492t2477r2005b2534],
8	-189	CD	NUMBER	-189	dep	4	SENT_401	[p23l1492t2477r2005b2534],
9	.	.	O	.	_	0	SENT_401	[p23l1492t2477r2005b2534],

1	Volume	NN	O	volume	_	0	SENT_402	[p23l1570t2711r1810b2771],
2	69	CD	NUMBER	69	num	1	SENT_402	[p23l1841t2713r1934b2777],
3	,	,	O	,	_	0	SENT_402	[p23l1841t2713r1934b2777],
4	No.	NN	O	no.	appos	1	SENT_402	[p23l1966t2715r2080b2770],
5	1	CD	NUMBER	1	num	4	SENT_402	[p23l2120t2717r2142b2769],

